data_2z4d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2z4d _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.272 0.558 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' A' ' 7' ' ' VAL . 7.9 p -78.51 86.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.5 -0.75 . . . . 0.0 110.051 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.461 HG21 HD12 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -72.11 168.9 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.07 -1.019 . . . . 0.0 109.744 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 20.8 mttp -126.09 144.23 50.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.553 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -134.67 -174.84 3.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.795 . . . . 0.0 109.608 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.23 119.28 24.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 0.0 110.854 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.414 ' HB2' HD12 ' A' ' 33' ' ' ILE . . . -150.15 -158.65 0.94 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 109.715 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -142.31 165.74 26.61 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.486 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 0.7 OUTLIER -103.88 -142.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.431 -1.041 . . . . 0.0 109.516 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -163.75 108.3 1.02 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.065 -1.022 . . . . 0.0 110.105 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HG2' HD12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -77.71 162.18 27.17 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.309 -0.869 . . . . 0.0 110.031 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.51 144.12 50.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.139 -0.625 . . . . 0.0 110.066 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' A' ' 22' ' ' ARG . 7.6 t-20 -110.11 124.97 52.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.903 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -24.74 52.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.368 -0.833 . . . . 0.0 110.305 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -68.55 -30.75 69.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.461 -0.775 . . . . 0.0 110.256 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -124.08 -2.21 8.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.383 -0.823 . . . . 0.0 110.61 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER 52.74 58.01 5.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.127 -0.983 . . . . 0.0 110.184 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.78 164.71 22.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.901 . . . . 0.0 110.302 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.94 90.04 3.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 110.062 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.41 167.38 12.4 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 110.188 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.464 ' CB ' ' CD2' ' A' ' 100' ' ' TRP . 44.1 Cg_endo -71.35 144.52 46.01 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.756 1.398 . . . . 0.0 110.332 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -82.77 140.9 43.92 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 109.431 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 27' ' ' ILE . 40.3 Cg_endo -66.14 -18.47 56.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.621 1.327 . . . . 0.0 110.565 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 59' ' ' ARG . 85.2 t -83.61 138.08 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.974 . . . . 0.0 109.459 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.19 -49.73 7.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 110.798 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.453 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . 54.82 -166.7 2.57 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -153.7 159.02 41.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.039 -1.271 . . . . 0.0 110.463 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.51 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 2.2 mp -106.69 168.7 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.507 0.67 . . . . 0.0 110.368 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 42.1 mt-10 -130.86 114.12 14.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.588 -0.695 . . . . 0.0 109.496 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.539 HG13 ' CE1' ' A' ' 48' ' ' PHE . 1.7 mp -68.72 127.22 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 18.1 mtpt -133.41 140.93 38.61 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 0.0 110.755 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -87.9 53.01 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.725 1.382 . . . . 0.0 109.973 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 65.02 164.63 0.15 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.559 -0.713 . . . . 0.0 110.121 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.33 -38.49 71.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 0.0 110.816 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -147.82 38.33 0.91 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.872 . . . . 0.0 110.389 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 51.1 49.87 20.24 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.35 -0.844 . . . . 0.0 110.438 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -103.04 -41.26 6.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -0.865 . . . . 0.0 109.807 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -106.26 -5.36 19.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.526 -0.734 . . . . 0.0 110.353 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.97 27.8 69.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 8.5 m-30 -88.22 120.67 29.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -1.027 . . . . 0.0 109.985 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.514 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 88.6 m95 -70.49 76.77 0.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' CB ' ' HB2' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -53.98 124.32 15.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.346 -0.846 . . . . 0.0 109.994 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.539 ' CE1' HG13 ' A' ' 35' ' ' ILE . 6.1 m-30 -107.29 102.85 12.12 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.164 -0.96 . . . . 0.0 109.804 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.413 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.2 tt0 -85.49 118.83 25.26 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.104 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.624 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 69.4 t90 -93.75 167.08 11.88 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.506 -0.746 . . . . 0.0 109.299 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 2.7 ptm180 -177.5 146.32 0.62 Allowed Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.226 -0.921 . . . . 0.0 110.832 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.1 Cg_endo -71.87 76.68 1.99 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.544 1.287 . . . . 0.0 109.945 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 t -118.26 10.0 12.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.173 -0.954 . . . . 0.0 109.848 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HB2' ' N ' ' A' ' 31' ' ' GLY . 60.9 mm-40 -116.2 -169.09 1.54 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 113.14 43.46 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.102 -0.999 . . . . 0.0 110.547 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.29 -167.34 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.484 1.255 . . . . 0.0 110.422 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.7 t -148.59 49.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.464 -0.772 . . . . 0.0 110.029 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.43 5.24 72.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.413 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 16.6 mmt180 -124.68 100.95 6.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -1.161 . . . . 0.0 110.131 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -73.88 122.98 23.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.329 -0.857 . . . . 0.0 110.367 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -116.53 -162.15 0.84 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.341 -0.849 . . . . 0.0 110.102 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.516 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -155.55 174.98 3.43 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.898 . . . . 0.0 110.144 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.624 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 38.3 Cg_endo -63.83 131.35 30.75 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.607 1.32 . . . . 0.0 111.526 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 6.5 mt -126.03 113.78 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.713 -0.617 . . . . 0.0 109.683 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.7 p -69.61 117.99 11.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 0.0 110.034 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 18.6 mt -107.76 147.42 30.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.926 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.417 HG21 HD11 ' A' ' 67' ' ' ILE . 15.3 mt -120.03 155.64 22.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.916 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.466 ' CD1' ' CE2' ' A' ' 48' ' ' PHE . 50.6 mt -132.36 99.62 4.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.428 -0.795 . . . . 0.0 110.13 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.443 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 52.6 mt -132.4 108.02 13.4 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.135 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.2 -7.99 21.36 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.526 1.277 . . . . 0.0 110.774 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -108.34 2.84 32.87 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -133.1 -68.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.072 -1.252 . . . . 0.0 110.351 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.41 126.95 31.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.323 -0.86 . . . . 0.0 110.108 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ttt -70.81 137.01 49.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.383 -0.823 . . . . 0.0 110.138 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.428 ' CD2' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -87.65 122.8 31.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.345 -0.847 . . . . 0.0 110.206 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.809 . . . . 0.0 110.056 -179.981 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.128 0.489 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.7 mt -117.0 101.3 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.351 -0.843 . . . . 0.0 110.091 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -72.17 108.47 5.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.832 . . . . 0.0 110.25 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.429 ' HB1' ' CD2' ' A' ' 98' ' ' PHE . . . -118.6 133.95 55.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 110.193 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.428 HD23 ' CD2' ' A' ' 75' ' ' TRP . 3.9 mt -112.5 116.96 31.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.848 . . . . 0.0 110.218 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.413 ' CG1' ' HG2' ' A' ' 96' ' ' ARG . 10.0 m -112.48 133.44 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 110.511 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -92.03 -79.65 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.426 -0.796 . . . . 0.0 110.168 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -172.82 -39.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.199 -0.938 . . . . 0.0 110.345 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.64 -81.58 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.895 . . . . 0.0 110.385 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -150.82 15.76 0.76 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.157 -0.964 . . . . 0.0 110.822 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -90.51 49.53 1.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.162 -0.961 . . . . 0.0 110.142 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.413 ' HG2' ' CG1' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -105.19 111.2 23.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.364 -0.835 . . . . 0.0 110.484 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 29.3 m-85 -113.94 155.49 25.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.497 -0.752 . . . . 0.0 110.204 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.429 ' CD2' ' HB1' ' A' ' 88' ' ' ALA . 25.9 m-85 -120.74 140.28 51.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.876 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 97' ' ' TYR . 19.6 m-85 -134.69 158.55 43.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -0.982 . . . . 0.0 110.358 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.464 ' CD2' ' CB ' ' A' ' 26' ' ' PRO . 2.6 p-90 -149.57 144.0 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 109.912 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.238 0.542 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 58.8 t -99.8 86.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.434 -0.791 . . . . 0.0 109.999 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 17.0 mt -94.39 175.21 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.222 -0.924 . . . . 0.0 109.627 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -131.04 132.38 44.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.201 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.45 ' CD1' HD13 ' A' ' 35' ' ' ILE . 1.6 m-85 -126.83 -174.61 3.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.455 -0.778 . . . . 0.0 109.439 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 23.6 mtt85 -127.09 149.53 49.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.147 -0.97 . . . . 0.0 110.826 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.72 -155.04 0.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.48 -0.762 . . . . 0.0 109.746 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.443 ' O ' ' CD2' ' A' ' 99' ' ' PHE . . . -145.68 146.55 16.85 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.49 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.1 t -89.55 -141.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.337 -1.096 . . . . 0.0 109.621 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 98' ' ' PHE . 42.5 t -162.99 110.13 1.21 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.056 -1.027 . . . . 0.0 110.01 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.533 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -76.96 154.77 33.24 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 109.849 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.33 145.85 33.05 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.028 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -123.68 134.61 53.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.45 -0.781 . . . . 0.0 110.202 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -77.1 -27.56 54.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.413 -0.804 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.45 -37.16 72.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.355 -0.841 . . . . 0.0 110.101 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.4 p -121.42 -2.82 9.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.472 -0.767 . . . . 0.0 110.369 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 52.49 57.38 6.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.27 -0.894 . . . . 0.0 110.15 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.74 159.65 26.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -0.833 . . . . 0.0 110.403 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.06 91.92 3.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.473 -0.767 . . . . 0.0 109.871 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.1 p -103.26 164.2 15.96 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.442 -0.786 . . . . 0.0 110.281 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.439 ' HB2' ' CE2' ' A' ' 100' ' ' TRP . 44.1 Cg_endo -71.16 142.4 41.74 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.85 1.447 . . . . 0.0 110.272 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.533 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.24 136.7 46.23 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 110.051 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HD2' HG22 ' A' ' 27' ' ' ILE . 48.7 Cg_endo -75.97 52.85 3.55 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.798 1.42 . . . . 0.0 110.189 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.4 t -150.06 115.88 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.86 . . . . 0.0 109.597 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -85.29 64.73 8.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 110.43 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.468 ' N ' ' HG2' ' A' ' 54' ' ' GLU . . . -61.52 -161.51 0.16 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -140.4 155.07 46.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.876 -1.367 . . . . 0.0 111.097 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 2.0 mp -105.75 169.96 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-O 121.4 0.619 . . . . 0.0 110.437 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 17.0 mt-10 -134.52 120.26 19.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.567 -0.708 . . . . 0.0 109.405 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.498 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 1.7 mp -69.78 127.61 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -134.74 123.12 15.93 Favored Pre-proline 0 N--CA 1.485 1.3 0 O-C-N 121.055 -1.028 . . . . 0.0 109.343 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -83.77 51.82 3.58 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.489 1.257 . . . . 0.0 110.07 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 62.45 150.16 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.62 -0.675 . . . . 0.0 110.028 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -52.6 -25.7 11.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.41 -0.806 . . . . 0.0 110.156 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -133.74 -154.38 0.6 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.418 -0.801 . . . . 0.0 109.747 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -123.41 52.03 1.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 109.691 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.31 -35.86 7.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.411 -0.806 . . . . 0.0 110.156 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.453 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 11.7 mt -118.23 -11.9 10.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 110.217 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.91 27.49 56.59 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.486 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 5.7 m-30 -68.3 118.31 11.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -1.02 . . . . 0.0 110.065 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.555 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 77.1 m95 -80.71 68.08 6.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.469 -0.77 . . . . 0.0 110.094 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.46 ' HB2' ' CG ' ' A' ' 36' ' ' LYS . 68.7 m-20 -53.21 137.97 33.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.444 -0.785 . . . . 0.0 110.207 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 5.5 m-30 -108.77 102.69 11.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.357 -0.84 . . . . 0.0 109.669 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.43 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 4.0 tt0 -82.48 121.41 26.73 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.053 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.524 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 71.7 t90 -93.66 171.84 8.63 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.361 -0.837 . . . . 0.0 109.508 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 1.3 ptm180 -175.44 146.2 0.88 Allowed Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.2 -0.938 . . . . 0.0 110.808 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.491 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 52.2 Cg_endo -74.82 80.17 2.44 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.711 1.374 . . . . 0.0 109.788 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.405 ' CG2' ' HB3' ' A' ' 32' ' ' GLU . 7.0 t -117.71 5.05 12.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.121 -0.987 . . . . 0.0 109.777 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.468 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 1.5 pp20? -100.9 -178.15 3.67 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.933 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -99.14 109.74 55.4 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.3 -0.875 . . . . 0.0 109.648 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -83.11 167.81 13.86 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.572 1.301 . . . . 0.0 110.679 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.5 t -112.42 36.2 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.468 -0.77 . . . . 0.0 109.534 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.84 16.95 6.61 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.1 mmt-85 -129.99 103.26 6.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -1.154 . . . . 0.0 110.261 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -80.15 140.78 36.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.352 -0.843 . . . . 0.0 110.103 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 1.3 mp -131.62 -168.21 1.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 0.0 110.332 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.529 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 53.9 m-20 -152.07 166.73 14.64 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.499 -0.751 . . . . 0.0 109.984 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 62' ' ' ASP . 37.5 Cg_endo -61.45 136.08 61.34 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.69 1.363 . . . . 0.0 111.573 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 5.1 mt -129.42 114.31 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 p -69.66 116.22 9.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.202 -0.936 . . . . 0.0 110.002 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 29.2 mt -105.76 154.68 20.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 109.801 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.405 ' CG2' ' CD1' ' A' ' 69' ' ' ILE . 43.0 mt -125.4 152.36 32.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.613 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.444 HD12 ' CE1' ' A' ' 48' ' ' PHE . 73.7 mt -122.97 82.8 2.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.388 -0.82 . . . . 0.0 110.236 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.486 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 64.3 mt -131.19 106.6 14.83 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.465 -0.772 . . . . 0.0 110.162 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.54 63.32 4.6 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.634 1.334 . . . . 0.0 110.278 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.69 -46.58 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -60.47 -76.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.195 -1.179 . . . . 0.0 110.259 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.71 -153.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.264 -0.898 . . . . 0.0 109.754 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -138.63 100.26 4.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.247 -0.908 . . . . 0.0 110.44 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.41 ' CD2' ' O ' ' A' ' 75' ' ' TRP . 64.0 p-90 -76.11 131.51 39.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.858 . . . . 0.0 110.163 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 -179.866 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 121.325 0.583 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.7 mt -133.73 114.13 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.263 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -76.18 115.13 15.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.347 -0.845 . . . . 0.0 109.961 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.454 ' CB ' ' CE2' ' A' ' 98' ' ' PHE . . . -99.41 110.93 23.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.425 -0.797 . . . . 0.0 110.563 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.01 119.08 38.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.823 . . . . 0.0 109.83 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.433 ' HA ' ' HG3' ' A' ' 96' ' ' ARG . 91.3 t -113.91 131.29 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 110.529 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -100.99 -61.62 1.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.47 -0.769 . . . . 0.0 110.133 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.9 m -142.53 -50.92 0.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.558 -0.713 . . . . 0.0 110.154 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.85 -29.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.883 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -116.89 11.94 14.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 111.075 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -130.38 36.29 3.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 0.0 110.298 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.433 ' HG3' ' HA ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -95.9 111.34 23.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 0.0 110.328 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 27.1 m-85 -105.79 142.59 35.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.453 -0.78 . . . . 0.0 110.295 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.454 ' CE2' ' CB ' ' A' ' 88' ' ' ALA . 20.1 m-85 -119.83 136.24 54.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.393 -0.817 . . . . 0.0 109.888 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CZ ' ' CD1' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -134.73 169.85 16.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.233 -0.917 . . . . 0.0 110.197 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.439 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 2.1 p-90 -158.37 175.39 13.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 110.257 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 mt . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.821 . . . . 0.0 110.147 -179.943 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.198 0.523 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 98.2 t -111.2 59.53 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.45 -0.781 . . . . 0.0 109.635 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 35' ' ' ILE . 15.4 tt -102.19 175.16 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 0.0 110.111 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 4.4 mptt -120.71 140.73 51.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.039 -1.038 . . . . 0.0 110.942 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -113.77 -179.11 3.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 109.686 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -113.72 127.39 56.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 110.322 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.81 -160.68 0.71 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 110.085 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.74 163.31 29.63 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.46 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.3 t -95.53 -138.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.454 -1.027 . . . . 0.0 109.85 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.7 t -155.53 108.12 2.69 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.148 -0.97 . . . . 0.0 109.652 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' N ' HG12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -78.82 128.39 33.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.993 -179.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.18 157.63 28.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.635 -0.666 . . . . 0.0 109.821 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -126.22 136.26 52.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -0.837 . . . . 0.0 110.412 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -82.48 -25.33 33.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 110.154 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -35.26 77.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.363 -0.836 . . . . 0.0 109.999 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 m -120.44 -1.38 10.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.476 -0.765 . . . . 0.0 110.584 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.15 56.14 8.44 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.206 -0.934 . . . . 0.0 109.91 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.7 pp -108.1 154.04 22.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.428 -0.795 . . . . 0.0 110.809 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.9 p -124.97 71.06 1.16 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.518 -0.739 . . . . 0.0 110.279 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 p -97.16 165.11 16.4 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.405 -0.809 . . . . 0.0 110.248 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.46 ' CB ' ' CD2' ' A' ' 100' ' ' TRP . 46.2 Cg_endo -74.26 152.96 45.41 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.789 1.415 . . . . 0.0 110.332 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.46 ' CD1' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -81.97 140.89 46.74 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.219 -0.926 . . . . 0.0 109.186 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.444 ' HD2' HG22 ' A' ' 27' ' ' ILE . 40.7 Cg_endo -67.25 -15.24 45.52 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.559 1.294 . . . . 0.0 110.497 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.4 t -94.36 115.34 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.58 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -88.42 72.02 8.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 110.276 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.427 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.5 -160.4 0.08 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -138.48 161.21 37.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -1.193 . . . . 0.0 110.64 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 96.6 mt -105.0 170.69 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.414 0.626 . . . . 0.0 110.571 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -128.95 105.98 8.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.527 -0.733 . . . . 0.0 109.065 179.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.547 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 1.2 mp -68.01 125.98 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 108.655 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.6 OUTLIER -137.03 161.93 58.6 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 110.977 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -93.14 55.41 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.677 1.585 . . . . 0.0 110.076 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 60.29 175.16 0.09 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.371 -0.831 . . . . 0.0 110.093 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.88 -65.26 0.71 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.321 -0.862 . . . . 0.0 110.628 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -122.15 37.38 4.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.776 . . . . 0.0 110.527 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 50.9 49.81 20.36 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.385 -0.822 . . . . 0.0 110.604 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.473 ' HG3' ' HG ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -118.58 -24.58 6.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.326 -0.859 . . . . 0.0 110.547 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.473 ' HG ' ' HG3' ' A' ' 42' ' ' GLU . 14.6 mt -108.82 -12.0 14.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.132 -0.98 . . . . 0.0 109.981 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.71 26.87 72.21 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.45 ' CD2' HG12 ' A' ' 69' ' ' ILE . 13.8 m-30 -91.49 122.79 34.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -1.098 . . . . 0.0 110.134 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.42 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 8.8 m0 -66.78 81.87 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 0.0 109.508 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -53.64 118.42 3.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.172 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.536 ' CE1' HG13 ' A' ' 35' ' ' ILE . 3.9 m-30 -107.7 102.5 11.72 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.332 -0.855 . . . . 0.0 109.188 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.435 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -89.58 123.13 33.38 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.711 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.495 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 70.5 t90 -91.75 173.84 7.66 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.331 -0.855 . . . . 0.0 109.579 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 179.55 146.89 0.41 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.095 -1.003 . . . . 0.0 110.848 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.9 Cg_endo -74.61 78.14 2.82 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.851 1.448 . . . . 0.0 109.694 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t -118.02 10.58 13.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 109.645 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 1.3 pp20? -100.62 -169.59 1.74 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.734 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.04 109.64 50.18 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 109.75 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -81.75 -178.01 3.92 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.482 1.254 . . . . 0.0 110.957 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -148.41 30.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.609 -0.682 . . . . 0.0 109.441 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.06 0.93 7.52 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -123.25 100.34 6.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.26 . . . . 0.0 110.323 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.89 112.65 21.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.394 -0.816 . . . . 0.0 110.265 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.425 HD23 ' CH2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -103.73 -163.46 0.98 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.37 -0.831 . . . . 0.0 110.39 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 8.8 m-20 -152.74 164.95 18.69 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.457 -0.777 . . . . 0.0 109.93 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 36.7 Cg_endo -59.4 146.45 94.86 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.648 1.341 . . . . 0.0 112.016 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.421 HD12 ' CE3' ' A' ' 50' ' ' TRP . 5.4 mt -137.51 118.02 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 p -69.67 118.16 12.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.095 -1.003 . . . . 0.0 109.787 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 24.6 mt -105.25 143.57 33.24 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.288 -0.882 . . . . 0.0 110.153 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.3 mm -112.93 139.58 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.474 -0.766 . . . . 0.0 109.751 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.463 HD11 ' CE2' ' A' ' 48' ' ' PHE . 73.1 mt -122.83 95.24 4.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -0.88 . . . . 0.0 110.214 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.45 HG12 ' CD2' ' A' ' 45' ' ' PHE . 51.2 mt -128.41 116.66 19.91 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.331 -0.856 . . . . 0.0 110.058 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.95 64.87 4.1 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.612 1.322 . . . . 0.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.77 -52.81 0.2 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.409 ' O ' ' CD1' ' A' ' 91' ' ' PHE . 13.3 mm-40 -61.86 -80.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.257 -1.143 . . . . 0.0 110.155 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.01 113.62 21.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.188 -0.945 . . . . 0.0 109.97 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.5 tpt -69.7 148.99 48.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.468 -0.77 . . . . 0.0 110.196 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -111.52 142.14 44.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.431 -0.793 . . . . 0.0 110.087 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 110.182 -179.897 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.097 0.475 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 59.9 mt -93.8 120.9 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 110.26 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -82.68 111.07 18.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.855 . . . . 0.0 110.053 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' CB ' ' CE2' ' A' ' 98' ' ' PHE . . . -92.43 97.94 11.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.294 -0.879 . . . . 0.0 110.476 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.423 HD11 ' CE2' ' A' ' 99' ' ' PHE . 3.2 mt -93.42 105.43 17.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.434 -0.791 . . . . 0.0 109.833 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.87 154.56 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.309 -0.869 . . . . 0.0 110.591 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.409 ' CD1' ' O ' ' A' ' 72' ' ' GLU . 22.8 t80 -117.32 -70.85 0.77 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.368 -0.832 . . . . 0.0 110.093 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.0 p -133.94 -68.04 0.57 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.784 . . . . 0.0 110.057 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.0 p -166.18 30.46 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.419 -0.801 . . . . 0.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.29 -40.66 0.73 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.494 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -116.57 87.21 2.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.342 -0.849 . . . . 0.0 110.406 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.401 ' N ' ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -128.12 110.4 12.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 110.223 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 33.9 m-85 -127.33 154.36 45.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 110.668 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.452 ' CE2' ' CB ' ' A' ' 88' ' ' ALA . 43.2 m-85 -129.21 132.37 47.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.595 -0.691 . . . . 0.0 109.43 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 97' ' ' TYR . 16.2 m-85 -127.1 160.84 29.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.148 -0.97 . . . . 0.0 110.403 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.46 ' CD2' ' CB ' ' A' ' 26' ' ' PRO . 2.3 p-90 -147.89 150.93 35.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.404 -0.81 . . . . 0.0 109.912 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.288 -0.882 . . . . 0.0 110.271 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.4 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.223 0.535 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.403 ' CG2' ' HD3' ' A' ' 36' ' ' LYS . 7.7 p -73.73 68.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.423 -0.798 . . . . 0.0 109.921 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.484 HG21 HD13 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -72.07 165.93 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.227 -0.921 . . . . 0.0 109.672 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.415 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 12.2 ttmt -122.43 141.77 51.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.338 -0.851 . . . . 0.0 110.34 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -135.69 -174.66 3.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.398 -0.813 . . . . 0.0 109.705 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.2 115.51 17.77 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.175 -0.953 . . . . 0.0 110.811 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.93 -160.59 1.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.472 -0.767 . . . . 0.0 109.622 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.412 ' HA3' ' NE1' ' A' ' 100' ' ' TRP . . . -139.99 155.1 24.25 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.481 ' C ' HG13 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -96.34 -142.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.44 -1.035 . . . . 0.0 109.394 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.423 ' N ' HD11 ' A' ' 27' ' ' ILE . 0.8 OUTLIER -162.39 107.64 1.2 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.971 -1.081 . . . . 0.0 110.184 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.525 ' CG ' HD12 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -78.7 162.4 26.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.383 -0.823 . . . . 0.0 110.089 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -129.7 149.75 51.31 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.635 -0.666 . . . . 0.0 109.637 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -113.26 124.82 53.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.364 -0.835 . . . . 0.0 110.061 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 20' ' ' ASP . 9.4 pt-20 -76.36 -25.32 54.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.527 -0.733 . . . . 0.0 110.147 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 9.8 t0 -64.75 -35.04 79.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.44 -0.787 . . . . 0.0 110.087 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -118.64 -5.44 10.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.426 -0.796 . . . . 0.0 110.504 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 54.63 60.19 3.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.142 -0.974 . . . . 0.0 110.105 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.94 158.52 43.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.307 -0.871 . . . . 0.0 110.369 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.49 150.58 26.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -0.835 . . . . 0.0 110.055 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.3 p -155.18 164.27 21.69 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.386 -0.821 . . . . 0.0 110.241 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.47 ' HB3' ' CD2' ' A' ' 100' ' ' TRP . 45.8 Cg_endo -71.81 137.13 29.14 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.764 1.402 . . . . 0.0 110.137 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.525 HD12 ' CG ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.94 137.6 43.43 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 109.822 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.462 ' HD2' HG23 ' A' ' 27' ' ' ILE . 48.2 Cg_endo -74.38 54.29 3.29 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.686 1.361 . . . . 0.0 110.553 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.2 p -157.84 115.87 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.939 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -83.57 71.75 10.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.3 -0.875 . . . . 0.0 110.11 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.621 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -58.05 -167.02 0.12 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.704 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 27.6 mt-10 -128.48 138.25 52.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -1.138 . . . . 0.0 112.323 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 2.0 mp -101.95 163.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.802 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.53 ' HB2' ' CB ' ' A' ' 49' ' ' GLU . 3.4 mt-10 -128.49 110.62 12.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.398 -0.814 . . . . 0.0 109.2 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.522 ' CD1' ' CE1' ' A' ' 48' ' ' PHE . 30.4 mm -69.19 120.02 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.396 -0.815 . . . . 0.0 110.32 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 16.9 mmmt -130.59 107.73 15.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 109.943 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.19 49.99 3.3 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.621 1.327 . . . . 0.0 110.213 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 t30 62.68 141.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.635 -0.665 . . . . 0.0 110.196 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.09 -29.1 28.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -0.904 . . . . 0.0 110.042 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -128.52 -151.53 0.48 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.49 -0.756 . . . . 0.0 109.638 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.58 52.83 1.39 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.264 -0.897 . . . . 0.0 109.62 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -101.31 -39.56 7.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.008 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 16.4 mt -118.8 -16.78 9.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.486 -0.759 . . . . 0.0 110.142 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.21 26.73 61.79 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 5.2 m-30 -71.47 118.92 14.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.544 -0.974 . . . . 0.0 109.951 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.531 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 35.8 m0 -83.82 71.19 10.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.463 -0.773 . . . . 0.0 110.427 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -52.17 122.95 9.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.409 -0.807 . . . . 0.0 110.429 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.548 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 10.3 m-30 -105.67 102.92 12.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.146 -0.971 . . . . 0.0 109.824 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.53 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 5.1 tt0 -85.8 120.95 27.77 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.053 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.704 ' HA ' ' O ' ' A' ' 32' ' ' GLU 0.25 71.0 t90 -95.59 158.61 15.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.572 -0.705 . . . . 0.0 109.868 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 1.8 ptm180 -164.38 142.64 5.66 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 120.825 -1.172 . . . . 0.0 110.993 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.484 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.4 Cg_endo -70.77 80.98 1.12 Allowed 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.646 1.34 . . . . 0.0 110.46 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.409 ' CG2' ' HB2' ' A' ' 32' ' ' GLU . 7.5 t -127.31 7.52 6.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -0.99 . . . . 0.0 110.015 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HG2' ' HA2' ' A' ' 31' ' ' GLY . 1.2 pp20? -100.62 -169.65 1.74 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.71 -0.619 . . . . 0.0 109.8 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -99.48 109.53 55.34 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.895 . . . . 0.0 109.673 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.39 -178.49 3.41 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.544 1.287 . . . . 0.0 110.885 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.0 p -126.32 29.11 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.682 . . . . 0.0 109.686 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.77 24.22 3.74 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -132.62 104.95 6.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.323 -1.104 . . . . 0.0 110.245 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -82.06 121.74 26.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.372 -0.83 . . . . 0.0 110.054 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -118.78 -169.21 1.68 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.887 . . . . 0.0 110.32 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.559 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 10.2 p-10 -147.54 167.34 13.7 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 110.339 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.0 Cg_endo -60.58 135.12 58.65 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.636 1.335 . . . . 0.0 111.624 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.476 ' CD1' ' CE3' ' A' ' 50' ' ' TRP . 5.4 mt -128.69 112.43 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.4 p -69.62 116.5 10.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.824 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 18.1 mt -105.4 144.26 32.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.976 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.4 mt -120.03 150.45 22.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.431 -0.793 . . . . 0.0 109.755 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.482 ' CD1' ' CE2' ' A' ' 48' ' ' PHE . 56.4 mt -120.73 91.48 3.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 110.275 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.446 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 76.8 mt -131.71 108.65 14.37 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.381 -0.824 . . . . 0.0 110.111 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.82 85.24 0.97 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.64 1.337 . . . . 0.0 110.335 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.65 -39.87 0.83 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.0 -49.45 72.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.491 -1.006 . . . . 0.0 110.088 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -115.75 156.06 26.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.421 -0.8 . . . . 0.0 110.09 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.2 mmt -70.56 126.25 29.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.325 -0.859 . . . . 0.0 110.325 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.465 ' CD1' ' O ' ' A' ' 75' ' ' TRP . 47.9 p90 -96.52 124.81 40.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 109.659 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.211 -0.93 . . . . 0.0 110.287 -179.432 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.14 0.495 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.6 mt -70.63 123.62 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.232 -0.918 . . . . 0.0 110.385 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.97 114.5 19.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.37 -0.831 . . . . 0.0 109.799 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.458 ' CB ' ' CE2' ' A' ' 98' ' ' PHE . . . -101.43 132.16 47.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.63 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -124.43 105.33 9.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.439 -0.788 . . . . 0.0 109.689 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.89 108.21 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.35 -0.844 . . . . 0.0 110.499 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -73.13 -68.77 0.46 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 0.0 109.993 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.2 p -141.94 -68.93 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.95 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.5 p -170.58 45.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.47 -0.768 . . . . 0.0 109.981 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -161.96 -33.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.868 . . . . 0.0 110.894 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -119.94 49.87 1.35 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.193 -0.942 . . . . 0.0 110.967 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.43 111.47 23.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.151 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 47.3 m-85 -114.68 158.09 22.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.62 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.458 ' CE2' ' CB ' ' A' ' 88' ' ' ALA . 63.0 m-85 -133.76 146.56 50.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.519 -0.738 . . . . 0.0 109.721 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 97' ' ' TYR . 48.8 m-85 -142.4 165.96 25.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.217 -0.927 . . . . 0.0 110.787 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.47 ' CD2' ' HB3' ' A' ' 26' ' ' PRO . 2.2 p-90 -159.44 146.84 17.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.46 -0.775 . . . . 0.0 109.99 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.254 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.188 0.518 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.6 t -95.41 84.16 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.31 -0.868 . . . . 0.0 110.373 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -84.42 163.12 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.815 . . . . 0.0 109.516 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HG3' ' CG ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -123.57 139.93 53.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.437 -0.79 . . . . 0.0 110.106 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.53 -174.98 3.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 110.079 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.98 134.88 54.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.781 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.407 ' CB ' ' CD1' ' A' ' 33' ' ' ILE . . . -163.93 -157.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.569 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -149.67 151.64 23.72 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.2 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.52 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.5 t -89.84 -136.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.609 -0.936 . . . . 0.0 109.32 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.401 ' CB ' ' CB ' ' A' ' 98' ' ' PHE . 0.9 OUTLIER -162.71 109.0 1.21 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.04 -1.038 . . . . 0.0 109.906 179.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.587 ' HG2' HD11 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -76.78 152.53 35.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.367 -0.833 . . . . 0.0 109.995 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -138.01 149.21 45.88 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.677 -0.639 . . . . 0.0 110.07 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -123.96 140.68 52.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.458 -0.776 . . . . 0.0 110.207 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.419 ' HG3' ' CE1' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -81.53 -26.35 35.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.405 -0.809 . . . . 0.0 110.212 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.45 -34.23 70.62 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.352 -0.843 . . . . 0.0 110.192 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -124.65 -2.07 7.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.423 -0.798 . . . . 0.0 110.413 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 52.42 58.98 4.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 0.0 110.219 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.88 160.14 28.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.438 -0.789 . . . . 0.0 110.542 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -119.25 72.49 0.9 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.393 -0.817 . . . . 0.0 110.133 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 p -80.07 156.38 74.43 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.281 -0.887 . . . . 0.0 110.306 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.458 ' HB2' ' CE2' ' A' ' 100' ' ' TRP . 44.8 Cg_endo -72.44 151.99 54.14 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.783 1.412 . . . . 0.0 110.256 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.587 HD11 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -84.23 137.66 39.7 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.873 . . . . 0.0 109.494 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.464 ' HD2' HG23 ' A' ' 27' ' ' ILE . 42.5 Cg_endo -69.29 -11.28 31.09 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.716 1.377 . . . . 0.0 111.038 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.8 t -100.28 115.43 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 110.083 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.69 81.44 8.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.383 -0.823 . . . . 0.0 110.021 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.66 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.43 -161.4 0.1 OUTLIER Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.765 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 65.1 mt-10 -126.45 151.68 47.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -1.07 . . . . 0.0 112.299 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.471 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -101.86 169.0 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.033 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 49' ' ' GLU . 15.0 mt-10 -144.21 112.83 6.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.431 -0.793 . . . . 0.0 109.752 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.544 ' CD1' ' CE1' ' A' ' 48' ' ' PHE . 32.4 mm -69.84 120.42 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.441 -0.787 . . . . 0.0 110.201 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 1.0 OUTLIER -126.11 114.08 23.97 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.211 -0.931 . . . . 0.0 109.916 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -85.59 52.34 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.802 1.422 . . . . 0.0 109.864 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.82 155.52 0.07 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.583 -0.698 . . . . 0.0 109.872 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.76 -42.52 97.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.638 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -131.12 30.44 4.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.392 -0.818 . . . . 0.0 110.411 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 51.23 54.82 10.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.289 -0.882 . . . . 0.0 110.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -99.36 -40.65 7.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 109.733 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.18 -6.88 19.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 110.186 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.12 27.53 70.66 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.468 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 5.1 m-30 -89.45 118.82 29.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -1.076 . . . . 0.0 109.953 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.59 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 10.2 m0 -84.97 73.52 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.502 ' HB2' ' CG ' ' A' ' 36' ' ' LYS . 41.6 m-20 -55.34 139.86 41.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.357 -0.84 . . . . 0.0 110.327 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 10.0 m-30 -109.75 102.27 11.08 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.862 0.839 . . . . 0.0 109.289 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.531 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.7 mt-10 -82.4 130.59 35.14 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.805 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.765 ' HA ' ' O ' ' A' ' 32' ' ' GLU 0.252 68.7 t90 -105.45 161.45 14.32 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.394 -0.816 . . . . 0.0 109.501 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 2.4 ptm85 -166.93 142.03 3.43 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 120.795 -1.191 . . . . 0.0 111.011 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.477 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 48.2 Cg_endo -70.75 80.53 1.15 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.633 1.333 . . . . 0.0 110.102 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.404 HG23 ' HG3' ' A' ' 32' ' ' GLU . 6.3 t -127.06 9.64 6.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.266 -0.896 . . . . 0.0 109.93 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.532 ' HG2' ' HA2' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -100.15 -169.53 1.74 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.785 -0.572 . . . . 0.0 109.724 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -89.1 110.44 38.22 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 54' ' ' GLU . 50.6 Cg_endo -84.22 171.61 10.07 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.538 1.283 . . . . 0.0 110.931 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.2 p -129.25 28.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 110.047 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.19 17.2 6.33 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -129.49 102.46 6.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -1.151 . . . . 0.0 110.201 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.66 109.61 14.22 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.405 -0.809 . . . . 0.0 110.318 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.9 mt -105.65 -166.95 1.26 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.289 -0.882 . . . . 0.0 110.34 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.516 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 3.7 p30 -148.94 165.86 16.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.769 . . . . 0.0 110.299 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.7 Cg_endo -61.82 145.5 97.1 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.646 1.34 . . . . 0.0 111.813 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.473 HD13 ' CE3' ' A' ' 50' ' ' TRP . 4.8 mt -136.73 113.4 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.9 m -70.56 115.52 9.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 109.736 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 42.8 mt -102.82 149.75 24.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.877 . . . . 0.0 110.012 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.7 mm -117.15 158.16 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.299 -0.876 . . . . 0.0 109.717 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.483 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 71.8 mt -129.52 94.33 3.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.468 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 68.0 mt -135.68 103.57 10.12 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.453 -0.779 . . . . 0.0 110.149 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.43 68.83 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.668 1.352 . . . . 0.0 110.394 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.04 -39.29 0.18 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.45 -74.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.357 -1.084 . . . . 0.0 110.15 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -75.19 -164.23 0.3 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.408 -0.808 . . . . 0.0 110.013 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpp -134.34 125.73 28.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.328 -0.858 . . . . 0.0 110.211 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -80.29 111.44 16.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.381 -0.824 . . . . 0.0 110.167 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 0.0 110.013 179.95 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.215 0.531 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.8 mt -133.7 105.78 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.342 -0.849 . . . . 0.0 110.301 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -86.16 108.57 18.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.781 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.447 ' CB ' ' CD2' ' A' ' 98' ' ' PHE . . . -98.74 151.0 21.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.819 . . . . 0.0 110.626 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.86 119.54 31.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.839 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.403 ' N ' HG23 ' A' ' 73' ' ' THR . 79.3 t -115.11 132.4 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.9 . . . . 0.0 110.472 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.406 ' CD2' ' OG ' ' A' ' 92' ' ' SER . 46.5 t80 -101.7 -77.1 0.55 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.418 -0.801 . . . . 0.0 110.133 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.406 ' OG ' ' CD2' ' A' ' 91' ' ' PHE . 10.0 p -175.87 -59.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.269 -0.894 . . . . 0.0 110.301 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.6 t -60.88 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.458 -0.776 . . . . 0.0 110.406 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -166.36 20.1 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 110.782 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -94.37 48.11 1.22 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.264 -0.897 . . . . 0.0 110.149 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -94.05 119.47 32.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.421 -0.799 . . . . 0.0 110.205 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 29.4 m-85 -114.6 162.03 17.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 0.0 110.546 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.447 ' CD2' ' CB ' ' A' ' 88' ' ' ALA . 33.8 m-85 -129.81 141.25 50.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.837 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 97' ' ' TYR . 23.2 m-85 -137.78 163.1 32.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.209 -0.932 . . . . 0.0 110.517 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.458 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 1.8 p-90 -158.5 165.97 33.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 110.1 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 110.148 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 60.6 m . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.218 0.532 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 82.4 t -110.45 85.32 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.413 -0.804 . . . . 0.0 110.069 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.468 ' CG2' ' HB ' ' A' ' 35' ' ' ILE . 14.9 tt -105.61 177.62 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.365 -0.834 . . . . 0.0 108.956 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 2.7 ptmt -146.6 158.29 43.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.826 -1.171 . . . . 0.0 111.094 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -134.23 -174.76 3.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 109.925 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -110.23 139.76 45.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.424 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.56 -158.44 0.51 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.428 -0.795 . . . . 0.0 110.131 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.428 ' O ' ' CD2' ' A' ' 99' ' ' PHE . . . -151.12 157.01 26.97 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.485 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 0.9 OUTLIER -93.91 -140.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.494 -1.003 . . . . 0.0 110.047 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 98' ' ' PHE . 1.6 m -157.56 109.32 2.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 109.573 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.425 ' N ' HG12 ' A' ' 27' ' ' ILE . 5.4 pt-20 -79.59 150.5 31.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 110.082 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -133.22 148.19 52.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.612 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -115.61 133.38 56.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 0.0 110.291 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -79.03 -25.6 43.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.5 -0.75 . . . . 0.0 110.246 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -62.86 -33.84 76.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 0.0 110.017 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 m -122.8 -2.65 8.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.479 -0.763 . . . . 0.0 110.373 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.419 ' HA ' ' CE2' ' A' ' 17' ' ' TYR . 7.7 mtp180 52.23 57.46 6.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.154 -0.966 . . . . 0.0 110.226 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.23 162.34 20.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.336 -0.852 . . . . 0.0 110.356 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -120.59 95.36 4.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 0.0 110.296 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.5 p -106.69 157.92 34.0 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 110.122 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HB2' ' CE2' ' A' ' 100' ' ' TRP . 44.0 Cg_endo -72.05 146.1 46.05 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.84 1.442 . . . . 0.0 110.267 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.491 HG23 ' HD2' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -82.04 138.83 45.93 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.491 ' HD2' HG23 ' A' ' 27' ' ' ILE . 41.2 Cg_endo -67.02 -13.69 40.86 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.656 1.345 . . . . 0.0 110.496 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.6 t -86.31 115.68 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 109.817 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -93.74 68.5 3.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.069 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.436 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.67 -150.91 0.01 OUTLIER Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 2.6 pt-20 -145.1 155.53 43.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.053 -1.263 . . . . 0.0 110.496 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.535 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 96.3 mt -102.05 167.6 2.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.599 -0.688 . . . . 0.0 110.096 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 49' ' ' GLU . 8.0 mt-10 -131.29 109.33 10.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.648 -0.658 . . . . 0.0 109.58 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.551 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -68.6 123.52 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 109.291 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -126.99 137.89 31.54 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 110.31 -179.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' O ' ' CG ' ' A' ' 38' ' ' ASN . 49.8 Cg_endo -90.8 57.25 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.38 1.387 . . . . 0.0 109.751 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.446 ' CG ' ' O ' ' A' ' 37' ' ' PRO . 11.9 p30 43.26 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.902 -0.499 . . . . 0.0 110.79 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -75.75 -76.35 0.16 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.939 . . . . 0.0 110.45 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -139.63 69.48 1.36 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.397 -0.815 . . . . 0.0 110.45 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 50.64 55.16 9.94 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.367 -0.833 . . . . 0.0 110.492 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -111.02 -40.36 4.51 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.37 -0.831 . . . . 0.0 109.739 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -117.76 -11.2 10.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.528 -0.732 . . . . 0.0 110.08 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.26 29.7 72.0 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.466 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 4.3 m-30 -91.78 119.64 31.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.995 . . . . 0.0 110.09 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.555 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 93.9 m95 -79.71 77.19 6.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 110.189 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 1.9 t0 -54.09 130.02 36.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 0.0 109.961 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 3.8 m-30 -110.49 103.14 11.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.194 -0.941 . . . . 0.0 109.68 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 34' ' ' GLU . 31.6 tt0 -87.59 119.03 27.49 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.669 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.55 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 67.7 t90 -93.2 169.28 10.52 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.521 -0.737 . . . . 0.0 109.449 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.457 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 0.7 OUTLIER -176.57 145.99 0.71 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.215 -0.928 . . . . 0.0 110.801 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.523 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 50.0 Cg_endo -74.68 78.7 2.72 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.595 1.313 . . . . 0.0 109.675 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.1 t -115.37 2.35 13.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.146 -0.971 . . . . 0.0 109.762 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 30' ' ' GLN . 54.9 mm-40 -109.84 -168.76 1.36 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 113.22 43.11 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.186 -0.946 . . . . 0.0 110.273 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.458 ' O ' ' CG1' ' A' ' 57' ' ' VAL . 45.0 Cg_endo -76.55 -61.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.618 1.325 . . . . 0.0 110.547 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.458 ' CG1' ' O ' ' A' ' 56' ' ' PRO . 10.9 p 37.93 34.34 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-O 121.408 0.623 . . . . 0.0 111.109 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.43 -47.25 0.02 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.533 ' O ' ' HG3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -172.59 133.73 0.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -1.195 . . . . 0.0 109.899 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -53.94 124.53 15.71 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.275 -0.891 . . . . 0.0 110.529 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.406 ' CD2' ' HD2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -113.89 -171.17 1.85 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.328 -0.858 . . . . 0.0 110.421 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.523 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 5.8 m-20 -160.82 168.43 11.75 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.462 -0.774 . . . . 0.0 110.003 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.8 Cg_endo -62.12 131.84 36.41 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.746 1.393 . . . . 0.0 111.646 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.453 ' CD1' ' CE3' ' A' ' 50' ' ' TRP . 4.9 mt -127.16 114.87 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.769 -0.582 . . . . 0.0 109.536 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 p -69.91 118.03 12.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 110.375 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 17.5 mt -109.72 148.97 30.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.232 -0.917 . . . . 0.0 109.825 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.5 mt -122.33 147.23 26.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.391 -0.818 . . . . 0.0 109.855 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.465 ' CD1' ' CE2' ' A' ' 48' ' ' PHE . 53.2 mt -121.14 106.41 11.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.37 -0.831 . . . . 0.0 110.283 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.466 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 72.6 mt -135.56 118.85 12.71 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.349 -0.844 . . . . 0.0 109.987 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.11 77.18 2.44 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.574 1.302 . . . . 0.0 110.507 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.09 -56.43 0.41 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -60.85 -58.47 8.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.369 -1.077 . . . . 0.0 110.218 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 m -99.0 145.1 27.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.842 . . . . 0.0 110.188 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.32 132.41 53.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -0.826 . . . . 0.0 110.29 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 75' ' ' TRP . 36.5 p90 -88.94 140.47 29.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.441 -0.787 . . . . 0.0 110.259 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 -179.975 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.9 0.381 . . . . 0.0 110.729 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.6 mm -88.69 85.14 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.167 -0.958 . . . . 0.0 110.21 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -75.35 95.54 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.864 . . . . 0.0 109.742 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.448 ' HB3' ' CE2' ' A' ' 98' ' ' PHE . . . -85.11 120.85 27.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.819 . . . . 0.0 110.774 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mp -106.07 77.93 1.27 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.416 -0.803 . . . . 0.0 109.752 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.469 ' HB ' ' CD ' ' A' ' 96' ' ' ARG . 30.6 m -81.99 123.59 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.395 -0.816 . . . . 0.0 110.939 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.14 -75.12 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.389 -0.819 . . . . 0.0 110.128 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.5 m -131.85 -67.27 0.68 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 110.145 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.06 43.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.435 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -167.92 -38.18 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.261 -0.899 . . . . 0.0 110.442 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -114.58 50.25 0.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 110.475 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.469 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 33.9 mtm180 -90.95 112.23 24.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.344 -0.847 . . . . 0.0 110.232 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -99.9 138.71 36.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.381 -0.825 . . . . 0.0 110.628 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 88' ' ' ALA . 4.7 m-85 -102.74 142.81 33.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.446 -0.784 . . . . 0.0 109.427 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.451 ' CZ ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -142.62 168.63 19.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -0.992 . . . . 0.0 110.616 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.485 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 1.1 p-90 -159.65 153.81 23.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.491 -0.756 . . . . 0.0 110.003 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.35 -0.844 . . . . 0.0 110.368 -179.878 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.0 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.482 0.658 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 85.4 t -91.16 75.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.611 -0.681 . . . . 0.0 109.904 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -72.1 167.43 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.341 -0.849 . . . . 0.0 109.824 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -124.31 136.04 53.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.508 -0.745 . . . . 0.0 109.932 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.83 -177.45 3.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 109.917 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.63 139.3 54.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 110.466 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.69 -155.53 0.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.45 -0.781 . . . . 0.0 109.888 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.436 ' HA3' ' CD1' ' A' ' 100' ' ' TRP . . . -144.52 150.65 22.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.499 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.4 t -90.68 -139.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.481 -1.011 . . . . 0.0 109.735 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -159.05 107.69 1.87 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.081 -1.012 . . . . 0.0 109.66 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.401 ' H ' HG12 ' A' ' 27' ' ' ILE . 8.8 pt-20 -79.37 147.58 32.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.469 -0.769 . . . . 0.0 109.842 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.437 ' CD1' ' C ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -123.25 148.69 45.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.887 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 22' ' ' ARG . 9.6 t30 -111.5 118.78 36.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.815 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -72.91 -25.32 61.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.784 . . . . 0.0 110.412 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.25 -32.96 74.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.773 . . . . 0.0 110.544 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.93 3.2 5.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.366 -0.834 . . . . 0.0 110.687 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' ASN . 4.3 mtp180 51.22 56.43 7.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.191 -0.943 . . . . 0.0 110.048 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 pp -112.94 167.82 10.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.83 . . . . 0.0 110.739 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.6 p -126.59 111.28 14.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.488 -0.757 . . . . 0.0 110.074 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.4 p -127.9 159.77 64.77 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.187 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' CB ' ' CD2' ' A' ' 100' ' ' TRP . 44.4 Cg_endo -72.2 142.12 37.21 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.833 1.438 . . . . 0.0 110.138 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.499 ' CD1' ' HB ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -80.31 139.4 52.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.492 ' HD2' HG21 ' A' ' 27' ' ' ILE . 40.1 Cg_endo -65.94 -27.81 50.52 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.581 1.306 . . . . 0.0 110.555 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.3 p -84.72 115.31 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.877 . . . . 0.0 109.787 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -93.32 79.41 4.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.308 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA2' ' HG2' ' A' ' 54' ' ' GLU . . . -61.98 -154.2 0.05 OUTLIER Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -137.97 160.57 38.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.115 -1.227 . . . . 0.0 110.434 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.531 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -103.12 176.88 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.409 0.623 . . . . 0.0 110.312 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.469 ' HB2' ' CB ' ' A' ' 49' ' ' GLU . 2.7 mt-10 -138.59 108.16 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.548 HG13 ' CE1' ' A' ' 48' ' ' PHE . 1.5 mp -68.51 126.1 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.203 -0.935 . . . . 0.0 108.935 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 28.1 mtpt -134.64 140.95 36.97 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.045 -1.034 . . . . 0.0 110.623 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -88.06 53.63 2.27 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.739 1.389 . . . . 0.0 109.965 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 t30 66.22 -177.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.646 -0.659 . . . . 0.0 110.075 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -77.27 -25.96 51.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.291 -0.881 . . . . 0.0 110.848 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -148.23 28.5 0.9 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.235 -0.916 . . . . 0.0 110.471 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 50.57 49.38 20.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.393 -0.817 . . . . 0.0 110.576 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.499 ' HG3' ' HG ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -116.46 -26.18 7.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -0.915 . . . . 0.0 110.616 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.499 ' HG ' ' HG3' ' A' ' 42' ' ' GLU . 14.7 mt -106.3 -8.48 17.24 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.12 -0.988 . . . . 0.0 110.002 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.27 27.47 70.71 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 6.4 m-30 -90.2 119.8 30.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.456 -1.026 . . . . 0.0 109.926 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.494 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 4.4 m-90 -75.44 76.91 2.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.081 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -54.79 122.72 11.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.443 -0.786 . . . . 0.0 109.989 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.548 ' CE1' HG13 ' A' ' 35' ' ' ILE . 4.7 m-30 -106.97 102.81 12.14 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.002 -1.061 . . . . 0.0 109.774 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.469 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.9 tp10 -87.71 126.68 35.12 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.778 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.561 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 75.6 t90 -99.18 172.42 7.38 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.459 -0.776 . . . . 0.0 109.817 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -179.79 145.29 0.41 Allowed Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.338 -0.851 . . . . 0.0 110.759 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 48.9 Cg_endo -71.88 80.98 1.43 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.808 1.425 . . . . 0.0 109.799 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.1 t -120.51 11.34 11.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 109.696 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.426 ' HG2' ' HA2' ' A' ' 31' ' ' GLY . 0.9 OUTLIER -100.63 -169.65 1.74 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.988 -0.445 . . . . 0.0 109.837 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.27 109.5 50.09 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -78.79 145.82 20.43 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.398 1.209 . . . . 0.0 110.81 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.3 t -142.32 29.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 109.632 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.29 -61.83 0.02 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -131.22 -157.59 0.83 Allowed 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.374 -1.074 . . . . 0.0 109.661 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -150.96 146.09 26.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.6 -0.687 . . . . 0.0 110.339 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -131.29 -161.13 1.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.301 -0.874 . . . . 0.0 110.513 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 1.7 m-20 -147.08 171.97 5.74 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.434 -0.791 . . . . 0.0 109.704 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 36.2 Cg_endo -58.43 135.87 70.61 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.528 1.278 . . . . 0.0 111.859 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.46 HD12 ' CE3' ' A' ' 50' ' ' TRP . 4.7 mt -128.94 116.74 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.58 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -69.76 118.87 13.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.215 -0.928 . . . . 0.0 110.059 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 15.8 mt -109.57 145.16 36.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.396 -0.815 . . . . 0.0 109.781 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 67' ' ' ILE . 17.0 mt -119.94 148.02 23.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.33 -0.857 . . . . 0.0 110.066 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.477 ' CD1' ' CE2' ' A' ' 48' ' ' PHE . 62.9 mt -125.57 97.56 5.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.437 -0.789 . . . . 0.0 110.282 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.446 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 61.6 mt -131.29 108.93 14.94 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.256 -0.902 . . . . 0.0 110.23 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.3 80.84 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.603 1.317 . . . . 0.0 110.214 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.05 -30.11 0.73 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -89.87 -34.53 16.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.429 -1.042 . . . . 0.0 110.164 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.406 HG22 ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -104.3 168.95 8.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.416 -0.802 . . . . 0.0 110.043 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 tpp -109.66 151.42 26.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.393 -0.817 . . . . 0.0 110.387 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -90.78 119.28 30.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 110.076 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.148 -179.879 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.118 0.485 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.67 108.32 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.1 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.69 79.9 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 0.0 109.994 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.36 113.43 12.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.124 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.406 ' HB3' HG22 ' A' ' 73' ' ' THR . 6.2 mt -104.84 125.71 51.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.9 t -114.94 109.63 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 110.417 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.405 ' N ' HG23 ' A' ' 73' ' ' THR . 0.2 OUTLIER -67.0 -78.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.333 -0.854 . . . . 0.0 110.236 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.2 t -176.44 -70.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.181 -0.949 . . . . 0.0 110.491 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.2 m -57.69 -83.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.319 -0.863 . . . . 0.0 110.446 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.35 15.64 0.39 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 110.72 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -99.85 50.95 0.91 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 110.13 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -90.36 121.48 32.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.448 -0.782 . . . . 0.0 110.095 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 26.6 m-85 -106.44 162.63 13.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.313 -0.867 . . . . 0.0 110.506 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.414 ' O ' ' CD1' ' A' ' 99' ' ' PHE . 8.3 m-85 -137.6 141.51 41.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 109.536 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.436 ' CE1' HD23 ' A' ' 66' ' ' LEU . 19.8 m-85 -135.58 161.71 34.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 110.409 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.465 ' CD2' ' CB ' ' A' ' 26' ' ' PRO . 3.0 p-90 -143.77 162.76 35.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.73 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.834 . . . . 0.0 110.242 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.2 m . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.198 0.523 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.51 76.12 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.726 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.477 HD12 HG22 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -89.18 168.48 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.531 -0.73 . . . . 0.0 109.751 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.44 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 8.9 mttt -130.38 131.19 45.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -124.4 131.92 53.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -79.45 121.88 25.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.344 -0.848 . . . . 0.0 110.48 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.68 -154.83 0.57 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.436 -0.79 . . . . 0.0 110.039 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.92 159.04 26.9 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.481 ' CG2' ' CE2' ' A' ' 50' ' ' TRP . 1.3 t -95.52 -137.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.388 -1.066 . . . . 0.0 109.52 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 42.5 t -162.46 107.96 1.21 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.973 -1.08 . . . . 0.0 110.033 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.493 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -77.37 161.49 27.99 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.377 -0.827 . . . . 0.0 110.112 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -145.63 141.72 28.41 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.892 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -107.75 135.33 49.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 110.135 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -79.54 -25.12 41.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.538 -0.726 . . . . 0.0 110.156 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.81 -39.28 91.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -115.73 -5.68 12.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 0.0 110.363 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.424 ' HA ' ' CE2' ' A' ' 17' ' ' TYR . 0.2 OUTLIER 54.41 58.75 4.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.254 -0.904 . . . . 0.0 110.287 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.42 169.78 14.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.268 -0.895 . . . . 0.0 110.414 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.3 141.53 52.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.45 -0.781 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.83 163.71 25.96 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.829 . . . . 0.0 110.26 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HB3' ' CD2' ' A' ' 100' ' ' TRP . 47.2 Cg_endo -72.53 135.38 24.07 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.75 1.395 . . . . 0.0 110.206 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.493 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.51 138.4 44.5 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.932 . . . . 0.0 109.786 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 27' ' ' ILE . 48.1 Cg_endo -74.77 51.86 2.81 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.75 1.395 . . . . 0.0 110.747 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.4 t -152.19 116.12 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.176 -0.953 . . . . 0.0 109.815 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -80.89 70.14 7.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 110.212 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.622 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -59.12 -167.48 0.19 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.717 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 26.4 mt-10 -129.7 138.72 51.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -1.151 . . . . 0.0 112.29 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 48' ' ' PHE . 39.9 mt -101.79 167.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.487 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -136.75 113.81 10.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.335 -0.853 . . . . 0.0 109.425 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 1.2 mp -68.35 123.71 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.334 -0.854 . . . . 0.0 109.106 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -132.88 142.81 46.08 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.292 -0.88 . . . . 0.0 110.282 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -88.1 52.76 2.13 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.656 1.345 . . . . 0.0 109.978 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 t30 64.83 161.54 0.12 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.532 -0.73 . . . . 0.0 109.991 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.36 -56.21 20.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.401 -0.812 . . . . 0.0 110.636 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -128.06 36.84 4.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.456 -0.777 . . . . 0.0 110.331 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 51.31 52.33 15.05 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 0.0 110.406 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -102.28 -38.67 7.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.432 -0.792 . . . . 0.0 109.781 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 11.8 mt -108.06 -8.79 15.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.574 -0.703 . . . . 0.0 110.262 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.23 27.36 71.43 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.467 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 12.6 m-30 -88.46 120.5 29.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.39 -1.065 . . . . 0.0 110.033 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.562 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 22.8 m-90 -68.06 75.66 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.844 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 6.3 t0 -52.31 129.84 29.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.355 -0.841 . . . . 0.0 110.283 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.517 ' CE1' HG13 ' A' ' 35' ' ' ILE . 6.8 m-30 -110.54 103.0 11.54 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.487 -0.758 . . . . 0.0 109.673 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.418 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -83.84 116.58 22.81 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.218 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.74 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 74.2 t90 -94.7 154.05 17.5 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.664 -0.648 . . . . 0.0 109.683 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.9 OUTLIER -163.27 138.56 5.13 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.931 -1.106 . . . . 0.0 110.638 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.514 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 44.0 Cg_endo -68.6 81.1 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.55 1.289 . . . . 0.0 110.372 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.412 ' CG2' ' HB2' ' A' ' 32' ' ' GLU . 7.0 t -120.86 5.68 10.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.383 -0.823 . . . . 0.0 109.473 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.47 ' HG2' ' HA2' ' A' ' 31' ' ' GLY . 0.8 OUTLIER -100.34 -169.68 1.76 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 109.71 51.54 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.2 -0.937 . . . . 0.0 109.908 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -81.08 -179.22 4.9 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.464 1.244 . . . . 0.0 110.801 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.1 p -131.18 29.38 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.794 . . . . 0.0 109.895 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.75 22.79 3.53 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -134.59 105.6 6.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -1.184 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -80.95 132.54 35.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 0.0 110.338 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 mt -129.82 -158.71 0.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 110.177 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.514 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -162.66 172.23 5.6 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.28 -0.888 . . . . 0.0 110.269 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.74 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.2 Cg_endo -61.36 126.44 19.3 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.72 1.379 . . . . 0.0 111.308 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.535 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 9.9 mt -124.96 111.33 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.788 -0.57 . . . . 0.0 110.088 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.9 m -69.8 117.48 11.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.144 -0.973 . . . . 0.0 109.438 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 26.7 mt -104.04 144.32 31.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.294 -0.879 . . . . 0.0 110.398 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 67' ' ' ILE . 8.8 mm -113.04 148.39 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.421 -0.8 . . . . 0.0 109.585 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.462 ' CD1' ' CE2' ' A' ' 48' ' ' PHE . 77.7 mt -121.71 87.57 2.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 110.188 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.467 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 74.2 mt -127.71 108.48 20.58 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.447 -0.783 . . . . 0.0 110.019 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.39 64.01 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.58 1.305 . . . . 0.0 110.449 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.85 -37.32 0.1 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -71.48 -53.35 14.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.339 -1.095 . . . . 0.0 110.227 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.25 148.24 25.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.416 -0.803 . . . . 0.0 110.2 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mmt -76.12 132.64 40.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.422 -0.799 . . . . 0.0 110.194 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.44 83.17 4.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.408 -0.807 . . . . 0.0 110.051 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 110.096 -179.893 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.199 0.524 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 2.1 tt -80.88 105.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.309 -0.87 . . . . 0.0 110.188 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -69.71 139.36 53.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.23 117.88 28.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.47 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.32 124.14 48.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.988 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.7 t -125.37 112.39 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.36 -0.837 . . . . 0.0 110.381 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -76.17 -76.38 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.855 . . . . 0.0 110.004 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.8 m -129.85 -66.65 0.78 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.374 -0.829 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.06 36.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.373 -0.829 . . . . 0.0 110.205 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -166.67 -39.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.397 -0.815 . . . . 0.0 110.415 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -97.51 43.14 1.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.447 -0.783 . . . . 0.0 110.144 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -98.83 111.21 23.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.261 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 41.7 m-85 -113.75 159.52 19.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.381 -0.825 . . . . 0.0 110.236 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.42 ' HB2' ' CB ' ' A' ' 15' ' ' CYS . 0.4 OUTLIER -141.55 141.46 33.53 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.258 -0.901 . . . . 0.0 109.827 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 97' ' ' TYR . 6.7 m-85 -137.66 169.51 17.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.149 -0.97 . . . . 0.0 110.328 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.43 ' CD2' ' HB3' ' A' ' 26' ' ' PRO . 3.2 p-90 -150.32 161.28 42.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.185 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.286 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.272 0.558 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' A' ' 7' ' ' VAL . 7.9 p -78.51 86.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.5 -0.75 . . . . 0.0 110.051 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.461 HG21 HD12 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -72.11 168.9 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.07 -1.019 . . . . 0.0 109.744 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 20.8 mttp -126.09 144.23 50.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.553 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -134.67 -174.84 3.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.795 . . . . 0.0 109.608 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.23 119.28 24.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 0.0 110.854 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.414 ' HB2' HD12 ' A' ' 33' ' ' ILE . . . -150.15 -158.65 0.94 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 109.715 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -142.31 165.74 26.61 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.486 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 0.7 OUTLIER -103.88 -142.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.431 -1.041 . . . . 0.0 109.516 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -163.75 108.3 1.02 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.065 -1.022 . . . . 0.0 110.105 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HG2' HD12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -77.71 162.18 27.17 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.309 -0.869 . . . . 0.0 110.031 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.51 144.12 50.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.139 -0.625 . . . . 0.0 110.066 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' A' ' 22' ' ' ARG . 7.6 t-20 -110.11 124.97 52.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.903 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -24.74 52.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.368 -0.833 . . . . 0.0 110.305 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -68.55 -30.75 69.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.461 -0.775 . . . . 0.0 110.256 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -124.08 -2.21 8.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.383 -0.823 . . . . 0.0 110.61 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER 52.74 58.01 5.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.127 -0.983 . . . . 0.0 110.184 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.78 164.71 22.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.901 . . . . 0.0 110.302 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.94 90.04 3.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 110.062 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.41 167.38 12.4 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 110.188 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.464 ' CB ' ' CD2' ' A' ' 100' ' ' TRP . 44.1 Cg_endo -71.35 144.52 46.01 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.756 1.398 . . . . 0.0 110.332 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -82.77 140.9 43.92 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 109.431 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.487 ' HD2' HG22 ' A' ' 27' ' ' ILE . 40.3 Cg_endo -66.14 -18.47 56.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.621 1.327 . . . . 0.0 110.565 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 59' ' ' ARG . 85.2 t -83.61 138.08 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.974 . . . . 0.0 109.459 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.19 -49.73 7.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 110.798 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.453 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . 54.82 -166.7 2.57 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -153.7 159.02 41.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.039 -1.271 . . . . 0.0 110.463 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.51 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 2.2 mp -106.69 168.7 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.507 0.67 . . . . 0.0 110.368 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 42.1 mt-10 -130.86 114.12 14.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.588 -0.695 . . . . 0.0 109.496 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.539 HG13 ' CE1' ' A' ' 48' ' ' PHE . 1.7 mp -68.72 127.22 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 18.1 mtpt -133.41 140.93 38.61 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 0.0 110.755 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -87.9 53.01 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.725 1.382 . . . . 0.0 109.973 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 65.02 164.63 0.15 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.559 -0.713 . . . . 0.0 110.121 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.33 -38.49 71.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 0.0 110.816 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -147.82 38.33 0.91 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.872 . . . . 0.0 110.389 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 51.1 49.87 20.24 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.35 -0.844 . . . . 0.0 110.438 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -103.04 -41.26 6.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -0.865 . . . . 0.0 109.807 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -106.26 -5.36 19.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.526 -0.734 . . . . 0.0 110.353 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.97 27.8 69.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 8.5 m-30 -88.22 120.67 29.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -1.027 . . . . 0.0 109.985 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.514 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 88.6 m95 -70.49 76.77 0.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' CB ' ' HB2' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -53.98 124.32 15.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.346 -0.846 . . . . 0.0 109.994 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.539 ' CE1' HG13 ' A' ' 35' ' ' ILE . 6.1 m-30 -107.29 102.85 12.12 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.164 -0.96 . . . . 0.0 109.804 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.413 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.2 tt0 -85.49 118.83 25.26 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.104 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.624 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 69.4 t90 -93.75 167.08 11.88 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.506 -0.746 . . . . 0.0 109.299 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 2.7 ptm180 -177.5 146.32 0.62 Allowed Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.226 -0.921 . . . . 0.0 110.832 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.1 Cg_endo -71.87 76.68 1.99 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.544 1.287 . . . . 0.0 109.945 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 t -118.26 10.0 12.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.173 -0.954 . . . . 0.0 109.848 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HB2' ' N ' ' A' ' 31' ' ' GLY . 60.9 mm-40 -116.2 -169.09 1.54 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 113.14 43.46 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.102 -0.999 . . . . 0.0 110.547 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.29 -167.34 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.484 1.255 . . . . 0.0 110.422 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.7 t -148.59 49.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.464 -0.772 . . . . 0.0 110.029 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.43 5.24 72.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.413 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 16.6 mmt180 -124.68 100.95 6.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -1.161 . . . . 0.0 110.131 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -73.88 122.98 23.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.329 -0.857 . . . . 0.0 110.367 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -116.53 -162.15 0.84 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.341 -0.849 . . . . 0.0 110.102 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.516 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -155.55 174.98 3.43 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.898 . . . . 0.0 110.144 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.624 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 38.3 Cg_endo -63.83 131.35 30.75 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.607 1.32 . . . . 0.0 111.526 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 6.5 mt -126.03 113.78 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.713 -0.617 . . . . 0.0 109.683 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.7 p -69.61 117.99 11.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 0.0 110.034 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 18.6 mt -107.76 147.42 30.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.926 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.417 HG21 HD11 ' A' ' 67' ' ' ILE . 15.3 mt -120.03 155.64 22.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.916 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.466 ' CD1' ' CE2' ' A' ' 48' ' ' PHE . 50.6 mt -132.36 99.62 4.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.428 -0.795 . . . . 0.0 110.13 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.443 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 52.6 mt -132.4 108.02 13.4 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.135 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.2 -7.99 21.36 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.526 1.277 . . . . 0.0 110.774 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -108.34 2.84 32.87 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -133.1 -68.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.072 -1.252 . . . . 0.0 110.351 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.41 126.95 31.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.323 -0.86 . . . . 0.0 110.108 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ttt -70.81 137.01 49.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.383 -0.823 . . . . 0.0 110.138 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.428 ' CD2' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -87.65 122.8 31.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.345 -0.847 . . . . 0.0 110.206 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.04 88.47 36.76 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.809 . . . . 0.0 110.056 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.9 -32.51 8.87 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.818 1.43 . . . . 0.0 110.484 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 tt -142.01 138.28 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.332 -0.855 . . . . 0.0 110.293 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -104.67 49.33 0.81 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.419 -0.801 . . . . 0.0 110.148 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.27 -173.61 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.381 -0.824 . . . . 0.0 110.382 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.9 m 52.43 -168.08 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.272 -0.892 . . . . 0.0 110.501 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.76 112.53 8.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.887 . . . . 0.0 110.192 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.2 t -151.39 127.57 10.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -0.822 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.06 -85.32 0.1 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -162.45 94.06 0.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -1.119 . . . . 0.0 110.195 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.7 mt -117.0 101.3 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.351 -0.843 . . . . 0.0 110.091 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -72.17 108.47 5.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.832 . . . . 0.0 110.25 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.429 ' HB1' ' CD2' ' A' ' 98' ' ' PHE . . . -118.6 133.95 55.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 110.193 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.428 HD23 ' CD2' ' A' ' 75' ' ' TRP . 3.9 mt -112.5 116.96 31.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.848 . . . . 0.0 110.218 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.413 ' CG1' ' HG2' ' A' ' 96' ' ' ARG . 10.0 m -112.48 133.44 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 110.511 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -92.03 -79.65 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.426 -0.796 . . . . 0.0 110.168 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -172.82 -39.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.199 -0.938 . . . . 0.0 110.345 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.64 -81.58 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.895 . . . . 0.0 110.385 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -150.82 15.76 0.76 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.157 -0.964 . . . . 0.0 110.822 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -90.51 49.53 1.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.162 -0.961 . . . . 0.0 110.142 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.413 ' HG2' ' CG1' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -105.19 111.2 23.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.364 -0.835 . . . . 0.0 110.484 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 29.3 m-85 -113.94 155.49 25.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.497 -0.752 . . . . 0.0 110.204 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.429 ' CD2' ' HB1' ' A' ' 88' ' ' ALA . 25.9 m-85 -120.74 140.28 51.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.876 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 97' ' ' TYR . 19.6 m-85 -134.69 158.55 43.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -0.982 . . . . 0.0 110.358 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.464 ' CD2' ' CB ' ' A' ' 26' ' ' PRO . 2.6 p-90 -149.57 144.0 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 109.912 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.238 0.542 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 58.8 t -99.8 86.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.434 -0.791 . . . . 0.0 109.999 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 17.0 mt -94.39 175.21 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.222 -0.924 . . . . 0.0 109.627 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -131.04 132.38 44.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.201 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.45 ' CD1' HD13 ' A' ' 35' ' ' ILE . 1.6 m-85 -126.83 -174.61 3.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.455 -0.778 . . . . 0.0 109.439 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 23.6 mtt85 -127.09 149.53 49.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.147 -0.97 . . . . 0.0 110.826 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.72 -155.04 0.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.48 -0.762 . . . . 0.0 109.746 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.443 ' O ' ' CD2' ' A' ' 99' ' ' PHE . . . -145.68 146.55 16.85 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.49 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.1 t -89.55 -141.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.337 -1.096 . . . . 0.0 109.621 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 98' ' ' PHE . 42.5 t -162.99 110.13 1.21 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.056 -1.027 . . . . 0.0 110.01 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.533 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -76.96 154.77 33.24 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 109.849 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.33 145.85 33.05 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.028 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -123.68 134.61 53.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.45 -0.781 . . . . 0.0 110.202 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -77.1 -27.56 54.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.413 -0.804 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.45 -37.16 72.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.355 -0.841 . . . . 0.0 110.101 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.4 p -121.42 -2.82 9.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.472 -0.767 . . . . 0.0 110.369 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 52.49 57.38 6.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.27 -0.894 . . . . 0.0 110.15 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.74 159.65 26.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -0.833 . . . . 0.0 110.403 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.06 91.92 3.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.473 -0.767 . . . . 0.0 109.871 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.1 p -103.26 164.2 15.96 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.442 -0.786 . . . . 0.0 110.281 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.439 ' HB2' ' CE2' ' A' ' 100' ' ' TRP . 44.1 Cg_endo -71.16 142.4 41.74 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.85 1.447 . . . . 0.0 110.272 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.533 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.24 136.7 46.23 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 110.051 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HD2' HG22 ' A' ' 27' ' ' ILE . 48.7 Cg_endo -75.97 52.85 3.55 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.798 1.42 . . . . 0.0 110.189 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.4 t -150.06 115.88 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.86 . . . . 0.0 109.597 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -85.29 64.73 8.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 110.43 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' N ' ' HG2' ' A' ' 54' ' ' GLU . . . -61.52 -161.51 0.16 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -140.4 155.07 46.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.876 -1.367 . . . . 0.0 111.097 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 2.0 mp -105.75 169.96 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-O 121.4 0.619 . . . . 0.0 110.437 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 17.0 mt-10 -134.52 120.26 19.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.567 -0.708 . . . . 0.0 109.405 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.498 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 1.7 mp -69.78 127.61 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -134.74 123.12 15.93 Favored Pre-proline 0 N--CA 1.485 1.3 0 O-C-N 121.055 -1.028 . . . . 0.0 109.343 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -83.77 51.82 3.58 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.489 1.257 . . . . 0.0 110.07 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 62.45 150.16 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.62 -0.675 . . . . 0.0 110.028 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -52.6 -25.7 11.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.41 -0.806 . . . . 0.0 110.156 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -133.74 -154.38 0.6 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.418 -0.801 . . . . 0.0 109.747 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -123.41 52.03 1.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 109.691 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.31 -35.86 7.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.411 -0.806 . . . . 0.0 110.156 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.453 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 11.7 mt -118.23 -11.9 10.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 110.217 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.91 27.49 56.59 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.486 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 5.7 m-30 -68.3 118.31 11.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -1.02 . . . . 0.0 110.065 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.555 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 77.1 m95 -80.71 68.08 6.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.469 -0.77 . . . . 0.0 110.094 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.46 ' HB2' ' CG ' ' A' ' 36' ' ' LYS . 68.7 m-20 -53.21 137.97 33.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.444 -0.785 . . . . 0.0 110.207 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 5.5 m-30 -108.77 102.69 11.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.357 -0.84 . . . . 0.0 109.669 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.43 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 4.0 tt0 -82.48 121.41 26.73 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.053 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.524 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 71.7 t90 -93.66 171.84 8.63 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.361 -0.837 . . . . 0.0 109.508 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 1.3 ptm180 -175.44 146.2 0.88 Allowed Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.2 -0.938 . . . . 0.0 110.808 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.491 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 52.2 Cg_endo -74.82 80.17 2.44 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.711 1.374 . . . . 0.0 109.788 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.405 ' CG2' ' HB3' ' A' ' 32' ' ' GLU . 7.0 t -117.71 5.05 12.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.121 -0.987 . . . . 0.0 109.777 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.468 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 1.5 pp20? -100.9 -178.15 3.67 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.933 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -99.14 109.74 55.4 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.3 -0.875 . . . . 0.0 109.648 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -83.11 167.81 13.86 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.572 1.301 . . . . 0.0 110.679 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.5 t -112.42 36.2 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.468 -0.77 . . . . 0.0 109.534 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.84 16.95 6.61 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.1 mmt-85 -129.99 103.26 6.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -1.154 . . . . 0.0 110.261 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -80.15 140.78 36.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.352 -0.843 . . . . 0.0 110.103 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.408 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 1.3 mp -131.62 -168.21 1.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 0.0 110.332 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.529 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 53.9 m-20 -152.07 166.73 14.64 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.499 -0.751 . . . . 0.0 109.984 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 62' ' ' ASP . 37.5 Cg_endo -61.45 136.08 61.34 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.69 1.363 . . . . 0.0 111.573 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 5.1 mt -129.42 114.31 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 p -69.66 116.22 9.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.202 -0.936 . . . . 0.0 110.002 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 29.2 mt -105.76 154.68 20.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 109.801 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.405 ' CG2' ' CD1' ' A' ' 69' ' ' ILE . 43.0 mt -125.4 152.36 32.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.613 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.444 HD12 ' CE1' ' A' ' 48' ' ' PHE . 73.7 mt -122.97 82.8 2.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.388 -0.82 . . . . 0.0 110.236 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.486 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 64.3 mt -131.19 106.6 14.83 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.465 -0.772 . . . . 0.0 110.162 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.54 63.32 4.6 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.634 1.334 . . . . 0.0 110.278 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.69 -46.58 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -60.47 -76.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.195 -1.179 . . . . 0.0 110.259 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.71 -153.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.264 -0.898 . . . . 0.0 109.754 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -138.63 100.26 4.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.247 -0.908 . . . . 0.0 110.44 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.41 ' CD2' ' O ' ' A' ' 75' ' ' TRP . 64.0 p-90 -76.11 131.51 39.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.858 . . . . 0.0 110.163 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.3 t -141.52 133.61 13.79 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.5 157.97 48.38 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.634 1.334 . . . . 0.0 110.393 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.2 mm -115.18 120.8 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.373 -0.83 . . . . 0.0 110.07 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -94.8 50.38 1.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.397 -0.814 . . . . 0.0 110.253 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.2 t -122.26 4.28 9.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 110.558 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -168.11 122.76 0.95 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.21 -0.931 . . . . 0.0 110.143 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -66.02 -31.68 72.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.38 -0.825 . . . . 0.0 110.104 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.5 p -108.72 170.06 8.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.864 . . . . 0.0 110.168 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.73 -65.99 3.93 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 62.49 134.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.432 -1.04 . . . . 0.0 110.48 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.7 mt -133.73 114.13 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.263 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -76.18 115.13 15.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.347 -0.845 . . . . 0.0 109.961 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.454 ' CB ' ' CE2' ' A' ' 98' ' ' PHE . . . -99.41 110.93 23.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.425 -0.797 . . . . 0.0 110.563 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.01 119.08 38.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.823 . . . . 0.0 109.83 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.433 ' HA ' ' HG3' ' A' ' 96' ' ' ARG . 91.3 t -113.91 131.29 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 110.529 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -100.99 -61.62 1.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.47 -0.769 . . . . 0.0 110.133 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.9 m -142.53 -50.92 0.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.558 -0.713 . . . . 0.0 110.154 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.85 -29.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.883 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -116.89 11.94 14.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 111.075 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -130.38 36.29 3.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 0.0 110.298 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.433 ' HG3' ' HA ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -95.9 111.34 23.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 0.0 110.328 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 27.1 m-85 -105.79 142.59 35.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.453 -0.78 . . . . 0.0 110.295 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.454 ' CE2' ' CB ' ' A' ' 88' ' ' ALA . 20.1 m-85 -119.83 136.24 54.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.393 -0.817 . . . . 0.0 109.888 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CZ ' ' CD1' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -134.73 169.85 16.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.233 -0.917 . . . . 0.0 110.197 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.439 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 2.1 p-90 -158.37 175.39 13.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 110.257 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 mt . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.821 . . . . 0.0 110.147 -179.943 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.198 0.523 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 98.2 t -111.2 59.53 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.45 -0.781 . . . . 0.0 109.635 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 35' ' ' ILE . 15.4 tt -102.19 175.16 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 0.0 110.111 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 4.4 mptt -120.71 140.73 51.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.039 -1.038 . . . . 0.0 110.942 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -113.77 -179.11 3.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 109.686 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -113.72 127.39 56.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 110.322 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.81 -160.68 0.71 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 110.085 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.74 163.31 29.63 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.46 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.3 t -95.53 -138.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.454 -1.027 . . . . 0.0 109.85 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.7 t -155.53 108.12 2.69 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.148 -0.97 . . . . 0.0 109.652 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' N ' HG12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -78.82 128.39 33.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.993 -179.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.18 157.63 28.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.635 -0.666 . . . . 0.0 109.821 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -126.22 136.26 52.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -0.837 . . . . 0.0 110.412 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -82.48 -25.33 33.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 110.154 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -35.26 77.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.363 -0.836 . . . . 0.0 109.999 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 m -120.44 -1.38 10.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.476 -0.765 . . . . 0.0 110.584 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.15 56.14 8.44 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.206 -0.934 . . . . 0.0 109.91 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.7 pp -108.1 154.04 22.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.428 -0.795 . . . . 0.0 110.809 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.9 p -124.97 71.06 1.16 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.518 -0.739 . . . . 0.0 110.279 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 p -97.16 165.11 16.4 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.405 -0.809 . . . . 0.0 110.248 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.46 ' CB ' ' CD2' ' A' ' 100' ' ' TRP . 46.2 Cg_endo -74.26 152.96 45.41 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.789 1.415 . . . . 0.0 110.332 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.46 ' CD1' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -81.97 140.89 46.74 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.219 -0.926 . . . . 0.0 109.186 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.444 ' HD2' HG22 ' A' ' 27' ' ' ILE . 40.7 Cg_endo -67.25 -15.24 45.52 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.559 1.294 . . . . 0.0 110.497 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.4 t -94.36 115.34 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.58 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -88.42 72.02 8.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 110.276 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.427 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.5 -160.4 0.08 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -138.48 161.21 37.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -1.193 . . . . 0.0 110.64 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 96.6 mt -105.0 170.69 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.414 0.626 . . . . 0.0 110.571 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -128.95 105.98 8.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.527 -0.733 . . . . 0.0 109.065 179.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.547 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 1.2 mp -68.01 125.98 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 108.655 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 47' ' ' ASP . 0.6 OUTLIER -137.03 161.93 58.6 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 110.977 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -93.14 55.41 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.677 1.585 . . . . 0.0 110.076 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 60.29 175.16 0.09 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.371 -0.831 . . . . 0.0 110.093 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.88 -65.26 0.71 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.321 -0.862 . . . . 0.0 110.628 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -122.15 37.38 4.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.776 . . . . 0.0 110.527 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 50.9 49.81 20.36 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.385 -0.822 . . . . 0.0 110.604 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.473 ' HG3' ' HG ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -118.58 -24.58 6.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.326 -0.859 . . . . 0.0 110.547 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.473 ' HG ' ' HG3' ' A' ' 42' ' ' GLU . 14.6 mt -108.82 -12.0 14.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.132 -0.98 . . . . 0.0 109.981 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.71 26.87 72.21 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.45 ' CD2' HG12 ' A' ' 69' ' ' ILE . 13.8 m-30 -91.49 122.79 34.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -1.098 . . . . 0.0 110.134 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.42 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 8.8 m0 -66.78 81.87 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 0.0 109.508 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -53.64 118.42 3.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.172 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.536 ' CE1' HG13 ' A' ' 35' ' ' ILE . 3.9 m-30 -107.7 102.5 11.72 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.332 -0.855 . . . . 0.0 109.188 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.435 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -89.58 123.13 33.38 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.711 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.495 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 70.5 t90 -91.75 173.84 7.66 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.331 -0.855 . . . . 0.0 109.579 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 179.55 146.89 0.41 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.095 -1.003 . . . . 0.0 110.848 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.9 Cg_endo -74.61 78.14 2.82 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.851 1.448 . . . . 0.0 109.694 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t -118.02 10.58 13.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 109.645 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 31' ' ' GLY . 1.3 pp20? -100.62 -169.59 1.74 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.734 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.04 109.64 50.18 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 109.75 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -81.75 -178.01 3.92 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.482 1.254 . . . . 0.0 110.957 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -148.41 30.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.609 -0.682 . . . . 0.0 109.441 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.06 0.93 7.52 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.0 mmt85 -123.25 100.34 6.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.26 . . . . 0.0 110.323 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.89 112.65 21.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.394 -0.816 . . . . 0.0 110.265 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.425 HD23 ' CH2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -103.73 -163.46 0.98 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.37 -0.831 . . . . 0.0 110.39 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 8.8 m-20 -152.74 164.95 18.69 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.457 -0.777 . . . . 0.0 109.93 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 36.7 Cg_endo -59.4 146.45 94.86 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.648 1.341 . . . . 0.0 112.016 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.421 HD12 ' CE3' ' A' ' 50' ' ' TRP . 5.4 mt -137.51 118.02 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 p -69.67 118.16 12.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.095 -1.003 . . . . 0.0 109.787 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 24.6 mt -105.25 143.57 33.24 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.288 -0.882 . . . . 0.0 110.153 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.3 mm -112.93 139.58 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.474 -0.766 . . . . 0.0 109.751 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.463 HD11 ' CE2' ' A' ' 48' ' ' PHE . 73.1 mt -122.83 95.24 4.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -0.88 . . . . 0.0 110.214 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.45 HG12 ' CD2' ' A' ' 45' ' ' PHE . 51.2 mt -128.41 116.66 19.91 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.331 -0.856 . . . . 0.0 110.058 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.95 64.87 4.1 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.612 1.322 . . . . 0.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.77 -52.81 0.2 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.409 ' O ' ' CD1' ' A' ' 91' ' ' PHE . 13.3 mm-40 -61.86 -80.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.257 -1.143 . . . . 0.0 110.155 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.01 113.62 21.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.188 -0.945 . . . . 0.0 109.97 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.5 tpt -69.7 148.99 48.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.468 -0.77 . . . . 0.0 110.196 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -111.52 142.14 44.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.431 -0.793 . . . . 0.0 110.087 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.08 103.03 18.59 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 110.182 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.24 96.82 0.81 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.601 1.316 . . . . 0.0 110.267 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.4 mp -61.31 166.51 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.328 -0.858 . . . . 0.0 110.022 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -57.76 149.93 21.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.264 -0.897 . . . . 0.0 110.212 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.3 p -61.3 -56.25 22.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.385 -0.822 . . . . 0.0 110.217 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.7 p 49.39 -156.08 0.09 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.457 -0.777 . . . . 0.0 110.573 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.99 49.8 0.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.212 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.3 p -117.82 -76.26 0.57 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.428 -0.795 . . . . 0.0 110.149 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.92 41.63 0.02 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 50.64 86.77 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.294 -1.121 . . . . 0.0 110.564 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 59.9 mt -93.8 120.9 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 110.26 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -82.68 111.07 18.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.855 . . . . 0.0 110.053 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' CB ' ' CE2' ' A' ' 98' ' ' PHE . . . -92.43 97.94 11.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.294 -0.879 . . . . 0.0 110.476 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.423 HD11 ' CE2' ' A' ' 99' ' ' PHE . 3.2 mt -93.42 105.43 17.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.434 -0.791 . . . . 0.0 109.833 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.87 154.56 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.309 -0.869 . . . . 0.0 110.591 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.409 ' CD1' ' O ' ' A' ' 72' ' ' GLU . 22.8 t80 -117.32 -70.85 0.77 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.368 -0.832 . . . . 0.0 110.093 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.0 p -133.94 -68.04 0.57 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.784 . . . . 0.0 110.057 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.0 p -166.18 30.46 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.419 -0.801 . . . . 0.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.29 -40.66 0.73 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.494 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -116.57 87.21 2.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.342 -0.849 . . . . 0.0 110.406 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.401 ' N ' ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -128.12 110.4 12.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 110.223 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 33.9 m-85 -127.33 154.36 45.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 110.668 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.452 ' CE2' ' CB ' ' A' ' 88' ' ' ALA . 43.2 m-85 -129.21 132.37 47.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.595 -0.691 . . . . 0.0 109.43 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 97' ' ' TYR . 16.2 m-85 -127.1 160.84 29.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.148 -0.97 . . . . 0.0 110.403 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.46 ' CD2' ' CB ' ' A' ' 26' ' ' PRO . 2.3 p-90 -147.89 150.93 35.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.404 -0.81 . . . . 0.0 109.912 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.288 -0.882 . . . . 0.0 110.271 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.4 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.223 0.535 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.403 ' CG2' ' HD3' ' A' ' 36' ' ' LYS . 7.7 p -73.73 68.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.423 -0.798 . . . . 0.0 109.921 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.484 HG21 HD13 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -72.07 165.93 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.227 -0.921 . . . . 0.0 109.672 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.415 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 12.2 ttmt -122.43 141.77 51.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.338 -0.851 . . . . 0.0 110.34 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -135.69 -174.66 3.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.398 -0.813 . . . . 0.0 109.705 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.2 115.51 17.77 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.175 -0.953 . . . . 0.0 110.811 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.93 -160.59 1.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.472 -0.767 . . . . 0.0 109.622 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.412 ' HA3' ' NE1' ' A' ' 100' ' ' TRP . . . -139.99 155.1 24.25 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.481 ' C ' HG13 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -96.34 -142.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.44 -1.035 . . . . 0.0 109.394 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.423 ' N ' HD11 ' A' ' 27' ' ' ILE . 0.8 OUTLIER -162.39 107.64 1.2 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.971 -1.081 . . . . 0.0 110.184 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.525 ' CG ' HD12 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -78.7 162.4 26.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.383 -0.823 . . . . 0.0 110.089 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -129.7 149.75 51.31 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.635 -0.666 . . . . 0.0 109.637 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -113.26 124.82 53.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.364 -0.835 . . . . 0.0 110.061 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 20' ' ' ASP . 9.4 pt-20 -76.36 -25.32 54.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.527 -0.733 . . . . 0.0 110.147 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 9.8 t0 -64.75 -35.04 79.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.44 -0.787 . . . . 0.0 110.087 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -118.64 -5.44 10.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.426 -0.796 . . . . 0.0 110.504 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 54.63 60.19 3.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.142 -0.974 . . . . 0.0 110.105 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.94 158.52 43.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.307 -0.871 . . . . 0.0 110.369 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.49 150.58 26.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -0.835 . . . . 0.0 110.055 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.3 p -155.18 164.27 21.69 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.386 -0.821 . . . . 0.0 110.241 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.47 ' HB3' ' CD2' ' A' ' 100' ' ' TRP . 45.8 Cg_endo -71.81 137.13 29.14 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.764 1.402 . . . . 0.0 110.137 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.525 HD12 ' CG ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.94 137.6 43.43 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 109.822 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.462 ' HD2' HG23 ' A' ' 27' ' ' ILE . 48.2 Cg_endo -74.38 54.29 3.29 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.686 1.361 . . . . 0.0 110.553 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.2 p -157.84 115.87 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.939 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -83.57 71.75 10.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.3 -0.875 . . . . 0.0 110.11 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.621 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -58.05 -167.02 0.12 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.704 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 27.6 mt-10 -128.48 138.25 52.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -1.138 . . . . 0.0 112.323 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 2.0 mp -101.95 163.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.802 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.53 ' HB2' ' CB ' ' A' ' 49' ' ' GLU . 3.4 mt-10 -128.49 110.62 12.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.398 -0.814 . . . . 0.0 109.2 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.522 ' CD1' ' CE1' ' A' ' 48' ' ' PHE . 30.4 mm -69.19 120.02 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.396 -0.815 . . . . 0.0 110.32 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 16.9 mmmt -130.59 107.73 15.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 109.943 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.19 49.99 3.3 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.621 1.327 . . . . 0.0 110.213 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 t30 62.68 141.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.635 -0.665 . . . . 0.0 110.196 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.09 -29.1 28.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -0.904 . . . . 0.0 110.042 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -128.52 -151.53 0.48 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.49 -0.756 . . . . 0.0 109.638 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.58 52.83 1.39 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.264 -0.897 . . . . 0.0 109.62 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -101.31 -39.56 7.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.008 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 16.4 mt -118.8 -16.78 9.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.486 -0.759 . . . . 0.0 110.142 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.21 26.73 61.79 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 5.2 m-30 -71.47 118.92 14.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.544 -0.974 . . . . 0.0 109.951 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.531 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 35.8 m0 -83.82 71.19 10.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.463 -0.773 . . . . 0.0 110.427 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -52.17 122.95 9.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.409 -0.807 . . . . 0.0 110.429 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.548 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 10.3 m-30 -105.67 102.92 12.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.146 -0.971 . . . . 0.0 109.824 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.53 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 5.1 tt0 -85.8 120.95 27.77 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.053 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.704 ' HA ' ' O ' ' A' ' 32' ' ' GLU 0.25 71.0 t90 -95.59 158.61 15.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.572 -0.705 . . . . 0.0 109.868 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 1.8 ptm180 -164.38 142.64 5.66 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 120.825 -1.172 . . . . 0.0 110.993 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.484 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.4 Cg_endo -70.77 80.98 1.12 Allowed 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.646 1.34 . . . . 0.0 110.46 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.409 ' CG2' ' HB2' ' A' ' 32' ' ' GLU . 7.5 t -127.31 7.52 6.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -0.99 . . . . 0.0 110.015 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HG2' ' HA2' ' A' ' 31' ' ' GLY . 1.2 pp20? -100.62 -169.65 1.74 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.71 -0.619 . . . . 0.0 109.8 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -99.48 109.53 55.34 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.895 . . . . 0.0 109.673 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.39 -178.49 3.41 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.544 1.287 . . . . 0.0 110.885 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.0 p -126.32 29.11 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.682 . . . . 0.0 109.686 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.77 24.22 3.74 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -132.62 104.95 6.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.323 -1.104 . . . . 0.0 110.245 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -82.06 121.74 26.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.372 -0.83 . . . . 0.0 110.054 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -118.78 -169.21 1.68 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.887 . . . . 0.0 110.32 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.559 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 10.2 p-10 -147.54 167.34 13.7 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 110.339 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.0 Cg_endo -60.58 135.12 58.65 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.636 1.335 . . . . 0.0 111.624 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.476 ' CD1' ' CE3' ' A' ' 50' ' ' TRP . 5.4 mt -128.69 112.43 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.4 p -69.62 116.5 10.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.824 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 18.1 mt -105.4 144.26 32.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.976 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.4 mt -120.03 150.45 22.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.431 -0.793 . . . . 0.0 109.755 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.482 ' CD1' ' CE2' ' A' ' 48' ' ' PHE . 56.4 mt -120.73 91.48 3.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 110.275 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.446 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 76.8 mt -131.71 108.65 14.37 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.381 -0.824 . . . . 0.0 110.111 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.82 85.24 0.97 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.64 1.337 . . . . 0.0 110.335 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.65 -39.87 0.83 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.0 -49.45 72.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.491 -1.006 . . . . 0.0 110.088 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -115.75 156.06 26.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.421 -0.8 . . . . 0.0 110.09 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.2 mmt -70.56 126.25 29.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.325 -0.859 . . . . 0.0 110.325 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.465 ' CD1' ' O ' ' A' ' 75' ' ' TRP . 47.9 p90 -96.52 124.81 40.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 109.659 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.8 m -151.39 90.24 4.06 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.211 -0.93 . . . . 0.0 110.287 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.2 -31.5 11.81 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.646 1.34 . . . . 0.0 110.493 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 50.6 mm -84.55 63.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.365 -0.834 . . . . 0.0 110.042 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -53.82 48.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.336 -0.852 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 t -83.82 168.19 16.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 110.111 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.1 m -64.43 -52.06 60.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.396 -0.815 . . . . 0.0 110.21 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -109.47 157.43 18.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.0 m 52.13 91.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.457 -0.777 . . . . 0.0 110.443 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.61 94.49 0.57 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -117.23 -27.33 6.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.355 -1.085 . . . . 0.0 110.393 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.6 mt -70.63 123.62 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.232 -0.918 . . . . 0.0 110.385 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.97 114.5 19.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.37 -0.831 . . . . 0.0 109.799 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.458 ' CB ' ' CE2' ' A' ' 98' ' ' PHE . . . -101.43 132.16 47.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.63 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -124.43 105.33 9.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.439 -0.788 . . . . 0.0 109.689 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.89 108.21 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.35 -0.844 . . . . 0.0 110.499 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -73.13 -68.77 0.46 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 0.0 109.993 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.2 p -141.94 -68.93 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.95 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.5 p -170.58 45.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.47 -0.768 . . . . 0.0 109.981 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -161.96 -33.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.868 . . . . 0.0 110.894 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -119.94 49.87 1.35 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.193 -0.942 . . . . 0.0 110.967 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.43 111.47 23.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.151 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 47.3 m-85 -114.68 158.09 22.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.62 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.458 ' CE2' ' CB ' ' A' ' 88' ' ' ALA . 63.0 m-85 -133.76 146.56 50.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.519 -0.738 . . . . 0.0 109.721 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 97' ' ' TYR . 48.8 m-85 -142.4 165.96 25.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.217 -0.927 . . . . 0.0 110.787 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.47 ' CD2' ' HB3' ' A' ' 26' ' ' PRO . 2.2 p-90 -159.44 146.84 17.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.46 -0.775 . . . . 0.0 109.99 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.254 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.188 0.518 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.6 t -95.41 84.16 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.31 -0.868 . . . . 0.0 110.373 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -84.42 163.12 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.815 . . . . 0.0 109.516 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HG3' ' CG ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -123.57 139.93 53.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.437 -0.79 . . . . 0.0 110.106 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.53 -174.98 3.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 110.079 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.98 134.88 54.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.781 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.407 ' CB ' ' CD1' ' A' ' 33' ' ' ILE . . . -163.93 -157.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.569 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -149.67 151.64 23.72 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.2 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.52 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.5 t -89.84 -136.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.609 -0.936 . . . . 0.0 109.32 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.401 ' CB ' ' CB ' ' A' ' 98' ' ' PHE . 0.9 OUTLIER -162.71 109.0 1.21 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.04 -1.038 . . . . 0.0 109.906 179.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.587 ' HG2' HD11 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -76.78 152.53 35.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.367 -0.833 . . . . 0.0 109.995 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -138.01 149.21 45.88 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.677 -0.639 . . . . 0.0 110.07 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -123.96 140.68 52.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.458 -0.776 . . . . 0.0 110.207 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.419 ' HG3' ' CE1' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -81.53 -26.35 35.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.405 -0.809 . . . . 0.0 110.212 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.45 -34.23 70.62 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.352 -0.843 . . . . 0.0 110.192 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -124.65 -2.07 7.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.423 -0.798 . . . . 0.0 110.413 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 52.42 58.98 4.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 0.0 110.219 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.88 160.14 28.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.438 -0.789 . . . . 0.0 110.542 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -119.25 72.49 0.9 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.393 -0.817 . . . . 0.0 110.133 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 p -80.07 156.38 74.43 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.281 -0.887 . . . . 0.0 110.306 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.458 ' HB2' ' CE2' ' A' ' 100' ' ' TRP . 44.8 Cg_endo -72.44 151.99 54.14 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.783 1.412 . . . . 0.0 110.256 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.587 HD11 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -84.23 137.66 39.7 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.873 . . . . 0.0 109.494 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.464 ' HD2' HG23 ' A' ' 27' ' ' ILE . 42.5 Cg_endo -69.29 -11.28 31.09 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.716 1.377 . . . . 0.0 111.038 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.8 t -100.28 115.43 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 110.083 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.69 81.44 8.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.383 -0.823 . . . . 0.0 110.021 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.66 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.43 -161.4 0.1 OUTLIER Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.765 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 65.1 mt-10 -126.45 151.68 47.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -1.07 . . . . 0.0 112.299 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.471 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -101.86 169.0 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.033 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 49' ' ' GLU . 15.0 mt-10 -144.21 112.83 6.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.431 -0.793 . . . . 0.0 109.752 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.544 ' CD1' ' CE1' ' A' ' 48' ' ' PHE . 32.4 mm -69.84 120.42 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.441 -0.787 . . . . 0.0 110.201 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 1.0 OUTLIER -126.11 114.08 23.97 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.211 -0.931 . . . . 0.0 109.916 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -85.59 52.34 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.802 1.422 . . . . 0.0 109.864 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.82 155.52 0.07 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.583 -0.698 . . . . 0.0 109.872 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.76 -42.52 97.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.638 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -131.12 30.44 4.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.392 -0.818 . . . . 0.0 110.411 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 51.23 54.82 10.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.289 -0.882 . . . . 0.0 110.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -99.36 -40.65 7.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 109.733 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.18 -6.88 19.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 110.186 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.12 27.53 70.66 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.468 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 5.1 m-30 -89.45 118.82 29.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -1.076 . . . . 0.0 109.953 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.59 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 10.2 m0 -84.97 73.52 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.502 ' HB2' ' CG ' ' A' ' 36' ' ' LYS . 41.6 m-20 -55.34 139.86 41.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.357 -0.84 . . . . 0.0 110.327 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 10.0 m-30 -109.75 102.27 11.08 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.862 0.839 . . . . 0.0 109.289 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.531 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.7 mt-10 -82.4 130.59 35.14 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.805 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.765 ' HA ' ' O ' ' A' ' 32' ' ' GLU 0.252 68.7 t90 -105.45 161.45 14.32 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.394 -0.816 . . . . 0.0 109.501 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 2.4 ptm85 -166.93 142.03 3.43 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 120.795 -1.191 . . . . 0.0 111.011 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.477 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 48.2 Cg_endo -70.75 80.53 1.15 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.633 1.333 . . . . 0.0 110.102 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.404 HG23 ' HG3' ' A' ' 32' ' ' GLU . 6.3 t -127.06 9.64 6.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.266 -0.896 . . . . 0.0 109.93 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.532 ' HG2' ' HA2' ' A' ' 31' ' ' GLY . 0.5 OUTLIER -100.15 -169.53 1.74 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.785 -0.572 . . . . 0.0 109.724 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -89.1 110.44 38.22 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 54' ' ' GLU . 50.6 Cg_endo -84.22 171.61 10.07 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.538 1.283 . . . . 0.0 110.931 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.2 p -129.25 28.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 110.047 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.19 17.2 6.33 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -129.49 102.46 6.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -1.151 . . . . 0.0 110.201 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.66 109.61 14.22 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.405 -0.809 . . . . 0.0 110.318 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.9 mt -105.65 -166.95 1.26 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.289 -0.882 . . . . 0.0 110.34 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.516 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 3.7 p30 -148.94 165.86 16.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.769 . . . . 0.0 110.299 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.7 Cg_endo -61.82 145.5 97.1 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.646 1.34 . . . . 0.0 111.813 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.473 HD13 ' CE3' ' A' ' 50' ' ' TRP . 4.8 mt -136.73 113.4 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.9 m -70.56 115.52 9.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 109.736 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 42.8 mt -102.82 149.75 24.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.877 . . . . 0.0 110.012 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.7 mm -117.15 158.16 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.299 -0.876 . . . . 0.0 109.717 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.483 ' CD1' ' CZ ' ' A' ' 48' ' ' PHE . 71.8 mt -129.52 94.33 3.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.468 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 68.0 mt -135.68 103.57 10.12 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.453 -0.779 . . . . 0.0 110.149 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.43 68.83 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.668 1.352 . . . . 0.0 110.394 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.04 -39.29 0.18 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.45 -74.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.357 -1.084 . . . . 0.0 110.15 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -75.19 -164.23 0.3 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.408 -0.808 . . . . 0.0 110.013 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpp -134.34 125.73 28.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.328 -0.858 . . . . 0.0 110.211 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -80.29 111.44 16.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.381 -0.824 . . . . 0.0 110.167 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.92 106.03 41.99 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 0.0 110.013 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.38 177.86 6.83 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.693 1.365 . . . . 0.0 110.46 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.1 mt -144.22 -56.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 110.164 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.3 mttt 52.14 45.15 28.88 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.413 -0.804 . . . . 0.0 110.46 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.5 p -78.76 -55.23 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.236 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.2 m -67.03 155.86 37.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.37 -0.831 . . . . 0.0 110.202 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -68.26 133.95 49.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.359 -0.838 . . . . 0.0 110.203 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.5 m 52.26 86.48 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.355 -0.841 . . . . 0.0 110.523 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -174.04 175.97 46.51 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -159.22 127.65 5.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.421 -1.046 . . . . 0.0 110.214 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.8 mt -133.7 105.78 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.342 -0.849 . . . . 0.0 110.301 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -86.16 108.57 18.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.781 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.447 ' CB ' ' CD2' ' A' ' 98' ' ' PHE . . . -98.74 151.0 21.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.819 . . . . 0.0 110.626 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.86 119.54 31.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.839 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.403 ' N ' HG23 ' A' ' 73' ' ' THR . 79.3 t -115.11 132.4 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.9 . . . . 0.0 110.472 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.406 ' CD2' ' OG ' ' A' ' 92' ' ' SER . 46.5 t80 -101.7 -77.1 0.55 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.418 -0.801 . . . . 0.0 110.133 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.406 ' OG ' ' CD2' ' A' ' 91' ' ' PHE . 10.0 p -175.87 -59.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.269 -0.894 . . . . 0.0 110.301 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.6 t -60.88 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.458 -0.776 . . . . 0.0 110.406 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -166.36 20.1 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 110.782 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -94.37 48.11 1.22 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.264 -0.897 . . . . 0.0 110.149 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -94.05 119.47 32.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.421 -0.799 . . . . 0.0 110.205 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 29.4 m-85 -114.6 162.03 17.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 0.0 110.546 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.447 ' CD2' ' CB ' ' A' ' 88' ' ' ALA . 33.8 m-85 -129.81 141.25 50.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.837 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 97' ' ' TYR . 23.2 m-85 -137.78 163.1 32.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.209 -0.932 . . . . 0.0 110.517 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.458 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 1.8 p-90 -158.5 165.97 33.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 110.1 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 110.148 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 60.6 m . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.218 0.532 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 82.4 t -110.45 85.32 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.413 -0.804 . . . . 0.0 110.069 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.468 ' CG2' ' HB ' ' A' ' 35' ' ' ILE . 14.9 tt -105.61 177.62 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.365 -0.834 . . . . 0.0 108.956 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 2.7 ptmt -146.6 158.29 43.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.826 -1.171 . . . . 0.0 111.094 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -134.23 -174.76 3.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 109.925 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -110.23 139.76 45.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.424 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.56 -158.44 0.51 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.428 -0.795 . . . . 0.0 110.131 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.428 ' O ' ' CD2' ' A' ' 99' ' ' PHE . . . -151.12 157.01 26.97 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.485 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 0.9 OUTLIER -93.91 -140.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.494 -1.003 . . . . 0.0 110.047 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 98' ' ' PHE . 1.6 m -157.56 109.32 2.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 109.573 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.425 ' N ' HG12 ' A' ' 27' ' ' ILE . 5.4 pt-20 -79.59 150.5 31.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 110.082 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -133.22 148.19 52.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.612 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -115.61 133.38 56.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 0.0 110.291 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -79.03 -25.6 43.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.5 -0.75 . . . . 0.0 110.246 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -62.86 -33.84 76.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 0.0 110.017 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 m -122.8 -2.65 8.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.479 -0.763 . . . . 0.0 110.373 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.419 ' HA ' ' CE2' ' A' ' 17' ' ' TYR . 7.7 mtp180 52.23 57.46 6.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.154 -0.966 . . . . 0.0 110.226 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.23 162.34 20.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.336 -0.852 . . . . 0.0 110.356 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -120.59 95.36 4.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 0.0 110.296 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.5 p -106.69 157.92 34.0 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 110.122 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HB2' ' CE2' ' A' ' 100' ' ' TRP . 44.0 Cg_endo -72.05 146.1 46.05 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.84 1.442 . . . . 0.0 110.267 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.491 HG23 ' HD2' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -82.04 138.83 45.93 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.491 ' HD2' HG23 ' A' ' 27' ' ' ILE . 41.2 Cg_endo -67.02 -13.69 40.86 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.656 1.345 . . . . 0.0 110.496 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.6 t -86.31 115.68 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 109.817 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -93.74 68.5 3.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.069 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.436 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.67 -150.91 0.01 OUTLIER Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 2.6 pt-20 -145.1 155.53 43.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.053 -1.263 . . . . 0.0 110.496 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.535 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 96.3 mt -102.05 167.6 2.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.599 -0.688 . . . . 0.0 110.096 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 49' ' ' GLU . 8.0 mt-10 -131.29 109.33 10.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.648 -0.658 . . . . 0.0 109.58 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.551 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -68.6 123.52 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 109.291 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -126.99 137.89 31.54 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 110.31 -179.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' O ' ' CG ' ' A' ' 38' ' ' ASN . 49.8 Cg_endo -90.8 57.25 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.38 1.387 . . . . 0.0 109.751 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.446 ' CG ' ' O ' ' A' ' 37' ' ' PRO . 11.9 p30 43.26 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.902 -0.499 . . . . 0.0 110.79 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -75.75 -76.35 0.16 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.939 . . . . 0.0 110.45 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -139.63 69.48 1.36 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.397 -0.815 . . . . 0.0 110.45 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 50.64 55.16 9.94 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.367 -0.833 . . . . 0.0 110.492 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -111.02 -40.36 4.51 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.37 -0.831 . . . . 0.0 109.739 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -117.76 -11.2 10.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.528 -0.732 . . . . 0.0 110.08 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.26 29.7 72.0 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.466 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 4.3 m-30 -91.78 119.64 31.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.995 . . . . 0.0 110.09 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.555 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 93.9 m95 -79.71 77.19 6.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 110.189 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 1.9 t0 -54.09 130.02 36.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 0.0 109.961 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 66' ' ' LEU . 3.8 m-30 -110.49 103.14 11.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.194 -0.941 . . . . 0.0 109.68 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 34' ' ' GLU . 31.6 tt0 -87.59 119.03 27.49 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.669 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.55 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 67.7 t90 -93.2 169.28 10.52 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.521 -0.737 . . . . 0.0 109.449 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.457 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 0.7 OUTLIER -176.57 145.99 0.71 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.215 -0.928 . . . . 0.0 110.801 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.523 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 50.0 Cg_endo -74.68 78.7 2.72 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.595 1.313 . . . . 0.0 109.675 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.1 t -115.37 2.35 13.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.146 -0.971 . . . . 0.0 109.762 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 30' ' ' GLN . 54.9 mm-40 -109.84 -168.76 1.36 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 113.22 43.11 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.186 -0.946 . . . . 0.0 110.273 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.458 ' O ' ' CG1' ' A' ' 57' ' ' VAL . 45.0 Cg_endo -76.55 -61.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.618 1.325 . . . . 0.0 110.547 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.458 ' CG1' ' O ' ' A' ' 56' ' ' PRO . 10.9 p 37.93 34.34 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-O 121.408 0.623 . . . . 0.0 111.109 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.43 -47.25 0.02 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.533 ' O ' ' HG3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -172.59 133.73 0.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -1.195 . . . . 0.0 109.899 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -53.94 124.53 15.71 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.275 -0.891 . . . . 0.0 110.529 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.406 ' CD2' ' HD2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -113.89 -171.17 1.85 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.328 -0.858 . . . . 0.0 110.421 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.523 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 5.8 m-20 -160.82 168.43 11.75 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.462 -0.774 . . . . 0.0 110.003 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.8 Cg_endo -62.12 131.84 36.41 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.746 1.393 . . . . 0.0 111.646 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.453 ' CD1' ' CE3' ' A' ' 50' ' ' TRP . 4.9 mt -127.16 114.87 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.769 -0.582 . . . . 0.0 109.536 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 p -69.91 118.03 12.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 110.375 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 17.5 mt -109.72 148.97 30.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.232 -0.917 . . . . 0.0 109.825 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.5 mt -122.33 147.23 26.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.391 -0.818 . . . . 0.0 109.855 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.465 ' CD1' ' CE2' ' A' ' 48' ' ' PHE . 53.2 mt -121.14 106.41 11.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.37 -0.831 . . . . 0.0 110.283 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.466 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 72.6 mt -135.56 118.85 12.71 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.349 -0.844 . . . . 0.0 109.987 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.11 77.18 2.44 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.574 1.302 . . . . 0.0 110.507 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.09 -56.43 0.41 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -60.85 -58.47 8.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.369 -1.077 . . . . 0.0 110.218 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.7 m -99.0 145.1 27.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.842 . . . . 0.0 110.188 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.32 132.41 53.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -0.826 . . . . 0.0 110.29 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 75' ' ' TRP . 36.5 p90 -88.94 140.47 29.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.441 -0.787 . . . . 0.0 110.259 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.9 t -141.02 100.39 6.47 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.81 -13.11 19.88 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.771 1.406 . . . . 0.0 110.813 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 mp 52.38 91.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -96.96 117.03 30.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.863 . . . . 0.0 110.179 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 80.1 p -156.6 120.79 4.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.386 -0.821 . . . . 0.0 110.09 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.5 t 52.38 -155.44 0.18 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.441 -0.787 . . . . 0.0 110.383 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 69.38 0.56 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.345 -0.847 . . . . 0.0 110.25 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.73 173.01 9.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.302 -0.873 . . . . 0.0 110.229 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.23 53.71 0.05 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.14 2.76 5.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.31 -1.112 . . . . 0.0 110.729 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.6 mm -88.69 85.14 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.167 -0.958 . . . . 0.0 110.21 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -75.35 95.54 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.864 . . . . 0.0 109.742 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.448 ' HB3' ' CE2' ' A' ' 98' ' ' PHE . . . -85.11 120.85 27.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.819 . . . . 0.0 110.774 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mp -106.07 77.93 1.27 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.416 -0.803 . . . . 0.0 109.752 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.469 ' HB ' ' CD ' ' A' ' 96' ' ' ARG . 30.6 m -81.99 123.59 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.395 -0.816 . . . . 0.0 110.939 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.14 -75.12 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.389 -0.819 . . . . 0.0 110.128 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.5 m -131.85 -67.27 0.68 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 110.145 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.06 43.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.435 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -167.92 -38.18 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.261 -0.899 . . . . 0.0 110.442 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -114.58 50.25 0.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 110.475 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.469 ' CD ' ' HB ' ' A' ' 90' ' ' VAL . 33.9 mtm180 -90.95 112.23 24.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.344 -0.847 . . . . 0.0 110.232 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -99.9 138.71 36.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.381 -0.825 . . . . 0.0 110.628 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 88' ' ' ALA . 4.7 m-85 -102.74 142.81 33.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.446 -0.784 . . . . 0.0 109.427 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.451 ' CZ ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -142.62 168.63 19.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -0.992 . . . . 0.0 110.616 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.485 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 1.1 p-90 -159.65 153.81 23.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.491 -0.756 . . . . 0.0 110.003 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.35 -0.844 . . . . 0.0 110.368 -179.878 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.0 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.482 0.658 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 85.4 t -91.16 75.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.611 -0.681 . . . . 0.0 109.904 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -72.1 167.43 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.341 -0.849 . . . . 0.0 109.824 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -124.31 136.04 53.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.508 -0.745 . . . . 0.0 109.932 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.83 -177.45 3.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 109.917 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.63 139.3 54.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 110.466 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.69 -155.53 0.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.45 -0.781 . . . . 0.0 109.888 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.436 ' HA3' ' CD1' ' A' ' 100' ' ' TRP . . . -144.52 150.65 22.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.499 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.4 t -90.68 -139.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.481 -1.011 . . . . 0.0 109.735 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -159.05 107.69 1.87 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.081 -1.012 . . . . 0.0 109.66 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.401 ' H ' HG12 ' A' ' 27' ' ' ILE . 8.8 pt-20 -79.37 147.58 32.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.469 -0.769 . . . . 0.0 109.842 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.437 ' CD1' ' C ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -123.25 148.69 45.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.887 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 22' ' ' ARG . 9.6 t30 -111.5 118.78 36.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.815 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -72.91 -25.32 61.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.784 . . . . 0.0 110.412 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.25 -32.96 74.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.773 . . . . 0.0 110.544 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.93 3.2 5.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.366 -0.834 . . . . 0.0 110.687 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' ASN . 4.3 mtp180 51.22 56.43 7.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.191 -0.943 . . . . 0.0 110.048 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 pp -112.94 167.82 10.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.83 . . . . 0.0 110.739 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.6 p -126.59 111.28 14.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.488 -0.757 . . . . 0.0 110.074 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.4 p -127.9 159.77 64.77 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.187 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' CB ' ' CD2' ' A' ' 100' ' ' TRP . 44.4 Cg_endo -72.2 142.12 37.21 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.833 1.438 . . . . 0.0 110.138 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.499 ' CD1' ' HB ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -80.31 139.4 52.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.492 ' HD2' HG21 ' A' ' 27' ' ' ILE . 40.1 Cg_endo -65.94 -27.81 50.52 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.581 1.306 . . . . 0.0 110.555 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.3 p -84.72 115.31 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.877 . . . . 0.0 109.787 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -93.32 79.41 4.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.308 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA2' ' HG2' ' A' ' 54' ' ' GLU . . . -61.98 -154.2 0.05 OUTLIER Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -137.97 160.57 38.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.115 -1.227 . . . . 0.0 110.434 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.531 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -103.12 176.88 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.409 0.623 . . . . 0.0 110.312 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.469 ' HB2' ' CB ' ' A' ' 49' ' ' GLU . 2.7 mt-10 -138.59 108.16 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.548 HG13 ' CE1' ' A' ' 48' ' ' PHE . 1.5 mp -68.51 126.1 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.203 -0.935 . . . . 0.0 108.935 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 28.1 mtpt -134.64 140.95 36.97 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.045 -1.034 . . . . 0.0 110.623 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -88.06 53.63 2.27 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.739 1.389 . . . . 0.0 109.965 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 t30 66.22 -177.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.646 -0.659 . . . . 0.0 110.075 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -77.27 -25.96 51.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.291 -0.881 . . . . 0.0 110.848 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -148.23 28.5 0.9 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.235 -0.916 . . . . 0.0 110.471 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 50.57 49.38 20.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.393 -0.817 . . . . 0.0 110.576 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.499 ' HG3' ' HG ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -116.46 -26.18 7.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -0.915 . . . . 0.0 110.616 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.499 ' HG ' ' HG3' ' A' ' 42' ' ' GLU . 14.7 mt -106.3 -8.48 17.24 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.12 -0.988 . . . . 0.0 110.002 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.27 27.47 70.71 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 6.4 m-30 -90.2 119.8 30.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.456 -1.026 . . . . 0.0 109.926 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.494 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 4.4 m-90 -75.44 76.91 2.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.081 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -54.79 122.72 11.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.443 -0.786 . . . . 0.0 109.989 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.548 ' CE1' HG13 ' A' ' 35' ' ' ILE . 4.7 m-30 -106.97 102.81 12.14 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.002 -1.061 . . . . 0.0 109.774 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.469 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.9 tp10 -87.71 126.68 35.12 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.778 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.561 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 75.6 t90 -99.18 172.42 7.38 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.459 -0.776 . . . . 0.0 109.817 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -179.79 145.29 0.41 Allowed Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.338 -0.851 . . . . 0.0 110.759 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 48.9 Cg_endo -71.88 80.98 1.43 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.808 1.425 . . . . 0.0 109.799 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.1 t -120.51 11.34 11.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 109.696 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.426 ' HG2' ' HA2' ' A' ' 31' ' ' GLY . 0.9 OUTLIER -100.63 -169.65 1.74 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.988 -0.445 . . . . 0.0 109.837 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.27 109.5 50.09 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -78.79 145.82 20.43 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.398 1.209 . . . . 0.0 110.81 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.3 t -142.32 29.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 109.632 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.29 -61.83 0.02 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -131.22 -157.59 0.83 Allowed 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.374 -1.074 . . . . 0.0 109.661 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -150.96 146.09 26.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.6 -0.687 . . . . 0.0 110.339 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -131.29 -161.13 1.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.301 -0.874 . . . . 0.0 110.513 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 1.7 m-20 -147.08 171.97 5.74 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.434 -0.791 . . . . 0.0 109.704 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 36.2 Cg_endo -58.43 135.87 70.61 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.528 1.278 . . . . 0.0 111.859 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.46 HD12 ' CE3' ' A' ' 50' ' ' TRP . 4.7 mt -128.94 116.74 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.58 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -69.76 118.87 13.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.215 -0.928 . . . . 0.0 110.059 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 15.8 mt -109.57 145.16 36.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.396 -0.815 . . . . 0.0 109.781 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 67' ' ' ILE . 17.0 mt -119.94 148.02 23.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.33 -0.857 . . . . 0.0 110.066 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.477 ' CD1' ' CE2' ' A' ' 48' ' ' PHE . 62.9 mt -125.57 97.56 5.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.437 -0.789 . . . . 0.0 110.282 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.446 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 61.6 mt -131.29 108.93 14.94 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.256 -0.902 . . . . 0.0 110.23 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.3 80.84 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.603 1.317 . . . . 0.0 110.214 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.05 -30.11 0.73 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -89.87 -34.53 16.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.429 -1.042 . . . . 0.0 110.164 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.406 HG22 ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -104.3 168.95 8.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.416 -0.802 . . . . 0.0 110.043 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 tpp -109.66 151.42 26.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.393 -0.817 . . . . 0.0 110.387 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -90.78 119.28 30.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 110.076 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.7 t -138.15 113.96 9.01 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.148 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -74.28 -79.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.497 1.262 . . . . 0.0 110.514 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -144.0 174.83 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.073 -1.017 . . . . 0.0 110.128 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -102.39 -65.41 0.99 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.21 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 t -133.22 99.16 4.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.402 -0.812 . . . . 0.0 110.269 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -166.09 168.01 15.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.858 . . . . 0.0 110.223 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -99.09 27.39 5.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.383 -0.823 . . . . 0.0 110.193 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.6 t -160.9 177.65 10.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.413 -0.805 . . . . 0.0 110.13 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.76 101.84 0.21 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -140.58 22.65 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.329 -1.101 . . . . 0.0 110.261 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.67 108.32 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.1 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.69 79.9 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 0.0 109.994 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.36 113.43 12.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.124 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.406 ' HB3' HG22 ' A' ' 73' ' ' THR . 6.2 mt -104.84 125.71 51.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.9 t -114.94 109.63 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 110.417 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.405 ' N ' HG23 ' A' ' 73' ' ' THR . 0.2 OUTLIER -67.0 -78.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.333 -0.854 . . . . 0.0 110.236 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.2 t -176.44 -70.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.181 -0.949 . . . . 0.0 110.491 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.2 m -57.69 -83.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.319 -0.863 . . . . 0.0 110.446 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.35 15.64 0.39 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 110.72 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -99.85 50.95 0.91 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 110.13 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -90.36 121.48 32.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.448 -0.782 . . . . 0.0 110.095 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 26.6 m-85 -106.44 162.63 13.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.313 -0.867 . . . . 0.0 110.506 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.414 ' O ' ' CD1' ' A' ' 99' ' ' PHE . 8.3 m-85 -137.6 141.51 41.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 109.536 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.436 ' CE1' HD23 ' A' ' 66' ' ' LEU . 19.8 m-85 -135.58 161.71 34.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 110.409 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.465 ' CD2' ' CB ' ' A' ' 26' ' ' PRO . 3.0 p-90 -143.77 162.76 35.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.73 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.834 . . . . 0.0 110.242 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.2 m . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.198 0.523 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.51 76.12 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.726 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.477 HD12 HG22 ' A' ' 8' ' ' ILE . 0.7 OUTLIER -89.18 168.48 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.531 -0.73 . . . . 0.0 109.751 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.44 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 8.9 mttt -130.38 131.19 45.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -124.4 131.92 53.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -79.45 121.88 25.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.344 -0.848 . . . . 0.0 110.48 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.68 -154.83 0.57 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.436 -0.79 . . . . 0.0 110.039 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.92 159.04 26.9 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.481 ' CG2' ' CE2' ' A' ' 50' ' ' TRP . 1.3 t -95.52 -137.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.388 -1.066 . . . . 0.0 109.52 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 42.5 t -162.46 107.96 1.21 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.973 -1.08 . . . . 0.0 110.033 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.493 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -77.37 161.49 27.99 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.377 -0.827 . . . . 0.0 110.112 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -145.63 141.72 28.41 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.892 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -107.75 135.33 49.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 110.135 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -79.54 -25.12 41.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.538 -0.726 . . . . 0.0 110.156 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.81 -39.28 91.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -115.73 -5.68 12.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 0.0 110.363 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.424 ' HA ' ' CE2' ' A' ' 17' ' ' TYR . 0.2 OUTLIER 54.41 58.75 4.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.254 -0.904 . . . . 0.0 110.287 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.42 169.78 14.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.268 -0.895 . . . . 0.0 110.414 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.3 141.53 52.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.45 -0.781 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.83 163.71 25.96 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.829 . . . . 0.0 110.26 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HB3' ' CD2' ' A' ' 100' ' ' TRP . 47.2 Cg_endo -72.53 135.38 24.07 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.75 1.395 . . . . 0.0 110.206 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.493 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.51 138.4 44.5 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.932 . . . . 0.0 109.786 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 27' ' ' ILE . 48.1 Cg_endo -74.77 51.86 2.81 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.75 1.395 . . . . 0.0 110.747 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.4 t -152.19 116.12 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.176 -0.953 . . . . 0.0 109.815 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -80.89 70.14 7.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 110.212 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.622 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -59.12 -167.48 0.19 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.717 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 26.4 mt-10 -129.7 138.72 51.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -1.151 . . . . 0.0 112.29 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 48' ' ' PHE . 39.9 mt -101.79 167.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.487 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -136.75 113.81 10.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.335 -0.853 . . . . 0.0 109.425 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 1.2 mp -68.35 123.71 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.334 -0.854 . . . . 0.0 109.106 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -132.88 142.81 46.08 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.292 -0.88 . . . . 0.0 110.282 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -88.1 52.76 2.13 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.656 1.345 . . . . 0.0 109.978 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 t30 64.83 161.54 0.12 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.532 -0.73 . . . . 0.0 109.991 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.36 -56.21 20.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.401 -0.812 . . . . 0.0 110.636 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -128.06 36.84 4.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.456 -0.777 . . . . 0.0 110.331 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 51.31 52.33 15.05 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 0.0 110.406 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -102.28 -38.67 7.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.432 -0.792 . . . . 0.0 109.781 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 11.8 mt -108.06 -8.79 15.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.574 -0.703 . . . . 0.0 110.262 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.23 27.36 71.43 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.467 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 12.6 m-30 -88.46 120.5 29.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.39 -1.065 . . . . 0.0 110.033 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.562 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 22.8 m-90 -68.06 75.66 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.844 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 6.3 t0 -52.31 129.84 29.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.355 -0.841 . . . . 0.0 110.283 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.517 ' CE1' HG13 ' A' ' 35' ' ' ILE . 6.8 m-30 -110.54 103.0 11.54 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.487 -0.758 . . . . 0.0 109.673 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.418 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -83.84 116.58 22.81 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.218 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.74 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 74.2 t90 -94.7 154.05 17.5 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.664 -0.648 . . . . 0.0 109.683 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.9 OUTLIER -163.27 138.56 5.13 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.931 -1.106 . . . . 0.0 110.638 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.514 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 44.0 Cg_endo -68.6 81.1 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.55 1.289 . . . . 0.0 110.372 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.412 ' CG2' ' HB2' ' A' ' 32' ' ' GLU . 7.0 t -120.86 5.68 10.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.383 -0.823 . . . . 0.0 109.473 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.47 ' HG2' ' HA2' ' A' ' 31' ' ' GLY . 0.8 OUTLIER -100.34 -169.68 1.76 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 109.71 51.54 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.2 -0.937 . . . . 0.0 109.908 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -81.08 -179.22 4.9 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.464 1.244 . . . . 0.0 110.801 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.1 p -131.18 29.38 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.794 . . . . 0.0 109.895 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.75 22.79 3.53 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -134.59 105.6 6.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -1.184 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -80.95 132.54 35.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 0.0 110.338 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 mt -129.82 -158.71 0.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 110.177 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.514 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -162.66 172.23 5.6 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.28 -0.888 . . . . 0.0 110.269 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.74 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.2 Cg_endo -61.36 126.44 19.3 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.72 1.379 . . . . 0.0 111.308 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.535 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 9.9 mt -124.96 111.33 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.788 -0.57 . . . . 0.0 110.088 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.9 m -69.8 117.48 11.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.144 -0.973 . . . . 0.0 109.438 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 26.7 mt -104.04 144.32 31.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.294 -0.879 . . . . 0.0 110.398 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 67' ' ' ILE . 8.8 mm -113.04 148.39 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.421 -0.8 . . . . 0.0 109.585 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.462 ' CD1' ' CE2' ' A' ' 48' ' ' PHE . 77.7 mt -121.71 87.57 2.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 110.188 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.467 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 74.2 mt -127.71 108.48 20.58 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.447 -0.783 . . . . 0.0 110.019 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.39 64.01 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.58 1.305 . . . . 0.0 110.449 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.85 -37.32 0.1 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -71.48 -53.35 14.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.339 -1.095 . . . . 0.0 110.227 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.25 148.24 25.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.416 -0.803 . . . . 0.0 110.2 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mmt -76.12 132.64 40.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.422 -0.799 . . . . 0.0 110.194 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.44 83.17 4.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.408 -0.807 . . . . 0.0 110.051 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.85 139.23 19.91 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 110.096 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -74.87 -78.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.7 1.369 . . . . 0.0 110.688 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.0 tt -166.48 160.77 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.172 -0.955 . . . . 0.0 110.167 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -58.75 164.93 2.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.289 -0.882 . . . . 0.0 110.265 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.9 t 53.07 -162.32 0.1 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.335 -0.853 . . . . 0.0 110.421 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 p -131.46 52.4 2.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.419 -0.801 . . . . 0.0 110.226 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.94 -49.65 7.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.363 -0.836 . . . . 0.0 110.157 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -155.84 -160.27 1.0 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.316 -0.865 . . . . 0.0 110.183 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.19 57.43 0.11 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.45 -39.14 8.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.326 -1.103 . . . . 0.0 110.114 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 2.1 tt -80.88 105.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.309 -0.87 . . . . 0.0 110.188 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -69.71 139.36 53.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.23 117.88 28.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.47 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.32 124.14 48.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.988 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.7 t -125.37 112.39 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.36 -0.837 . . . . 0.0 110.381 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -76.17 -76.38 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.855 . . . . 0.0 110.004 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.8 m -129.85 -66.65 0.78 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.374 -0.829 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.06 36.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.373 -0.829 . . . . 0.0 110.205 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -166.67 -39.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.397 -0.815 . . . . 0.0 110.415 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -97.51 43.14 1.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.447 -0.783 . . . . 0.0 110.144 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -98.83 111.21 23.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.261 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 41.7 m-85 -113.75 159.52 19.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.381 -0.825 . . . . 0.0 110.236 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.42 ' HB2' ' CB ' ' A' ' 15' ' ' CYS . 0.4 OUTLIER -141.55 141.46 33.53 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.258 -0.901 . . . . 0.0 109.827 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 97' ' ' TYR . 6.7 m-85 -137.66 169.51 17.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.149 -0.97 . . . . 0.0 110.328 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.43 ' CD2' ' HB3' ' A' ' 26' ' ' PRO . 3.2 p-90 -150.32 161.28 42.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.185 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.286 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.272 0.558 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.9 p -78.51 86.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.5 -0.75 . . . . 0.0 110.051 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.467 HD13 ' HA ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -72.11 168.9 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.07 -1.019 . . . . 0.0 109.744 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 20.8 mttp -126.09 144.23 50.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.553 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -134.67 -174.84 3.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.795 . . . . 0.0 109.608 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.23 119.28 24.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 0.0 110.854 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.772 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . . . -150.15 -158.65 0.94 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 109.715 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' HA3' ' NE1' ' A' ' 100' ' ' TRP . . . -142.31 165.74 26.61 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.493 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 0.7 OUTLIER -103.88 -142.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.431 -1.041 . . . . 0.0 109.516 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.423 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -163.75 108.3 1.02 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.065 -1.022 . . . . 0.0 110.105 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.499 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -77.71 162.18 27.17 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.309 -0.869 . . . . 0.0 110.031 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -126.51 144.12 50.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.139 -0.625 . . . . 0.0 110.066 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.407 ' HB3' HD22 ' A' ' 23' ' ' LEU . 7.6 t-20 -110.11 124.97 52.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.903 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -24.74 52.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.368 -0.833 . . . . 0.0 110.305 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -68.55 -30.75 69.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.461 -0.775 . . . . 0.0 110.256 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -124.08 -2.21 8.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.383 -0.823 . . . . 0.0 110.61 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER 52.74 58.01 5.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.127 -0.983 . . . . 0.0 110.184 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.639 ' O ' HD23 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -128.78 164.71 22.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.901 . . . . 0.0 110.302 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.94 90.04 3.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 110.062 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.41 167.38 12.4 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 110.188 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.464 ' CB ' ' CD2' ' A' ' 100' ' ' TRP . 44.1 Cg_endo -71.35 144.52 46.01 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.756 1.398 . . . . 0.0 110.332 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.499 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.77 140.9 43.92 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 109.431 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.458 ' HD2' HG22 ' A' ' 27' ' ' ILE . 40.3 Cg_endo -66.14 -18.47 56.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.621 1.327 . . . . 0.0 110.565 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.632 HG21 ' O ' ' A' ' 59' ' ' ARG . 85.2 t -83.61 138.08 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.974 . . . . 0.0 109.459 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.19 -49.73 7.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 110.798 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . 54.82 -166.7 2.57 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.62 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -153.7 159.02 41.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.039 -1.271 . . . . 0.0 110.463 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.772 ' CD1' ' HB3' ' A' ' 12' ' ' ALA . 2.2 mp -106.69 168.7 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.507 0.67 . . . . 0.0 110.368 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 42.1 mt-10 -130.86 114.12 14.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.588 -0.695 . . . . 0.0 109.496 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 35' ' ' ILE . 1.7 mp -68.72 127.22 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 18.1 mtpt -133.41 140.93 38.61 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 0.0 110.755 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 49.8 Cg_endo -87.9 53.01 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.725 1.382 . . . . 0.0 109.973 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 65.02 164.63 0.15 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.559 -0.713 . . . . 0.0 110.121 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.33 -38.49 71.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 0.0 110.816 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -147.82 38.33 0.91 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.872 . . . . 0.0 110.389 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 51.1 49.87 20.24 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.35 -0.844 . . . . 0.0 110.438 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -103.04 -41.26 6.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -0.865 . . . . 0.0 109.807 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -106.26 -5.36 19.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.526 -0.734 . . . . 0.0 110.353 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.97 27.8 69.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 8.5 m-30 -88.22 120.67 29.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -1.027 . . . . 0.0 109.985 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.566 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 88.6 m95 -70.49 76.77 0.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -53.98 124.32 15.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.346 -0.846 . . . . 0.0 109.994 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.857 ' CD2' HD11 ' A' ' 68' ' ' LEU . 6.1 m-30 -107.29 102.85 12.12 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.164 -0.96 . . . . 0.0 109.804 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.42 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.2 tt0 -85.49 118.83 25.26 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.104 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.925 ' CE3' HD12 ' A' ' 64' ' ' ILE . 69.4 t90 -93.75 167.08 11.88 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.506 -0.746 . . . . 0.0 109.299 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.457 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 2.7 ptm180 -177.5 146.32 0.62 Allowed Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.226 -0.921 . . . . 0.0 110.832 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.553 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.1 Cg_endo -71.87 76.68 1.99 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.544 1.287 . . . . 0.0 109.945 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 t -118.26 10.0 12.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.173 -0.954 . . . . 0.0 109.848 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HB2' ' N ' ' A' ' 31' ' ' GLY . 60.9 mm-40 -116.2 -169.09 1.54 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 113.14 43.46 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.102 -0.999 . . . . 0.0 110.547 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.448 ' C ' HG23 ' A' ' 57' ' ' VAL . 50.8 Cg_endo -78.29 -167.34 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.484 1.255 . . . . 0.0 110.422 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 57' ' ' VAL . 57.7 t -148.59 49.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.464 -0.772 . . . . 0.0 110.029 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.43 5.24 72.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.632 ' O ' HG21 ' A' ' 29' ' ' VAL . 16.6 mmt180 -124.68 100.95 6.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -1.161 . . . . 0.0 110.131 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -73.88 122.98 23.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.329 -0.857 . . . . 0.0 110.367 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.423 ' HA ' HD13 ' A' ' 61' ' ' LEU . 1.4 mm? -116.53 -162.15 0.84 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.341 -0.849 . . . . 0.0 110.102 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.553 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -155.55 174.98 3.43 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.898 . . . . 0.0 110.144 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.676 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 38.3 Cg_endo -63.83 131.35 30.75 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.607 1.32 . . . . 0.0 111.526 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.925 HD12 ' CE3' ' A' ' 50' ' ' TRP . 6.5 mt -126.03 113.78 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.713 -0.617 . . . . 0.0 109.683 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.7 p -69.61 117.99 11.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 0.0 110.034 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.722 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 18.6 mt -107.76 147.42 30.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.926 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.63 ' O ' HD23 ' A' ' 68' ' ' LEU . 15.3 mt -120.03 155.64 22.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.916 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.857 HD11 ' CD2' ' A' ' 48' ' ' PHE . 50.6 mt -132.36 99.62 4.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.428 -0.795 . . . . 0.0 110.13 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.566 HG21 ' CG ' ' A' ' 72' ' ' GLU . 52.6 mt -132.4 108.02 13.4 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.135 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.2 -7.99 21.36 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.526 1.277 . . . . 0.0 110.774 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -108.34 2.84 32.87 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.566 ' CG ' HG21 ' A' ' 69' ' ' ILE . 66.8 mm-40 -133.1 -68.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.072 -1.252 . . . . 0.0 110.351 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.645 HG22 ' C ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -79.41 126.95 31.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.323 -0.86 . . . . 0.0 110.108 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ttt -70.81 137.01 49.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.383 -0.823 . . . . 0.0 110.138 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.426 ' CD2' HD21 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -87.65 122.8 31.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.345 -0.847 . . . . 0.0 110.206 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.809 . . . . 0.0 110.056 -179.981 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.128 0.489 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 72.7 mt -117.0 101.3 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.351 -0.843 . . . . 0.0 110.091 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.596 ' CE2' HD21 ' A' ' 101' ' ' LEU . 48.7 m-85 -72.17 108.47 5.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.832 . . . . 0.0 110.25 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.6 133.95 55.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 110.193 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.426 HD21 ' CD2' ' A' ' 75' ' ' TRP . 3.9 mt -112.5 116.96 31.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.848 . . . . 0.0 110.218 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.872 HG12 ' HB3' ' A' ' 96' ' ' ARG . 10.0 m -112.48 133.44 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 110.511 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.46 ' HB2' HG23 ' A' ' 73' ' ' THR . 46.6 t80 -92.03 -79.65 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.426 -0.796 . . . . 0.0 110.168 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -172.82 -39.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.199 -0.938 . . . . 0.0 110.345 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.64 -81.58 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.895 . . . . 0.0 110.385 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -150.82 15.76 0.76 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.157 -0.964 . . . . 0.0 110.822 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -90.51 49.53 1.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.162 -0.961 . . . . 0.0 110.142 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.872 ' HB3' HG12 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -105.19 111.2 23.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.364 -0.835 . . . . 0.0 110.484 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 29.3 m-85 -113.94 155.49 25.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.497 -0.752 . . . . 0.0 110.204 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.423 ' HB2' ' CB ' ' A' ' 15' ' ' CYS . 25.9 m-85 -120.74 140.28 51.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.876 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.722 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 19.6 m-85 -134.69 158.55 43.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -0.982 . . . . 0.0 110.358 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.464 ' CD2' ' CB ' ' A' ' 26' ' ' PRO . 2.6 p-90 -149.57 144.0 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 109.912 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.596 HD21 ' CE2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.238 0.542 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 58.8 t -99.8 86.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.434 -0.791 . . . . 0.0 109.999 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.535 HG22 ' H ' ' A' ' 9' ' ' LYS . 17.0 mt -94.39 175.21 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.222 -0.924 . . . . 0.0 109.627 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.535 ' H ' HG22 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -131.04 132.38 44.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.201 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -126.83 -174.61 3.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.455 -0.778 . . . . 0.0 109.439 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 23.6 mtt85 -127.09 149.53 49.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.147 -0.97 . . . . 0.0 110.826 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.692 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . . . -170.72 -155.04 0.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.48 -0.762 . . . . 0.0 109.746 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.443 ' O ' ' CD2' ' A' ' 99' ' ' PHE . . . -145.68 146.55 16.85 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.818 HG13 ' CE1' ' A' ' 99' ' ' PHE . 1.1 t -89.55 -141.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.337 -1.096 . . . . 0.0 109.621 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 98' ' ' PHE . 42.5 t -162.99 110.13 1.21 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.056 -1.027 . . . . 0.0 110.01 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.549 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -76.96 154.77 33.24 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 109.849 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.33 145.85 33.05 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.028 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -123.68 134.61 53.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.45 -0.781 . . . . 0.0 110.202 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -77.1 -27.56 54.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.413 -0.804 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.45 -37.16 72.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.355 -0.841 . . . . 0.0 110.101 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.4 p -121.42 -2.82 9.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.472 -0.767 . . . . 0.0 110.369 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 52.49 57.38 6.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.27 -0.894 . . . . 0.0 110.15 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.74 159.65 26.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -0.833 . . . . 0.0 110.403 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.06 91.92 3.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.473 -0.767 . . . . 0.0 109.871 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.1 p -103.26 164.2 15.96 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.442 -0.786 . . . . 0.0 110.281 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.471 ' HB3' ' CD2' ' A' ' 100' ' ' TRP . 44.1 Cg_endo -71.16 142.4 41.74 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.85 1.447 . . . . 0.0 110.272 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.549 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.24 136.7 46.23 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 110.051 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.478 ' C ' HG23 ' A' ' 29' ' ' VAL . 48.7 Cg_endo -75.97 52.85 3.55 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.798 1.42 . . . . 0.0 110.189 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.809 HG13 ' OE2' ' A' ' 54' ' ' GLU . 75.4 t -150.06 115.88 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.86 . . . . 0.0 109.597 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -85.29 64.73 8.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 110.43 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.468 ' N ' ' HG2' ' A' ' 54' ' ' GLU . . . -61.52 -161.51 0.16 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.566 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -140.4 155.07 46.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.876 -1.367 . . . . 0.0 111.097 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.692 ' CD1' ' HB3' ' A' ' 12' ' ' ALA . 2.0 mp -105.75 169.96 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-O 121.4 0.619 . . . . 0.0 110.437 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 17.0 mt-10 -134.52 120.26 19.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.567 -0.708 . . . . 0.0 109.405 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.577 ' N ' HD12 ' A' ' 35' ' ' ILE . 1.7 mp -69.78 127.61 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -134.74 123.12 15.93 Favored Pre-proline 0 N--CA 1.485 1.3 0 O-C-N 121.055 -1.028 . . . . 0.0 109.343 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HD2' ' HD3' ' A' ' 36' ' ' LYS . 48.8 Cg_endo -83.77 51.82 3.58 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.489 1.257 . . . . 0.0 110.07 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 62.45 150.16 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.62 -0.675 . . . . 0.0 110.028 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -52.6 -25.7 11.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.41 -0.806 . . . . 0.0 110.156 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -133.74 -154.38 0.6 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.418 -0.801 . . . . 0.0 109.747 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -123.41 52.03 1.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 109.691 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.31 -35.86 7.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.411 -0.806 . . . . 0.0 110.156 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 11.7 mt -118.23 -11.9 10.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 110.217 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.91 27.49 56.59 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.486 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 5.7 m-30 -68.3 118.31 11.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -1.02 . . . . 0.0 110.065 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 77.1 m95 -80.71 68.08 6.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.469 -0.77 . . . . 0.0 110.094 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.47 ' HB2' ' CG ' ' A' ' 36' ' ' LYS . 68.7 m-20 -53.21 137.97 33.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.444 -0.785 . . . . 0.0 110.207 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.803 ' CE2' HD11 ' A' ' 68' ' ' LEU . 5.5 m-30 -108.77 102.69 11.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.357 -0.84 . . . . 0.0 109.669 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.44 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 4.0 tt0 -82.48 121.41 26.73 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.053 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.902 ' CE3' HD12 ' A' ' 64' ' ' ILE . 71.7 t90 -93.66 171.84 8.63 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.361 -0.837 . . . . 0.0 109.508 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 1.3 ptm180 -175.44 146.2 0.88 Allowed Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.2 -0.938 . . . . 0.0 110.808 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.511 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 52.2 Cg_endo -74.82 80.17 2.44 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.711 1.374 . . . . 0.0 109.788 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.463 HG21 ' CD ' ' A' ' 32' ' ' GLU . 7.0 t -117.71 5.05 12.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.121 -0.987 . . . . 0.0 109.777 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.809 ' OE2' HG13 ' A' ' 29' ' ' VAL . 1.5 pp20? -100.9 -178.15 3.67 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.933 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -99.14 109.74 55.4 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.3 -0.875 . . . . 0.0 109.648 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -83.11 167.81 13.86 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.572 1.301 . . . . 0.0 110.679 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 57' ' ' VAL . 55.5 t -112.42 36.2 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.468 -0.77 . . . . 0.0 109.534 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.84 16.95 6.61 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.1 mmt-85 -129.99 103.26 6.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -1.154 . . . . 0.0 110.261 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -80.15 140.78 36.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.352 -0.843 . . . . 0.0 110.103 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.514 HD21 HG21 ' A' ' 27' ' ' ILE . 1.3 mp -131.62 -168.21 1.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 0.0 110.332 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.521 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 53.9 m-20 -152.07 166.73 14.64 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.499 -0.751 . . . . 0.0 109.984 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.5 Cg_endo -61.45 136.08 61.34 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.69 1.363 . . . . 0.0 111.573 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.902 HD12 ' CE3' ' A' ' 50' ' ' TRP . 5.1 mt -129.42 114.31 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 p -69.66 116.22 9.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.202 -0.936 . . . . 0.0 110.002 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.669 HD11 ' CZ ' ' A' ' 99' ' ' PHE . 29.2 mt -105.76 154.68 20.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 109.801 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.477 HG21 HD12 ' A' ' 69' ' ' ILE . 43.0 mt -125.4 152.36 32.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.613 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.803 HD11 ' CE2' ' A' ' 48' ' ' PHE . 73.7 mt -122.97 82.8 2.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.388 -0.82 . . . . 0.0 110.236 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.486 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 64.3 mt -131.19 106.6 14.83 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.465 -0.772 . . . . 0.0 110.162 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.54 63.32 4.6 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.634 1.334 . . . . 0.0 110.278 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.69 -46.58 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -60.47 -76.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.195 -1.179 . . . . 0.0 110.259 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.717 ' HB ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -71.71 -153.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.264 -0.898 . . . . 0.0 109.754 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -138.63 100.26 4.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.247 -0.908 . . . . 0.0 110.44 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.41 ' O ' ' CD2' ' A' ' 75' ' ' TRP . 64.0 p-90 -76.11 131.51 39.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.858 . . . . 0.0 110.163 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 -179.866 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 121.325 0.583 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 99' ' ' PHE . 57.7 mt -133.73 114.13 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.263 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -76.18 115.13 15.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.347 -0.845 . . . . 0.0 109.961 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.499 ' HB1' ' CE2' ' A' ' 98' ' ' PHE . . . -99.41 110.93 23.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.425 -0.797 . . . . 0.0 110.563 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.717 HD12 ' HB ' ' A' ' 73' ' ' THR . 4.1 mm? -102.01 119.08 38.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.823 . . . . 0.0 109.83 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.764 HG13 ' HG2' ' A' ' 96' ' ' ARG . 91.3 t -113.91 131.29 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 110.529 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.422 ' HB2' HG23 ' A' ' 73' ' ' THR . 33.3 t80 -100.99 -61.62 1.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.47 -0.769 . . . . 0.0 110.133 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.9 m -142.53 -50.92 0.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.558 -0.713 . . . . 0.0 110.154 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.85 -29.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.883 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -116.89 11.94 14.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 111.075 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 21.6 mt-10 -130.38 36.29 3.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 0.0 110.298 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.764 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -95.9 111.34 23.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 0.0 110.328 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 27.1 m-85 -105.79 142.59 35.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.453 -0.78 . . . . 0.0 110.295 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 20.1 m-85 -119.83 136.24 54.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.393 -0.817 . . . . 0.0 109.888 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.818 ' CE1' HG13 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -134.73 169.85 16.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.233 -0.917 . . . . 0.0 110.197 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.471 ' CD2' ' HB3' ' A' ' 26' ' ' PRO . 2.1 p-90 -158.37 175.39 13.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 110.257 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 mt . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.821 . . . . 0.0 110.147 -179.943 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.198 0.523 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.938 HG13 ' HD3' ' A' ' 36' ' ' LYS . 98.2 t -111.2 59.53 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.45 -0.781 . . . . 0.0 109.635 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 35' ' ' ILE . 15.4 tt -102.19 175.16 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 0.0 110.111 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 4.4 mptt -120.71 140.73 51.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.039 -1.038 . . . . 0.0 110.942 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -113.77 -179.11 3.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 109.686 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -113.72 127.39 56.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 110.322 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.81 -160.68 0.71 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 110.085 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.74 163.31 29.63 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.466 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.3 t -95.53 -138.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.454 -1.027 . . . . 0.0 109.85 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.416 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 34.7 t -155.53 108.12 2.69 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.148 -0.97 . . . . 0.0 109.652 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.4 ' N ' HG12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -78.82 128.39 33.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.993 -179.642 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.18 157.63 28.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.635 -0.666 . . . . 0.0 109.821 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.422 ' HB2' HD21 ' A' ' 23' ' ' LEU . 11.5 t-20 -126.22 136.26 52.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -0.837 . . . . 0.0 110.412 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -82.48 -25.33 33.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 110.154 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -35.26 77.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.363 -0.836 . . . . 0.0 109.999 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 m -120.44 -1.38 10.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.476 -0.765 . . . . 0.0 110.584 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.15 56.14 8.44 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.206 -0.934 . . . . 0.0 109.91 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 23' ' ' LEU . 3.7 pp -108.1 154.04 22.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.428 -0.795 . . . . 0.0 110.809 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.9 p -124.97 71.06 1.16 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.518 -0.739 . . . . 0.0 110.279 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 p -97.16 165.11 16.4 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.405 -0.809 . . . . 0.0 110.248 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HB2' ' CD2' ' A' ' 100' ' ' TRP . 46.2 Cg_endo -74.26 152.96 45.41 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.789 1.415 . . . . 0.0 110.332 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.466 ' CD1' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -81.97 140.89 46.74 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.219 -0.926 . . . . 0.0 109.186 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' A' ' 27' ' ' ILE . 40.7 Cg_endo -67.25 -15.24 45.52 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.559 1.294 . . . . 0.0 110.497 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.774 HG13 ' OE2' ' A' ' 54' ' ' GLU . 93.4 t -94.36 115.34 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.58 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -88.42 72.02 8.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 110.276 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.429 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.5 -160.4 0.08 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -138.48 161.21 37.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -1.193 . . . . 0.0 110.64 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 34' ' ' GLU . 96.6 mt -105.0 170.69 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.414 0.626 . . . . 0.0 110.571 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.55 ' N ' HG22 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -128.95 105.98 8.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.527 -0.733 . . . . 0.0 109.065 179.066 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.547 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 1.2 mp -68.01 125.98 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 108.655 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.938 ' HD3' HG13 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -137.03 161.93 58.6 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 110.977 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -93.14 55.41 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.677 1.585 . . . . 0.0 110.076 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.421 HD21 HD12 ' A' ' 43' ' ' LEU . 6.2 t-20 60.29 175.16 0.09 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.371 -0.831 . . . . 0.0 110.093 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.88 -65.26 0.71 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.321 -0.862 . . . . 0.0 110.628 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -122.15 37.38 4.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.776 . . . . 0.0 110.527 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 50.9 49.81 20.36 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.385 -0.822 . . . . 0.0 110.604 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.506 ' OE2' HD21 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -118.58 -24.58 6.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.326 -0.859 . . . . 0.0 110.547 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.506 HD21 ' OE2' ' A' ' 42' ' ' GLU . 14.6 mt -108.82 -12.0 14.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.132 -0.98 . . . . 0.0 109.981 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.71 26.87 72.21 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.459 ' CD2' HG12 ' A' ' 69' ' ' ILE . 13.8 m-30 -91.49 122.79 34.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -1.098 . . . . 0.0 110.134 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.572 ' HB2' HD12 ' A' ' 68' ' ' LEU . 8.8 m0 -66.78 81.87 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 0.0 109.508 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.447 ' CB ' ' HB2' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -53.64 118.42 3.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.172 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.961 ' CD2' HD11 ' A' ' 68' ' ' LEU . 3.9 m-30 -107.7 102.5 11.72 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.332 -0.855 . . . . 0.0 109.188 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.445 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -89.58 123.13 33.38 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.711 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.783 ' CE3' HD12 ' A' ' 64' ' ' ILE . 70.5 t90 -91.75 173.84 7.66 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.331 -0.855 . . . . 0.0 109.579 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 179.55 146.89 0.41 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.095 -1.003 . . . . 0.0 110.848 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.9 Cg_endo -74.61 78.14 2.82 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.851 1.448 . . . . 0.0 109.694 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t -118.02 10.58 13.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 109.645 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.774 ' OE2' HG13 ' A' ' 29' ' ' VAL . 1.3 pp20? -100.62 -169.59 1.74 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.734 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -97.04 109.64 50.18 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 109.75 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.442 ' C ' HG23 ' A' ' 57' ' ' VAL . 52.3 Cg_endo -81.75 -178.01 3.92 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.482 1.254 . . . . 0.0 110.957 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 57' ' ' VAL . 59.5 t -148.41 30.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.609 -0.682 . . . . 0.0 109.441 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.06 0.93 7.52 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.5 ' O ' HG21 ' A' ' 29' ' ' VAL . 3.0 mmt85 -123.25 100.34 6.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.26 . . . . 0.0 110.323 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.89 112.65 21.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.394 -0.816 . . . . 0.0 110.265 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.41 HD21 HD12 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -103.73 -163.46 0.98 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.37 -0.831 . . . . 0.0 110.39 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 8.8 m-20 -152.74 164.95 18.69 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.457 -0.777 . . . . 0.0 109.93 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 36.7 Cg_endo -59.4 146.45 94.86 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.648 1.341 . . . . 0.0 112.016 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.783 HD12 ' CE3' ' A' ' 50' ' ' TRP . 5.4 mt -137.51 118.02 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 p -69.67 118.16 12.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.095 -1.003 . . . . 0.0 109.787 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.725 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 24.6 mt -105.25 143.57 33.24 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.288 -0.882 . . . . 0.0 110.153 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.3 mm -112.93 139.58 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.474 -0.766 . . . . 0.0 109.751 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.961 HD11 ' CD2' ' A' ' 48' ' ' PHE . 73.1 mt -122.83 95.24 4.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -0.88 . . . . 0.0 110.214 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.459 HG12 ' CD2' ' A' ' 45' ' ' PHE . 51.2 mt -128.41 116.66 19.91 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.331 -0.856 . . . . 0.0 110.058 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.95 64.87 4.1 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.612 1.322 . . . . 0.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.77 -52.81 0.2 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.409 ' O ' ' CD1' ' A' ' 91' ' ' PHE . 13.3 mm-40 -61.86 -80.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.257 -1.143 . . . . 0.0 110.155 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.603 HG23 ' HB2' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -85.01 113.62 21.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.188 -0.945 . . . . 0.0 109.97 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.5 tpt -69.7 148.99 48.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.468 -0.77 . . . . 0.0 110.196 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -111.52 142.14 44.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.431 -0.793 . . . . 0.0 110.087 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 110.182 -179.897 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.097 0.475 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 59.9 mt -93.8 120.9 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 110.26 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -82.68 111.07 18.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.855 . . . . 0.0 110.053 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.488 ' HB1' ' CE2' ' A' ' 98' ' ' PHE . . . -92.43 97.94 11.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.294 -0.879 . . . . 0.0 110.476 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mt -93.42 105.43 17.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.434 -0.791 . . . . 0.0 109.833 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.763 HG23 ' CG ' ' A' ' 96' ' ' ARG . 7.7 p -134.87 154.56 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.309 -0.869 . . . . 0.0 110.591 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.603 ' HB2' HG23 ' A' ' 73' ' ' THR . 22.8 t80 -117.32 -70.85 0.77 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.368 -0.832 . . . . 0.0 110.093 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.0 p -133.94 -68.04 0.57 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.784 . . . . 0.0 110.057 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.0 p -166.18 30.46 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.419 -0.801 . . . . 0.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.413 ' N ' ' HD2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -135.29 -40.66 0.73 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.494 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -116.57 87.21 2.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.342 -0.849 . . . . 0.0 110.406 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.763 ' CG ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -128.12 110.4 12.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 110.223 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 97' ' ' TYR . 33.9 m-85 -127.33 154.36 45.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 110.668 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.488 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 43.2 m-85 -129.21 132.37 47.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.595 -0.691 . . . . 0.0 109.43 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.725 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 16.2 m-85 -127.1 160.84 29.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.148 -0.97 . . . . 0.0 110.403 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.484 ' CD2' ' HB2' ' A' ' 26' ' ' PRO . 2.3 p-90 -147.89 150.93 35.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.404 -0.81 . . . . 0.0 109.912 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.288 -0.882 . . . . 0.0 110.271 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.412 HG22 HG12 ' A' ' 8' ' ' ILE . 90.4 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.223 0.535 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.7 p -73.73 68.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.423 -0.798 . . . . 0.0 109.921 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -72.07 165.93 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.227 -0.921 . . . . 0.0 109.672 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.415 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 12.2 ttmt -122.43 141.77 51.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.338 -0.851 . . . . 0.0 110.34 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -135.69 -174.66 3.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.398 -0.813 . . . . 0.0 109.705 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.2 115.51 17.77 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.175 -0.953 . . . . 0.0 110.811 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.758 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . . . -137.93 -160.59 1.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.472 -0.767 . . . . 0.0 109.622 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.418 ' HA3' ' NE1' ' A' ' 100' ' ' TRP . . . -139.99 155.1 24.25 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.503 ' C ' HG13 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -96.34 -142.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.44 -1.035 . . . . 0.0 109.394 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.447 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -162.39 107.64 1.2 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.971 -1.081 . . . . 0.0 110.184 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.524 ' CG ' HD13 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -78.7 162.4 26.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.383 -0.823 . . . . 0.0 110.089 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.408 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -129.7 149.75 51.31 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.635 -0.666 . . . . 0.0 109.637 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -113.26 124.82 53.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.364 -0.835 . . . . 0.0 110.061 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 20' ' ' ASP . 9.4 pt-20 -76.36 -25.32 54.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.527 -0.733 . . . . 0.0 110.147 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.422 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 9.8 t0 -64.75 -35.04 79.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.44 -0.787 . . . . 0.0 110.087 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -118.64 -5.44 10.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.426 -0.796 . . . . 0.0 110.504 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.408 ' HA ' ' CE2' ' A' ' 17' ' ' TYR . 6.5 mtt180 54.63 60.19 3.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.142 -0.974 . . . . 0.0 110.105 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.94 158.52 43.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.307 -0.871 . . . . 0.0 110.369 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.564 ' O ' HG23 ' A' ' 25' ' ' THR . 0.1 OUTLIER -107.49 150.58 26.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -0.835 . . . . 0.0 110.055 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 24' ' ' CYS . 4.3 p -155.18 164.27 21.69 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.386 -0.821 . . . . 0.0 110.241 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.511 ' HB3' ' CD2' ' A' ' 100' ' ' TRP . 45.8 Cg_endo -71.81 137.13 29.14 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.764 1.402 . . . . 0.0 110.137 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.524 HD13 ' CG ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.94 137.6 43.43 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 109.822 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.38 54.29 3.29 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.686 1.361 . . . . 0.0 110.553 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.704 HG23 ' OE2' ' A' ' 54' ' ' GLU . 9.2 p -157.84 115.87 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.939 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -83.57 71.75 10.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.3 -0.875 . . . . 0.0 110.11 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.637 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -58.05 -167.02 0.12 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.784 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 27.6 mt-10 -128.48 138.25 52.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -1.138 . . . . 0.0 112.323 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.758 ' CD1' ' HB3' ' A' ' 12' ' ' ALA . 2.0 mp -101.95 163.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.802 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.541 ' HB2' ' CB ' ' A' ' 49' ' ' GLU . 3.4 mt-10 -128.49 110.62 12.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.398 -0.814 . . . . 0.0 109.2 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.525 HD12 ' CE1' ' A' ' 48' ' ' PHE . 30.4 mm -69.19 120.02 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.396 -0.815 . . . . 0.0 110.32 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 16.9 mmmt -130.59 107.73 15.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 109.943 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.19 49.99 3.3 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.621 1.327 . . . . 0.0 110.213 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 t30 62.68 141.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.635 -0.665 . . . . 0.0 110.196 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.09 -29.1 28.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -0.904 . . . . 0.0 110.042 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -128.52 -151.53 0.48 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.49 -0.756 . . . . 0.0 109.638 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.58 52.83 1.39 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.264 -0.897 . . . . 0.0 109.62 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.431 ' O ' HD23 ' A' ' 43' ' ' LEU . 11.6 mt-10 -101.31 -39.56 7.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.008 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.446 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 16.4 mt -118.8 -16.78 9.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.486 -0.759 . . . . 0.0 110.142 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.21 26.73 61.79 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 5.2 m-30 -71.47 118.92 14.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.544 -0.974 . . . . 0.0 109.951 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.643 ' HB2' HD12 ' A' ' 68' ' ' LEU . 35.8 m0 -83.82 71.19 10.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.463 -0.773 . . . . 0.0 110.427 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -52.17 122.95 9.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.409 -0.807 . . . . 0.0 110.429 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.886 ' CE2' HD11 ' A' ' 68' ' ' LEU . 10.3 m-30 -105.67 102.92 12.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.146 -0.971 . . . . 0.0 109.824 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.541 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 5.1 tt0 -85.8 120.95 27.77 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.053 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.919 ' CE3' HD12 ' A' ' 64' ' ' ILE 0.25 71.0 t90 -95.59 158.61 15.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.572 -0.705 . . . . 0.0 109.868 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -164.38 142.64 5.66 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 120.825 -1.172 . . . . 0.0 110.993 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.51 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.4 Cg_endo -70.77 80.98 1.12 Allowed 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.646 1.34 . . . . 0.0 110.46 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.435 HG23 ' OE2' ' A' ' 32' ' ' GLU . 7.5 t -127.31 7.52 6.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -0.99 . . . . 0.0 110.015 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.704 ' OE2' HG23 ' A' ' 29' ' ' VAL . 1.2 pp20? -100.62 -169.65 1.74 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.71 -0.619 . . . . 0.0 109.8 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -99.48 109.53 55.34 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.895 . . . . 0.0 109.673 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.39 -178.49 3.41 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.544 1.287 . . . . 0.0 110.885 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.618 ' O ' HG22 ' A' ' 57' ' ' VAL . 12.0 p -126.32 29.11 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.682 . . . . 0.0 109.686 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.77 24.22 3.74 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -132.62 104.95 6.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.323 -1.104 . . . . 0.0 110.245 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.461 ' O ' HD22 ' A' ' 61' ' ' LEU . 1.5 mp0 -82.06 121.74 26.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.372 -0.83 . . . . 0.0 110.054 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 60' ' ' GLU . 2.4 mm? -118.78 -169.21 1.68 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.887 . . . . 0.0 110.32 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.564 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 10.2 p-10 -147.54 167.34 13.7 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 110.339 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.698 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.0 Cg_endo -60.58 135.12 58.65 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.636 1.335 . . . . 0.0 111.624 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.919 HD12 ' CE3' ' A' ' 50' ' ' TRP . 5.4 mt -128.69 112.43 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.4 p -69.62 116.5 10.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.824 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.841 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 18.1 mt -105.4 144.26 32.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.976 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.4 mt -120.03 150.45 22.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.431 -0.793 . . . . 0.0 109.755 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.886 HD11 ' CE2' ' A' ' 48' ' ' PHE . 56.4 mt -120.73 91.48 3.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 110.275 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.446 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 76.8 mt -131.71 108.65 14.37 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.381 -0.824 . . . . 0.0 110.111 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.82 85.24 0.97 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.64 1.337 . . . . 0.0 110.335 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.65 -39.87 0.83 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.0 -49.45 72.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.491 -1.006 . . . . 0.0 110.088 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 91' ' ' PHE . 1.3 m -115.75 156.06 26.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.421 -0.8 . . . . 0.0 110.09 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.2 mmt -70.56 126.25 29.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.325 -0.859 . . . . 0.0 110.325 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.474 ' C ' HG13 ' A' ' 76' ' ' VAL . 47.9 p90 -96.52 124.81 40.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 109.659 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.929 HG23 ' HB3' ' A' ' 88' ' ' ALA . 29.8 m . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.211 -0.93 . . . . 0.0 110.287 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.14 0.495 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 99' ' ' PHE . 67.6 mt -70.63 123.62 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.232 -0.918 . . . . 0.0 110.385 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.97 114.5 19.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.37 -0.831 . . . . 0.0 109.799 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.929 ' HB3' HG23 ' A' ' 76' ' ' VAL . . . -101.43 132.16 47.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.63 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -124.43 105.33 9.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.439 -0.788 . . . . 0.0 109.689 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.898 HG13 ' HG2' ' A' ' 96' ' ' ARG . 58.3 t -115.89 108.21 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.35 -0.844 . . . . 0.0 110.499 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.528 ' HB2' HG23 ' A' ' 73' ' ' THR . 23.9 t80 -73.13 -68.77 0.46 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 0.0 109.993 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.2 p -141.94 -68.93 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.95 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.5 p -170.58 45.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.47 -0.768 . . . . 0.0 109.981 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -161.96 -33.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.868 . . . . 0.0 110.894 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -119.94 49.87 1.35 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.193 -0.942 . . . . 0.0 110.967 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.898 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -94.43 111.47 23.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.151 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 47.3 m-85 -114.68 158.09 22.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.62 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.673 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 63.0 m-85 -133.76 146.56 50.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.519 -0.738 . . . . 0.0 109.721 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.841 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 48.8 m-85 -142.4 165.96 25.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.217 -0.927 . . . . 0.0 110.787 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.511 ' CD2' ' HB3' ' A' ' 26' ' ' PRO . 2.2 p-90 -159.44 146.84 17.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.46 -0.775 . . . . 0.0 109.99 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 101' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.254 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.188 0.518 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 61.6 t -95.41 84.16 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.31 -0.868 . . . . 0.0 110.373 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -84.42 163.12 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.815 . . . . 0.0 109.516 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.406 ' HG3' ' CG ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -123.57 139.93 53.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.437 -0.79 . . . . 0.0 110.106 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.53 -174.98 3.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 110.079 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.98 134.88 54.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.781 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.083 ' HB3' HD11 ' A' ' 33' ' ' ILE . . . -163.93 -157.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.569 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -149.67 151.64 23.72 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.2 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.528 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.5 t -89.84 -136.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.609 -0.936 . . . . 0.0 109.32 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 0.9 OUTLIER -162.71 109.0 1.21 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.04 -1.038 . . . . 0.0 109.906 179.203 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.61 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -76.78 152.53 35.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.367 -0.833 . . . . 0.0 109.995 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -138.01 149.21 45.88 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.677 -0.639 . . . . 0.0 110.07 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -123.96 140.68 52.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.458 -0.776 . . . . 0.0 110.207 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' HG3' ' CE1' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -81.53 -26.35 35.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.405 -0.809 . . . . 0.0 110.212 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.45 -34.23 70.62 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.352 -0.843 . . . . 0.0 110.192 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -124.65 -2.07 7.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.423 -0.798 . . . . 0.0 110.413 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 52.42 58.98 4.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 0.0 110.219 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.88 160.14 28.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.438 -0.789 . . . . 0.0 110.542 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -119.25 72.49 0.9 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.393 -0.817 . . . . 0.0 110.133 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 p -80.07 156.38 74.43 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.281 -0.887 . . . . 0.0 110.306 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.483 ' HB2' ' CE2' ' A' ' 100' ' ' TRP . 44.8 Cg_endo -72.44 151.99 54.14 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.783 1.412 . . . . 0.0 110.256 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.61 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -84.23 137.66 39.7 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.873 . . . . 0.0 109.494 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.29 -11.28 31.09 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.716 1.377 . . . . 0.0 111.038 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.633 HG13 ' OE2' ' A' ' 54' ' ' GLU . 84.8 t -100.28 115.43 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 110.083 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.69 81.44 8.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.383 -0.823 . . . . 0.0 110.021 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.666 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.43 -161.4 0.1 OUTLIER Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.823 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 65.1 mt-10 -126.45 151.68 47.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -1.07 . . . . 0.0 112.299 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.083 HD11 ' HB3' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -101.86 169.0 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.033 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.557 ' HB2' ' CB ' ' A' ' 49' ' ' GLU . 15.0 mt-10 -144.21 112.83 6.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.431 -0.793 . . . . 0.0 109.752 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.544 ' CD1' ' CE1' ' A' ' 48' ' ' PHE . 32.4 mm -69.84 120.42 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.441 -0.787 . . . . 0.0 110.201 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 1.0 OUTLIER -126.11 114.08 23.97 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.211 -0.931 . . . . 0.0 109.916 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -85.59 52.34 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.802 1.422 . . . . 0.0 109.864 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.82 155.52 0.07 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.583 -0.698 . . . . 0.0 109.872 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.76 -42.52 97.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.638 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -131.12 30.44 4.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.392 -0.818 . . . . 0.0 110.411 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 51.23 54.82 10.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.289 -0.882 . . . . 0.0 110.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -99.36 -40.65 7.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 109.733 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.18 -6.88 19.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 110.186 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.12 27.53 70.66 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.468 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 5.1 m-30 -89.45 118.82 29.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -1.076 . . . . 0.0 109.953 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.638 ' O ' HD12 ' A' ' 68' ' ' LEU . 10.2 m0 -84.97 73.52 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.51 ' HB2' ' CG ' ' A' ' 36' ' ' LYS . 41.6 m-20 -55.34 139.86 41.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.357 -0.84 . . . . 0.0 110.327 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.77 ' CE2' HD11 ' A' ' 68' ' ' LEU . 10.0 m-30 -109.75 102.27 11.08 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.862 0.839 . . . . 0.0 109.289 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.557 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.7 mt-10 -82.4 130.59 35.14 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.805 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.944 ' CE3' HD12 ' A' ' 64' ' ' ILE 0.252 68.7 t90 -105.45 161.45 14.32 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.394 -0.816 . . . . 0.0 109.501 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.4 ptm85 -166.93 142.03 3.43 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 120.795 -1.191 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.502 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 48.2 Cg_endo -70.75 80.53 1.15 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.633 1.333 . . . . 0.0 110.102 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.475 HG23 ' CD ' ' A' ' 32' ' ' GLU . 6.3 t -127.06 9.64 6.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.266 -0.896 . . . . 0.0 109.93 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.633 ' OE2' HG13 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -100.15 -169.53 1.74 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.785 -0.572 . . . . 0.0 109.724 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -89.1 110.44 38.22 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 54' ' ' GLU . 50.6 Cg_endo -84.22 171.61 10.07 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.538 1.283 . . . . 0.0 110.931 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.616 ' O ' HG22 ' A' ' 57' ' ' VAL . 13.2 p -129.25 28.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 110.047 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.19 17.2 6.33 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 18.2 mmt180 -129.49 102.46 6.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -1.151 . . . . 0.0 110.201 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.66 109.61 14.22 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.405 -0.809 . . . . 0.0 110.318 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.439 HD11 ' HB ' ' A' ' 29' ' ' VAL . 39.9 mt -105.65 -166.95 1.26 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.289 -0.882 . . . . 0.0 110.34 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.519 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 3.7 p30 -148.94 165.86 16.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.769 . . . . 0.0 110.299 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.7 Cg_endo -61.82 145.5 97.1 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.646 1.34 . . . . 0.0 111.813 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.944 HD12 ' CE3' ' A' ' 50' ' ' TRP . 4.8 mt -136.73 113.4 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.9 m -70.56 115.52 9.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 109.736 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.792 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 42.8 mt -102.82 149.75 24.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.877 . . . . 0.0 110.012 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.7 mm -117.15 158.16 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.299 -0.876 . . . . 0.0 109.717 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.77 HD11 ' CE2' ' A' ' 48' ' ' PHE . 71.8 mt -129.52 94.33 3.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.468 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 68.0 mt -135.68 103.57 10.12 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.453 -0.779 . . . . 0.0 110.149 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.43 68.83 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.668 1.352 . . . . 0.0 110.394 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.04 -39.29 0.18 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.45 -74.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.357 -1.084 . . . . 0.0 110.15 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.764 HG22 ' C ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -75.19 -164.23 0.3 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.408 -0.808 . . . . 0.0 110.013 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpp -134.34 125.73 28.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.328 -0.858 . . . . 0.0 110.211 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -80.29 111.44 16.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.381 -0.824 . . . . 0.0 110.167 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 0.0 110.013 179.95 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.215 0.531 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.8 mt -133.7 105.78 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.342 -0.849 . . . . 0.0 110.301 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -86.16 108.57 18.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.781 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.594 ' HB2' ' CD2' ' A' ' 98' ' ' PHE . . . -98.74 151.0 21.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.819 . . . . 0.0 110.626 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -121.86 119.54 31.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.839 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.8 HG13 ' CD ' ' A' ' 96' ' ' ARG . 79.3 t -115.11 132.4 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.9 . . . . 0.0 110.472 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.528 ' HB2' HG23 ' A' ' 73' ' ' THR . 46.5 t80 -101.7 -77.1 0.55 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.418 -0.801 . . . . 0.0 110.133 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.402 ' OG ' ' CD2' ' A' ' 91' ' ' PHE . 10.0 p -175.87 -59.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.269 -0.894 . . . . 0.0 110.301 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.6 t -60.88 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.458 -0.776 . . . . 0.0 110.406 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -166.36 20.1 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 110.782 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' HG3' ' HB3' ' A' ' 91' ' ' PHE . 1.3 pt-20 -94.37 48.11 1.22 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.264 -0.897 . . . . 0.0 110.149 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.8 ' CD ' HG13 ' A' ' 90' ' ' VAL . 61.5 mtm180 -94.05 119.47 32.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.421 -0.799 . . . . 0.0 110.205 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 29.4 m-85 -114.6 162.03 17.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 0.0 110.546 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 33.8 m-85 -129.81 141.25 50.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.837 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.792 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 23.2 m-85 -137.78 163.1 32.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.209 -0.932 . . . . 0.0 110.517 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.483 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 1.8 p-90 -158.5 165.97 33.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 110.1 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 110.148 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 60.6 m . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.218 0.532 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 82.4 t -110.45 85.32 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.413 -0.804 . . . . 0.0 110.069 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 35' ' ' ILE . 14.9 tt -105.61 177.62 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.365 -0.834 . . . . 0.0 108.956 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 2.7 ptmt -146.6 158.29 43.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.826 -1.171 . . . . 0.0 111.094 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -134.23 -174.76 3.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 109.925 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 8.5 mpt_? -110.23 139.76 45.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.424 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.56 -158.44 0.51 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.428 -0.795 . . . . 0.0 110.131 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.428 ' O ' ' CD2' ' A' ' 99' ' ' PHE . . . -151.12 157.01 26.97 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.866 HG13 ' CE1' ' A' ' 99' ' ' PHE . 0.9 OUTLIER -93.91 -140.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.494 -1.003 . . . . 0.0 110.047 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 98' ' ' PHE . 1.6 m -157.56 109.32 2.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 109.573 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.427 ' N ' HG12 ' A' ' 27' ' ' ILE . 5.4 pt-20 -79.59 150.5 31.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 110.082 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.456 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -133.22 148.19 52.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.612 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -115.61 133.38 56.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 0.0 110.291 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -79.03 -25.6 43.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.5 -0.75 . . . . 0.0 110.246 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -62.86 -33.84 76.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 0.0 110.017 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 m -122.8 -2.65 8.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.479 -0.763 . . . . 0.0 110.373 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.456 ' HA ' ' CE2' ' A' ' 17' ' ' TYR . 7.7 mtp180 52.23 57.46 6.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.154 -0.966 . . . . 0.0 110.226 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.23 162.34 20.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.336 -0.852 . . . . 0.0 110.356 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -120.59 95.36 4.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 0.0 110.296 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.5 p -106.69 157.92 34.0 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 110.122 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.513 ' HB2' ' CE2' ' A' ' 100' ' ' TRP . 44.0 Cg_endo -72.05 146.1 46.05 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.84 1.442 . . . . 0.0 110.267 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.618 HG21 HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -82.04 138.83 45.93 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.439 ' HD2' HG22 ' A' ' 27' ' ' ILE . 41.2 Cg_endo -67.02 -13.69 40.86 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.656 1.345 . . . . 0.0 110.496 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.722 HG21 ' O ' ' A' ' 59' ' ' ARG . 94.6 t -86.31 115.68 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 109.817 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 54' ' ' GLU . 1.9 mt-30 -93.74 68.5 3.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.069 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.67 -150.91 0.01 OUTLIER Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.774 ' OE2' HG21 ' A' ' 53' ' ' THR . 2.6 pt-20 -145.1 155.53 43.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.053 -1.263 . . . . 0.0 110.496 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.539 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 96.3 mt -102.05 167.6 2.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.599 -0.688 . . . . 0.0 110.096 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 49' ' ' GLU . 8.0 mt-10 -131.29 109.33 10.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.648 -0.658 . . . . 0.0 109.58 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.551 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -68.6 123.52 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 109.291 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -126.99 137.89 31.54 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 110.31 -179.436 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 49.8 Cg_endo -90.8 57.25 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.38 1.387 . . . . 0.0 109.751 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.446 ' CG ' ' O ' ' A' ' 37' ' ' PRO . 11.9 p30 43.26 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.902 -0.499 . . . . 0.0 110.79 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -75.75 -76.35 0.16 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.939 . . . . 0.0 110.45 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -139.63 69.48 1.36 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.397 -0.815 . . . . 0.0 110.45 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 50.64 55.16 9.94 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.367 -0.833 . . . . 0.0 110.492 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -111.02 -40.36 4.51 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.37 -0.831 . . . . 0.0 109.739 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -117.76 -11.2 10.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.528 -0.732 . . . . 0.0 110.08 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.26 29.7 72.0 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.466 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 4.3 m-30 -91.78 119.64 31.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.995 . . . . 0.0 110.09 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 93.9 m95 -79.71 77.19 6.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 110.189 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 1.9 t0 -54.09 130.02 36.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 0.0 109.961 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.828 ' CE2' HD11 ' A' ' 68' ' ' LEU . 3.8 m-30 -110.49 103.14 11.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.194 -0.941 . . . . 0.0 109.68 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 34' ' ' GLU . 31.6 tt0 -87.59 119.03 27.49 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.669 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.907 ' CE3' HD12 ' A' ' 64' ' ' ILE . 67.7 t90 -93.2 169.28 10.52 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.521 -0.737 . . . . 0.0 109.449 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.457 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 0.7 OUTLIER -176.57 145.99 0.71 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.215 -0.928 . . . . 0.0 110.801 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.553 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 50.0 Cg_endo -74.68 78.7 2.72 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.595 1.313 . . . . 0.0 109.675 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.774 HG21 ' OE2' ' A' ' 32' ' ' GLU . 8.1 t -115.37 2.35 13.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.146 -0.971 . . . . 0.0 109.762 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 30' ' ' GLN . 54.9 mm-40 -109.84 -168.76 1.36 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 113.22 43.11 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.186 -0.946 . . . . 0.0 110.273 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.537 ' O ' HG12 ' A' ' 57' ' ' VAL . 45.0 Cg_endo -76.55 -61.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.618 1.325 . . . . 0.0 110.547 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 56' ' ' PRO . 10.9 p 37.93 34.34 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-O 121.408 0.623 . . . . 0.0 111.109 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.403 ' HA3' ' HG2' ' A' ' 28' ' ' PRO . . . -153.43 -47.25 0.02 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.722 ' O ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -172.59 133.73 0.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -1.195 . . . . 0.0 109.899 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.412 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 20.4 mt-10 -53.94 124.53 15.71 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.275 -0.891 . . . . 0.0 110.529 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.623 HD22 ' HD2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -113.89 -171.17 1.85 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.328 -0.858 . . . . 0.0 110.421 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.553 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 5.8 m-20 -160.82 168.43 11.75 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.462 -0.774 . . . . 0.0 110.003 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.8 Cg_endo -62.12 131.84 36.41 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.746 1.393 . . . . 0.0 111.646 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.907 HD12 ' CE3' ' A' ' 50' ' ' TRP . 4.9 mt -127.16 114.87 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.769 -0.582 . . . . 0.0 109.536 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 p -69.91 118.03 12.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 110.375 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.674 HD11 ' CZ ' ' A' ' 99' ' ' PHE . 17.5 mt -109.72 148.97 30.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.232 -0.917 . . . . 0.0 109.825 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.5 mt -122.33 147.23 26.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.391 -0.818 . . . . 0.0 109.855 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.828 HD11 ' CE2' ' A' ' 48' ' ' PHE . 53.2 mt -121.14 106.41 11.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.37 -0.831 . . . . 0.0 110.283 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.466 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 72.6 mt -135.56 118.85 12.71 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.349 -0.844 . . . . 0.0 109.987 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.11 77.18 2.44 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.574 1.302 . . . . 0.0 110.507 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.09 -56.43 0.41 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -60.85 -58.47 8.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.369 -1.077 . . . . 0.0 110.218 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.611 HG23 ' C ' ' A' ' 90' ' ' VAL . 1.7 m -99.0 145.1 27.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.842 . . . . 0.0 110.188 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.32 132.41 53.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -0.826 . . . . 0.0 110.29 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.41 ' O ' ' CD1' ' A' ' 75' ' ' TRP . 36.5 p90 -88.94 140.47 29.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.441 -0.787 . . . . 0.0 110.259 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 88' ' ' ALA . 61.9 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.9 0.381 . . . . 0.0 110.729 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 86' ' ' ILE . 24.6 mm -88.69 85.14 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.167 -0.958 . . . . 0.0 110.21 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -75.35 95.54 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.864 . . . . 0.0 109.742 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -85.11 120.85 27.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.819 . . . . 0.0 110.774 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mp -106.07 77.93 1.27 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.416 -0.803 . . . . 0.0 109.752 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.867 HG12 ' HB3' ' A' ' 96' ' ' ARG . 30.6 m -81.99 123.59 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.395 -0.816 . . . . 0.0 110.939 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.586 ' N ' HG23 ' A' ' 73' ' ' THR . 0.2 OUTLIER -72.14 -75.12 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.389 -0.819 . . . . 0.0 110.128 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.5 m -131.85 -67.27 0.68 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 110.145 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.06 43.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.435 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -167.92 -38.18 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.261 -0.899 . . . . 0.0 110.442 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -114.58 50.25 0.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 110.475 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.867 ' HB3' HG12 ' A' ' 90' ' ' VAL . 33.9 mtm180 -90.95 112.23 24.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.344 -0.847 . . . . 0.0 110.232 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -99.9 138.71 36.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.381 -0.825 . . . . 0.0 110.628 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.447 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 4.7 m-85 -102.74 142.81 33.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.446 -0.784 . . . . 0.0 109.427 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.866 ' CE1' HG13 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -142.62 168.63 19.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -0.992 . . . . 0.0 110.616 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.513 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 1.1 p-90 -159.65 153.81 23.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.491 -0.756 . . . . 0.0 110.003 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.35 -0.844 . . . . 0.0 110.368 -179.878 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.0 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.482 0.658 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 85.4 t -91.16 75.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.611 -0.681 . . . . 0.0 109.904 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -72.1 167.43 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.341 -0.849 . . . . 0.0 109.824 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -124.31 136.04 53.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.508 -0.745 . . . . 0.0 109.932 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.83 -177.45 3.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 109.917 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.63 139.3 54.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 110.466 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.093 ' HB3' HD11 ' A' ' 33' ' ' ILE . . . -167.69 -155.53 0.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.45 -0.781 . . . . 0.0 109.888 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 100' ' ' TRP . . . -144.52 150.65 22.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.504 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.4 t -90.68 -139.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.481 -1.011 . . . . 0.0 109.735 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.4 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 1.2 m -159.05 107.69 1.87 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.081 -1.012 . . . . 0.0 109.66 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -79.37 147.58 32.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.469 -0.769 . . . . 0.0 109.842 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.442 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -123.25 148.69 45.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.887 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 22' ' ' ARG . 9.6 t30 -111.5 118.78 36.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.815 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -72.91 -25.32 61.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.784 . . . . 0.0 110.412 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.25 -32.96 74.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.773 . . . . 0.0 110.544 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.93 3.2 5.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.366 -0.834 . . . . 0.0 110.687 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' ASN . 4.3 mtp180 51.22 56.43 7.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.191 -0.943 . . . . 0.0 110.048 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.553 HD13 HG23 ' A' ' 25' ' ' THR . 3.4 pp -112.94 167.82 10.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.83 . . . . 0.0 110.739 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.6 p -126.59 111.28 14.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.488 -0.757 . . . . 0.0 110.074 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.553 HG23 HD13 ' A' ' 23' ' ' LEU . 8.4 p -127.9 159.77 64.77 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.187 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' CB ' ' CD2' ' A' ' 100' ' ' TRP . 44.4 Cg_endo -72.2 142.12 37.21 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.833 1.438 . . . . 0.0 110.138 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.521 HG22 HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -80.31 139.4 52.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 27' ' ' ILE . 40.1 Cg_endo -65.94 -27.81 50.52 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.581 1.306 . . . . 0.0 110.555 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.722 HG23 ' OE2' ' A' ' 54' ' ' GLU . 11.3 p -84.72 115.31 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.877 . . . . 0.0 109.787 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -93.32 79.41 4.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.308 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' HA2' ' HG2' ' A' ' 54' ' ' GLU . . . -61.98 -154.2 0.05 OUTLIER Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.629 ' C ' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -137.97 160.57 38.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.115 -1.227 . . . . 0.0 110.434 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.093 HD11 ' HB3' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -103.12 176.88 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.409 0.623 . . . . 0.0 110.312 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 2.7 mt-10 -138.59 108.16 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.551 HG13 ' CE1' ' A' ' 48' ' ' PHE . 1.5 mp -68.51 126.1 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.203 -0.935 . . . . 0.0 108.935 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 28.1 mtpt -134.64 140.95 36.97 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.045 -1.034 . . . . 0.0 110.623 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 51.2 Cg_endo -88.06 53.63 2.27 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.739 1.389 . . . . 0.0 109.965 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 t30 66.22 -177.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.646 -0.659 . . . . 0.0 110.075 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 40' ' ' GLU . 8.4 pt-20 -77.27 -25.96 51.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.291 -0.881 . . . . 0.0 110.848 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.408 ' N ' ' HG3' ' A' ' 39' ' ' GLU . 39.3 mt-10 -148.23 28.5 0.9 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.235 -0.916 . . . . 0.0 110.471 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 50.57 49.38 20.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.393 -0.817 . . . . 0.0 110.576 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.612 ' OE1' HD21 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -116.46 -26.18 7.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -0.915 . . . . 0.0 110.616 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.612 HD21 ' OE1' ' A' ' 42' ' ' GLU . 14.7 mt -106.3 -8.48 17.24 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.12 -0.988 . . . . 0.0 110.002 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.27 27.47 70.71 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 6.4 m-30 -90.2 119.8 30.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.456 -1.026 . . . . 0.0 109.926 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.566 ' HB2' HD12 ' A' ' 68' ' ' LEU . 4.4 m-90 -75.44 76.91 2.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.081 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -54.79 122.72 11.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.443 -0.786 . . . . 0.0 109.989 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.903 ' CD2' HD11 ' A' ' 68' ' ' LEU . 4.7 m-30 -106.97 102.81 12.14 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.002 -1.061 . . . . 0.0 109.774 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.486 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.9 tp10 -87.71 126.68 35.12 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.778 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.903 ' CE3' HD12 ' A' ' 64' ' ' ILE . 75.6 t90 -99.18 172.42 7.38 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.459 -0.776 . . . . 0.0 109.817 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.463 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -179.79 145.29 0.41 Allowed Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.338 -0.851 . . . . 0.0 110.759 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 48.9 Cg_endo -71.88 80.98 1.43 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.808 1.425 . . . . 0.0 109.799 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.1 t -120.51 11.34 11.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 109.696 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.722 ' OE2' HG23 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -100.63 -169.65 1.74 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.988 -0.445 . . . . 0.0 109.837 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.27 109.5 50.09 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -78.79 145.82 20.43 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.398 1.209 . . . . 0.0 110.81 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.624 HG12 ' O ' ' A' ' 57' ' ' VAL . 55.3 t -142.32 29.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 109.632 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.29 -61.83 0.02 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -131.22 -157.59 0.83 Allowed 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.374 -1.074 . . . . 0.0 109.661 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.77 ' O ' HD22 ' A' ' 61' ' ' LEU . 11.1 pt-20 -150.96 146.09 26.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.6 -0.687 . . . . 0.0 110.339 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.77 HD22 ' O ' ' A' ' 60' ' ' GLU . 1.4 mm? -131.29 -161.13 1.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.301 -0.874 . . . . 0.0 110.513 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 1.7 m-20 -147.08 171.97 5.74 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.434 -0.791 . . . . 0.0 109.704 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 36.2 Cg_endo -58.43 135.87 70.61 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.528 1.278 . . . . 0.0 111.859 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.903 HD12 ' CE3' ' A' ' 50' ' ' TRP . 4.7 mt -128.94 116.74 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.58 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -69.76 118.87 13.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.215 -0.928 . . . . 0.0 110.059 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.812 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 15.8 mt -109.57 145.16 36.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.396 -0.815 . . . . 0.0 109.781 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.0 mt -119.94 148.02 23.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.33 -0.857 . . . . 0.0 110.066 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.903 HD11 ' CD2' ' A' ' 48' ' ' PHE . 62.9 mt -125.57 97.56 5.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.437 -0.789 . . . . 0.0 110.282 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.763 HG21 ' HG3' ' A' ' 72' ' ' GLU . 61.6 mt -131.29 108.93 14.94 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.256 -0.902 . . . . 0.0 110.23 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.3 80.84 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.603 1.317 . . . . 0.0 110.214 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.05 -30.11 0.73 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.763 ' HG3' HG21 ' A' ' 69' ' ' ILE . 4.1 mm-40 -89.87 -34.53 16.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.429 -1.042 . . . . 0.0 110.164 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.428 HG21 ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -104.3 168.95 8.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.416 -0.802 . . . . 0.0 110.043 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 tpp -109.66 151.42 26.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.393 -0.817 . . . . 0.0 110.387 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -90.78 119.28 30.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 110.076 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.869 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 73.7 t . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.148 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.118 0.485 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.67 108.32 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.1 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.69 79.9 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 0.0 109.994 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.869 ' HB3' ' O ' ' A' ' 76' ' ' VAL . . . -75.36 113.43 12.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.124 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.428 ' HB3' HG21 ' A' ' 73' ' ' THR . 6.2 mt -104.84 125.71 51.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.893 HG13 ' CD ' ' A' ' 96' ' ' ARG . 50.9 t -114.94 109.63 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 110.417 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.415 ' HB2' ' HG3' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -67.0 -78.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.333 -0.854 . . . . 0.0 110.236 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.2 t -176.44 -70.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.181 -0.949 . . . . 0.0 110.491 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.2 m -57.69 -83.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.319 -0.863 . . . . 0.0 110.446 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.35 15.64 0.39 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 110.72 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 91' ' ' PHE . 4.8 pt-20 -99.85 50.95 0.91 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 110.13 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.893 ' CD ' HG13 ' A' ' 90' ' ' VAL . 38.0 mtm105 -90.36 121.48 32.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.448 -0.782 . . . . 0.0 110.095 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 26.6 m-85 -106.44 162.63 13.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.313 -0.867 . . . . 0.0 110.506 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.414 ' O ' ' CD1' ' A' ' 99' ' ' PHE . 8.3 m-85 -137.6 141.51 41.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 109.536 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.812 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 19.8 m-85 -135.58 161.71 34.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 110.409 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.465 ' CD2' ' CB ' ' A' ' 26' ' ' PRO . 3.0 p-90 -143.77 162.76 35.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.73 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.834 . . . . 0.0 110.242 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.2 m . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.198 0.523 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.51 76.12 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.726 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -89.18 168.48 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.531 -0.73 . . . . 0.0 109.751 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.44 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 8.9 mttt -130.38 131.19 45.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -124.4 131.92 53.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -79.45 121.88 25.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.344 -0.848 . . . . 0.0 110.48 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.421 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . . . -146.68 -154.83 0.57 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.436 -0.79 . . . . 0.0 110.039 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.92 159.04 26.9 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.487 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.3 t -95.52 -137.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.388 -1.066 . . . . 0.0 109.52 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.706 ' SG ' HD11 ' A' ' 86' ' ' ILE . 42.5 t -162.46 107.96 1.21 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.973 -1.08 . . . . 0.0 110.033 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.495 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -77.37 161.49 27.99 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.377 -0.827 . . . . 0.0 110.112 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -145.63 141.72 28.41 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.892 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -107.75 135.33 49.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 110.135 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -79.54 -25.12 41.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.538 -0.726 . . . . 0.0 110.156 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.81 -39.28 91.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -115.73 -5.68 12.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 0.0 110.363 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HA ' ' CE2' ' A' ' 17' ' ' TYR . 0.2 OUTLIER 54.41 58.75 4.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.254 -0.904 . . . . 0.0 110.287 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.42 169.78 14.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.268 -0.895 . . . . 0.0 110.414 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.3 141.53 52.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.45 -0.781 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.83 163.71 25.96 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.829 . . . . 0.0 110.26 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.468 ' HB3' ' CD2' ' A' ' 100' ' ' TRP . 47.2 Cg_endo -72.53 135.38 24.07 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.75 1.395 . . . . 0.0 110.206 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.495 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.51 138.4 44.5 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.932 . . . . 0.0 109.786 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.491 ' C ' HG23 ' A' ' 29' ' ' VAL . 48.1 Cg_endo -74.77 51.86 2.81 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.75 1.395 . . . . 0.0 110.747 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.491 HG23 ' C ' ' A' ' 28' ' ' PRO . 83.4 t -152.19 116.12 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.176 -0.953 . . . . 0.0 109.815 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -80.89 70.14 7.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 110.212 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.636 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -59.12 -167.48 0.19 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.79 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 26.4 mt-10 -129.7 138.72 51.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -1.151 . . . . 0.0 112.29 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.567 HG23 ' HB3' ' A' ' 48' ' ' PHE . 39.9 mt -101.79 167.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.487 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -136.75 113.81 10.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.335 -0.853 . . . . 0.0 109.425 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 1.2 mp -68.35 123.71 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.334 -0.854 . . . . 0.0 109.106 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -132.88 142.81 46.08 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.292 -0.88 . . . . 0.0 110.282 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 51.5 Cg_endo -88.1 52.76 2.13 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.656 1.345 . . . . 0.0 109.978 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 t30 64.83 161.54 0.12 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.532 -0.73 . . . . 0.0 109.991 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.36 -56.21 20.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.401 -0.812 . . . . 0.0 110.636 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -128.06 36.84 4.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.456 -0.777 . . . . 0.0 110.331 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 51.31 52.33 15.05 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 0.0 110.406 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -102.28 -38.67 7.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.432 -0.792 . . . . 0.0 109.781 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 11.8 mt -108.06 -8.79 15.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.574 -0.703 . . . . 0.0 110.262 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.23 27.36 71.43 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.467 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 12.6 m-30 -88.46 120.5 29.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.39 -1.065 . . . . 0.0 110.033 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.616 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 22.8 m-90 -68.06 75.66 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.844 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 6.3 t0 -52.31 129.84 29.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.355 -0.841 . . . . 0.0 110.283 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.818 ' CD2' HD11 ' A' ' 68' ' ' LEU . 6.8 m-30 -110.54 103.0 11.54 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.487 -0.758 . . . . 0.0 109.673 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -83.84 116.58 22.81 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.218 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.947 ' CE3' HD12 ' A' ' 64' ' ' ILE . 74.2 t90 -94.7 154.05 17.5 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.664 -0.648 . . . . 0.0 109.683 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -163.27 138.56 5.13 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.931 -1.106 . . . . 0.0 110.638 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 44.0 Cg_endo -68.6 81.1 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.55 1.289 . . . . 0.0 110.372 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.417 ' CG2' ' HB2' ' A' ' 32' ' ' GLU . 7.0 t -120.86 5.68 10.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.383 -0.823 . . . . 0.0 109.473 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.483 ' HG2' ' HA2' ' A' ' 31' ' ' GLY . 0.8 OUTLIER -100.34 -169.68 1.76 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 109.71 51.54 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.2 -0.937 . . . . 0.0 109.908 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -81.08 -179.22 4.9 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.464 1.244 . . . . 0.0 110.801 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.554 ' O ' HG22 ' A' ' 57' ' ' VAL . 13.1 p -131.18 29.38 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.794 . . . . 0.0 109.895 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.75 22.79 3.53 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -134.59 105.6 6.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -1.184 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -80.95 132.54 35.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 0.0 110.338 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 mt -129.82 -158.71 0.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 110.177 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.552 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -162.66 172.23 5.6 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.28 -0.888 . . . . 0.0 110.269 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.799 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.2 Cg_endo -61.36 126.44 19.3 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.72 1.379 . . . . 0.0 111.308 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.947 HD12 ' CE3' ' A' ' 50' ' ' TRP . 9.9 mt -124.96 111.33 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.788 -0.57 . . . . 0.0 110.088 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.9 m -69.8 117.48 11.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.144 -0.973 . . . . 0.0 109.438 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.86 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 26.7 mt -104.04 144.32 31.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.294 -0.879 . . . . 0.0 110.398 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.417 ' CG2' ' CD1' ' A' ' 69' ' ' ILE . 8.8 mm -113.04 148.39 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.421 -0.8 . . . . 0.0 109.585 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.818 HD11 ' CD2' ' A' ' 48' ' ' PHE . 77.7 mt -121.71 87.57 2.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 110.188 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.467 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 74.2 mt -127.71 108.48 20.58 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.447 -0.783 . . . . 0.0 110.019 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.39 64.01 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.58 1.305 . . . . 0.0 110.449 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.85 -37.32 0.1 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -71.48 -53.35 14.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.339 -1.095 . . . . 0.0 110.227 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.801 HG22 ' N ' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -101.25 148.24 25.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.416 -0.803 . . . . 0.0 110.2 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mmt -76.12 132.64 40.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.422 -0.799 . . . . 0.0 110.194 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.44 83.17 4.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.408 -0.807 . . . . 0.0 110.051 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 110.096 -179.893 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.199 0.524 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.706 HD11 ' SG ' ' A' ' 15' ' ' CYS . 2.1 tt -80.88 105.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.309 -0.87 . . . . 0.0 110.188 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -69.71 139.36 53.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.23 117.88 28.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.47 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 89' ' ' LEU . 6.7 mp -104.32 124.14 48.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.988 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.836 HG13 ' CD ' ' A' ' 96' ' ' ARG . 75.7 t -125.37 112.39 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.36 -0.837 . . . . 0.0 110.381 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.801 ' N ' HG22 ' A' ' 73' ' ' THR . 24.5 t80 -76.17 -76.38 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.855 . . . . 0.0 110.004 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.8 m -129.85 -66.65 0.78 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.374 -0.829 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.06 36.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.373 -0.829 . . . . 0.0 110.205 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -166.67 -39.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.397 -0.815 . . . . 0.0 110.415 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -97.51 43.14 1.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.447 -0.783 . . . . 0.0 110.144 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.836 ' CD ' HG13 ' A' ' 90' ' ' VAL . 42.3 mtm180 -98.83 111.21 23.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.261 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 41.7 m-85 -113.75 159.52 19.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.381 -0.825 . . . . 0.0 110.236 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.427 ' HB2' ' CB ' ' A' ' 15' ' ' CYS . 0.4 OUTLIER -141.55 141.46 33.53 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.258 -0.901 . . . . 0.0 109.827 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.86 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 6.7 m-85 -137.66 169.51 17.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.149 -0.97 . . . . 0.0 110.328 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.468 ' CD2' ' HB3' ' A' ' 26' ' ' PRO . 3.2 p-90 -150.32 161.28 42.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.185 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.286 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.272 0.558 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.9 p -78.51 86.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.5 -0.75 . . . . 0.0 110.051 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.467 HD13 ' HA ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -72.11 168.9 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.07 -1.019 . . . . 0.0 109.744 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 20.8 mttp -126.09 144.23 50.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.553 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -134.67 -174.84 3.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.795 . . . . 0.0 109.608 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.23 119.28 24.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 0.0 110.854 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.772 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . . . -150.15 -158.65 0.94 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 109.715 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' HA3' ' NE1' ' A' ' 100' ' ' TRP . . . -142.31 165.74 26.61 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.493 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 0.7 OUTLIER -103.88 -142.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.431 -1.041 . . . . 0.0 109.516 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.423 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -163.75 108.3 1.02 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.065 -1.022 . . . . 0.0 110.105 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.499 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -77.71 162.18 27.17 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.309 -0.869 . . . . 0.0 110.031 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -126.51 144.12 50.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.139 -0.625 . . . . 0.0 110.066 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.407 ' HB3' HD22 ' A' ' 23' ' ' LEU . 7.6 t-20 -110.11 124.97 52.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.903 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -24.74 52.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.368 -0.833 . . . . 0.0 110.305 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -68.55 -30.75 69.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.461 -0.775 . . . . 0.0 110.256 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -124.08 -2.21 8.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.383 -0.823 . . . . 0.0 110.61 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER 52.74 58.01 5.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.127 -0.983 . . . . 0.0 110.184 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.639 ' O ' HD23 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -128.78 164.71 22.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.901 . . . . 0.0 110.302 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.94 90.04 3.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 110.062 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.41 167.38 12.4 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 110.188 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.464 ' CB ' ' CD2' ' A' ' 100' ' ' TRP . 44.1 Cg_endo -71.35 144.52 46.01 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.756 1.398 . . . . 0.0 110.332 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.499 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.77 140.9 43.92 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 109.431 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.458 ' HD2' HG22 ' A' ' 27' ' ' ILE . 40.3 Cg_endo -66.14 -18.47 56.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.621 1.327 . . . . 0.0 110.565 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.632 HG21 ' O ' ' A' ' 59' ' ' ARG . 85.2 t -83.61 138.08 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.974 . . . . 0.0 109.459 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.19 -49.73 7.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 110.798 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . 54.82 -166.7 2.57 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.62 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -153.7 159.02 41.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.039 -1.271 . . . . 0.0 110.463 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.772 ' CD1' ' HB3' ' A' ' 12' ' ' ALA . 2.2 mp -106.69 168.7 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.507 0.67 . . . . 0.0 110.368 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 42.1 mt-10 -130.86 114.12 14.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.588 -0.695 . . . . 0.0 109.496 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 35' ' ' ILE . 1.7 mp -68.72 127.22 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 18.1 mtpt -133.41 140.93 38.61 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 0.0 110.755 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 49.8 Cg_endo -87.9 53.01 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.725 1.382 . . . . 0.0 109.973 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 65.02 164.63 0.15 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.559 -0.713 . . . . 0.0 110.121 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.33 -38.49 71.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 0.0 110.816 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -147.82 38.33 0.91 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.872 . . . . 0.0 110.389 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 51.1 49.87 20.24 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.35 -0.844 . . . . 0.0 110.438 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -103.04 -41.26 6.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -0.865 . . . . 0.0 109.807 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -106.26 -5.36 19.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.526 -0.734 . . . . 0.0 110.353 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.97 27.8 69.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 8.5 m-30 -88.22 120.67 29.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -1.027 . . . . 0.0 109.985 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.566 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 88.6 m95 -70.49 76.77 0.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -53.98 124.32 15.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.346 -0.846 . . . . 0.0 109.994 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.857 ' CD2' HD11 ' A' ' 68' ' ' LEU . 6.1 m-30 -107.29 102.85 12.12 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.164 -0.96 . . . . 0.0 109.804 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.42 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.2 tt0 -85.49 118.83 25.26 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.104 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.925 ' CE3' HD12 ' A' ' 64' ' ' ILE . 69.4 t90 -93.75 167.08 11.88 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.506 -0.746 . . . . 0.0 109.299 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.457 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 2.7 ptm180 -177.5 146.32 0.62 Allowed Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.226 -0.921 . . . . 0.0 110.832 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.553 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.1 Cg_endo -71.87 76.68 1.99 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.544 1.287 . . . . 0.0 109.945 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 t -118.26 10.0 12.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.173 -0.954 . . . . 0.0 109.848 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HB2' ' N ' ' A' ' 31' ' ' GLY . 60.9 mm-40 -116.2 -169.09 1.54 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 113.14 43.46 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.102 -0.999 . . . . 0.0 110.547 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.448 ' C ' HG23 ' A' ' 57' ' ' VAL . 50.8 Cg_endo -78.29 -167.34 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.484 1.255 . . . . 0.0 110.422 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.614 HG12 ' O ' ' A' ' 57' ' ' VAL . 57.7 t -148.59 49.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.464 -0.772 . . . . 0.0 110.029 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.43 5.24 72.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.632 ' O ' HG21 ' A' ' 29' ' ' VAL . 16.6 mmt180 -124.68 100.95 6.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -1.161 . . . . 0.0 110.131 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -73.88 122.98 23.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.329 -0.857 . . . . 0.0 110.367 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.423 ' HA ' HD13 ' A' ' 61' ' ' LEU . 1.4 mm? -116.53 -162.15 0.84 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.341 -0.849 . . . . 0.0 110.102 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.553 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -155.55 174.98 3.43 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.898 . . . . 0.0 110.144 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.676 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 38.3 Cg_endo -63.83 131.35 30.75 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.607 1.32 . . . . 0.0 111.526 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.925 HD12 ' CE3' ' A' ' 50' ' ' TRP . 6.5 mt -126.03 113.78 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.713 -0.617 . . . . 0.0 109.683 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.7 p -69.61 117.99 11.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 0.0 110.034 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.722 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 18.6 mt -107.76 147.42 30.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.926 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.63 ' O ' HD23 ' A' ' 68' ' ' LEU . 15.3 mt -120.03 155.64 22.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.916 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.857 HD11 ' CD2' ' A' ' 48' ' ' PHE . 50.6 mt -132.36 99.62 4.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.428 -0.795 . . . . 0.0 110.13 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.566 HG21 ' CG ' ' A' ' 72' ' ' GLU . 52.6 mt -132.4 108.02 13.4 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.135 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.2 -7.99 21.36 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.526 1.277 . . . . 0.0 110.774 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -108.34 2.84 32.87 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.566 ' CG ' HG21 ' A' ' 69' ' ' ILE . 66.8 mm-40 -133.1 -68.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.072 -1.252 . . . . 0.0 110.351 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.645 HG22 ' C ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -79.41 126.95 31.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.323 -0.86 . . . . 0.0 110.108 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ttt -70.81 137.01 49.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.383 -0.823 . . . . 0.0 110.138 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.426 ' CD2' HD21 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -87.65 122.8 31.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.345 -0.847 . . . . 0.0 110.206 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.04 88.47 36.76 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.809 . . . . 0.0 110.056 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.9 -32.51 8.87 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.818 1.43 . . . . 0.0 110.484 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 tt -142.01 138.28 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.332 -0.855 . . . . 0.0 110.293 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -104.67 49.33 0.81 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.419 -0.801 . . . . 0.0 110.148 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.27 -173.61 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.381 -0.824 . . . . 0.0 110.382 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.9 m 52.43 -168.08 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.272 -0.892 . . . . 0.0 110.501 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.76 112.53 8.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.887 . . . . 0.0 110.192 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.2 t -151.39 127.57 10.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -0.822 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.06 -85.32 0.1 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -162.45 94.06 0.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -1.119 . . . . 0.0 110.195 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 72.7 mt -117.0 101.3 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.351 -0.843 . . . . 0.0 110.091 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.596 ' CE2' HD21 ' A' ' 101' ' ' LEU . 48.7 m-85 -72.17 108.47 5.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.832 . . . . 0.0 110.25 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.6 133.95 55.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 110.193 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.426 HD21 ' CD2' ' A' ' 75' ' ' TRP . 3.9 mt -112.5 116.96 31.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.848 . . . . 0.0 110.218 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.872 HG12 ' HB3' ' A' ' 96' ' ' ARG . 10.0 m -112.48 133.44 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 110.511 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.46 ' HB2' HG23 ' A' ' 73' ' ' THR . 46.6 t80 -92.03 -79.65 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.426 -0.796 . . . . 0.0 110.168 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -172.82 -39.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.199 -0.938 . . . . 0.0 110.345 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.64 -81.58 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.895 . . . . 0.0 110.385 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -150.82 15.76 0.76 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.157 -0.964 . . . . 0.0 110.822 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -90.51 49.53 1.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.162 -0.961 . . . . 0.0 110.142 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.872 ' HB3' HG12 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -105.19 111.2 23.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.364 -0.835 . . . . 0.0 110.484 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 29.3 m-85 -113.94 155.49 25.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.497 -0.752 . . . . 0.0 110.204 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.423 ' HB2' ' CB ' ' A' ' 15' ' ' CYS . 25.9 m-85 -120.74 140.28 51.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.876 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.722 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 19.6 m-85 -134.69 158.55 43.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -0.982 . . . . 0.0 110.358 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.464 ' CD2' ' CB ' ' A' ' 26' ' ' PRO . 2.6 p-90 -149.57 144.0 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 109.912 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.596 HD21 ' CE2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.238 0.542 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 58.8 t -99.8 86.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.434 -0.791 . . . . 0.0 109.999 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.535 HG22 ' H ' ' A' ' 9' ' ' LYS . 17.0 mt -94.39 175.21 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.222 -0.924 . . . . 0.0 109.627 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.535 ' H ' HG22 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -131.04 132.38 44.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.201 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -126.83 -174.61 3.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.455 -0.778 . . . . 0.0 109.439 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 23.6 mtt85 -127.09 149.53 49.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.147 -0.97 . . . . 0.0 110.826 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.692 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . . . -170.72 -155.04 0.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.48 -0.762 . . . . 0.0 109.746 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.443 ' O ' ' CD2' ' A' ' 99' ' ' PHE . . . -145.68 146.55 16.85 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.818 HG13 ' CE1' ' A' ' 99' ' ' PHE . 1.1 t -89.55 -141.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.337 -1.096 . . . . 0.0 109.621 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 98' ' ' PHE . 42.5 t -162.99 110.13 1.21 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.056 -1.027 . . . . 0.0 110.01 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.549 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -76.96 154.77 33.24 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 109.849 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.33 145.85 33.05 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.028 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -123.68 134.61 53.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.45 -0.781 . . . . 0.0 110.202 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -77.1 -27.56 54.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.413 -0.804 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.45 -37.16 72.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.355 -0.841 . . . . 0.0 110.101 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.4 p -121.42 -2.82 9.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.472 -0.767 . . . . 0.0 110.369 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 52.49 57.38 6.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.27 -0.894 . . . . 0.0 110.15 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.74 159.65 26.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -0.833 . . . . 0.0 110.403 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.06 91.92 3.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.473 -0.767 . . . . 0.0 109.871 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.1 p -103.26 164.2 15.96 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.442 -0.786 . . . . 0.0 110.281 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.471 ' HB3' ' CD2' ' A' ' 100' ' ' TRP . 44.1 Cg_endo -71.16 142.4 41.74 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.85 1.447 . . . . 0.0 110.272 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.549 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.24 136.7 46.23 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 110.051 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.478 ' C ' HG23 ' A' ' 29' ' ' VAL . 48.7 Cg_endo -75.97 52.85 3.55 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.798 1.42 . . . . 0.0 110.189 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.809 HG13 ' OE2' ' A' ' 54' ' ' GLU . 75.4 t -150.06 115.88 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.86 . . . . 0.0 109.597 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -85.29 64.73 8.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 110.43 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' N ' ' HG2' ' A' ' 54' ' ' GLU . . . -61.52 -161.51 0.16 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.566 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -140.4 155.07 46.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.876 -1.367 . . . . 0.0 111.097 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.692 ' CD1' ' HB3' ' A' ' 12' ' ' ALA . 2.0 mp -105.75 169.96 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-O 121.4 0.619 . . . . 0.0 110.437 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 17.0 mt-10 -134.52 120.26 19.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.567 -0.708 . . . . 0.0 109.405 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.577 ' N ' HD12 ' A' ' 35' ' ' ILE . 1.7 mp -69.78 127.61 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -134.74 123.12 15.93 Favored Pre-proline 0 N--CA 1.485 1.3 0 O-C-N 121.055 -1.028 . . . . 0.0 109.343 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HD2' ' HD3' ' A' ' 36' ' ' LYS . 48.8 Cg_endo -83.77 51.82 3.58 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.489 1.257 . . . . 0.0 110.07 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 62.45 150.16 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.62 -0.675 . . . . 0.0 110.028 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -52.6 -25.7 11.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.41 -0.806 . . . . 0.0 110.156 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -133.74 -154.38 0.6 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.418 -0.801 . . . . 0.0 109.747 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -123.41 52.03 1.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 109.691 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.31 -35.86 7.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.411 -0.806 . . . . 0.0 110.156 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 11.7 mt -118.23 -11.9 10.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 110.217 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.91 27.49 56.59 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.486 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 5.7 m-30 -68.3 118.31 11.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -1.02 . . . . 0.0 110.065 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 77.1 m95 -80.71 68.08 6.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.469 -0.77 . . . . 0.0 110.094 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.47 ' HB2' ' CG ' ' A' ' 36' ' ' LYS . 68.7 m-20 -53.21 137.97 33.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.444 -0.785 . . . . 0.0 110.207 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.803 ' CE2' HD11 ' A' ' 68' ' ' LEU . 5.5 m-30 -108.77 102.69 11.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.357 -0.84 . . . . 0.0 109.669 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.44 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 4.0 tt0 -82.48 121.41 26.73 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.053 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.902 ' CE3' HD12 ' A' ' 64' ' ' ILE . 71.7 t90 -93.66 171.84 8.63 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.361 -0.837 . . . . 0.0 109.508 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 1.3 ptm180 -175.44 146.2 0.88 Allowed Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.2 -0.938 . . . . 0.0 110.808 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.511 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 52.2 Cg_endo -74.82 80.17 2.44 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.711 1.374 . . . . 0.0 109.788 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.463 HG21 ' CD ' ' A' ' 32' ' ' GLU . 7.0 t -117.71 5.05 12.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.121 -0.987 . . . . 0.0 109.777 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.809 ' OE2' HG13 ' A' ' 29' ' ' VAL . 1.5 pp20? -100.9 -178.15 3.67 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.933 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -99.14 109.74 55.4 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.3 -0.875 . . . . 0.0 109.648 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -83.11 167.81 13.86 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.572 1.301 . . . . 0.0 110.679 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 57' ' ' VAL . 55.5 t -112.42 36.2 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.468 -0.77 . . . . 0.0 109.534 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.84 16.95 6.61 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.1 mmt-85 -129.99 103.26 6.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -1.154 . . . . 0.0 110.261 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -80.15 140.78 36.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.352 -0.843 . . . . 0.0 110.103 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.514 HD21 HG21 ' A' ' 27' ' ' ILE . 1.3 mp -131.62 -168.21 1.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 0.0 110.332 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.521 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 53.9 m-20 -152.07 166.73 14.64 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.499 -0.751 . . . . 0.0 109.984 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.5 Cg_endo -61.45 136.08 61.34 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.69 1.363 . . . . 0.0 111.573 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.902 HD12 ' CE3' ' A' ' 50' ' ' TRP . 5.1 mt -129.42 114.31 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 p -69.66 116.22 9.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.202 -0.936 . . . . 0.0 110.002 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.669 HD11 ' CZ ' ' A' ' 99' ' ' PHE . 29.2 mt -105.76 154.68 20.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 109.801 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.477 HG21 HD12 ' A' ' 69' ' ' ILE . 43.0 mt -125.4 152.36 32.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.613 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.803 HD11 ' CE2' ' A' ' 48' ' ' PHE . 73.7 mt -122.97 82.8 2.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.388 -0.82 . . . . 0.0 110.236 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.486 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 64.3 mt -131.19 106.6 14.83 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.465 -0.772 . . . . 0.0 110.162 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.54 63.32 4.6 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.634 1.334 . . . . 0.0 110.278 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.69 -46.58 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -60.47 -76.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.195 -1.179 . . . . 0.0 110.259 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.717 ' HB ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -71.71 -153.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.264 -0.898 . . . . 0.0 109.754 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -138.63 100.26 4.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.247 -0.908 . . . . 0.0 110.44 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.41 ' O ' ' CD2' ' A' ' 75' ' ' TRP . 64.0 p-90 -76.11 131.51 39.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.858 . . . . 0.0 110.163 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.3 t -141.52 133.61 13.79 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.5 157.97 48.38 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.634 1.334 . . . . 0.0 110.393 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.2 mm -115.18 120.8 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.373 -0.83 . . . . 0.0 110.07 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -94.8 50.38 1.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.397 -0.814 . . . . 0.0 110.253 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.2 t -122.26 4.28 9.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 110.558 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -168.11 122.76 0.95 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.21 -0.931 . . . . 0.0 110.143 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -66.02 -31.68 72.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.38 -0.825 . . . . 0.0 110.104 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.5 p -108.72 170.06 8.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.864 . . . . 0.0 110.168 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.73 -65.99 3.93 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 62.49 134.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.432 -1.04 . . . . 0.0 110.48 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 99' ' ' PHE . 57.7 mt -133.73 114.13 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.263 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -76.18 115.13 15.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.347 -0.845 . . . . 0.0 109.961 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.499 ' HB1' ' CE2' ' A' ' 98' ' ' PHE . . . -99.41 110.93 23.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.425 -0.797 . . . . 0.0 110.563 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.717 HD12 ' HB ' ' A' ' 73' ' ' THR . 4.1 mm? -102.01 119.08 38.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.823 . . . . 0.0 109.83 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.764 HG13 ' HG2' ' A' ' 96' ' ' ARG . 91.3 t -113.91 131.29 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 110.529 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.422 ' HB2' HG23 ' A' ' 73' ' ' THR . 33.3 t80 -100.99 -61.62 1.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.47 -0.769 . . . . 0.0 110.133 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.9 m -142.53 -50.92 0.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.558 -0.713 . . . . 0.0 110.154 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.85 -29.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.883 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -116.89 11.94 14.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 111.075 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 21.6 mt-10 -130.38 36.29 3.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 0.0 110.298 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.764 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -95.9 111.34 23.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 0.0 110.328 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 27.1 m-85 -105.79 142.59 35.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.453 -0.78 . . . . 0.0 110.295 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 20.1 m-85 -119.83 136.24 54.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.393 -0.817 . . . . 0.0 109.888 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.818 ' CE1' HG13 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -134.73 169.85 16.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.233 -0.917 . . . . 0.0 110.197 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.471 ' CD2' ' HB3' ' A' ' 26' ' ' PRO . 2.1 p-90 -158.37 175.39 13.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 110.257 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 mt . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.821 . . . . 0.0 110.147 -179.943 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.198 0.523 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.938 HG13 ' HD3' ' A' ' 36' ' ' LYS . 98.2 t -111.2 59.53 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.45 -0.781 . . . . 0.0 109.635 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 35' ' ' ILE . 15.4 tt -102.19 175.16 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 0.0 110.111 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 4.4 mptt -120.71 140.73 51.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.039 -1.038 . . . . 0.0 110.942 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -113.77 -179.11 3.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 109.686 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -113.72 127.39 56.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 110.322 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.81 -160.68 0.71 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 110.085 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.74 163.31 29.63 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.466 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.3 t -95.53 -138.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.454 -1.027 . . . . 0.0 109.85 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.416 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 34.7 t -155.53 108.12 2.69 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.148 -0.97 . . . . 0.0 109.652 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.4 ' N ' HG12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -78.82 128.39 33.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.993 -179.642 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.18 157.63 28.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.635 -0.666 . . . . 0.0 109.821 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.422 ' HB2' HD21 ' A' ' 23' ' ' LEU . 11.5 t-20 -126.22 136.26 52.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -0.837 . . . . 0.0 110.412 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -82.48 -25.33 33.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 110.154 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -35.26 77.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.363 -0.836 . . . . 0.0 109.999 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 m -120.44 -1.38 10.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.476 -0.765 . . . . 0.0 110.584 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.15 56.14 8.44 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.206 -0.934 . . . . 0.0 109.91 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 23' ' ' LEU . 3.7 pp -108.1 154.04 22.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.428 -0.795 . . . . 0.0 110.809 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.9 p -124.97 71.06 1.16 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.518 -0.739 . . . . 0.0 110.279 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 p -97.16 165.11 16.4 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.405 -0.809 . . . . 0.0 110.248 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HB2' ' CD2' ' A' ' 100' ' ' TRP . 46.2 Cg_endo -74.26 152.96 45.41 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.789 1.415 . . . . 0.0 110.332 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.466 ' CD1' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -81.97 140.89 46.74 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.219 -0.926 . . . . 0.0 109.186 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' A' ' 27' ' ' ILE . 40.7 Cg_endo -67.25 -15.24 45.52 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.559 1.294 . . . . 0.0 110.497 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.774 HG13 ' OE2' ' A' ' 54' ' ' GLU . 93.4 t -94.36 115.34 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.58 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -88.42 72.02 8.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 110.276 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.429 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.5 -160.4 0.08 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -138.48 161.21 37.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -1.193 . . . . 0.0 110.64 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 34' ' ' GLU . 96.6 mt -105.0 170.69 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.414 0.626 . . . . 0.0 110.571 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.55 ' N ' HG22 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -128.95 105.98 8.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.527 -0.733 . . . . 0.0 109.065 179.066 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.547 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 1.2 mp -68.01 125.98 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 108.655 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.938 ' HD3' HG13 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -137.03 161.93 58.6 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 110.977 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -93.14 55.41 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.677 1.585 . . . . 0.0 110.076 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.421 HD21 HD12 ' A' ' 43' ' ' LEU . 6.2 t-20 60.29 175.16 0.09 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.371 -0.831 . . . . 0.0 110.093 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.88 -65.26 0.71 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.321 -0.862 . . . . 0.0 110.628 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -122.15 37.38 4.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.776 . . . . 0.0 110.527 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 50.9 49.81 20.36 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.385 -0.822 . . . . 0.0 110.604 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.506 ' OE2' HD21 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -118.58 -24.58 6.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.326 -0.859 . . . . 0.0 110.547 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.506 HD21 ' OE2' ' A' ' 42' ' ' GLU . 14.6 mt -108.82 -12.0 14.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.132 -0.98 . . . . 0.0 109.981 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.71 26.87 72.21 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.459 ' CD2' HG12 ' A' ' 69' ' ' ILE . 13.8 m-30 -91.49 122.79 34.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -1.098 . . . . 0.0 110.134 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.572 ' HB2' HD12 ' A' ' 68' ' ' LEU . 8.8 m0 -66.78 81.87 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 0.0 109.508 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.447 ' CB ' ' HB2' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -53.64 118.42 3.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.172 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.961 ' CD2' HD11 ' A' ' 68' ' ' LEU . 3.9 m-30 -107.7 102.5 11.72 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.332 -0.855 . . . . 0.0 109.188 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.445 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -89.58 123.13 33.38 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.711 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.783 ' CE3' HD12 ' A' ' 64' ' ' ILE . 70.5 t90 -91.75 173.84 7.66 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.331 -0.855 . . . . 0.0 109.579 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 179.55 146.89 0.41 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.095 -1.003 . . . . 0.0 110.848 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.9 Cg_endo -74.61 78.14 2.82 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.851 1.448 . . . . 0.0 109.694 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t -118.02 10.58 13.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 109.645 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.774 ' OE2' HG13 ' A' ' 29' ' ' VAL . 1.3 pp20? -100.62 -169.59 1.74 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.734 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -97.04 109.64 50.18 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 109.75 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.442 ' C ' HG23 ' A' ' 57' ' ' VAL . 52.3 Cg_endo -81.75 -178.01 3.92 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.482 1.254 . . . . 0.0 110.957 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 57' ' ' VAL . 59.5 t -148.41 30.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.609 -0.682 . . . . 0.0 109.441 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.06 0.93 7.52 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.5 ' O ' HG21 ' A' ' 29' ' ' VAL . 3.0 mmt85 -123.25 100.34 6.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.26 . . . . 0.0 110.323 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.89 112.65 21.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.394 -0.816 . . . . 0.0 110.265 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.41 HD21 HD12 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -103.73 -163.46 0.98 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.37 -0.831 . . . . 0.0 110.39 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 8.8 m-20 -152.74 164.95 18.69 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.457 -0.777 . . . . 0.0 109.93 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 36.7 Cg_endo -59.4 146.45 94.86 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.648 1.341 . . . . 0.0 112.016 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.783 HD12 ' CE3' ' A' ' 50' ' ' TRP . 5.4 mt -137.51 118.02 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 p -69.67 118.16 12.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.095 -1.003 . . . . 0.0 109.787 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.725 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 24.6 mt -105.25 143.57 33.24 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.288 -0.882 . . . . 0.0 110.153 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.3 mm -112.93 139.58 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.474 -0.766 . . . . 0.0 109.751 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.961 HD11 ' CD2' ' A' ' 48' ' ' PHE . 73.1 mt -122.83 95.24 4.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -0.88 . . . . 0.0 110.214 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.459 HG12 ' CD2' ' A' ' 45' ' ' PHE . 51.2 mt -128.41 116.66 19.91 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.331 -0.856 . . . . 0.0 110.058 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.95 64.87 4.1 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.612 1.322 . . . . 0.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.77 -52.81 0.2 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.409 ' O ' ' CD1' ' A' ' 91' ' ' PHE . 13.3 mm-40 -61.86 -80.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.257 -1.143 . . . . 0.0 110.155 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.603 HG23 ' HB2' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -85.01 113.62 21.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.188 -0.945 . . . . 0.0 109.97 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.5 tpt -69.7 148.99 48.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.468 -0.77 . . . . 0.0 110.196 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -111.52 142.14 44.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.431 -0.793 . . . . 0.0 110.087 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.08 103.03 18.59 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 110.182 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.24 96.82 0.81 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.601 1.316 . . . . 0.0 110.267 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 88' ' ' ALA . 3.4 mp -61.31 166.51 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.328 -0.858 . . . . 0.0 110.022 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.477 ' N ' HG22 ' A' ' 78' ' ' ILE . 41.5 tttt -57.76 149.93 21.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.264 -0.897 . . . . 0.0 110.212 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.3 p -61.3 -56.25 22.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.385 -0.822 . . . . 0.0 110.217 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.7 p 49.39 -156.08 0.09 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.457 -0.777 . . . . 0.0 110.573 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.99 49.8 0.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.212 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.3 p -117.82 -76.26 0.57 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.428 -0.795 . . . . 0.0 110.149 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.92 41.63 0.02 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 50.64 86.77 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.294 -1.121 . . . . 0.0 110.564 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 59.9 mt -93.8 120.9 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 110.26 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -82.68 111.07 18.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.855 . . . . 0.0 110.053 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.829 ' HB2' HD11 ' A' ' 78' ' ' ILE . . . -92.43 97.94 11.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.294 -0.879 . . . . 0.0 110.476 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mt -93.42 105.43 17.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.434 -0.791 . . . . 0.0 109.833 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.763 HG23 ' CG ' ' A' ' 96' ' ' ARG . 7.7 p -134.87 154.56 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.309 -0.869 . . . . 0.0 110.591 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.603 ' HB2' HG23 ' A' ' 73' ' ' THR . 22.8 t80 -117.32 -70.85 0.77 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.368 -0.832 . . . . 0.0 110.093 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.0 p -133.94 -68.04 0.57 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.784 . . . . 0.0 110.057 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.0 p -166.18 30.46 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.419 -0.801 . . . . 0.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.413 ' N ' ' HD2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -135.29 -40.66 0.73 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.494 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -116.57 87.21 2.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.342 -0.849 . . . . 0.0 110.406 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.763 ' CG ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -128.12 110.4 12.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 110.223 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 97' ' ' TYR . 33.9 m-85 -127.33 154.36 45.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 110.668 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.488 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 43.2 m-85 -129.21 132.37 47.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.595 -0.691 . . . . 0.0 109.43 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.725 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 16.2 m-85 -127.1 160.84 29.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.148 -0.97 . . . . 0.0 110.403 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.484 ' CD2' ' HB2' ' A' ' 26' ' ' PRO . 2.3 p-90 -147.89 150.93 35.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.404 -0.81 . . . . 0.0 109.912 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.288 -0.882 . . . . 0.0 110.271 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.412 HG22 HG12 ' A' ' 8' ' ' ILE . 90.4 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.223 0.535 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.7 p -73.73 68.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.423 -0.798 . . . . 0.0 109.921 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -72.07 165.93 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.227 -0.921 . . . . 0.0 109.672 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.415 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 12.2 ttmt -122.43 141.77 51.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.338 -0.851 . . . . 0.0 110.34 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -135.69 -174.66 3.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.398 -0.813 . . . . 0.0 109.705 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.2 115.51 17.77 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.175 -0.953 . . . . 0.0 110.811 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.758 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . . . -137.93 -160.59 1.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.472 -0.767 . . . . 0.0 109.622 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.418 ' HA3' ' NE1' ' A' ' 100' ' ' TRP . . . -139.99 155.1 24.25 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.503 ' C ' HG13 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -96.34 -142.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.44 -1.035 . . . . 0.0 109.394 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.447 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -162.39 107.64 1.2 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.971 -1.081 . . . . 0.0 110.184 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.524 ' CG ' HD13 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -78.7 162.4 26.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.383 -0.823 . . . . 0.0 110.089 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.408 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -129.7 149.75 51.31 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.635 -0.666 . . . . 0.0 109.637 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -113.26 124.82 53.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.364 -0.835 . . . . 0.0 110.061 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 20' ' ' ASP . 9.4 pt-20 -76.36 -25.32 54.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.527 -0.733 . . . . 0.0 110.147 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.422 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 9.8 t0 -64.75 -35.04 79.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.44 -0.787 . . . . 0.0 110.087 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -118.64 -5.44 10.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.426 -0.796 . . . . 0.0 110.504 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.408 ' HA ' ' CE2' ' A' ' 17' ' ' TYR . 6.5 mtt180 54.63 60.19 3.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.142 -0.974 . . . . 0.0 110.105 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.94 158.52 43.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.307 -0.871 . . . . 0.0 110.369 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.564 ' O ' HG23 ' A' ' 25' ' ' THR . 0.1 OUTLIER -107.49 150.58 26.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -0.835 . . . . 0.0 110.055 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 24' ' ' CYS . 4.3 p -155.18 164.27 21.69 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.386 -0.821 . . . . 0.0 110.241 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.511 ' HB3' ' CD2' ' A' ' 100' ' ' TRP . 45.8 Cg_endo -71.81 137.13 29.14 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.764 1.402 . . . . 0.0 110.137 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.524 HD13 ' CG ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.94 137.6 43.43 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 109.822 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.38 54.29 3.29 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.686 1.361 . . . . 0.0 110.553 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.704 HG23 ' OE2' ' A' ' 54' ' ' GLU . 9.2 p -157.84 115.87 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.939 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -83.57 71.75 10.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.3 -0.875 . . . . 0.0 110.11 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.637 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -58.05 -167.02 0.12 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.784 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 27.6 mt-10 -128.48 138.25 52.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -1.138 . . . . 0.0 112.323 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.758 ' CD1' ' HB3' ' A' ' 12' ' ' ALA . 2.0 mp -101.95 163.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.802 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.541 ' HB2' ' CB ' ' A' ' 49' ' ' GLU . 3.4 mt-10 -128.49 110.62 12.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.398 -0.814 . . . . 0.0 109.2 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.525 HD12 ' CE1' ' A' ' 48' ' ' PHE . 30.4 mm -69.19 120.02 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.396 -0.815 . . . . 0.0 110.32 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 16.9 mmmt -130.59 107.73 15.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 109.943 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.19 49.99 3.3 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.621 1.327 . . . . 0.0 110.213 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 t30 62.68 141.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.635 -0.665 . . . . 0.0 110.196 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.09 -29.1 28.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -0.904 . . . . 0.0 110.042 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -128.52 -151.53 0.48 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.49 -0.756 . . . . 0.0 109.638 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.58 52.83 1.39 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.264 -0.897 . . . . 0.0 109.62 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.431 ' O ' HD23 ' A' ' 43' ' ' LEU . 11.6 mt-10 -101.31 -39.56 7.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.008 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.446 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 16.4 mt -118.8 -16.78 9.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.486 -0.759 . . . . 0.0 110.142 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.21 26.73 61.79 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 5.2 m-30 -71.47 118.92 14.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.544 -0.974 . . . . 0.0 109.951 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.643 ' HB2' HD12 ' A' ' 68' ' ' LEU . 35.8 m0 -83.82 71.19 10.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.463 -0.773 . . . . 0.0 110.427 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -52.17 122.95 9.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.409 -0.807 . . . . 0.0 110.429 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.886 ' CE2' HD11 ' A' ' 68' ' ' LEU . 10.3 m-30 -105.67 102.92 12.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.146 -0.971 . . . . 0.0 109.824 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.541 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 5.1 tt0 -85.8 120.95 27.77 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.053 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.919 ' CE3' HD12 ' A' ' 64' ' ' ILE 0.25 71.0 t90 -95.59 158.61 15.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.572 -0.705 . . . . 0.0 109.868 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -164.38 142.64 5.66 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 120.825 -1.172 . . . . 0.0 110.993 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.51 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.4 Cg_endo -70.77 80.98 1.12 Allowed 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.646 1.34 . . . . 0.0 110.46 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.435 HG23 ' OE2' ' A' ' 32' ' ' GLU . 7.5 t -127.31 7.52 6.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -0.99 . . . . 0.0 110.015 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.704 ' OE2' HG23 ' A' ' 29' ' ' VAL . 1.2 pp20? -100.62 -169.65 1.74 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.71 -0.619 . . . . 0.0 109.8 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -99.48 109.53 55.34 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.895 . . . . 0.0 109.673 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.39 -178.49 3.41 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.544 1.287 . . . . 0.0 110.885 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.618 ' O ' HG22 ' A' ' 57' ' ' VAL . 12.0 p -126.32 29.11 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.682 . . . . 0.0 109.686 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.77 24.22 3.74 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -132.62 104.95 6.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.323 -1.104 . . . . 0.0 110.245 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.461 ' O ' HD22 ' A' ' 61' ' ' LEU . 1.5 mp0 -82.06 121.74 26.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.372 -0.83 . . . . 0.0 110.054 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 60' ' ' GLU . 2.4 mm? -118.78 -169.21 1.68 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.887 . . . . 0.0 110.32 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.564 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 10.2 p-10 -147.54 167.34 13.7 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 110.339 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.698 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.0 Cg_endo -60.58 135.12 58.65 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.636 1.335 . . . . 0.0 111.624 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.919 HD12 ' CE3' ' A' ' 50' ' ' TRP . 5.4 mt -128.69 112.43 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.4 p -69.62 116.5 10.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.824 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.841 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 18.1 mt -105.4 144.26 32.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.976 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.4 mt -120.03 150.45 22.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.431 -0.793 . . . . 0.0 109.755 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.886 HD11 ' CE2' ' A' ' 48' ' ' PHE . 56.4 mt -120.73 91.48 3.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 110.275 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.446 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 76.8 mt -131.71 108.65 14.37 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.381 -0.824 . . . . 0.0 110.111 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.82 85.24 0.97 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.64 1.337 . . . . 0.0 110.335 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.65 -39.87 0.83 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.0 -49.45 72.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.491 -1.006 . . . . 0.0 110.088 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 91' ' ' PHE . 1.3 m -115.75 156.06 26.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.421 -0.8 . . . . 0.0 110.09 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.2 mmt -70.56 126.25 29.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.325 -0.859 . . . . 0.0 110.325 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.474 ' C ' HG13 ' A' ' 76' ' ' VAL . 47.9 p90 -96.52 124.81 40.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 109.659 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.929 HG23 ' HB3' ' A' ' 88' ' ' ALA . 29.8 m -151.39 90.24 4.06 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.211 -0.93 . . . . 0.0 110.287 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.2 -31.5 11.81 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.646 1.34 . . . . 0.0 110.493 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 78' ' ' ILE . 50.6 mm -84.55 63.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.365 -0.834 . . . . 0.0 110.042 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -53.82 48.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.336 -0.852 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 t -83.82 168.19 16.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 110.111 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.1 m -64.43 -52.06 60.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.396 -0.815 . . . . 0.0 110.21 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -109.47 157.43 18.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.0 m 52.13 91.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.457 -0.777 . . . . 0.0 110.443 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.43 ' HA3' HD13 ' A' ' 78' ' ' ILE . . . -119.61 94.49 0.57 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -117.23 -27.33 6.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.355 -1.085 . . . . 0.0 110.393 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 99' ' ' PHE . 67.6 mt -70.63 123.62 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.232 -0.918 . . . . 0.0 110.385 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.97 114.5 19.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.37 -0.831 . . . . 0.0 109.799 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.929 ' HB3' HG23 ' A' ' 76' ' ' VAL . . . -101.43 132.16 47.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.63 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -124.43 105.33 9.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.439 -0.788 . . . . 0.0 109.689 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.898 HG13 ' HG2' ' A' ' 96' ' ' ARG . 58.3 t -115.89 108.21 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.35 -0.844 . . . . 0.0 110.499 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.528 ' HB2' HG23 ' A' ' 73' ' ' THR . 23.9 t80 -73.13 -68.77 0.46 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 0.0 109.993 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.2 p -141.94 -68.93 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.95 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.5 p -170.58 45.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.47 -0.768 . . . . 0.0 109.981 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -161.96 -33.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.868 . . . . 0.0 110.894 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -119.94 49.87 1.35 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.193 -0.942 . . . . 0.0 110.967 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.898 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -94.43 111.47 23.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.151 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 47.3 m-85 -114.68 158.09 22.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.62 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.673 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 63.0 m-85 -133.76 146.56 50.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.519 -0.738 . . . . 0.0 109.721 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.841 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 48.8 m-85 -142.4 165.96 25.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.217 -0.927 . . . . 0.0 110.787 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.511 ' CD2' ' HB3' ' A' ' 26' ' ' PRO . 2.2 p-90 -159.44 146.84 17.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.46 -0.775 . . . . 0.0 109.99 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 101' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.254 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.188 0.518 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 61.6 t -95.41 84.16 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.31 -0.868 . . . . 0.0 110.373 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -84.42 163.12 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.815 . . . . 0.0 109.516 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.406 ' HG3' ' CG ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -123.57 139.93 53.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.437 -0.79 . . . . 0.0 110.106 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.53 -174.98 3.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 110.079 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.98 134.88 54.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.781 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.083 ' HB3' HD11 ' A' ' 33' ' ' ILE . . . -163.93 -157.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.569 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -149.67 151.64 23.72 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.2 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.528 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.5 t -89.84 -136.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.609 -0.936 . . . . 0.0 109.32 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 0.9 OUTLIER -162.71 109.0 1.21 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.04 -1.038 . . . . 0.0 109.906 179.203 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.61 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -76.78 152.53 35.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.367 -0.833 . . . . 0.0 109.995 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -138.01 149.21 45.88 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.677 -0.639 . . . . 0.0 110.07 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -123.96 140.68 52.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.458 -0.776 . . . . 0.0 110.207 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' HG3' ' CE1' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -81.53 -26.35 35.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.405 -0.809 . . . . 0.0 110.212 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.45 -34.23 70.62 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.352 -0.843 . . . . 0.0 110.192 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -124.65 -2.07 7.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.423 -0.798 . . . . 0.0 110.413 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 52.42 58.98 4.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 0.0 110.219 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.88 160.14 28.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.438 -0.789 . . . . 0.0 110.542 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -119.25 72.49 0.9 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.393 -0.817 . . . . 0.0 110.133 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 p -80.07 156.38 74.43 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.281 -0.887 . . . . 0.0 110.306 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.483 ' HB2' ' CE2' ' A' ' 100' ' ' TRP . 44.8 Cg_endo -72.44 151.99 54.14 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.783 1.412 . . . . 0.0 110.256 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.61 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -84.23 137.66 39.7 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.873 . . . . 0.0 109.494 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.29 -11.28 31.09 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.716 1.377 . . . . 0.0 111.038 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.633 HG13 ' OE2' ' A' ' 54' ' ' GLU . 84.8 t -100.28 115.43 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 110.083 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.69 81.44 8.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.383 -0.823 . . . . 0.0 110.021 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.666 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.43 -161.4 0.1 OUTLIER Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.823 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 65.1 mt-10 -126.45 151.68 47.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -1.07 . . . . 0.0 112.299 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.083 HD11 ' HB3' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -101.86 169.0 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.033 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.557 ' HB2' ' CB ' ' A' ' 49' ' ' GLU . 15.0 mt-10 -144.21 112.83 6.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.431 -0.793 . . . . 0.0 109.752 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.544 ' CD1' ' CE1' ' A' ' 48' ' ' PHE . 32.4 mm -69.84 120.42 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.441 -0.787 . . . . 0.0 110.201 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 1.0 OUTLIER -126.11 114.08 23.97 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.211 -0.931 . . . . 0.0 109.916 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -85.59 52.34 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.802 1.422 . . . . 0.0 109.864 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.82 155.52 0.07 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.583 -0.698 . . . . 0.0 109.872 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.76 -42.52 97.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.638 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -131.12 30.44 4.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.392 -0.818 . . . . 0.0 110.411 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 51.23 54.82 10.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.289 -0.882 . . . . 0.0 110.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -99.36 -40.65 7.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 109.733 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.18 -6.88 19.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 110.186 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.12 27.53 70.66 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.468 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 5.1 m-30 -89.45 118.82 29.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -1.076 . . . . 0.0 109.953 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.638 ' O ' HD12 ' A' ' 68' ' ' LEU . 10.2 m0 -84.97 73.52 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.51 ' HB2' ' CG ' ' A' ' 36' ' ' LYS . 41.6 m-20 -55.34 139.86 41.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.357 -0.84 . . . . 0.0 110.327 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.77 ' CE2' HD11 ' A' ' 68' ' ' LEU . 10.0 m-30 -109.75 102.27 11.08 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.862 0.839 . . . . 0.0 109.289 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.557 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.7 mt-10 -82.4 130.59 35.14 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.805 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.944 ' CE3' HD12 ' A' ' 64' ' ' ILE 0.252 68.7 t90 -105.45 161.45 14.32 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.394 -0.816 . . . . 0.0 109.501 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.4 ptm85 -166.93 142.03 3.43 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 120.795 -1.191 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.502 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 48.2 Cg_endo -70.75 80.53 1.15 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.633 1.333 . . . . 0.0 110.102 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.475 HG23 ' CD ' ' A' ' 32' ' ' GLU . 6.3 t -127.06 9.64 6.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.266 -0.896 . . . . 0.0 109.93 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.633 ' OE2' HG13 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -100.15 -169.53 1.74 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.785 -0.572 . . . . 0.0 109.724 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -89.1 110.44 38.22 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 54' ' ' GLU . 50.6 Cg_endo -84.22 171.61 10.07 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.538 1.283 . . . . 0.0 110.931 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.616 ' O ' HG22 ' A' ' 57' ' ' VAL . 13.2 p -129.25 28.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 110.047 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.19 17.2 6.33 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 18.2 mmt180 -129.49 102.46 6.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -1.151 . . . . 0.0 110.201 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.66 109.61 14.22 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.405 -0.809 . . . . 0.0 110.318 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.439 HD11 ' HB ' ' A' ' 29' ' ' VAL . 39.9 mt -105.65 -166.95 1.26 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.289 -0.882 . . . . 0.0 110.34 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.519 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 3.7 p30 -148.94 165.86 16.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.769 . . . . 0.0 110.299 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.7 Cg_endo -61.82 145.5 97.1 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.646 1.34 . . . . 0.0 111.813 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.944 HD12 ' CE3' ' A' ' 50' ' ' TRP . 4.8 mt -136.73 113.4 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.9 m -70.56 115.52 9.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 109.736 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.792 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 42.8 mt -102.82 149.75 24.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.877 . . . . 0.0 110.012 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.7 mm -117.15 158.16 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.299 -0.876 . . . . 0.0 109.717 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.77 HD11 ' CE2' ' A' ' 48' ' ' PHE . 71.8 mt -129.52 94.33 3.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.468 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 68.0 mt -135.68 103.57 10.12 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.453 -0.779 . . . . 0.0 110.149 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.43 68.83 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.668 1.352 . . . . 0.0 110.394 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.04 -39.29 0.18 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.45 -74.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.357 -1.084 . . . . 0.0 110.15 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.764 HG22 ' C ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -75.19 -164.23 0.3 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.408 -0.808 . . . . 0.0 110.013 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpp -134.34 125.73 28.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.328 -0.858 . . . . 0.0 110.211 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -80.29 111.44 16.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.381 -0.824 . . . . 0.0 110.167 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.92 106.03 41.99 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 0.0 110.013 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.38 177.86 6.83 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.693 1.365 . . . . 0.0 110.46 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.1 mt -144.22 -56.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 110.164 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.3 mttt 52.14 45.15 28.88 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.413 -0.804 . . . . 0.0 110.46 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.5 p -78.76 -55.23 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.236 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.2 m -67.03 155.86 37.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.37 -0.831 . . . . 0.0 110.202 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -68.26 133.95 49.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.359 -0.838 . . . . 0.0 110.203 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.5 m 52.26 86.48 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.355 -0.841 . . . . 0.0 110.523 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -174.04 175.97 46.51 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -159.22 127.65 5.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.421 -1.046 . . . . 0.0 110.214 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.8 mt -133.7 105.78 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.342 -0.849 . . . . 0.0 110.301 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -86.16 108.57 18.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.781 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.594 ' HB2' ' CD2' ' A' ' 98' ' ' PHE . . . -98.74 151.0 21.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.819 . . . . 0.0 110.626 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -121.86 119.54 31.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.839 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.8 HG13 ' CD ' ' A' ' 96' ' ' ARG . 79.3 t -115.11 132.4 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.9 . . . . 0.0 110.472 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.528 ' HB2' HG23 ' A' ' 73' ' ' THR . 46.5 t80 -101.7 -77.1 0.55 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.418 -0.801 . . . . 0.0 110.133 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.402 ' OG ' ' CD2' ' A' ' 91' ' ' PHE . 10.0 p -175.87 -59.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.269 -0.894 . . . . 0.0 110.301 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.6 t -60.88 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.458 -0.776 . . . . 0.0 110.406 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -166.36 20.1 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 110.782 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' HG3' ' HB3' ' A' ' 91' ' ' PHE . 1.3 pt-20 -94.37 48.11 1.22 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.264 -0.897 . . . . 0.0 110.149 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.8 ' CD ' HG13 ' A' ' 90' ' ' VAL . 61.5 mtm180 -94.05 119.47 32.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.421 -0.799 . . . . 0.0 110.205 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 29.4 m-85 -114.6 162.03 17.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 0.0 110.546 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 33.8 m-85 -129.81 141.25 50.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.837 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.792 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 23.2 m-85 -137.78 163.1 32.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.209 -0.932 . . . . 0.0 110.517 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.483 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 1.8 p-90 -158.5 165.97 33.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 110.1 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 110.148 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 60.6 m . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.218 0.532 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 82.4 t -110.45 85.32 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.413 -0.804 . . . . 0.0 110.069 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 35' ' ' ILE . 14.9 tt -105.61 177.62 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.365 -0.834 . . . . 0.0 108.956 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 2.7 ptmt -146.6 158.29 43.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.826 -1.171 . . . . 0.0 111.094 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -134.23 -174.76 3.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 109.925 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 8.5 mpt_? -110.23 139.76 45.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.424 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.56 -158.44 0.51 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.428 -0.795 . . . . 0.0 110.131 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.428 ' O ' ' CD2' ' A' ' 99' ' ' PHE . . . -151.12 157.01 26.97 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.866 HG13 ' CE1' ' A' ' 99' ' ' PHE . 0.9 OUTLIER -93.91 -140.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.494 -1.003 . . . . 0.0 110.047 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 98' ' ' PHE . 1.6 m -157.56 109.32 2.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 109.573 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' N ' HG12 ' A' ' 27' ' ' ILE . 5.4 pt-20 -79.59 150.5 31.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 110.082 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.456 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -133.22 148.19 52.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.612 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -115.61 133.38 56.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 0.0 110.291 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -79.03 -25.6 43.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.5 -0.75 . . . . 0.0 110.246 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -62.86 -33.84 76.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 0.0 110.017 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 m -122.8 -2.65 8.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.479 -0.763 . . . . 0.0 110.373 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.456 ' HA ' ' CE2' ' A' ' 17' ' ' TYR . 7.7 mtp180 52.23 57.46 6.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.154 -0.966 . . . . 0.0 110.226 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.23 162.34 20.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.336 -0.852 . . . . 0.0 110.356 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -120.59 95.36 4.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 0.0 110.296 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.5 p -106.69 157.92 34.0 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 110.122 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.513 ' HB2' ' CE2' ' A' ' 100' ' ' TRP . 44.0 Cg_endo -72.05 146.1 46.05 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.84 1.442 . . . . 0.0 110.267 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.618 HG21 HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -82.04 138.83 45.93 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.439 ' HD2' HG22 ' A' ' 27' ' ' ILE . 41.2 Cg_endo -67.02 -13.69 40.86 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.656 1.345 . . . . 0.0 110.496 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.722 HG21 ' O ' ' A' ' 59' ' ' ARG . 94.6 t -86.31 115.68 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 109.817 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 54' ' ' GLU . 1.9 mt-30 -93.74 68.5 3.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.069 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.67 -150.91 0.01 OUTLIER Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.774 ' OE2' HG21 ' A' ' 53' ' ' THR . 2.6 pt-20 -145.1 155.53 43.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.053 -1.263 . . . . 0.0 110.496 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.539 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 96.3 mt -102.05 167.6 2.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.599 -0.688 . . . . 0.0 110.096 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 49' ' ' GLU . 8.0 mt-10 -131.29 109.33 10.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.648 -0.658 . . . . 0.0 109.58 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.551 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -68.6 123.52 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 109.291 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -126.99 137.89 31.54 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 110.31 -179.436 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 49.8 Cg_endo -90.8 57.25 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.38 1.387 . . . . 0.0 109.751 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.446 ' CG ' ' O ' ' A' ' 37' ' ' PRO . 11.9 p30 43.26 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.902 -0.499 . . . . 0.0 110.79 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -75.75 -76.35 0.16 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.939 . . . . 0.0 110.45 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -139.63 69.48 1.36 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.397 -0.815 . . . . 0.0 110.45 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 50.64 55.16 9.94 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.367 -0.833 . . . . 0.0 110.492 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -111.02 -40.36 4.51 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.37 -0.831 . . . . 0.0 109.739 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -117.76 -11.2 10.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.528 -0.732 . . . . 0.0 110.08 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.26 29.7 72.0 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.466 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 4.3 m-30 -91.78 119.64 31.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.995 . . . . 0.0 110.09 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 93.9 m95 -79.71 77.19 6.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 110.189 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 1.9 t0 -54.09 130.02 36.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 0.0 109.961 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.828 ' CE2' HD11 ' A' ' 68' ' ' LEU . 3.8 m-30 -110.49 103.14 11.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.194 -0.941 . . . . 0.0 109.68 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 34' ' ' GLU . 31.6 tt0 -87.59 119.03 27.49 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.669 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.907 ' CE3' HD12 ' A' ' 64' ' ' ILE . 67.7 t90 -93.2 169.28 10.52 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.521 -0.737 . . . . 0.0 109.449 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.457 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 0.7 OUTLIER -176.57 145.99 0.71 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.215 -0.928 . . . . 0.0 110.801 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.553 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 50.0 Cg_endo -74.68 78.7 2.72 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.595 1.313 . . . . 0.0 109.675 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.774 HG21 ' OE2' ' A' ' 32' ' ' GLU . 8.1 t -115.37 2.35 13.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.146 -0.971 . . . . 0.0 109.762 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 30' ' ' GLN . 54.9 mm-40 -109.84 -168.76 1.36 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 113.22 43.11 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.186 -0.946 . . . . 0.0 110.273 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.537 ' O ' HG12 ' A' ' 57' ' ' VAL . 45.0 Cg_endo -76.55 -61.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.618 1.325 . . . . 0.0 110.547 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 56' ' ' PRO . 10.9 p 37.93 34.34 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-O 121.408 0.623 . . . . 0.0 111.109 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.403 ' HA3' ' HG2' ' A' ' 28' ' ' PRO . . . -153.43 -47.25 0.02 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.722 ' O ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -172.59 133.73 0.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -1.195 . . . . 0.0 109.899 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.412 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 20.4 mt-10 -53.94 124.53 15.71 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.275 -0.891 . . . . 0.0 110.529 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.623 HD22 ' HD2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -113.89 -171.17 1.85 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.328 -0.858 . . . . 0.0 110.421 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.553 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 5.8 m-20 -160.82 168.43 11.75 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.462 -0.774 . . . . 0.0 110.003 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.8 Cg_endo -62.12 131.84 36.41 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.746 1.393 . . . . 0.0 111.646 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.907 HD12 ' CE3' ' A' ' 50' ' ' TRP . 4.9 mt -127.16 114.87 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.769 -0.582 . . . . 0.0 109.536 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 p -69.91 118.03 12.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 110.375 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.674 HD11 ' CZ ' ' A' ' 99' ' ' PHE . 17.5 mt -109.72 148.97 30.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.232 -0.917 . . . . 0.0 109.825 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.5 mt -122.33 147.23 26.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.391 -0.818 . . . . 0.0 109.855 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.828 HD11 ' CE2' ' A' ' 48' ' ' PHE . 53.2 mt -121.14 106.41 11.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.37 -0.831 . . . . 0.0 110.283 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.466 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 72.6 mt -135.56 118.85 12.71 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.349 -0.844 . . . . 0.0 109.987 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.11 77.18 2.44 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.574 1.302 . . . . 0.0 110.507 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.09 -56.43 0.41 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -60.85 -58.47 8.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.369 -1.077 . . . . 0.0 110.218 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.611 HG23 ' C ' ' A' ' 90' ' ' VAL . 1.7 m -99.0 145.1 27.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.842 . . . . 0.0 110.188 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.32 132.41 53.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -0.826 . . . . 0.0 110.29 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.41 ' O ' ' CD1' ' A' ' 75' ' ' TRP . 36.5 p90 -88.94 140.47 29.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.441 -0.787 . . . . 0.0 110.259 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.768 ' O ' HD12 ' A' ' 78' ' ' ILE . 61.9 t -141.02 100.39 6.47 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.81 -13.11 19.88 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.771 1.406 . . . . 0.0 110.813 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.768 HD12 ' O ' ' A' ' 76' ' ' VAL . 2.3 mp 52.38 91.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -96.96 117.03 30.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.863 . . . . 0.0 110.179 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 80.1 p -156.6 120.79 4.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.386 -0.821 . . . . 0.0 110.09 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.5 t 52.38 -155.44 0.18 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.441 -0.787 . . . . 0.0 110.383 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 69.38 0.56 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.345 -0.847 . . . . 0.0 110.25 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.73 173.01 9.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.302 -0.873 . . . . 0.0 110.229 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.23 53.71 0.05 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.14 2.76 5.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.31 -1.112 . . . . 0.0 110.729 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 86' ' ' ILE . 24.6 mm -88.69 85.14 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.167 -0.958 . . . . 0.0 110.21 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -75.35 95.54 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.864 . . . . 0.0 109.742 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -85.11 120.85 27.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.819 . . . . 0.0 110.774 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mp -106.07 77.93 1.27 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.416 -0.803 . . . . 0.0 109.752 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.867 HG12 ' HB3' ' A' ' 96' ' ' ARG . 30.6 m -81.99 123.59 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.395 -0.816 . . . . 0.0 110.939 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.586 ' N ' HG23 ' A' ' 73' ' ' THR . 0.2 OUTLIER -72.14 -75.12 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.389 -0.819 . . . . 0.0 110.128 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.5 m -131.85 -67.27 0.68 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 110.145 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.06 43.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.435 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -167.92 -38.18 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.261 -0.899 . . . . 0.0 110.442 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -114.58 50.25 0.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 110.475 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.867 ' HB3' HG12 ' A' ' 90' ' ' VAL . 33.9 mtm180 -90.95 112.23 24.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.344 -0.847 . . . . 0.0 110.232 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -99.9 138.71 36.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.381 -0.825 . . . . 0.0 110.628 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.447 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 4.7 m-85 -102.74 142.81 33.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.446 -0.784 . . . . 0.0 109.427 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.866 ' CE1' HG13 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -142.62 168.63 19.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -0.992 . . . . 0.0 110.616 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.513 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 1.1 p-90 -159.65 153.81 23.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.491 -0.756 . . . . 0.0 110.003 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.35 -0.844 . . . . 0.0 110.368 -179.878 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.0 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.482 0.658 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 85.4 t -91.16 75.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.611 -0.681 . . . . 0.0 109.904 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -72.1 167.43 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.341 -0.849 . . . . 0.0 109.824 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -124.31 136.04 53.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.508 -0.745 . . . . 0.0 109.932 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.83 -177.45 3.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 109.917 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.63 139.3 54.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 110.466 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.093 ' HB3' HD11 ' A' ' 33' ' ' ILE . . . -167.69 -155.53 0.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.45 -0.781 . . . . 0.0 109.888 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 100' ' ' TRP . . . -144.52 150.65 22.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.504 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.4 t -90.68 -139.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.481 -1.011 . . . . 0.0 109.735 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.4 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 1.2 m -159.05 107.69 1.87 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.081 -1.012 . . . . 0.0 109.66 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -79.37 147.58 32.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.469 -0.769 . . . . 0.0 109.842 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.442 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -123.25 148.69 45.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.887 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 22' ' ' ARG . 9.6 t30 -111.5 118.78 36.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.815 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -72.91 -25.32 61.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.784 . . . . 0.0 110.412 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.25 -32.96 74.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.773 . . . . 0.0 110.544 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.93 3.2 5.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.366 -0.834 . . . . 0.0 110.687 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' ASN . 4.3 mtp180 51.22 56.43 7.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.191 -0.943 . . . . 0.0 110.048 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.553 HD13 HG23 ' A' ' 25' ' ' THR . 3.4 pp -112.94 167.82 10.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.83 . . . . 0.0 110.739 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.6 p -126.59 111.28 14.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.488 -0.757 . . . . 0.0 110.074 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.553 HG23 HD13 ' A' ' 23' ' ' LEU . 8.4 p -127.9 159.77 64.77 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.187 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' CB ' ' CD2' ' A' ' 100' ' ' TRP . 44.4 Cg_endo -72.2 142.12 37.21 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.833 1.438 . . . . 0.0 110.138 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.521 HG22 HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -80.31 139.4 52.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 27' ' ' ILE . 40.1 Cg_endo -65.94 -27.81 50.52 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.581 1.306 . . . . 0.0 110.555 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.722 HG23 ' OE2' ' A' ' 54' ' ' GLU . 11.3 p -84.72 115.31 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.877 . . . . 0.0 109.787 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -93.32 79.41 4.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.308 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' HA2' ' HG2' ' A' ' 54' ' ' GLU . . . -61.98 -154.2 0.05 OUTLIER Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.629 ' C ' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -137.97 160.57 38.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.115 -1.227 . . . . 0.0 110.434 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.093 HD11 ' HB3' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -103.12 176.88 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.409 0.623 . . . . 0.0 110.312 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 2.7 mt-10 -138.59 108.16 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.551 HG13 ' CE1' ' A' ' 48' ' ' PHE . 1.5 mp -68.51 126.1 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.203 -0.935 . . . . 0.0 108.935 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 28.1 mtpt -134.64 140.95 36.97 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.045 -1.034 . . . . 0.0 110.623 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 51.2 Cg_endo -88.06 53.63 2.27 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.739 1.389 . . . . 0.0 109.965 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 t30 66.22 -177.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.646 -0.659 . . . . 0.0 110.075 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 40' ' ' GLU . 8.4 pt-20 -77.27 -25.96 51.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.291 -0.881 . . . . 0.0 110.848 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.408 ' N ' ' HG3' ' A' ' 39' ' ' GLU . 39.3 mt-10 -148.23 28.5 0.9 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.235 -0.916 . . . . 0.0 110.471 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 50.57 49.38 20.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.393 -0.817 . . . . 0.0 110.576 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.612 ' OE1' HD21 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -116.46 -26.18 7.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -0.915 . . . . 0.0 110.616 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.612 HD21 ' OE1' ' A' ' 42' ' ' GLU . 14.7 mt -106.3 -8.48 17.24 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.12 -0.988 . . . . 0.0 110.002 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.27 27.47 70.71 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 6.4 m-30 -90.2 119.8 30.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.456 -1.026 . . . . 0.0 109.926 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.566 ' HB2' HD12 ' A' ' 68' ' ' LEU . 4.4 m-90 -75.44 76.91 2.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.081 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -54.79 122.72 11.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.443 -0.786 . . . . 0.0 109.989 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.903 ' CD2' HD11 ' A' ' 68' ' ' LEU . 4.7 m-30 -106.97 102.81 12.14 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.002 -1.061 . . . . 0.0 109.774 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.486 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.9 tp10 -87.71 126.68 35.12 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.778 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.903 ' CE3' HD12 ' A' ' 64' ' ' ILE . 75.6 t90 -99.18 172.42 7.38 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.459 -0.776 . . . . 0.0 109.817 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.463 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -179.79 145.29 0.41 Allowed Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.338 -0.851 . . . . 0.0 110.759 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 48.9 Cg_endo -71.88 80.98 1.43 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.808 1.425 . . . . 0.0 109.799 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.1 t -120.51 11.34 11.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 109.696 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.722 ' OE2' HG23 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -100.63 -169.65 1.74 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.988 -0.445 . . . . 0.0 109.837 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.27 109.5 50.09 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -78.79 145.82 20.43 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.398 1.209 . . . . 0.0 110.81 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.624 HG12 ' O ' ' A' ' 57' ' ' VAL . 55.3 t -142.32 29.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 109.632 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.29 -61.83 0.02 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -131.22 -157.59 0.83 Allowed 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.374 -1.074 . . . . 0.0 109.661 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.77 ' O ' HD22 ' A' ' 61' ' ' LEU . 11.1 pt-20 -150.96 146.09 26.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.6 -0.687 . . . . 0.0 110.339 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.77 HD22 ' O ' ' A' ' 60' ' ' GLU . 1.4 mm? -131.29 -161.13 1.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.301 -0.874 . . . . 0.0 110.513 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 1.7 m-20 -147.08 171.97 5.74 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.434 -0.791 . . . . 0.0 109.704 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 36.2 Cg_endo -58.43 135.87 70.61 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.528 1.278 . . . . 0.0 111.859 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.903 HD12 ' CE3' ' A' ' 50' ' ' TRP . 4.7 mt -128.94 116.74 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.58 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -69.76 118.87 13.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.215 -0.928 . . . . 0.0 110.059 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.812 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 15.8 mt -109.57 145.16 36.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.396 -0.815 . . . . 0.0 109.781 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.0 mt -119.94 148.02 23.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.33 -0.857 . . . . 0.0 110.066 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.903 HD11 ' CD2' ' A' ' 48' ' ' PHE . 62.9 mt -125.57 97.56 5.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.437 -0.789 . . . . 0.0 110.282 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.763 HG21 ' HG3' ' A' ' 72' ' ' GLU . 61.6 mt -131.29 108.93 14.94 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.256 -0.902 . . . . 0.0 110.23 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.3 80.84 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.603 1.317 . . . . 0.0 110.214 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.05 -30.11 0.73 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.763 ' HG3' HG21 ' A' ' 69' ' ' ILE . 4.1 mm-40 -89.87 -34.53 16.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.429 -1.042 . . . . 0.0 110.164 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.428 HG21 ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -104.3 168.95 8.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.416 -0.802 . . . . 0.0 110.043 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 tpp -109.66 151.42 26.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.393 -0.817 . . . . 0.0 110.387 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -90.78 119.28 30.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 110.076 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.869 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 73.7 t -138.15 113.96 9.01 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.148 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -74.28 -79.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.497 1.262 . . . . 0.0 110.514 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.514 HD12 ' C ' ' A' ' 78' ' ' ILE . 2.7 pp -144.0 174.83 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.073 -1.017 . . . . 0.0 110.128 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -102.39 -65.41 0.99 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.21 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 t -133.22 99.16 4.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.402 -0.812 . . . . 0.0 110.269 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -166.09 168.01 15.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.858 . . . . 0.0 110.223 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -99.09 27.39 5.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.383 -0.823 . . . . 0.0 110.193 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.6 t -160.9 177.65 10.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.413 -0.805 . . . . 0.0 110.13 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.76 101.84 0.21 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -140.58 22.65 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.329 -1.101 . . . . 0.0 110.261 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.67 108.32 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.1 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.69 79.9 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 0.0 109.994 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.869 ' HB3' ' O ' ' A' ' 76' ' ' VAL . . . -75.36 113.43 12.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.124 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.428 ' HB3' HG21 ' A' ' 73' ' ' THR . 6.2 mt -104.84 125.71 51.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.893 HG13 ' CD ' ' A' ' 96' ' ' ARG . 50.9 t -114.94 109.63 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 110.417 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.415 ' HB2' ' HG3' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -67.0 -78.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.333 -0.854 . . . . 0.0 110.236 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.2 t -176.44 -70.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.181 -0.949 . . . . 0.0 110.491 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.2 m -57.69 -83.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.319 -0.863 . . . . 0.0 110.446 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.35 15.64 0.39 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 110.72 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 91' ' ' PHE . 4.8 pt-20 -99.85 50.95 0.91 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 110.13 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.893 ' CD ' HG13 ' A' ' 90' ' ' VAL . 38.0 mtm105 -90.36 121.48 32.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.448 -0.782 . . . . 0.0 110.095 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 26.6 m-85 -106.44 162.63 13.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.313 -0.867 . . . . 0.0 110.506 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.414 ' O ' ' CD1' ' A' ' 99' ' ' PHE . 8.3 m-85 -137.6 141.51 41.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 109.536 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.812 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 19.8 m-85 -135.58 161.71 34.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 110.409 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.465 ' CD2' ' CB ' ' A' ' 26' ' ' PRO . 3.0 p-90 -143.77 162.76 35.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.73 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.834 . . . . 0.0 110.242 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.2 m . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.198 0.523 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.51 76.12 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.726 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -89.18 168.48 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.531 -0.73 . . . . 0.0 109.751 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.44 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 8.9 mttt -130.38 131.19 45.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -124.4 131.92 53.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -79.45 121.88 25.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.344 -0.848 . . . . 0.0 110.48 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . . . -146.68 -154.83 0.57 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.436 -0.79 . . . . 0.0 110.039 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.92 159.04 26.9 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.487 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.3 t -95.52 -137.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.388 -1.066 . . . . 0.0 109.52 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.706 ' SG ' HD11 ' A' ' 86' ' ' ILE . 42.5 t -162.46 107.96 1.21 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.973 -1.08 . . . . 0.0 110.033 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.495 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -77.37 161.49 27.99 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.377 -0.827 . . . . 0.0 110.112 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -145.63 141.72 28.41 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.892 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -107.75 135.33 49.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 110.135 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -79.54 -25.12 41.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.538 -0.726 . . . . 0.0 110.156 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.81 -39.28 91.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -115.73 -5.68 12.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 0.0 110.363 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HA ' ' CE2' ' A' ' 17' ' ' TYR . 0.2 OUTLIER 54.41 58.75 4.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.254 -0.904 . . . . 0.0 110.287 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.42 169.78 14.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.268 -0.895 . . . . 0.0 110.414 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.3 141.53 52.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.45 -0.781 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.83 163.71 25.96 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.829 . . . . 0.0 110.26 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.468 ' HB3' ' CD2' ' A' ' 100' ' ' TRP . 47.2 Cg_endo -72.53 135.38 24.07 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.75 1.395 . . . . 0.0 110.206 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.495 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.51 138.4 44.5 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.932 . . . . 0.0 109.786 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.491 ' C ' HG23 ' A' ' 29' ' ' VAL . 48.1 Cg_endo -74.77 51.86 2.81 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.75 1.395 . . . . 0.0 110.747 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.491 HG23 ' C ' ' A' ' 28' ' ' PRO . 83.4 t -152.19 116.12 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.176 -0.953 . . . . 0.0 109.815 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -80.89 70.14 7.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 110.212 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.636 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -59.12 -167.48 0.19 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.79 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 26.4 mt-10 -129.7 138.72 51.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -1.151 . . . . 0.0 112.29 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.567 HG23 ' HB3' ' A' ' 48' ' ' PHE . 39.9 mt -101.79 167.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.487 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -136.75 113.81 10.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.335 -0.853 . . . . 0.0 109.425 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 1.2 mp -68.35 123.71 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.334 -0.854 . . . . 0.0 109.106 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -132.88 142.81 46.08 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.292 -0.88 . . . . 0.0 110.282 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 51.5 Cg_endo -88.1 52.76 2.13 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.656 1.345 . . . . 0.0 109.978 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 t30 64.83 161.54 0.12 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.532 -0.73 . . . . 0.0 109.991 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.36 -56.21 20.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.401 -0.812 . . . . 0.0 110.636 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -128.06 36.84 4.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.456 -0.777 . . . . 0.0 110.331 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 51.31 52.33 15.05 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 0.0 110.406 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -102.28 -38.67 7.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.432 -0.792 . . . . 0.0 109.781 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 11.8 mt -108.06 -8.79 15.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.574 -0.703 . . . . 0.0 110.262 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.23 27.36 71.43 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.467 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 12.6 m-30 -88.46 120.5 29.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.39 -1.065 . . . . 0.0 110.033 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.616 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 22.8 m-90 -68.06 75.66 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.844 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 6.3 t0 -52.31 129.84 29.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.355 -0.841 . . . . 0.0 110.283 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.818 ' CD2' HD11 ' A' ' 68' ' ' LEU . 6.8 m-30 -110.54 103.0 11.54 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.487 -0.758 . . . . 0.0 109.673 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -83.84 116.58 22.81 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.218 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.947 ' CE3' HD12 ' A' ' 64' ' ' ILE . 74.2 t90 -94.7 154.05 17.5 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.664 -0.648 . . . . 0.0 109.683 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -163.27 138.56 5.13 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.931 -1.106 . . . . 0.0 110.638 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 44.0 Cg_endo -68.6 81.1 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.55 1.289 . . . . 0.0 110.372 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.417 ' CG2' ' HB2' ' A' ' 32' ' ' GLU . 7.0 t -120.86 5.68 10.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.383 -0.823 . . . . 0.0 109.473 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.483 ' HG2' ' HA2' ' A' ' 31' ' ' GLY . 0.8 OUTLIER -100.34 -169.68 1.76 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 109.71 51.54 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.2 -0.937 . . . . 0.0 109.908 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -81.08 -179.22 4.9 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.464 1.244 . . . . 0.0 110.801 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.554 ' O ' HG22 ' A' ' 57' ' ' VAL . 13.1 p -131.18 29.38 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.794 . . . . 0.0 109.895 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.75 22.79 3.53 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -134.59 105.6 6.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -1.184 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -80.95 132.54 35.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 0.0 110.338 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 mt -129.82 -158.71 0.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 110.177 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.552 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -162.66 172.23 5.6 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.28 -0.888 . . . . 0.0 110.269 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.799 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.2 Cg_endo -61.36 126.44 19.3 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.72 1.379 . . . . 0.0 111.308 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.947 HD12 ' CE3' ' A' ' 50' ' ' TRP . 9.9 mt -124.96 111.33 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.788 -0.57 . . . . 0.0 110.088 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.9 m -69.8 117.48 11.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.144 -0.973 . . . . 0.0 109.438 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.86 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 26.7 mt -104.04 144.32 31.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.294 -0.879 . . . . 0.0 110.398 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.417 ' CG2' ' CD1' ' A' ' 69' ' ' ILE . 8.8 mm -113.04 148.39 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.421 -0.8 . . . . 0.0 109.585 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.818 HD11 ' CD2' ' A' ' 48' ' ' PHE . 77.7 mt -121.71 87.57 2.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 110.188 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.467 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 74.2 mt -127.71 108.48 20.58 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.447 -0.783 . . . . 0.0 110.019 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.39 64.01 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.58 1.305 . . . . 0.0 110.449 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.85 -37.32 0.1 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -71.48 -53.35 14.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.339 -1.095 . . . . 0.0 110.227 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.801 HG22 ' N ' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -101.25 148.24 25.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.416 -0.803 . . . . 0.0 110.2 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mmt -76.12 132.64 40.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.422 -0.799 . . . . 0.0 110.194 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.44 83.17 4.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.408 -0.807 . . . . 0.0 110.051 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.85 139.23 19.91 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 110.096 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -74.87 -78.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.7 1.369 . . . . 0.0 110.688 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.0 tt -166.48 160.77 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.172 -0.955 . . . . 0.0 110.167 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -58.75 164.93 2.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.289 -0.882 . . . . 0.0 110.265 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.9 t 53.07 -162.32 0.1 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.335 -0.853 . . . . 0.0 110.421 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 p -131.46 52.4 2.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.419 -0.801 . . . . 0.0 110.226 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.94 -49.65 7.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.363 -0.836 . . . . 0.0 110.157 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -155.84 -160.27 1.0 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.316 -0.865 . . . . 0.0 110.183 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.19 57.43 0.11 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.45 -39.14 8.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.326 -1.103 . . . . 0.0 110.114 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.706 HD11 ' SG ' ' A' ' 15' ' ' CYS . 2.1 tt -80.88 105.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.309 -0.87 . . . . 0.0 110.188 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -69.71 139.36 53.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.23 117.88 28.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.47 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 89' ' ' LEU . 6.7 mp -104.32 124.14 48.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.988 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.836 HG13 ' CD ' ' A' ' 96' ' ' ARG . 75.7 t -125.37 112.39 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.36 -0.837 . . . . 0.0 110.381 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.801 ' N ' HG22 ' A' ' 73' ' ' THR . 24.5 t80 -76.17 -76.38 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.855 . . . . 0.0 110.004 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.8 m -129.85 -66.65 0.78 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.374 -0.829 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.06 36.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.373 -0.829 . . . . 0.0 110.205 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -166.67 -39.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.397 -0.815 . . . . 0.0 110.415 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -97.51 43.14 1.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.447 -0.783 . . . . 0.0 110.144 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.836 ' CD ' HG13 ' A' ' 90' ' ' VAL . 42.3 mtm180 -98.83 111.21 23.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.261 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 41.7 m-85 -113.75 159.52 19.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.381 -0.825 . . . . 0.0 110.236 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.427 ' HB2' ' CB ' ' A' ' 15' ' ' CYS . 0.4 OUTLIER -141.55 141.46 33.53 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.258 -0.901 . . . . 0.0 109.827 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.86 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 6.7 m-85 -137.66 169.51 17.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.149 -0.97 . . . . 0.0 110.328 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.468 ' CD2' ' HB3' ' A' ' 26' ' ' PRO . 3.2 p-90 -150.32 161.28 42.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.185 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.286 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.272 0.558 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.9 p -78.51 86.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.5 -0.75 . . . . 0.0 110.051 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -72.11 168.9 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.07 -1.019 . . . . 0.0 109.744 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 20.8 mttp -126.09 144.23 50.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.553 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -134.67 -174.84 3.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.795 . . . . 0.0 109.608 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.23 119.28 24.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 0.0 110.854 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.772 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . . . -150.15 -158.65 0.94 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 109.715 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' HA3' ' NE1' ' A' ' 100' ' ' TRP . . . -142.31 165.74 26.61 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.493 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 0.7 OUTLIER -103.88 -142.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.431 -1.041 . . . . 0.0 109.516 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.423 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -163.75 108.3 1.02 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.065 -1.022 . . . . 0.0 110.105 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.499 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -77.71 162.18 27.17 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.309 -0.869 . . . . 0.0 110.031 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -126.51 144.12 50.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.139 -0.625 . . . . 0.0 110.066 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.407 ' HB3' HD22 ' A' ' 23' ' ' LEU . 7.6 t-20 -110.11 124.97 52.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.903 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -24.74 52.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.368 -0.833 . . . . 0.0 110.305 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -68.55 -30.75 69.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.461 -0.775 . . . . 0.0 110.256 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -124.08 -2.21 8.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.383 -0.823 . . . . 0.0 110.61 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER 52.74 58.01 5.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.127 -0.983 . . . . 0.0 110.184 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -128.78 164.71 22.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.901 . . . . 0.0 110.302 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.94 90.04 3.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 110.062 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.41 167.38 12.4 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 110.188 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.464 ' CB ' ' CD2' ' A' ' 100' ' ' TRP . 44.1 Cg_endo -71.35 144.52 46.01 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.756 1.398 . . . . 0.0 110.332 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.499 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.77 140.9 43.92 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 109.431 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.458 ' HD2' HG22 ' A' ' 27' ' ' ILE . 40.3 Cg_endo -66.14 -18.47 56.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.621 1.327 . . . . 0.0 110.565 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.632 HG21 ' O ' ' A' ' 59' ' ' ARG . 85.2 t -83.61 138.08 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.974 . . . . 0.0 109.459 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.19 -49.73 7.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 110.798 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . 54.82 -166.7 2.57 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.62 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -153.7 159.02 41.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.039 -1.271 . . . . 0.0 110.463 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.772 ' CD1' ' HB3' ' A' ' 12' ' ' ALA . 2.2 mp -106.69 168.7 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.507 0.67 . . . . 0.0 110.368 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 42.1 mt-10 -130.86 114.12 14.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.588 -0.695 . . . . 0.0 109.496 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 35' ' ' ILE . 1.7 mp -68.72 127.22 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 18.1 mtpt -133.41 140.93 38.61 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 0.0 110.755 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 49.8 Cg_endo -87.9 53.01 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.725 1.382 . . . . 0.0 109.973 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 65.02 164.63 0.15 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.559 -0.713 . . . . 0.0 110.121 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.33 -38.49 71.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 0.0 110.816 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -147.82 38.33 0.91 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.872 . . . . 0.0 110.389 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 51.1 49.87 20.24 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.35 -0.844 . . . . 0.0 110.438 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -103.04 -41.26 6.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -0.865 . . . . 0.0 109.807 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -106.26 -5.36 19.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.526 -0.734 . . . . 0.0 110.353 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.97 27.8 69.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 8.5 m-30 -88.22 120.67 29.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -1.027 . . . . 0.0 109.985 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.566 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 88.6 m95 -70.49 76.77 0.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -53.98 124.32 15.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.346 -0.846 . . . . 0.0 109.994 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.857 ' CD2' HD11 ' A' ' 68' ' ' LEU . 6.1 m-30 -107.29 102.85 12.12 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.164 -0.96 . . . . 0.0 109.804 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.42 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.2 tt0 -85.49 118.83 25.26 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.104 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.925 ' CE3' HD12 ' A' ' 64' ' ' ILE . 69.4 t90 -93.75 167.08 11.88 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.506 -0.746 . . . . 0.0 109.299 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.457 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 2.7 ptm180 -177.5 146.32 0.62 Allowed Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.226 -0.921 . . . . 0.0 110.832 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.553 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.1 Cg_endo -71.87 76.68 1.99 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.544 1.287 . . . . 0.0 109.945 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 t -118.26 10.0 12.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.173 -0.954 . . . . 0.0 109.848 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HB2' ' N ' ' A' ' 31' ' ' GLY . 60.9 mm-40 -116.2 -169.09 1.54 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 113.14 43.46 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.102 -0.999 . . . . 0.0 110.547 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.448 ' C ' HG23 ' A' ' 57' ' ' VAL . 50.8 Cg_endo -78.29 -167.34 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.484 1.255 . . . . 0.0 110.422 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.614 ' O ' HG12 ' A' ' 57' ' ' VAL . 57.7 t -148.59 49.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.464 -0.772 . . . . 0.0 110.029 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.43 5.24 72.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.632 ' O ' HG21 ' A' ' 29' ' ' VAL . 16.6 mmt180 -124.68 100.95 6.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -1.161 . . . . 0.0 110.131 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -73.88 122.98 23.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.329 -0.857 . . . . 0.0 110.367 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.423 ' HA ' HD13 ' A' ' 61' ' ' LEU . 1.4 mm? -116.53 -162.15 0.84 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.341 -0.849 . . . . 0.0 110.102 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.553 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -155.55 174.98 3.43 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.898 . . . . 0.0 110.144 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.676 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 38.3 Cg_endo -63.83 131.35 30.75 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.607 1.32 . . . . 0.0 111.526 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.925 HD12 ' CE3' ' A' ' 50' ' ' TRP . 6.5 mt -126.03 113.78 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.713 -0.617 . . . . 0.0 109.683 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.7 p -69.61 117.99 11.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 0.0 110.034 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.722 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 18.6 mt -107.76 147.42 30.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.926 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.63 ' O ' HD23 ' A' ' 68' ' ' LEU . 15.3 mt -120.03 155.64 22.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.916 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.857 HD11 ' CD2' ' A' ' 48' ' ' PHE . 50.6 mt -132.36 99.62 4.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.428 -0.795 . . . . 0.0 110.13 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.566 HG21 ' CG ' ' A' ' 72' ' ' GLU . 52.6 mt -132.4 108.02 13.4 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.135 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.2 -7.99 21.36 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.526 1.277 . . . . 0.0 110.774 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -108.34 2.84 32.87 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.566 ' CG ' HG21 ' A' ' 69' ' ' ILE . 66.8 mm-40 -133.1 -68.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.072 -1.252 . . . . 0.0 110.351 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.645 HG22 ' C ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -79.41 126.95 31.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.323 -0.86 . . . . 0.0 110.108 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ttt -70.81 137.01 49.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.383 -0.823 . . . . 0.0 110.138 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.426 ' CD2' HD21 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -87.65 122.8 31.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.345 -0.847 . . . . 0.0 110.206 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.809 . . . . 0.0 110.056 -179.981 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.128 0.489 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 72.7 mt -117.0 101.3 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.351 -0.843 . . . . 0.0 110.091 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.596 ' CE2' HD21 ' A' ' 101' ' ' LEU . 48.7 m-85 -72.17 108.47 5.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.832 . . . . 0.0 110.25 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.6 133.95 55.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 110.193 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.426 HD21 ' CD2' ' A' ' 75' ' ' TRP . 3.9 mt -112.5 116.96 31.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.848 . . . . 0.0 110.218 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.872 HG12 ' HB3' ' A' ' 96' ' ' ARG . 10.0 m -112.48 133.44 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 110.511 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.46 ' HB2' HG23 ' A' ' 73' ' ' THR . 46.6 t80 -92.03 -79.65 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.426 -0.796 . . . . 0.0 110.168 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -172.82 -39.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.199 -0.938 . . . . 0.0 110.345 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.64 -81.58 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.895 . . . . 0.0 110.385 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -150.82 15.76 0.76 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.157 -0.964 . . . . 0.0 110.822 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -90.51 49.53 1.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.162 -0.961 . . . . 0.0 110.142 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.872 ' HB3' HG12 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -105.19 111.2 23.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.364 -0.835 . . . . 0.0 110.484 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 29.3 m-85 -113.94 155.49 25.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.497 -0.752 . . . . 0.0 110.204 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.423 ' HB2' ' CB ' ' A' ' 15' ' ' CYS . 25.9 m-85 -120.74 140.28 51.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.876 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.722 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 19.6 m-85 -134.69 158.55 43.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -0.982 . . . . 0.0 110.358 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.464 ' CD2' ' CB ' ' A' ' 26' ' ' PRO . 2.6 p-90 -149.57 144.0 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 109.912 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.596 HD21 ' CE2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.238 0.542 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 58.8 t -99.8 86.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.434 -0.791 . . . . 0.0 109.999 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.535 HG22 ' H ' ' A' ' 9' ' ' LYS . 17.0 mt -94.39 175.21 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.222 -0.924 . . . . 0.0 109.627 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.535 ' H ' HG22 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -131.04 132.38 44.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.201 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -126.83 -174.61 3.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.455 -0.778 . . . . 0.0 109.439 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 23.6 mtt85 -127.09 149.53 49.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.147 -0.97 . . . . 0.0 110.826 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.692 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . . . -170.72 -155.04 0.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.48 -0.762 . . . . 0.0 109.746 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.443 ' O ' ' CD2' ' A' ' 99' ' ' PHE . . . -145.68 146.55 16.85 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.818 HG13 ' CE1' ' A' ' 99' ' ' PHE . 1.1 t -89.55 -141.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.337 -1.096 . . . . 0.0 109.621 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 98' ' ' PHE . 42.5 t -162.99 110.13 1.21 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.056 -1.027 . . . . 0.0 110.01 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.549 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -76.96 154.77 33.24 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 109.849 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.33 145.85 33.05 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.028 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -123.68 134.61 53.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.45 -0.781 . . . . 0.0 110.202 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -77.1 -27.56 54.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.413 -0.804 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.45 -37.16 72.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.355 -0.841 . . . . 0.0 110.101 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.4 p -121.42 -2.82 9.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.472 -0.767 . . . . 0.0 110.369 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 52.49 57.38 6.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.27 -0.894 . . . . 0.0 110.15 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.74 159.65 26.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -0.833 . . . . 0.0 110.403 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.06 91.92 3.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.473 -0.767 . . . . 0.0 109.871 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.1 p -103.26 164.2 15.96 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.442 -0.786 . . . . 0.0 110.281 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.471 ' HB3' ' CD2' ' A' ' 100' ' ' TRP . 44.1 Cg_endo -71.16 142.4 41.74 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.85 1.447 . . . . 0.0 110.272 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.549 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.24 136.7 46.23 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 110.051 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.478 ' C ' HG23 ' A' ' 29' ' ' VAL . 48.7 Cg_endo -75.97 52.85 3.55 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.798 1.42 . . . . 0.0 110.189 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.809 HG13 ' OE2' ' A' ' 54' ' ' GLU . 75.4 t -150.06 115.88 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.86 . . . . 0.0 109.597 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -85.29 64.73 8.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 110.43 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.468 ' N ' ' HG2' ' A' ' 54' ' ' GLU . . . -61.52 -161.51 0.16 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.566 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -140.4 155.07 46.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.876 -1.367 . . . . 0.0 111.097 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.692 ' CD1' ' HB3' ' A' ' 12' ' ' ALA . 2.0 mp -105.75 169.96 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-O 121.4 0.619 . . . . 0.0 110.437 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 17.0 mt-10 -134.52 120.26 19.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.567 -0.708 . . . . 0.0 109.405 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.577 ' N ' HD12 ' A' ' 35' ' ' ILE . 1.7 mp -69.78 127.61 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -134.74 123.12 15.93 Favored Pre-proline 0 N--CA 1.485 1.3 0 O-C-N 121.055 -1.028 . . . . 0.0 109.343 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HD2' ' HD3' ' A' ' 36' ' ' LYS . 48.8 Cg_endo -83.77 51.82 3.58 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.489 1.257 . . . . 0.0 110.07 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 62.45 150.16 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.62 -0.675 . . . . 0.0 110.028 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -52.6 -25.7 11.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.41 -0.806 . . . . 0.0 110.156 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -133.74 -154.38 0.6 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.418 -0.801 . . . . 0.0 109.747 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -123.41 52.03 1.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 109.691 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.31 -35.86 7.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.411 -0.806 . . . . 0.0 110.156 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 11.7 mt -118.23 -11.9 10.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 110.217 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.91 27.49 56.59 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.486 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 5.7 m-30 -68.3 118.31 11.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -1.02 . . . . 0.0 110.065 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 77.1 m95 -80.71 68.08 6.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.469 -0.77 . . . . 0.0 110.094 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.47 ' HB2' ' CG ' ' A' ' 36' ' ' LYS . 68.7 m-20 -53.21 137.97 33.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.444 -0.785 . . . . 0.0 110.207 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.803 ' CE2' HD11 ' A' ' 68' ' ' LEU . 5.5 m-30 -108.77 102.69 11.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.357 -0.84 . . . . 0.0 109.669 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.44 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 4.0 tt0 -82.48 121.41 26.73 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.053 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.902 ' CE3' HD12 ' A' ' 64' ' ' ILE . 71.7 t90 -93.66 171.84 8.63 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.361 -0.837 . . . . 0.0 109.508 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 1.3 ptm180 -175.44 146.2 0.88 Allowed Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.2 -0.938 . . . . 0.0 110.808 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.511 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 52.2 Cg_endo -74.82 80.17 2.44 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.711 1.374 . . . . 0.0 109.788 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.463 HG21 ' CD ' ' A' ' 32' ' ' GLU . 7.0 t -117.71 5.05 12.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.121 -0.987 . . . . 0.0 109.777 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.809 ' OE2' HG13 ' A' ' 29' ' ' VAL . 1.5 pp20? -100.9 -178.15 3.67 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.933 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -99.14 109.74 55.4 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.3 -0.875 . . . . 0.0 109.648 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -83.11 167.81 13.86 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.572 1.301 . . . . 0.0 110.679 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.609 ' O ' HG12 ' A' ' 57' ' ' VAL . 55.5 t -112.42 36.2 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.468 -0.77 . . . . 0.0 109.534 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.84 16.95 6.61 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.1 mmt-85 -129.99 103.26 6.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -1.154 . . . . 0.0 110.261 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -80.15 140.78 36.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.352 -0.843 . . . . 0.0 110.103 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.514 HD21 HG21 ' A' ' 27' ' ' ILE . 1.3 mp -131.62 -168.21 1.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 0.0 110.332 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.521 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 53.9 m-20 -152.07 166.73 14.64 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.499 -0.751 . . . . 0.0 109.984 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.5 Cg_endo -61.45 136.08 61.34 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.69 1.363 . . . . 0.0 111.573 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.902 HD12 ' CE3' ' A' ' 50' ' ' TRP . 5.1 mt -129.42 114.31 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 p -69.66 116.22 9.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.202 -0.936 . . . . 0.0 110.002 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.669 HD11 ' CZ ' ' A' ' 99' ' ' PHE . 29.2 mt -105.76 154.68 20.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 109.801 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.477 HG21 HD12 ' A' ' 69' ' ' ILE . 43.0 mt -125.4 152.36 32.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.613 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.803 HD11 ' CE2' ' A' ' 48' ' ' PHE . 73.7 mt -122.97 82.8 2.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.388 -0.82 . . . . 0.0 110.236 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.486 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 64.3 mt -131.19 106.6 14.83 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.465 -0.772 . . . . 0.0 110.162 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.54 63.32 4.6 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.634 1.334 . . . . 0.0 110.278 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.69 -46.58 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -60.47 -76.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.195 -1.179 . . . . 0.0 110.259 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.717 ' HB ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -71.71 -153.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.264 -0.898 . . . . 0.0 109.754 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -138.63 100.26 4.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.247 -0.908 . . . . 0.0 110.44 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.41 ' CD2' ' O ' ' A' ' 75' ' ' TRP . 64.0 p-90 -76.11 131.51 39.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.858 . . . . 0.0 110.163 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 -179.866 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 121.325 0.583 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 99' ' ' PHE . 57.7 mt -133.73 114.13 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.263 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -76.18 115.13 15.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.347 -0.845 . . . . 0.0 109.961 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.499 ' HB1' ' CE2' ' A' ' 98' ' ' PHE . . . -99.41 110.93 23.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.425 -0.797 . . . . 0.0 110.563 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.717 HD12 ' HB ' ' A' ' 73' ' ' THR . 4.1 mm? -102.01 119.08 38.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.823 . . . . 0.0 109.83 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.764 HG13 ' HG2' ' A' ' 96' ' ' ARG . 91.3 t -113.91 131.29 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 110.529 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.422 ' HB2' HG23 ' A' ' 73' ' ' THR . 33.3 t80 -100.99 -61.62 1.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.47 -0.769 . . . . 0.0 110.133 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.9 m -142.53 -50.92 0.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.558 -0.713 . . . . 0.0 110.154 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.85 -29.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.883 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -116.89 11.94 14.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 111.075 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 21.6 mt-10 -130.38 36.29 3.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 0.0 110.298 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.764 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -95.9 111.34 23.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 0.0 110.328 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 27.1 m-85 -105.79 142.59 35.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.453 -0.78 . . . . 0.0 110.295 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 20.1 m-85 -119.83 136.24 54.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.393 -0.817 . . . . 0.0 109.888 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.818 ' CE1' HG13 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -134.73 169.85 16.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.233 -0.917 . . . . 0.0 110.197 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.471 ' CD2' ' HB3' ' A' ' 26' ' ' PRO . 2.1 p-90 -158.37 175.39 13.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 110.257 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 mt . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.821 . . . . 0.0 110.147 -179.943 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.198 0.523 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.938 HG13 ' HD3' ' A' ' 36' ' ' LYS . 98.2 t -111.2 59.53 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.45 -0.781 . . . . 0.0 109.635 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 35' ' ' ILE . 15.4 tt -102.19 175.16 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 0.0 110.111 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 4.4 mptt -120.71 140.73 51.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.039 -1.038 . . . . 0.0 110.942 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -113.77 -179.11 3.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 109.686 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -113.72 127.39 56.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 110.322 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.81 -160.68 0.71 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 110.085 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.74 163.31 29.63 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.466 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.3 t -95.53 -138.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.454 -1.027 . . . . 0.0 109.85 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.416 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 34.7 t -155.53 108.12 2.69 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.148 -0.97 . . . . 0.0 109.652 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.4 ' N ' HG12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -78.82 128.39 33.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.993 -179.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.18 157.63 28.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.635 -0.666 . . . . 0.0 109.821 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.422 ' HB2' HD21 ' A' ' 23' ' ' LEU . 11.5 t-20 -126.22 136.26 52.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -0.837 . . . . 0.0 110.412 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -82.48 -25.33 33.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 110.154 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -35.26 77.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.363 -0.836 . . . . 0.0 109.999 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 m -120.44 -1.38 10.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.476 -0.765 . . . . 0.0 110.584 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.15 56.14 8.44 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.206 -0.934 . . . . 0.0 109.91 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.523 ' C ' HD12 ' A' ' 23' ' ' LEU . 3.7 pp -108.1 154.04 22.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.428 -0.795 . . . . 0.0 110.809 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.9 p -124.97 71.06 1.16 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.518 -0.739 . . . . 0.0 110.279 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 p -97.16 165.11 16.4 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.405 -0.809 . . . . 0.0 110.248 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HB2' ' CD2' ' A' ' 100' ' ' TRP . 46.2 Cg_endo -74.26 152.96 45.41 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.789 1.415 . . . . 0.0 110.332 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.466 ' CD1' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -81.97 140.89 46.74 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.219 -0.926 . . . . 0.0 109.186 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' A' ' 27' ' ' ILE . 40.7 Cg_endo -67.25 -15.24 45.52 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.559 1.294 . . . . 0.0 110.497 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.774 HG13 ' OE2' ' A' ' 54' ' ' GLU . 93.4 t -94.36 115.34 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.58 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -88.42 72.02 8.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 110.276 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.429 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.5 -160.4 0.08 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -138.48 161.21 37.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -1.193 . . . . 0.0 110.64 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 34' ' ' GLU . 96.6 mt -105.0 170.69 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.414 0.626 . . . . 0.0 110.571 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.55 ' N ' HG22 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -128.95 105.98 8.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.527 -0.733 . . . . 0.0 109.065 179.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.547 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 1.2 mp -68.01 125.98 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 108.655 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.938 ' HD3' HG13 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -137.03 161.93 58.6 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 110.977 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -93.14 55.41 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.677 1.585 . . . . 0.0 110.076 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.421 HD21 HD12 ' A' ' 43' ' ' LEU . 6.2 t-20 60.29 175.16 0.09 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.371 -0.831 . . . . 0.0 110.093 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.88 -65.26 0.71 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.321 -0.862 . . . . 0.0 110.628 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -122.15 37.38 4.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.776 . . . . 0.0 110.527 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 50.9 49.81 20.36 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.385 -0.822 . . . . 0.0 110.604 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.506 ' OE2' HD21 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -118.58 -24.58 6.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.326 -0.859 . . . . 0.0 110.547 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.506 HD21 ' OE2' ' A' ' 42' ' ' GLU . 14.6 mt -108.82 -12.0 14.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.132 -0.98 . . . . 0.0 109.981 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.71 26.87 72.21 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.459 ' CD2' HG12 ' A' ' 69' ' ' ILE . 13.8 m-30 -91.49 122.79 34.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -1.098 . . . . 0.0 110.134 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.572 ' HB2' HD12 ' A' ' 68' ' ' LEU . 8.8 m0 -66.78 81.87 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 0.0 109.508 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.447 ' CB ' ' HB2' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -53.64 118.42 3.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.172 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.961 ' CD2' HD11 ' A' ' 68' ' ' LEU . 3.9 m-30 -107.7 102.5 11.72 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.332 -0.855 . . . . 0.0 109.188 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.445 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -89.58 123.13 33.38 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.711 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.783 ' CE3' HD12 ' A' ' 64' ' ' ILE . 70.5 t90 -91.75 173.84 7.66 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.331 -0.855 . . . . 0.0 109.579 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 179.55 146.89 0.41 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.095 -1.003 . . . . 0.0 110.848 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.9 Cg_endo -74.61 78.14 2.82 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.851 1.448 . . . . 0.0 109.694 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t -118.02 10.58 13.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 109.645 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.774 ' OE2' HG13 ' A' ' 29' ' ' VAL . 1.3 pp20? -100.62 -169.59 1.74 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.734 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -97.04 109.64 50.18 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 109.75 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.442 ' C ' HG23 ' A' ' 57' ' ' VAL . 52.3 Cg_endo -81.75 -178.01 3.92 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.482 1.254 . . . . 0.0 110.957 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.633 ' O ' HG12 ' A' ' 57' ' ' VAL . 59.5 t -148.41 30.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.609 -0.682 . . . . 0.0 109.441 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.06 0.93 7.52 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.5 ' O ' HG21 ' A' ' 29' ' ' VAL . 3.0 mmt85 -123.25 100.34 6.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.26 . . . . 0.0 110.323 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.89 112.65 21.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.394 -0.816 . . . . 0.0 110.265 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.41 HD21 HD12 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -103.73 -163.46 0.98 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.37 -0.831 . . . . 0.0 110.39 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 8.8 m-20 -152.74 164.95 18.69 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.457 -0.777 . . . . 0.0 109.93 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 36.7 Cg_endo -59.4 146.45 94.86 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.648 1.341 . . . . 0.0 112.016 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.783 HD12 ' CE3' ' A' ' 50' ' ' TRP . 5.4 mt -137.51 118.02 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 p -69.67 118.16 12.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.095 -1.003 . . . . 0.0 109.787 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.725 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 24.6 mt -105.25 143.57 33.24 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.288 -0.882 . . . . 0.0 110.153 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.3 mm -112.93 139.58 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.474 -0.766 . . . . 0.0 109.751 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.961 HD11 ' CD2' ' A' ' 48' ' ' PHE . 73.1 mt -122.83 95.24 4.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -0.88 . . . . 0.0 110.214 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.459 HG12 ' CD2' ' A' ' 45' ' ' PHE . 51.2 mt -128.41 116.66 19.91 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.331 -0.856 . . . . 0.0 110.058 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.95 64.87 4.1 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.612 1.322 . . . . 0.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.77 -52.81 0.2 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.409 ' O ' ' CD1' ' A' ' 91' ' ' PHE . 13.3 mm-40 -61.86 -80.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.257 -1.143 . . . . 0.0 110.155 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.603 HG23 ' HB2' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -85.01 113.62 21.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.188 -0.945 . . . . 0.0 109.97 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.5 tpt -69.7 148.99 48.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.468 -0.77 . . . . 0.0 110.196 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -111.52 142.14 44.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.431 -0.793 . . . . 0.0 110.087 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 110.182 -179.897 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.097 0.475 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 59.9 mt -93.8 120.9 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 110.26 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -82.68 111.07 18.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.855 . . . . 0.0 110.053 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.488 ' HB1' ' CE2' ' A' ' 98' ' ' PHE . . . -92.43 97.94 11.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.294 -0.879 . . . . 0.0 110.476 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mt -93.42 105.43 17.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.434 -0.791 . . . . 0.0 109.833 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.763 HG23 ' CG ' ' A' ' 96' ' ' ARG . 7.7 p -134.87 154.56 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.309 -0.869 . . . . 0.0 110.591 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.603 ' HB2' HG23 ' A' ' 73' ' ' THR . 22.8 t80 -117.32 -70.85 0.77 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.368 -0.832 . . . . 0.0 110.093 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.0 p -133.94 -68.04 0.57 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.784 . . . . 0.0 110.057 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.0 p -166.18 30.46 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.419 -0.801 . . . . 0.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.413 ' N ' ' HD2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -135.29 -40.66 0.73 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.494 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -116.57 87.21 2.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.342 -0.849 . . . . 0.0 110.406 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.763 ' CG ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -128.12 110.4 12.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 110.223 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 33.9 m-85 -127.33 154.36 45.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 110.668 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.488 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 43.2 m-85 -129.21 132.37 47.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.595 -0.691 . . . . 0.0 109.43 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.725 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 16.2 m-85 -127.1 160.84 29.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.148 -0.97 . . . . 0.0 110.403 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.484 ' CD2' ' HB2' ' A' ' 26' ' ' PRO . 2.3 p-90 -147.89 150.93 35.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.404 -0.81 . . . . 0.0 109.912 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.288 -0.882 . . . . 0.0 110.271 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.412 HG22 HG12 ' A' ' 8' ' ' ILE . 90.4 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.223 0.535 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.7 p -73.73 68.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.423 -0.798 . . . . 0.0 109.921 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -72.07 165.93 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.227 -0.921 . . . . 0.0 109.672 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.415 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 12.2 ttmt -122.43 141.77 51.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.338 -0.851 . . . . 0.0 110.34 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -135.69 -174.66 3.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.398 -0.813 . . . . 0.0 109.705 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.2 115.51 17.77 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.175 -0.953 . . . . 0.0 110.811 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.758 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . . . -137.93 -160.59 1.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.472 -0.767 . . . . 0.0 109.622 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.418 ' HA3' ' NE1' ' A' ' 100' ' ' TRP . . . -139.99 155.1 24.25 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.503 ' C ' HG13 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -96.34 -142.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.44 -1.035 . . . . 0.0 109.394 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.447 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -162.39 107.64 1.2 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.971 -1.081 . . . . 0.0 110.184 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.524 ' CG ' HD13 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -78.7 162.4 26.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.383 -0.823 . . . . 0.0 110.089 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.408 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -129.7 149.75 51.31 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.635 -0.666 . . . . 0.0 109.637 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -113.26 124.82 53.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.364 -0.835 . . . . 0.0 110.061 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 20' ' ' ASP . 9.4 pt-20 -76.36 -25.32 54.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.527 -0.733 . . . . 0.0 110.147 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.422 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 9.8 t0 -64.75 -35.04 79.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.44 -0.787 . . . . 0.0 110.087 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -118.64 -5.44 10.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.426 -0.796 . . . . 0.0 110.504 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.408 ' HA ' ' CE2' ' A' ' 17' ' ' TYR . 6.5 mtt180 54.63 60.19 3.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.142 -0.974 . . . . 0.0 110.105 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.94 158.52 43.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.307 -0.871 . . . . 0.0 110.369 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.564 ' O ' HG23 ' A' ' 25' ' ' THR . 0.1 OUTLIER -107.49 150.58 26.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -0.835 . . . . 0.0 110.055 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 24' ' ' CYS . 4.3 p -155.18 164.27 21.69 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.386 -0.821 . . . . 0.0 110.241 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.511 ' HB3' ' CD2' ' A' ' 100' ' ' TRP . 45.8 Cg_endo -71.81 137.13 29.14 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.764 1.402 . . . . 0.0 110.137 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.524 HD13 ' CG ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.94 137.6 43.43 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 109.822 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.38 54.29 3.29 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.686 1.361 . . . . 0.0 110.553 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.704 HG23 ' OE2' ' A' ' 54' ' ' GLU . 9.2 p -157.84 115.87 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.939 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -83.57 71.75 10.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.3 -0.875 . . . . 0.0 110.11 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.637 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -58.05 -167.02 0.12 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.784 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 27.6 mt-10 -128.48 138.25 52.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -1.138 . . . . 0.0 112.323 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.758 ' CD1' ' HB3' ' A' ' 12' ' ' ALA . 2.0 mp -101.95 163.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.802 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.541 ' HB2' ' CB ' ' A' ' 49' ' ' GLU . 3.4 mt-10 -128.49 110.62 12.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.398 -0.814 . . . . 0.0 109.2 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.525 HD12 ' CE1' ' A' ' 48' ' ' PHE . 30.4 mm -69.19 120.02 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.396 -0.815 . . . . 0.0 110.32 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 16.9 mmmt -130.59 107.73 15.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 109.943 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.19 49.99 3.3 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.621 1.327 . . . . 0.0 110.213 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 t30 62.68 141.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.635 -0.665 . . . . 0.0 110.196 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.09 -29.1 28.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -0.904 . . . . 0.0 110.042 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -128.52 -151.53 0.48 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.49 -0.756 . . . . 0.0 109.638 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.58 52.83 1.39 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.264 -0.897 . . . . 0.0 109.62 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.431 ' O ' HD23 ' A' ' 43' ' ' LEU . 11.6 mt-10 -101.31 -39.56 7.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.008 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.446 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 16.4 mt -118.8 -16.78 9.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.486 -0.759 . . . . 0.0 110.142 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.21 26.73 61.79 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 5.2 m-30 -71.47 118.92 14.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.544 -0.974 . . . . 0.0 109.951 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.643 ' HB2' HD12 ' A' ' 68' ' ' LEU . 35.8 m0 -83.82 71.19 10.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.463 -0.773 . . . . 0.0 110.427 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -52.17 122.95 9.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.409 -0.807 . . . . 0.0 110.429 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.886 ' CE2' HD11 ' A' ' 68' ' ' LEU . 10.3 m-30 -105.67 102.92 12.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.146 -0.971 . . . . 0.0 109.824 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.541 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 5.1 tt0 -85.8 120.95 27.77 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.053 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.919 ' CE3' HD12 ' A' ' 64' ' ' ILE 0.25 71.0 t90 -95.59 158.61 15.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.572 -0.705 . . . . 0.0 109.868 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -164.38 142.64 5.66 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 120.825 -1.172 . . . . 0.0 110.993 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.51 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.4 Cg_endo -70.77 80.98 1.12 Allowed 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.646 1.34 . . . . 0.0 110.46 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.435 HG23 ' OE2' ' A' ' 32' ' ' GLU . 7.5 t -127.31 7.52 6.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -0.99 . . . . 0.0 110.015 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.704 ' OE2' HG23 ' A' ' 29' ' ' VAL . 1.2 pp20? -100.62 -169.65 1.74 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.71 -0.619 . . . . 0.0 109.8 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -99.48 109.53 55.34 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.895 . . . . 0.0 109.673 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.39 -178.49 3.41 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.544 1.287 . . . . 0.0 110.885 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 57' ' ' VAL . 12.0 p -126.32 29.11 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.682 . . . . 0.0 109.686 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.77 24.22 3.74 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -132.62 104.95 6.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.323 -1.104 . . . . 0.0 110.245 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.461 ' O ' HD22 ' A' ' 61' ' ' LEU . 1.5 mp0 -82.06 121.74 26.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.372 -0.83 . . . . 0.0 110.054 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 60' ' ' GLU . 2.4 mm? -118.78 -169.21 1.68 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.887 . . . . 0.0 110.32 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.564 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 10.2 p-10 -147.54 167.34 13.7 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 110.339 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.698 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.0 Cg_endo -60.58 135.12 58.65 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.636 1.335 . . . . 0.0 111.624 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.919 HD12 ' CE3' ' A' ' 50' ' ' TRP . 5.4 mt -128.69 112.43 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.4 p -69.62 116.5 10.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.824 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.841 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 18.1 mt -105.4 144.26 32.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.976 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.4 mt -120.03 150.45 22.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.431 -0.793 . . . . 0.0 109.755 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.886 HD11 ' CE2' ' A' ' 48' ' ' PHE . 56.4 mt -120.73 91.48 3.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 110.275 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.446 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 76.8 mt -131.71 108.65 14.37 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.381 -0.824 . . . . 0.0 110.111 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.82 85.24 0.97 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.64 1.337 . . . . 0.0 110.335 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.65 -39.87 0.83 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.0 -49.45 72.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.491 -1.006 . . . . 0.0 110.088 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 91' ' ' PHE . 1.3 m -115.75 156.06 26.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.421 -0.8 . . . . 0.0 110.09 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.2 mmt -70.56 126.25 29.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.325 -0.859 . . . . 0.0 110.325 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.474 ' C ' HG13 ' A' ' 76' ' ' VAL . 47.9 p90 -96.52 124.81 40.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 109.659 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.929 HG23 ' HB3' ' A' ' 88' ' ' ALA . 29.8 m . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.211 -0.93 . . . . 0.0 110.287 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.14 0.495 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 99' ' ' PHE . 67.6 mt -70.63 123.62 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.232 -0.918 . . . . 0.0 110.385 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.97 114.5 19.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.37 -0.831 . . . . 0.0 109.799 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.929 ' HB3' HG23 ' A' ' 76' ' ' VAL . . . -101.43 132.16 47.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.63 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -124.43 105.33 9.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.439 -0.788 . . . . 0.0 109.689 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.898 HG13 ' HG2' ' A' ' 96' ' ' ARG . 58.3 t -115.89 108.21 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.35 -0.844 . . . . 0.0 110.499 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.528 ' HB2' HG23 ' A' ' 73' ' ' THR . 23.9 t80 -73.13 -68.77 0.46 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 0.0 109.993 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.2 p -141.94 -68.93 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.95 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.5 p -170.58 45.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.47 -0.768 . . . . 0.0 109.981 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -161.96 -33.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.868 . . . . 0.0 110.894 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -119.94 49.87 1.35 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.193 -0.942 . . . . 0.0 110.967 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.898 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -94.43 111.47 23.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.151 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 47.3 m-85 -114.68 158.09 22.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.62 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.673 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 63.0 m-85 -133.76 146.56 50.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.519 -0.738 . . . . 0.0 109.721 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.841 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 48.8 m-85 -142.4 165.96 25.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.217 -0.927 . . . . 0.0 110.787 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.511 ' CD2' ' HB3' ' A' ' 26' ' ' PRO . 2.2 p-90 -159.44 146.84 17.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.46 -0.775 . . . . 0.0 109.99 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 101' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.254 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.188 0.518 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 61.6 t -95.41 84.16 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.31 -0.868 . . . . 0.0 110.373 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -84.42 163.12 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.815 . . . . 0.0 109.516 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.406 ' HG3' ' CG ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -123.57 139.93 53.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.437 -0.79 . . . . 0.0 110.106 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.53 -174.98 3.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 110.079 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.98 134.88 54.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.781 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.083 ' HB3' HD11 ' A' ' 33' ' ' ILE . . . -163.93 -157.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.569 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -149.67 151.64 23.72 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.2 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.528 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.5 t -89.84 -136.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.609 -0.936 . . . . 0.0 109.32 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 0.9 OUTLIER -162.71 109.0 1.21 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.04 -1.038 . . . . 0.0 109.906 179.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.61 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -76.78 152.53 35.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.367 -0.833 . . . . 0.0 109.995 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -138.01 149.21 45.88 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.677 -0.639 . . . . 0.0 110.07 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -123.96 140.68 52.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.458 -0.776 . . . . 0.0 110.207 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' HG3' ' CE1' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -81.53 -26.35 35.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.405 -0.809 . . . . 0.0 110.212 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.45 -34.23 70.62 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.352 -0.843 . . . . 0.0 110.192 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -124.65 -2.07 7.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.423 -0.798 . . . . 0.0 110.413 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 52.42 58.98 4.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 0.0 110.219 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.88 160.14 28.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.438 -0.789 . . . . 0.0 110.542 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -119.25 72.49 0.9 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.393 -0.817 . . . . 0.0 110.133 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 p -80.07 156.38 74.43 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.281 -0.887 . . . . 0.0 110.306 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.483 ' HB2' ' CE2' ' A' ' 100' ' ' TRP . 44.8 Cg_endo -72.44 151.99 54.14 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.783 1.412 . . . . 0.0 110.256 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.61 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -84.23 137.66 39.7 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.873 . . . . 0.0 109.494 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.29 -11.28 31.09 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.716 1.377 . . . . 0.0 111.038 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.633 HG13 ' OE2' ' A' ' 54' ' ' GLU . 84.8 t -100.28 115.43 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 110.083 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.69 81.44 8.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.383 -0.823 . . . . 0.0 110.021 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.666 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.43 -161.4 0.1 OUTLIER Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.823 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 65.1 mt-10 -126.45 151.68 47.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -1.07 . . . . 0.0 112.299 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.083 HD11 ' HB3' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -101.86 169.0 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.033 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.557 ' HB2' ' CB ' ' A' ' 49' ' ' GLU . 15.0 mt-10 -144.21 112.83 6.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.431 -0.793 . . . . 0.0 109.752 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.544 ' CD1' ' CE1' ' A' ' 48' ' ' PHE . 32.4 mm -69.84 120.42 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.441 -0.787 . . . . 0.0 110.201 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 1.0 OUTLIER -126.11 114.08 23.97 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.211 -0.931 . . . . 0.0 109.916 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -85.59 52.34 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.802 1.422 . . . . 0.0 109.864 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.82 155.52 0.07 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.583 -0.698 . . . . 0.0 109.872 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.76 -42.52 97.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.638 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -131.12 30.44 4.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.392 -0.818 . . . . 0.0 110.411 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 51.23 54.82 10.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.289 -0.882 . . . . 0.0 110.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -99.36 -40.65 7.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 109.733 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.18 -6.88 19.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 110.186 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.12 27.53 70.66 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.468 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 5.1 m-30 -89.45 118.82 29.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -1.076 . . . . 0.0 109.953 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.638 ' O ' HD12 ' A' ' 68' ' ' LEU . 10.2 m0 -84.97 73.52 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.51 ' HB2' ' CG ' ' A' ' 36' ' ' LYS . 41.6 m-20 -55.34 139.86 41.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.357 -0.84 . . . . 0.0 110.327 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.77 ' CE2' HD11 ' A' ' 68' ' ' LEU . 10.0 m-30 -109.75 102.27 11.08 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.862 0.839 . . . . 0.0 109.289 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.557 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.7 mt-10 -82.4 130.59 35.14 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.805 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.944 ' CE3' HD12 ' A' ' 64' ' ' ILE 0.252 68.7 t90 -105.45 161.45 14.32 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.394 -0.816 . . . . 0.0 109.501 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.4 ptm85 -166.93 142.03 3.43 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 120.795 -1.191 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.502 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 48.2 Cg_endo -70.75 80.53 1.15 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.633 1.333 . . . . 0.0 110.102 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.475 HG23 ' CD ' ' A' ' 32' ' ' GLU . 6.3 t -127.06 9.64 6.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.266 -0.896 . . . . 0.0 109.93 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.633 ' OE2' HG13 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -100.15 -169.53 1.74 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.785 -0.572 . . . . 0.0 109.724 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -89.1 110.44 38.22 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 54' ' ' GLU . 50.6 Cg_endo -84.22 171.61 10.07 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.538 1.283 . . . . 0.0 110.931 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 57' ' ' VAL . 13.2 p -129.25 28.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 110.047 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.19 17.2 6.33 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 18.2 mmt180 -129.49 102.46 6.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -1.151 . . . . 0.0 110.201 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.66 109.61 14.22 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.405 -0.809 . . . . 0.0 110.318 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.439 HD11 ' HB ' ' A' ' 29' ' ' VAL . 39.9 mt -105.65 -166.95 1.26 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.289 -0.882 . . . . 0.0 110.34 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.519 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 3.7 p30 -148.94 165.86 16.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.769 . . . . 0.0 110.299 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.7 Cg_endo -61.82 145.5 97.1 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.646 1.34 . . . . 0.0 111.813 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.944 HD12 ' CE3' ' A' ' 50' ' ' TRP . 4.8 mt -136.73 113.4 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.9 m -70.56 115.52 9.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 109.736 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.792 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 42.8 mt -102.82 149.75 24.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.877 . . . . 0.0 110.012 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.7 mm -117.15 158.16 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.299 -0.876 . . . . 0.0 109.717 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.77 HD11 ' CE2' ' A' ' 48' ' ' PHE . 71.8 mt -129.52 94.33 3.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.468 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 68.0 mt -135.68 103.57 10.12 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.453 -0.779 . . . . 0.0 110.149 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.43 68.83 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.668 1.352 . . . . 0.0 110.394 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.04 -39.29 0.18 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.45 -74.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.357 -1.084 . . . . 0.0 110.15 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.764 HG22 ' C ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -75.19 -164.23 0.3 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.408 -0.808 . . . . 0.0 110.013 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpp -134.34 125.73 28.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.328 -0.858 . . . . 0.0 110.211 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -80.29 111.44 16.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.381 -0.824 . . . . 0.0 110.167 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 0.0 110.013 179.95 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.215 0.531 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.8 mt -133.7 105.78 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.342 -0.849 . . . . 0.0 110.301 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -86.16 108.57 18.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.781 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.594 ' HB2' ' CD2' ' A' ' 98' ' ' PHE . . . -98.74 151.0 21.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.819 . . . . 0.0 110.626 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -121.86 119.54 31.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.839 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.8 HG13 ' CD ' ' A' ' 96' ' ' ARG . 79.3 t -115.11 132.4 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.9 . . . . 0.0 110.472 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.528 ' HB2' HG23 ' A' ' 73' ' ' THR . 46.5 t80 -101.7 -77.1 0.55 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.418 -0.801 . . . . 0.0 110.133 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.402 ' OG ' ' CD2' ' A' ' 91' ' ' PHE . 10.0 p -175.87 -59.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.269 -0.894 . . . . 0.0 110.301 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.6 t -60.88 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.458 -0.776 . . . . 0.0 110.406 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -166.36 20.1 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 110.782 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' HG3' ' HB3' ' A' ' 91' ' ' PHE . 1.3 pt-20 -94.37 48.11 1.22 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.264 -0.897 . . . . 0.0 110.149 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.8 ' CD ' HG13 ' A' ' 90' ' ' VAL . 61.5 mtm180 -94.05 119.47 32.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.421 -0.799 . . . . 0.0 110.205 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 29.4 m-85 -114.6 162.03 17.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 0.0 110.546 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 33.8 m-85 -129.81 141.25 50.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.837 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.792 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 23.2 m-85 -137.78 163.1 32.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.209 -0.932 . . . . 0.0 110.517 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.483 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 1.8 p-90 -158.5 165.97 33.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 110.1 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 110.148 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 60.6 m . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.218 0.532 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 82.4 t -110.45 85.32 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.413 -0.804 . . . . 0.0 110.069 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 35' ' ' ILE . 14.9 tt -105.61 177.62 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.365 -0.834 . . . . 0.0 108.956 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 2.7 ptmt -146.6 158.29 43.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.826 -1.171 . . . . 0.0 111.094 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -134.23 -174.76 3.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 109.925 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 8.5 mpt_? -110.23 139.76 45.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.424 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.56 -158.44 0.51 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.428 -0.795 . . . . 0.0 110.131 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.428 ' O ' ' CD2' ' A' ' 99' ' ' PHE . . . -151.12 157.01 26.97 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.866 HG13 ' CE1' ' A' ' 99' ' ' PHE . 0.9 OUTLIER -93.91 -140.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.494 -1.003 . . . . 0.0 110.047 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 98' ' ' PHE . 1.6 m -157.56 109.32 2.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 109.573 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.427 ' N ' HG12 ' A' ' 27' ' ' ILE . 5.4 pt-20 -79.59 150.5 31.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 110.082 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.456 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -133.22 148.19 52.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.612 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -115.61 133.38 56.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 0.0 110.291 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -79.03 -25.6 43.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.5 -0.75 . . . . 0.0 110.246 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -62.86 -33.84 76.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 0.0 110.017 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 m -122.8 -2.65 8.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.479 -0.763 . . . . 0.0 110.373 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.456 ' HA ' ' CE2' ' A' ' 17' ' ' TYR . 7.7 mtp180 52.23 57.46 6.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.154 -0.966 . . . . 0.0 110.226 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.23 162.34 20.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.336 -0.852 . . . . 0.0 110.356 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -120.59 95.36 4.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 0.0 110.296 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.5 p -106.69 157.92 34.0 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 110.122 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.513 ' HB2' ' CE2' ' A' ' 100' ' ' TRP . 44.0 Cg_endo -72.05 146.1 46.05 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.84 1.442 . . . . 0.0 110.267 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.618 HG21 HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -82.04 138.83 45.93 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.439 ' HD2' HG22 ' A' ' 27' ' ' ILE . 41.2 Cg_endo -67.02 -13.69 40.86 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.656 1.345 . . . . 0.0 110.496 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.722 HG21 ' O ' ' A' ' 59' ' ' ARG . 94.6 t -86.31 115.68 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 109.817 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -93.74 68.5 3.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.069 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.67 -150.91 0.01 OUTLIER Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.774 ' OE2' HG21 ' A' ' 53' ' ' THR . 2.6 pt-20 -145.1 155.53 43.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.053 -1.263 . . . . 0.0 110.496 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.539 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 96.3 mt -102.05 167.6 2.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.599 -0.688 . . . . 0.0 110.096 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 49' ' ' GLU . 8.0 mt-10 -131.29 109.33 10.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.648 -0.658 . . . . 0.0 109.58 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.551 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -68.6 123.52 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 109.291 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -126.99 137.89 31.54 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 110.31 -179.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 49.8 Cg_endo -90.8 57.25 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.38 1.387 . . . . 0.0 109.751 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.446 ' CG ' ' O ' ' A' ' 37' ' ' PRO . 11.9 p30 43.26 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.902 -0.499 . . . . 0.0 110.79 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -75.75 -76.35 0.16 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.939 . . . . 0.0 110.45 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -139.63 69.48 1.36 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.397 -0.815 . . . . 0.0 110.45 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 50.64 55.16 9.94 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.367 -0.833 . . . . 0.0 110.492 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -111.02 -40.36 4.51 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.37 -0.831 . . . . 0.0 109.739 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -117.76 -11.2 10.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.528 -0.732 . . . . 0.0 110.08 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.26 29.7 72.0 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.466 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 4.3 m-30 -91.78 119.64 31.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.995 . . . . 0.0 110.09 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 93.9 m95 -79.71 77.19 6.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 110.189 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 1.9 t0 -54.09 130.02 36.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 0.0 109.961 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.828 ' CE2' HD11 ' A' ' 68' ' ' LEU . 3.8 m-30 -110.49 103.14 11.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.194 -0.941 . . . . 0.0 109.68 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 34' ' ' GLU . 31.6 tt0 -87.59 119.03 27.49 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.669 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.907 ' CE3' HD12 ' A' ' 64' ' ' ILE . 67.7 t90 -93.2 169.28 10.52 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.521 -0.737 . . . . 0.0 109.449 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.457 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 0.7 OUTLIER -176.57 145.99 0.71 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.215 -0.928 . . . . 0.0 110.801 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.553 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 50.0 Cg_endo -74.68 78.7 2.72 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.595 1.313 . . . . 0.0 109.675 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.774 HG21 ' OE2' ' A' ' 32' ' ' GLU . 8.1 t -115.37 2.35 13.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.146 -0.971 . . . . 0.0 109.762 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 30' ' ' GLN . 54.9 mm-40 -109.84 -168.76 1.36 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 113.22 43.11 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.186 -0.946 . . . . 0.0 110.273 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.537 ' O ' HG12 ' A' ' 57' ' ' VAL . 45.0 Cg_endo -76.55 -61.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.618 1.325 . . . . 0.0 110.547 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 56' ' ' PRO . 10.9 p 37.93 34.34 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-O 121.408 0.623 . . . . 0.0 111.109 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.403 ' HA3' ' HG2' ' A' ' 28' ' ' PRO . . . -153.43 -47.25 0.02 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.722 ' O ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -172.59 133.73 0.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -1.195 . . . . 0.0 109.899 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.412 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 20.4 mt-10 -53.94 124.53 15.71 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.275 -0.891 . . . . 0.0 110.529 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.623 HD22 ' HD2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -113.89 -171.17 1.85 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.328 -0.858 . . . . 0.0 110.421 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.553 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 5.8 m-20 -160.82 168.43 11.75 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.462 -0.774 . . . . 0.0 110.003 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.8 Cg_endo -62.12 131.84 36.41 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.746 1.393 . . . . 0.0 111.646 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.907 HD12 ' CE3' ' A' ' 50' ' ' TRP . 4.9 mt -127.16 114.87 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.769 -0.582 . . . . 0.0 109.536 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 p -69.91 118.03 12.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 110.375 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.674 HD11 ' CZ ' ' A' ' 99' ' ' PHE . 17.5 mt -109.72 148.97 30.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.232 -0.917 . . . . 0.0 109.825 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.5 mt -122.33 147.23 26.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.391 -0.818 . . . . 0.0 109.855 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.828 HD11 ' CE2' ' A' ' 48' ' ' PHE . 53.2 mt -121.14 106.41 11.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.37 -0.831 . . . . 0.0 110.283 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.466 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 72.6 mt -135.56 118.85 12.71 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.349 -0.844 . . . . 0.0 109.987 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.11 77.18 2.44 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.574 1.302 . . . . 0.0 110.507 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.09 -56.43 0.41 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -60.85 -58.47 8.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.369 -1.077 . . . . 0.0 110.218 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.611 HG23 ' C ' ' A' ' 90' ' ' VAL . 1.7 m -99.0 145.1 27.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.842 . . . . 0.0 110.188 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.32 132.41 53.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -0.826 . . . . 0.0 110.29 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 75' ' ' TRP . 36.5 p90 -88.94 140.47 29.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.441 -0.787 . . . . 0.0 110.259 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 88' ' ' ALA . 61.9 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.9 0.381 . . . . 0.0 110.729 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 86' ' ' ILE . 24.6 mm -88.69 85.14 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.167 -0.958 . . . . 0.0 110.21 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -75.35 95.54 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.864 . . . . 0.0 109.742 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -85.11 120.85 27.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.819 . . . . 0.0 110.774 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mp -106.07 77.93 1.27 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.416 -0.803 . . . . 0.0 109.752 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.867 HG12 ' HB3' ' A' ' 96' ' ' ARG . 30.6 m -81.99 123.59 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.395 -0.816 . . . . 0.0 110.939 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.586 ' N ' HG23 ' A' ' 73' ' ' THR . 0.2 OUTLIER -72.14 -75.12 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.389 -0.819 . . . . 0.0 110.128 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.5 m -131.85 -67.27 0.68 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 110.145 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.06 43.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.435 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -167.92 -38.18 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.261 -0.899 . . . . 0.0 110.442 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -114.58 50.25 0.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 110.475 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.867 ' HB3' HG12 ' A' ' 90' ' ' VAL . 33.9 mtm180 -90.95 112.23 24.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.344 -0.847 . . . . 0.0 110.232 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -99.9 138.71 36.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.381 -0.825 . . . . 0.0 110.628 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.447 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 4.7 m-85 -102.74 142.81 33.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.446 -0.784 . . . . 0.0 109.427 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.866 ' CE1' HG13 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -142.62 168.63 19.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -0.992 . . . . 0.0 110.616 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.513 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 1.1 p-90 -159.65 153.81 23.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.491 -0.756 . . . . 0.0 110.003 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.35 -0.844 . . . . 0.0 110.368 -179.878 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.0 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.482 0.658 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 85.4 t -91.16 75.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.611 -0.681 . . . . 0.0 109.904 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -72.1 167.43 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.341 -0.849 . . . . 0.0 109.824 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -124.31 136.04 53.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.508 -0.745 . . . . 0.0 109.932 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.83 -177.45 3.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 109.917 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.63 139.3 54.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 110.466 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.093 ' HB3' HD11 ' A' ' 33' ' ' ILE . . . -167.69 -155.53 0.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.45 -0.781 . . . . 0.0 109.888 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 100' ' ' TRP . . . -144.52 150.65 22.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.504 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.4 t -90.68 -139.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.481 -1.011 . . . . 0.0 109.735 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.4 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 1.2 m -159.05 107.69 1.87 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.081 -1.012 . . . . 0.0 109.66 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -79.37 147.58 32.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.469 -0.769 . . . . 0.0 109.842 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.442 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -123.25 148.69 45.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.887 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 22' ' ' ARG . 9.6 t30 -111.5 118.78 36.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.815 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -72.91 -25.32 61.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.784 . . . . 0.0 110.412 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.25 -32.96 74.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.773 . . . . 0.0 110.544 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.93 3.2 5.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.366 -0.834 . . . . 0.0 110.687 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' ASN . 4.3 mtp180 51.22 56.43 7.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.191 -0.943 . . . . 0.0 110.048 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.553 HD13 HG23 ' A' ' 25' ' ' THR . 3.4 pp -112.94 167.82 10.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.83 . . . . 0.0 110.739 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.6 p -126.59 111.28 14.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.488 -0.757 . . . . 0.0 110.074 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.553 HG23 HD13 ' A' ' 23' ' ' LEU . 8.4 p -127.9 159.77 64.77 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.187 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' CB ' ' CD2' ' A' ' 100' ' ' TRP . 44.4 Cg_endo -72.2 142.12 37.21 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.833 1.438 . . . . 0.0 110.138 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.521 HG22 HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -80.31 139.4 52.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 27' ' ' ILE . 40.1 Cg_endo -65.94 -27.81 50.52 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.581 1.306 . . . . 0.0 110.555 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.722 HG23 ' OE2' ' A' ' 54' ' ' GLU . 11.3 p -84.72 115.31 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.877 . . . . 0.0 109.787 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -93.32 79.41 4.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.308 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' HA2' ' HG2' ' A' ' 54' ' ' GLU . . . -61.98 -154.2 0.05 OUTLIER Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.629 ' C ' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -137.97 160.57 38.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.115 -1.227 . . . . 0.0 110.434 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.093 HD11 ' HB3' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -103.12 176.88 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.409 0.623 . . . . 0.0 110.312 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 2.7 mt-10 -138.59 108.16 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.551 HG13 ' CE1' ' A' ' 48' ' ' PHE . 1.5 mp -68.51 126.1 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.203 -0.935 . . . . 0.0 108.935 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 28.1 mtpt -134.64 140.95 36.97 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.045 -1.034 . . . . 0.0 110.623 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 51.2 Cg_endo -88.06 53.63 2.27 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.739 1.389 . . . . 0.0 109.965 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 t30 66.22 -177.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.646 -0.659 . . . . 0.0 110.075 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 40' ' ' GLU . 8.4 pt-20 -77.27 -25.96 51.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.291 -0.881 . . . . 0.0 110.848 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.408 ' N ' ' HG3' ' A' ' 39' ' ' GLU . 39.3 mt-10 -148.23 28.5 0.9 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.235 -0.916 . . . . 0.0 110.471 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 50.57 49.38 20.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.393 -0.817 . . . . 0.0 110.576 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.612 ' OE1' HD21 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -116.46 -26.18 7.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -0.915 . . . . 0.0 110.616 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.612 HD21 ' OE1' ' A' ' 42' ' ' GLU . 14.7 mt -106.3 -8.48 17.24 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.12 -0.988 . . . . 0.0 110.002 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.27 27.47 70.71 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 6.4 m-30 -90.2 119.8 30.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.456 -1.026 . . . . 0.0 109.926 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.566 ' HB2' HD12 ' A' ' 68' ' ' LEU . 4.4 m-90 -75.44 76.91 2.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.081 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -54.79 122.72 11.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.443 -0.786 . . . . 0.0 109.989 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.903 ' CD2' HD11 ' A' ' 68' ' ' LEU . 4.7 m-30 -106.97 102.81 12.14 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.002 -1.061 . . . . 0.0 109.774 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.486 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.9 tp10 -87.71 126.68 35.12 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.778 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.903 ' CE3' HD12 ' A' ' 64' ' ' ILE . 75.6 t90 -99.18 172.42 7.38 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.459 -0.776 . . . . 0.0 109.817 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.463 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -179.79 145.29 0.41 Allowed Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.338 -0.851 . . . . 0.0 110.759 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 48.9 Cg_endo -71.88 80.98 1.43 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.808 1.425 . . . . 0.0 109.799 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.1 t -120.51 11.34 11.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 109.696 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.722 ' OE2' HG23 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -100.63 -169.65 1.74 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.988 -0.445 . . . . 0.0 109.837 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.27 109.5 50.09 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -78.79 145.82 20.43 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.398 1.209 . . . . 0.0 110.81 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.624 ' O ' HG12 ' A' ' 57' ' ' VAL . 55.3 t -142.32 29.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 109.632 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.29 -61.83 0.02 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -131.22 -157.59 0.83 Allowed 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.374 -1.074 . . . . 0.0 109.661 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.77 ' O ' HD22 ' A' ' 61' ' ' LEU . 11.1 pt-20 -150.96 146.09 26.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.6 -0.687 . . . . 0.0 110.339 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.77 HD22 ' O ' ' A' ' 60' ' ' GLU . 1.4 mm? -131.29 -161.13 1.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.301 -0.874 . . . . 0.0 110.513 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 1.7 m-20 -147.08 171.97 5.74 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.434 -0.791 . . . . 0.0 109.704 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 36.2 Cg_endo -58.43 135.87 70.61 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.528 1.278 . . . . 0.0 111.859 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.903 HD12 ' CE3' ' A' ' 50' ' ' TRP . 4.7 mt -128.94 116.74 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.58 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -69.76 118.87 13.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.215 -0.928 . . . . 0.0 110.059 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.812 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 15.8 mt -109.57 145.16 36.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.396 -0.815 . . . . 0.0 109.781 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.0 mt -119.94 148.02 23.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.33 -0.857 . . . . 0.0 110.066 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.903 HD11 ' CD2' ' A' ' 48' ' ' PHE . 62.9 mt -125.57 97.56 5.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.437 -0.789 . . . . 0.0 110.282 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.763 HG21 ' HG3' ' A' ' 72' ' ' GLU . 61.6 mt -131.29 108.93 14.94 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.256 -0.902 . . . . 0.0 110.23 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.3 80.84 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.603 1.317 . . . . 0.0 110.214 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.05 -30.11 0.73 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.763 ' HG3' HG21 ' A' ' 69' ' ' ILE . 4.1 mm-40 -89.87 -34.53 16.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.429 -1.042 . . . . 0.0 110.164 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.428 HG21 ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -104.3 168.95 8.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.416 -0.802 . . . . 0.0 110.043 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 tpp -109.66 151.42 26.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.393 -0.817 . . . . 0.0 110.387 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -90.78 119.28 30.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 110.076 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.869 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 73.7 t . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.148 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.118 0.485 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.67 108.32 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.1 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.69 79.9 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 0.0 109.994 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.869 ' HB3' ' O ' ' A' ' 76' ' ' VAL . . . -75.36 113.43 12.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.124 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.428 ' HB3' HG21 ' A' ' 73' ' ' THR . 6.2 mt -104.84 125.71 51.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.893 HG13 ' CD ' ' A' ' 96' ' ' ARG . 50.9 t -114.94 109.63 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 110.417 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.415 ' HB2' ' HG3' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -67.0 -78.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.333 -0.854 . . . . 0.0 110.236 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.2 t -176.44 -70.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.181 -0.949 . . . . 0.0 110.491 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.2 m -57.69 -83.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.319 -0.863 . . . . 0.0 110.446 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.35 15.64 0.39 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 110.72 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 91' ' ' PHE . 4.8 pt-20 -99.85 50.95 0.91 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 110.13 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.893 ' CD ' HG13 ' A' ' 90' ' ' VAL . 38.0 mtm105 -90.36 121.48 32.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.448 -0.782 . . . . 0.0 110.095 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 26.6 m-85 -106.44 162.63 13.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.313 -0.867 . . . . 0.0 110.506 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.414 ' O ' ' CD1' ' A' ' 99' ' ' PHE . 8.3 m-85 -137.6 141.51 41.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 109.536 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.812 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 19.8 m-85 -135.58 161.71 34.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 110.409 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.465 ' CD2' ' CB ' ' A' ' 26' ' ' PRO . 3.0 p-90 -143.77 162.76 35.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.73 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.834 . . . . 0.0 110.242 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.2 m . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.198 0.523 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.51 76.12 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.726 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -89.18 168.48 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.531 -0.73 . . . . 0.0 109.751 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.44 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 8.9 mttt -130.38 131.19 45.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -124.4 131.92 53.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -79.45 121.88 25.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.344 -0.848 . . . . 0.0 110.48 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.421 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . . . -146.68 -154.83 0.57 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.436 -0.79 . . . . 0.0 110.039 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.92 159.04 26.9 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.487 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.3 t -95.52 -137.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.388 -1.066 . . . . 0.0 109.52 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.706 ' SG ' HD11 ' A' ' 86' ' ' ILE . 42.5 t -162.46 107.96 1.21 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.973 -1.08 . . . . 0.0 110.033 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.495 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -77.37 161.49 27.99 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.377 -0.827 . . . . 0.0 110.112 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -145.63 141.72 28.41 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.892 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -107.75 135.33 49.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 110.135 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -79.54 -25.12 41.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.538 -0.726 . . . . 0.0 110.156 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.81 -39.28 91.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -115.73 -5.68 12.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 0.0 110.363 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HA ' ' CE2' ' A' ' 17' ' ' TYR . 0.2 OUTLIER 54.41 58.75 4.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.254 -0.904 . . . . 0.0 110.287 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.42 169.78 14.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.268 -0.895 . . . . 0.0 110.414 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.3 141.53 52.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.45 -0.781 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.83 163.71 25.96 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.829 . . . . 0.0 110.26 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.468 ' HB3' ' CD2' ' A' ' 100' ' ' TRP . 47.2 Cg_endo -72.53 135.38 24.07 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.75 1.395 . . . . 0.0 110.206 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.495 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.51 138.4 44.5 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.932 . . . . 0.0 109.786 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.491 ' C ' HG23 ' A' ' 29' ' ' VAL . 48.1 Cg_endo -74.77 51.86 2.81 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.75 1.395 . . . . 0.0 110.747 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.491 HG23 ' C ' ' A' ' 28' ' ' PRO . 83.4 t -152.19 116.12 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.176 -0.953 . . . . 0.0 109.815 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -80.89 70.14 7.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 110.212 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.636 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -59.12 -167.48 0.19 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.79 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 26.4 mt-10 -129.7 138.72 51.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -1.151 . . . . 0.0 112.29 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.567 HG23 ' HB3' ' A' ' 48' ' ' PHE . 39.9 mt -101.79 167.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.487 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -136.75 113.81 10.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.335 -0.853 . . . . 0.0 109.425 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 1.2 mp -68.35 123.71 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.334 -0.854 . . . . 0.0 109.106 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -132.88 142.81 46.08 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.292 -0.88 . . . . 0.0 110.282 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 51.5 Cg_endo -88.1 52.76 2.13 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.656 1.345 . . . . 0.0 109.978 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 t30 64.83 161.54 0.12 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.532 -0.73 . . . . 0.0 109.991 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.36 -56.21 20.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.401 -0.812 . . . . 0.0 110.636 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -128.06 36.84 4.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.456 -0.777 . . . . 0.0 110.331 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 51.31 52.33 15.05 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 0.0 110.406 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -102.28 -38.67 7.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.432 -0.792 . . . . 0.0 109.781 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 11.8 mt -108.06 -8.79 15.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.574 -0.703 . . . . 0.0 110.262 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.23 27.36 71.43 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.467 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 12.6 m-30 -88.46 120.5 29.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.39 -1.065 . . . . 0.0 110.033 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.616 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 22.8 m-90 -68.06 75.66 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.844 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 6.3 t0 -52.31 129.84 29.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.355 -0.841 . . . . 0.0 110.283 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.818 ' CD2' HD11 ' A' ' 68' ' ' LEU . 6.8 m-30 -110.54 103.0 11.54 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.487 -0.758 . . . . 0.0 109.673 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -83.84 116.58 22.81 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.218 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.947 ' CE3' HD12 ' A' ' 64' ' ' ILE . 74.2 t90 -94.7 154.05 17.5 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.664 -0.648 . . . . 0.0 109.683 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -163.27 138.56 5.13 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.931 -1.106 . . . . 0.0 110.638 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 44.0 Cg_endo -68.6 81.1 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.55 1.289 . . . . 0.0 110.372 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.417 ' CG2' ' HB2' ' A' ' 32' ' ' GLU . 7.0 t -120.86 5.68 10.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.383 -0.823 . . . . 0.0 109.473 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.483 ' HG2' ' HA2' ' A' ' 31' ' ' GLY . 0.8 OUTLIER -100.34 -169.68 1.76 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 109.71 51.54 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.2 -0.937 . . . . 0.0 109.908 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -81.08 -179.22 4.9 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.464 1.244 . . . . 0.0 110.801 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 57' ' ' VAL . 13.1 p -131.18 29.38 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.794 . . . . 0.0 109.895 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.75 22.79 3.53 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -134.59 105.6 6.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -1.184 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -80.95 132.54 35.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 0.0 110.338 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 mt -129.82 -158.71 0.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 110.177 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.552 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -162.66 172.23 5.6 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.28 -0.888 . . . . 0.0 110.269 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.799 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.2 Cg_endo -61.36 126.44 19.3 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.72 1.379 . . . . 0.0 111.308 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.947 HD12 ' CE3' ' A' ' 50' ' ' TRP . 9.9 mt -124.96 111.33 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.788 -0.57 . . . . 0.0 110.088 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.9 m -69.8 117.48 11.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.144 -0.973 . . . . 0.0 109.438 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.86 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 26.7 mt -104.04 144.32 31.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.294 -0.879 . . . . 0.0 110.398 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.417 ' CG2' ' CD1' ' A' ' 69' ' ' ILE . 8.8 mm -113.04 148.39 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.421 -0.8 . . . . 0.0 109.585 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.818 HD11 ' CD2' ' A' ' 48' ' ' PHE . 77.7 mt -121.71 87.57 2.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 110.188 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.467 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 74.2 mt -127.71 108.48 20.58 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.447 -0.783 . . . . 0.0 110.019 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.39 64.01 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.58 1.305 . . . . 0.0 110.449 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.85 -37.32 0.1 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -71.48 -53.35 14.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.339 -1.095 . . . . 0.0 110.227 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.801 HG22 ' N ' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -101.25 148.24 25.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.416 -0.803 . . . . 0.0 110.2 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mmt -76.12 132.64 40.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.422 -0.799 . . . . 0.0 110.194 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.44 83.17 4.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.408 -0.807 . . . . 0.0 110.051 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 110.096 -179.893 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.199 0.524 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.706 HD11 ' SG ' ' A' ' 15' ' ' CYS . 2.1 tt -80.88 105.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.309 -0.87 . . . . 0.0 110.188 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -69.71 139.36 53.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.23 117.88 28.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.47 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 89' ' ' LEU . 6.7 mp -104.32 124.14 48.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.988 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.836 HG13 ' CD ' ' A' ' 96' ' ' ARG . 75.7 t -125.37 112.39 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.36 -0.837 . . . . 0.0 110.381 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.801 ' N ' HG22 ' A' ' 73' ' ' THR . 24.5 t80 -76.17 -76.38 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.855 . . . . 0.0 110.004 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.8 m -129.85 -66.65 0.78 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.374 -0.829 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.06 36.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.373 -0.829 . . . . 0.0 110.205 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -166.67 -39.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.397 -0.815 . . . . 0.0 110.415 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -97.51 43.14 1.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.447 -0.783 . . . . 0.0 110.144 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.836 ' CD ' HG13 ' A' ' 90' ' ' VAL . 42.3 mtm180 -98.83 111.21 23.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.261 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 41.7 m-85 -113.75 159.52 19.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.381 -0.825 . . . . 0.0 110.236 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.427 ' HB2' ' CB ' ' A' ' 15' ' ' CYS . 0.4 OUTLIER -141.55 141.46 33.53 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.258 -0.901 . . . . 0.0 109.827 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.86 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 6.7 m-85 -137.66 169.51 17.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.149 -0.97 . . . . 0.0 110.328 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.468 ' CD2' ' HB3' ' A' ' 26' ' ' PRO . 3.2 p-90 -150.32 161.28 42.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.185 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.286 -179.883 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.272 0.558 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.9 p -78.51 86.7 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.5 -0.75 . . . . 0.0 110.051 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.467 ' HA ' HD13 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -72.11 168.9 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.07 -1.019 . . . . 0.0 109.744 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 20.8 mttp -126.09 144.23 50.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.338 -0.851 . . . . 0.0 110.553 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -134.67 -174.84 3.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.795 . . . . 0.0 109.608 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.23 119.28 24.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 0.0 110.854 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.772 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . . . -150.15 -158.65 0.94 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 109.715 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' HA3' ' NE1' ' A' ' 100' ' ' TRP . . . -142.31 165.74 26.61 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.493 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 0.7 OUTLIER -103.88 -142.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.431 -1.041 . . . . 0.0 109.516 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.423 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -163.75 108.3 1.02 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.065 -1.022 . . . . 0.0 110.105 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.499 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -77.71 162.18 27.17 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.309 -0.869 . . . . 0.0 110.031 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -126.51 144.12 50.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.139 -0.625 . . . . 0.0 110.066 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.407 ' HB3' HD22 ' A' ' 23' ' ' LEU . 7.6 t-20 -110.11 124.97 52.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.903 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -24.74 52.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.368 -0.833 . . . . 0.0 110.305 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -68.55 -30.75 69.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.461 -0.775 . . . . 0.0 110.256 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -124.08 -2.21 8.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.383 -0.823 . . . . 0.0 110.61 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER 52.74 58.01 5.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.127 -0.983 . . . . 0.0 110.184 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -128.78 164.71 22.42 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.258 -0.901 . . . . 0.0 110.302 -179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.94 90.04 3.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.417 -0.802 . . . . 0.0 110.062 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.41 167.38 12.4 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.327 -0.858 . . . . 0.0 110.188 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.464 ' CB ' ' CD2' ' A' ' 100' ' ' TRP . 44.1 Cg_endo -71.35 144.52 46.01 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.756 1.398 . . . . 0.0 110.332 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.499 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.77 140.9 43.92 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 109.431 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.458 ' HD2' HG22 ' A' ' 27' ' ' ILE . 40.3 Cg_endo -66.14 -18.47 56.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.621 1.327 . . . . 0.0 110.565 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.632 HG21 ' O ' ' A' ' 59' ' ' ARG . 85.2 t -83.61 138.08 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.974 . . . . 0.0 109.459 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.19 -49.73 7.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 110.798 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . 54.82 -166.7 2.57 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.62 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -153.7 159.02 41.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.039 -1.271 . . . . 0.0 110.463 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.772 ' CD1' ' HB3' ' A' ' 12' ' ' ALA . 2.2 mp -106.69 168.7 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.507 0.67 . . . . 0.0 110.368 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 42.1 mt-10 -130.86 114.12 14.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.588 -0.695 . . . . 0.0 109.496 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 35' ' ' ILE . 1.7 mp -68.72 127.22 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 18.1 mtpt -133.41 140.93 38.61 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.071 -1.018 . . . . 0.0 110.755 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 49.8 Cg_endo -87.9 53.01 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.725 1.382 . . . . 0.0 109.973 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 65.02 164.63 0.15 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.559 -0.713 . . . . 0.0 110.121 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -56.33 -38.49 71.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 0.0 110.816 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -147.82 38.33 0.91 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.304 -0.872 . . . . 0.0 110.389 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 51.1 49.87 20.24 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.35 -0.844 . . . . 0.0 110.438 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -103.04 -41.26 6.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -0.865 . . . . 0.0 109.807 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -106.26 -5.36 19.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.526 -0.734 . . . . 0.0 110.353 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.97 27.8 69.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 8.5 m-30 -88.22 120.67 29.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.454 -1.027 . . . . 0.0 109.985 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.566 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 88.6 m95 -70.49 76.77 0.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.204 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -53.98 124.32 15.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.346 -0.846 . . . . 0.0 109.994 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.857 ' CD2' HD11 ' A' ' 68' ' ' LEU . 6.1 m-30 -107.29 102.85 12.12 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.164 -0.96 . . . . 0.0 109.804 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.42 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.2 tt0 -85.49 118.83 25.26 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.104 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.925 ' CE3' HD12 ' A' ' 64' ' ' ILE . 69.4 t90 -93.75 167.08 11.88 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.506 -0.746 . . . . 0.0 109.299 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.457 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 2.7 ptm180 -177.5 146.32 0.62 Allowed Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.226 -0.921 . . . . 0.0 110.832 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.553 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.1 Cg_endo -71.87 76.68 1.99 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.544 1.287 . . . . 0.0 109.945 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 t -118.26 10.0 12.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.173 -0.954 . . . . 0.0 109.848 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HB2' ' N ' ' A' ' 31' ' ' GLY . 60.9 mm-40 -116.2 -169.09 1.54 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 113.14 43.46 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.102 -0.999 . . . . 0.0 110.547 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.448 ' C ' HG23 ' A' ' 57' ' ' VAL . 50.8 Cg_endo -78.29 -167.34 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.484 1.255 . . . . 0.0 110.422 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.614 ' O ' HG12 ' A' ' 57' ' ' VAL . 57.7 t -148.59 49.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.464 -0.772 . . . . 0.0 110.029 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.43 5.24 72.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.632 ' O ' HG21 ' A' ' 29' ' ' VAL . 16.6 mmt180 -124.68 100.95 6.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -1.161 . . . . 0.0 110.131 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -73.88 122.98 23.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.329 -0.857 . . . . 0.0 110.367 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.423 ' HA ' HD13 ' A' ' 61' ' ' LEU . 1.4 mm? -116.53 -162.15 0.84 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.341 -0.849 . . . . 0.0 110.102 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.553 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -155.55 174.98 3.43 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.898 . . . . 0.0 110.144 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.676 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 38.3 Cg_endo -63.83 131.35 30.75 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.607 1.32 . . . . 0.0 111.526 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.925 HD12 ' CE3' ' A' ' 50' ' ' TRP . 6.5 mt -126.03 113.78 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.713 -0.617 . . . . 0.0 109.683 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.7 p -69.61 117.99 11.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 0.0 110.034 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.722 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 18.6 mt -107.76 147.42 30.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.926 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.63 ' O ' HD23 ' A' ' 68' ' ' LEU . 15.3 mt -120.03 155.64 22.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.916 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.857 HD11 ' CD2' ' A' ' 48' ' ' PHE . 50.6 mt -132.36 99.62 4.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.428 -0.795 . . . . 0.0 110.13 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.566 HG21 ' CG ' ' A' ' 72' ' ' GLU . 52.6 mt -132.4 108.02 13.4 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.343 -0.848 . . . . 0.0 110.135 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.2 -7.99 21.36 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.526 1.277 . . . . 0.0 110.774 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -108.34 2.84 32.87 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.566 ' CG ' HG21 ' A' ' 69' ' ' ILE . 66.8 mm-40 -133.1 -68.29 0.59 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.072 -1.252 . . . . 0.0 110.351 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.645 HG22 ' C ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -79.41 126.95 31.49 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.323 -0.86 . . . . 0.0 110.108 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ttt -70.81 137.01 49.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.383 -0.823 . . . . 0.0 110.138 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.426 ' CD2' HD21 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -87.65 122.8 31.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.345 -0.847 . . . . 0.0 110.206 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.04 88.47 36.76 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.809 . . . . 0.0 110.056 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.9 -32.51 8.87 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.818 1.43 . . . . 0.0 110.484 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 tt -142.01 138.28 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.332 -0.855 . . . . 0.0 110.293 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -104.67 49.33 0.81 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.419 -0.801 . . . . 0.0 110.148 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.27 -173.61 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.381 -0.824 . . . . 0.0 110.382 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.9 m 52.43 -168.08 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.272 -0.892 . . . . 0.0 110.501 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.76 112.53 8.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.887 . . . . 0.0 110.192 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.2 t -151.39 127.57 10.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -0.822 . . . . 0.0 110.179 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.06 -85.32 0.1 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -162.45 94.06 0.87 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -1.119 . . . . 0.0 110.195 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 72.7 mt -117.0 101.3 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.351 -0.843 . . . . 0.0 110.091 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.596 ' CE2' HD21 ' A' ' 101' ' ' LEU . 48.7 m-85 -72.17 108.47 5.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.832 . . . . 0.0 110.25 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.6 133.95 55.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 110.193 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.426 HD21 ' CD2' ' A' ' 75' ' ' TRP . 3.9 mt -112.5 116.96 31.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.848 . . . . 0.0 110.218 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.872 HG12 ' HB3' ' A' ' 96' ' ' ARG . 10.0 m -112.48 133.44 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 110.511 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.46 ' HB2' HG23 ' A' ' 73' ' ' THR . 46.6 t80 -92.03 -79.65 0.38 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.426 -0.796 . . . . 0.0 110.168 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -172.82 -39.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.199 -0.938 . . . . 0.0 110.345 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.64 -81.58 0.17 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.895 . . . . 0.0 110.385 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -150.82 15.76 0.76 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.157 -0.964 . . . . 0.0 110.822 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -90.51 49.53 1.69 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.162 -0.961 . . . . 0.0 110.142 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.872 ' HB3' HG12 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -105.19 111.2 23.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.364 -0.835 . . . . 0.0 110.484 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 29.3 m-85 -113.94 155.49 25.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.497 -0.752 . . . . 0.0 110.204 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.423 ' HB2' ' CB ' ' A' ' 15' ' ' CYS . 25.9 m-85 -120.74 140.28 51.88 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.876 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.722 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 19.6 m-85 -134.69 158.55 43.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -0.982 . . . . 0.0 110.358 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.464 ' CD2' ' CB ' ' A' ' 26' ' ' PRO . 2.6 p-90 -149.57 144.0 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 109.912 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.596 HD21 ' CE2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.238 0.542 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 58.8 t -99.8 86.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.434 -0.791 . . . . 0.0 109.999 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.535 HG22 ' H ' ' A' ' 9' ' ' LYS . 17.0 mt -94.39 175.21 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.222 -0.924 . . . . 0.0 109.627 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.535 ' H ' HG22 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -131.04 132.38 44.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.201 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -126.83 -174.61 3.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.455 -0.778 . . . . 0.0 109.439 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 23.6 mtt85 -127.09 149.53 49.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.147 -0.97 . . . . 0.0 110.826 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.692 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . . . -170.72 -155.04 0.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.48 -0.762 . . . . 0.0 109.746 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.443 ' O ' ' CD2' ' A' ' 99' ' ' PHE . . . -145.68 146.55 16.85 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.818 HG13 ' CE1' ' A' ' 99' ' ' PHE . 1.1 t -89.55 -141.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.337 -1.096 . . . . 0.0 109.621 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 98' ' ' PHE . 42.5 t -162.99 110.13 1.21 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.056 -1.027 . . . . 0.0 110.01 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.549 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -76.96 154.77 33.24 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 109.849 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.33 145.85 33.05 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.028 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -123.68 134.61 53.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.45 -0.781 . . . . 0.0 110.202 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -77.1 -27.56 54.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.413 -0.804 . . . . 0.0 110.25 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.45 -37.16 72.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.355 -0.841 . . . . 0.0 110.101 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.4 p -121.42 -2.82 9.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.472 -0.767 . . . . 0.0 110.369 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 52.49 57.38 6.47 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.27 -0.894 . . . . 0.0 110.15 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.74 159.65 26.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -0.833 . . . . 0.0 110.403 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.06 91.92 3.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.473 -0.767 . . . . 0.0 109.871 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.1 p -103.26 164.2 15.96 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.442 -0.786 . . . . 0.0 110.281 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.471 ' HB3' ' CD2' ' A' ' 100' ' ' TRP . 44.1 Cg_endo -71.16 142.4 41.74 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.85 1.447 . . . . 0.0 110.272 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.549 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.24 136.7 46.23 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 110.051 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.478 ' C ' HG23 ' A' ' 29' ' ' VAL . 48.7 Cg_endo -75.97 52.85 3.55 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.798 1.42 . . . . 0.0 110.189 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.809 HG13 ' OE2' ' A' ' 54' ' ' GLU . 75.4 t -150.06 115.88 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.86 . . . . 0.0 109.597 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -85.29 64.73 8.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.253 -0.904 . . . . 0.0 110.43 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' N ' ' HG2' ' A' ' 54' ' ' GLU . . . -61.52 -161.51 0.16 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.566 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -140.4 155.07 46.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.876 -1.367 . . . . 0.0 111.097 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.692 ' CD1' ' HB3' ' A' ' 12' ' ' ALA . 2.0 mp -105.75 169.96 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-O 121.4 0.619 . . . . 0.0 110.437 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.471 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 17.0 mt-10 -134.52 120.26 19.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.567 -0.708 . . . . 0.0 109.405 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.577 ' N ' HD12 ' A' ' 35' ' ' ILE . 1.7 mp -69.78 127.61 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -134.74 123.12 15.93 Favored Pre-proline 0 N--CA 1.485 1.3 0 O-C-N 121.055 -1.028 . . . . 0.0 109.343 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HD2' ' HD3' ' A' ' 36' ' ' LYS . 48.8 Cg_endo -83.77 51.82 3.58 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.489 1.257 . . . . 0.0 110.07 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 62.45 150.16 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.62 -0.675 . . . . 0.0 110.028 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -52.6 -25.7 11.38 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.41 -0.806 . . . . 0.0 110.156 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -133.74 -154.38 0.6 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.418 -0.801 . . . . 0.0 109.747 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -123.41 52.03 1.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -0.856 . . . . 0.0 109.691 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.31 -35.86 7.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.411 -0.806 . . . . 0.0 110.156 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 11.7 mt -118.23 -11.9 10.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 110.217 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.91 27.49 56.59 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.486 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 5.7 m-30 -68.3 118.31 11.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -1.02 . . . . 0.0 110.065 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 77.1 m95 -80.71 68.08 6.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.469 -0.77 . . . . 0.0 110.094 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.47 ' HB2' ' CG ' ' A' ' 36' ' ' LYS . 68.7 m-20 -53.21 137.97 33.0 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.444 -0.785 . . . . 0.0 110.207 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.803 ' CE2' HD11 ' A' ' 68' ' ' LEU . 5.5 m-30 -108.77 102.69 11.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.357 -0.84 . . . . 0.0 109.669 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.44 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 4.0 tt0 -82.48 121.41 26.73 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.053 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.902 ' CE3' HD12 ' A' ' 64' ' ' ILE . 71.7 t90 -93.66 171.84 8.63 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.361 -0.837 . . . . 0.0 109.508 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 1.3 ptm180 -175.44 146.2 0.88 Allowed Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.2 -0.938 . . . . 0.0 110.808 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.511 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 52.2 Cg_endo -74.82 80.17 2.44 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.711 1.374 . . . . 0.0 109.788 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.463 HG21 ' CD ' ' A' ' 32' ' ' GLU . 7.0 t -117.71 5.05 12.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.121 -0.987 . . . . 0.0 109.777 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.809 ' OE2' HG13 ' A' ' 29' ' ' VAL . 1.5 pp20? -100.9 -178.15 3.67 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.933 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -99.14 109.74 55.4 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.3 -0.875 . . . . 0.0 109.648 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -83.11 167.81 13.86 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.572 1.301 . . . . 0.0 110.679 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.609 ' O ' HG12 ' A' ' 57' ' ' VAL . 55.5 t -112.42 36.2 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.468 -0.77 . . . . 0.0 109.534 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.84 16.95 6.61 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.1 mmt-85 -129.99 103.26 6.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -1.154 . . . . 0.0 110.261 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -80.15 140.78 36.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.352 -0.843 . . . . 0.0 110.103 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.514 HD21 HG21 ' A' ' 27' ' ' ILE . 1.3 mp -131.62 -168.21 1.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 0.0 110.332 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.521 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 53.9 m-20 -152.07 166.73 14.64 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.499 -0.751 . . . . 0.0 109.984 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.5 Cg_endo -61.45 136.08 61.34 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.69 1.363 . . . . 0.0 111.573 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.902 HD12 ' CE3' ' A' ' 50' ' ' TRP . 5.1 mt -129.42 114.31 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 p -69.66 116.22 9.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.202 -0.936 . . . . 0.0 110.002 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.669 HD11 ' CZ ' ' A' ' 99' ' ' PHE . 29.2 mt -105.76 154.68 20.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 109.801 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.477 HG21 HD12 ' A' ' 69' ' ' ILE . 43.0 mt -125.4 152.36 32.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.346 -0.846 . . . . 0.0 109.613 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.803 HD11 ' CE2' ' A' ' 48' ' ' PHE . 73.7 mt -122.97 82.8 2.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.388 -0.82 . . . . 0.0 110.236 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.486 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 64.3 mt -131.19 106.6 14.83 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.465 -0.772 . . . . 0.0 110.162 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.54 63.32 4.6 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.634 1.334 . . . . 0.0 110.278 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.69 -46.58 0.08 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -60.47 -76.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.195 -1.179 . . . . 0.0 110.259 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.717 ' HB ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -71.71 -153.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.264 -0.898 . . . . 0.0 109.754 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -138.63 100.26 4.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.247 -0.908 . . . . 0.0 110.44 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.41 ' CD2' ' O ' ' A' ' 75' ' ' TRP . 64.0 p-90 -76.11 131.51 39.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.858 . . . . 0.0 110.163 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.3 t -141.52 133.61 13.79 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.5 157.97 48.38 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.634 1.334 . . . . 0.0 110.393 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 49.2 mm -115.18 120.8 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.373 -0.83 . . . . 0.0 110.07 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -94.8 50.38 1.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.397 -0.814 . . . . 0.0 110.253 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.2 t -122.26 4.28 9.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 110.558 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -168.11 122.76 0.95 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.21 -0.931 . . . . 0.0 110.143 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -66.02 -31.68 72.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.38 -0.825 . . . . 0.0 110.104 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.5 p -108.72 170.06 8.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.864 . . . . 0.0 110.168 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.73 -65.99 3.93 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 62.49 134.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.432 -1.04 . . . . 0.0 110.48 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 99' ' ' PHE . 57.7 mt -133.73 114.13 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.263 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -76.18 115.13 15.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.347 -0.845 . . . . 0.0 109.961 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.499 ' HB1' ' CE2' ' A' ' 98' ' ' PHE . . . -99.41 110.93 23.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.425 -0.797 . . . . 0.0 110.563 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.717 HD12 ' HB ' ' A' ' 73' ' ' THR . 4.1 mm? -102.01 119.08 38.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.823 . . . . 0.0 109.83 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.764 HG13 ' HG2' ' A' ' 96' ' ' ARG . 91.3 t -113.91 131.29 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 110.529 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.422 ' HB2' HG23 ' A' ' 73' ' ' THR . 33.3 t80 -100.99 -61.62 1.35 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.47 -0.769 . . . . 0.0 110.133 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.9 m -142.53 -50.92 0.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.558 -0.713 . . . . 0.0 110.154 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.85 -29.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.337 -0.852 . . . . 0.0 110.883 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -116.89 11.94 14.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 111.075 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 21.6 mt-10 -130.38 36.29 3.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 0.0 110.298 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.764 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -95.9 111.34 23.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 0.0 110.328 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 27.1 m-85 -105.79 142.59 35.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.453 -0.78 . . . . 0.0 110.295 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 20.1 m-85 -119.83 136.24 54.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.393 -0.817 . . . . 0.0 109.888 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.818 ' CE1' HG13 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -134.73 169.85 16.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.233 -0.917 . . . . 0.0 110.197 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.471 ' CD2' ' HB3' ' A' ' 26' ' ' PRO . 2.1 p-90 -158.37 175.39 13.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 110.257 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 mt . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.821 . . . . 0.0 110.147 -179.943 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.198 0.523 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.938 HG13 ' HD3' ' A' ' 36' ' ' LYS . 98.2 t -111.2 59.53 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.45 -0.781 . . . . 0.0 109.635 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 35' ' ' ILE . 15.4 tt -102.19 175.16 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 0.0 110.111 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 4.4 mptt -120.71 140.73 51.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.039 -1.038 . . . . 0.0 110.942 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -113.77 -179.11 3.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 109.686 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -113.72 127.39 56.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 110.322 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.81 -160.68 0.71 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 110.085 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.74 163.31 29.63 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.466 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.3 t -95.53 -138.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.454 -1.027 . . . . 0.0 109.85 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.416 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 34.7 t -155.53 108.12 2.69 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.148 -0.97 . . . . 0.0 109.652 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.4 ' N ' HG12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -78.82 128.39 33.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.37 -0.831 . . . . 0.0 109.993 -179.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.18 157.63 28.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.635 -0.666 . . . . 0.0 109.821 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.422 ' HB2' HD21 ' A' ' 23' ' ' LEU . 11.5 t-20 -126.22 136.26 52.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.362 -0.837 . . . . 0.0 110.412 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -82.48 -25.33 33.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.585 -0.697 . . . . 0.0 110.154 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -35.26 77.52 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.363 -0.836 . . . . 0.0 109.999 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 m -120.44 -1.38 10.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.476 -0.765 . . . . 0.0 110.584 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.15 56.14 8.44 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.206 -0.934 . . . . 0.0 109.91 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.523 ' C ' HD12 ' A' ' 23' ' ' LEU . 3.7 pp -108.1 154.04 22.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.428 -0.795 . . . . 0.0 110.809 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.9 p -124.97 71.06 1.16 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.518 -0.739 . . . . 0.0 110.279 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.4 p -97.16 165.11 16.4 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.405 -0.809 . . . . 0.0 110.248 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.484 ' HB2' ' CD2' ' A' ' 100' ' ' TRP . 46.2 Cg_endo -74.26 152.96 45.41 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.789 1.415 . . . . 0.0 110.332 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.466 ' CD1' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -81.97 140.89 46.74 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.219 -0.926 . . . . 0.0 109.186 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' A' ' 27' ' ' ILE . 40.7 Cg_endo -67.25 -15.24 45.52 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.559 1.294 . . . . 0.0 110.497 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.774 HG13 ' OE2' ' A' ' 54' ' ' GLU . 93.4 t -94.36 115.34 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.58 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -88.42 72.02 8.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 110.276 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.429 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.5 -160.4 0.08 OUTLIER Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -138.48 161.21 37.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -1.193 . . . . 0.0 110.64 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 34' ' ' GLU . 96.6 mt -105.0 170.69 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.414 0.626 . . . . 0.0 110.571 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.55 ' N ' HG22 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -128.95 105.98 8.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.527 -0.733 . . . . 0.0 109.065 179.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.547 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 1.2 mp -68.01 125.98 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 108.655 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.938 ' HD3' HG13 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -137.03 161.93 58.6 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 110.977 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -93.14 55.41 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.677 1.585 . . . . 0.0 110.076 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.421 HD21 HD12 ' A' ' 43' ' ' LEU . 6.2 t-20 60.29 175.16 0.09 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.371 -0.831 . . . . 0.0 110.093 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.88 -65.26 0.71 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.321 -0.862 . . . . 0.0 110.628 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -122.15 37.38 4.39 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.776 . . . . 0.0 110.527 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 50.9 49.81 20.36 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.385 -0.822 . . . . 0.0 110.604 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.506 ' OE2' HD21 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -118.58 -24.58 6.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.326 -0.859 . . . . 0.0 110.547 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.506 HD21 ' OE2' ' A' ' 42' ' ' GLU . 14.6 mt -108.82 -12.0 14.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.132 -0.98 . . . . 0.0 109.981 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.71 26.87 72.21 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.459 ' CD2' HG12 ' A' ' 69' ' ' ILE . 13.8 m-30 -91.49 122.79 34.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -1.098 . . . . 0.0 110.134 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.572 ' HB2' HD12 ' A' ' 68' ' ' LEU . 8.8 m0 -66.78 81.87 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 0.0 109.508 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.447 ' CB ' ' HB2' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -53.64 118.42 3.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.172 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.961 ' CD2' HD11 ' A' ' 68' ' ' LEU . 3.9 m-30 -107.7 102.5 11.72 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.332 -0.855 . . . . 0.0 109.188 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.445 ' CB ' ' HB3' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -89.58 123.13 33.38 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.711 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.783 ' CE3' HD12 ' A' ' 64' ' ' ILE . 70.5 t90 -91.75 173.84 7.66 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.331 -0.855 . . . . 0.0 109.579 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.0 OUTLIER 179.55 146.89 0.41 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.095 -1.003 . . . . 0.0 110.848 -179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.9 Cg_endo -74.61 78.14 2.82 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.851 1.448 . . . . 0.0 109.694 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.2 t -118.02 10.58 13.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.212 -0.93 . . . . 0.0 109.645 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.774 ' OE2' HG13 ' A' ' 29' ' ' VAL . 1.3 pp20? -100.62 -169.59 1.74 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.734 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -97.04 109.64 50.18 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.222 -0.924 . . . . 0.0 109.75 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.442 ' C ' HG23 ' A' ' 57' ' ' VAL . 52.3 Cg_endo -81.75 -178.01 3.92 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.482 1.254 . . . . 0.0 110.957 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.633 ' O ' HG12 ' A' ' 57' ' ' VAL . 59.5 t -148.41 30.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.609 -0.682 . . . . 0.0 109.441 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.06 0.93 7.52 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.5 ' O ' HG21 ' A' ' 29' ' ' VAL . 3.0 mmt85 -123.25 100.34 6.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.26 . . . . 0.0 110.323 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.89 112.65 21.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.394 -0.816 . . . . 0.0 110.265 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.41 HD21 HD12 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -103.73 -163.46 0.98 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.37 -0.831 . . . . 0.0 110.39 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 8.8 m-20 -152.74 164.95 18.69 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.457 -0.777 . . . . 0.0 109.93 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 36.7 Cg_endo -59.4 146.45 94.86 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.648 1.341 . . . . 0.0 112.016 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.783 HD12 ' CE3' ' A' ' 50' ' ' TRP . 5.4 mt -137.51 118.02 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 p -69.67 118.16 12.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.095 -1.003 . . . . 0.0 109.787 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.725 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 24.6 mt -105.25 143.57 33.24 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.288 -0.882 . . . . 0.0 110.153 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.3 mm -112.93 139.58 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.474 -0.766 . . . . 0.0 109.751 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.961 HD11 ' CD2' ' A' ' 48' ' ' PHE . 73.1 mt -122.83 95.24 4.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -0.88 . . . . 0.0 110.214 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.459 HG12 ' CD2' ' A' ' 45' ' ' PHE . 51.2 mt -128.41 116.66 19.91 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.331 -0.856 . . . . 0.0 110.058 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.95 64.87 4.1 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.612 1.322 . . . . 0.0 110.402 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.77 -52.81 0.2 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.409 ' O ' ' CD1' ' A' ' 91' ' ' PHE . 13.3 mm-40 -61.86 -80.55 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.257 -1.143 . . . . 0.0 110.155 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.603 HG23 ' HB2' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -85.01 113.62 21.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.188 -0.945 . . . . 0.0 109.97 179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.5 tpt -69.7 148.99 48.52 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.468 -0.77 . . . . 0.0 110.196 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -111.52 142.14 44.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.431 -0.793 . . . . 0.0 110.087 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.2 t -129.08 103.03 18.59 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 110.182 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.24 96.82 0.81 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.601 1.316 . . . . 0.0 110.267 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 88' ' ' ALA . 3.4 mp -61.31 166.51 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.328 -0.858 . . . . 0.0 110.022 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.477 ' N ' HG22 ' A' ' 78' ' ' ILE . 41.5 tttt -57.76 149.93 21.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.264 -0.897 . . . . 0.0 110.212 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.3 p -61.3 -56.25 22.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.385 -0.822 . . . . 0.0 110.217 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.7 p 49.39 -156.08 0.09 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.457 -0.777 . . . . 0.0 110.573 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.99 49.8 0.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.212 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 55.3 p -117.82 -76.26 0.57 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.428 -0.795 . . . . 0.0 110.149 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.92 41.63 0.02 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 50.64 86.77 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.294 -1.121 . . . . 0.0 110.564 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 59.9 mt -93.8 120.9 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 110.26 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -82.68 111.07 18.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.331 -0.855 . . . . 0.0 110.053 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.829 ' HB2' HD11 ' A' ' 78' ' ' ILE . . . -92.43 97.94 11.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.294 -0.879 . . . . 0.0 110.476 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mt -93.42 105.43 17.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.434 -0.791 . . . . 0.0 109.833 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.763 HG23 ' CG ' ' A' ' 96' ' ' ARG . 7.7 p -134.87 154.56 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.309 -0.869 . . . . 0.0 110.591 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.603 ' HB2' HG23 ' A' ' 73' ' ' THR . 22.8 t80 -117.32 -70.85 0.77 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.368 -0.832 . . . . 0.0 110.093 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.0 p -133.94 -68.04 0.57 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.784 . . . . 0.0 110.057 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.0 p -166.18 30.46 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.419 -0.801 . . . . 0.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.413 ' N ' ' HD2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -135.29 -40.66 0.73 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.494 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -116.57 87.21 2.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.342 -0.849 . . . . 0.0 110.406 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.763 ' CG ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -128.12 110.4 12.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 110.223 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 97' ' ' TYR . 33.9 m-85 -127.33 154.36 45.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 110.668 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.488 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 43.2 m-85 -129.21 132.37 47.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.595 -0.691 . . . . 0.0 109.43 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.725 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 16.2 m-85 -127.1 160.84 29.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.148 -0.97 . . . . 0.0 110.403 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.484 ' CD2' ' HB2' ' A' ' 26' ' ' PRO . 2.3 p-90 -147.89 150.93 35.02 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.404 -0.81 . . . . 0.0 109.912 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.288 -0.882 . . . . 0.0 110.271 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.412 HG22 HG12 ' A' ' 8' ' ' ILE . 90.4 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.223 0.535 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.7 p -73.73 68.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.423 -0.798 . . . . 0.0 109.921 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -72.07 165.93 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.227 -0.921 . . . . 0.0 109.672 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.415 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 12.2 ttmt -122.43 141.77 51.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.338 -0.851 . . . . 0.0 110.34 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -135.69 -174.66 3.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.398 -0.813 . . . . 0.0 109.705 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.2 115.51 17.77 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.175 -0.953 . . . . 0.0 110.811 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.758 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . . . -137.93 -160.59 1.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.472 -0.767 . . . . 0.0 109.622 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.418 ' HA3' ' NE1' ' A' ' 100' ' ' TRP . . . -139.99 155.1 24.25 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.503 ' C ' HG13 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -96.34 -142.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.44 -1.035 . . . . 0.0 109.394 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.447 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 0.8 OUTLIER -162.39 107.64 1.2 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.971 -1.081 . . . . 0.0 110.184 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.524 ' CG ' HD13 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -78.7 162.4 26.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.383 -0.823 . . . . 0.0 110.089 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.408 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -129.7 149.75 51.31 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.635 -0.666 . . . . 0.0 109.637 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -113.26 124.82 53.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.364 -0.835 . . . . 0.0 110.061 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 20' ' ' ASP . 9.4 pt-20 -76.36 -25.32 54.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.527 -0.733 . . . . 0.0 110.147 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.422 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 9.8 t0 -64.75 -35.04 79.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.44 -0.787 . . . . 0.0 110.087 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -118.64 -5.44 10.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.426 -0.796 . . . . 0.0 110.504 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.408 ' HA ' ' CE2' ' A' ' 17' ' ' TYR . 6.5 mtt180 54.63 60.19 3.67 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.142 -0.974 . . . . 0.0 110.105 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.94 158.52 43.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.307 -0.871 . . . . 0.0 110.369 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.564 ' O ' HG23 ' A' ' 25' ' ' THR . 0.1 OUTLIER -107.49 150.58 26.64 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -0.835 . . . . 0.0 110.055 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 24' ' ' CYS . 4.3 p -155.18 164.27 21.69 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.386 -0.821 . . . . 0.0 110.241 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.511 ' HB3' ' CD2' ' A' ' 100' ' ' TRP . 45.8 Cg_endo -71.81 137.13 29.14 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.764 1.402 . . . . 0.0 110.137 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.524 HD13 ' CG ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.94 137.6 43.43 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 109.822 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.38 54.29 3.29 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.686 1.361 . . . . 0.0 110.553 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.704 HG23 ' OE2' ' A' ' 54' ' ' GLU . 9.2 p -157.84 115.87 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.939 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -83.57 71.75 10.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.3 -0.875 . . . . 0.0 110.11 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.637 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -58.05 -167.02 0.12 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.784 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 27.6 mt-10 -128.48 138.25 52.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -1.138 . . . . 0.0 112.323 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.758 ' CD1' ' HB3' ' A' ' 12' ' ' ALA . 2.0 mp -101.95 163.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.802 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.541 ' HB2' ' CB ' ' A' ' 49' ' ' GLU . 3.4 mt-10 -128.49 110.62 12.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.398 -0.814 . . . . 0.0 109.2 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.525 HD12 ' CE1' ' A' ' 48' ' ' PHE . 30.4 mm -69.19 120.02 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.396 -0.815 . . . . 0.0 110.32 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 16.9 mmmt -130.59 107.73 15.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.324 -0.86 . . . . 0.0 109.943 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -82.19 49.99 3.3 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.621 1.327 . . . . 0.0 110.213 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 t30 62.68 141.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.635 -0.665 . . . . 0.0 110.196 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -53.09 -29.1 28.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.253 -0.904 . . . . 0.0 110.042 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -128.52 -151.53 0.48 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.49 -0.756 . . . . 0.0 109.638 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -123.58 52.83 1.39 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.264 -0.897 . . . . 0.0 109.62 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.431 ' O ' HD23 ' A' ' 43' ' ' LEU . 11.6 mt-10 -101.31 -39.56 7.55 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.008 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.446 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 16.4 mt -118.8 -16.78 9.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.486 -0.759 . . . . 0.0 110.142 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.21 26.73 61.79 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 5.2 m-30 -71.47 118.92 14.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.544 -0.974 . . . . 0.0 109.951 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.643 ' HB2' HD12 ' A' ' 68' ' ' LEU . 35.8 m0 -83.82 71.19 10.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.463 -0.773 . . . . 0.0 110.427 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 1.0 OUTLIER -52.17 122.95 9.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.409 -0.807 . . . . 0.0 110.429 179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.886 ' CE2' HD11 ' A' ' 68' ' ' LEU . 10.3 m-30 -105.67 102.92 12.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.146 -0.971 . . . . 0.0 109.824 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.541 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 5.1 tt0 -85.8 120.95 27.77 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.053 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.919 ' CE3' HD12 ' A' ' 64' ' ' ILE 0.25 71.0 t90 -95.59 158.61 15.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.572 -0.705 . . . . 0.0 109.868 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -164.38 142.64 5.66 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 120.825 -1.172 . . . . 0.0 110.993 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.51 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 49.4 Cg_endo -70.77 80.98 1.12 Allowed 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.646 1.34 . . . . 0.0 110.46 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.435 HG23 ' OE2' ' A' ' 32' ' ' GLU . 7.5 t -127.31 7.52 6.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.115 -0.99 . . . . 0.0 110.015 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.704 ' OE2' HG23 ' A' ' 29' ' ' VAL . 1.2 pp20? -100.62 -169.65 1.74 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.71 -0.619 . . . . 0.0 109.8 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -99.48 109.53 55.34 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.895 . . . . 0.0 109.673 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.39 -178.49 3.41 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.544 1.287 . . . . 0.0 110.885 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 57' ' ' VAL . 12.0 p -126.32 29.11 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.682 . . . . 0.0 109.686 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.77 24.22 3.74 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -132.62 104.95 6.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.323 -1.104 . . . . 0.0 110.245 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.461 ' O ' HD22 ' A' ' 61' ' ' LEU . 1.5 mp0 -82.06 121.74 26.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.372 -0.83 . . . . 0.0 110.054 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 60' ' ' GLU . 2.4 mm? -118.78 -169.21 1.68 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.887 . . . . 0.0 110.32 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.564 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 10.2 p-10 -147.54 167.34 13.7 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.347 -0.846 . . . . 0.0 110.339 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.698 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.0 Cg_endo -60.58 135.12 58.65 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.636 1.335 . . . . 0.0 111.624 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.919 HD12 ' CE3' ' A' ' 50' ' ' TRP . 5.4 mt -128.69 112.43 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.4 p -69.62 116.5 10.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.824 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.841 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 18.1 mt -105.4 144.26 32.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.976 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.4 mt -120.03 150.45 22.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.431 -0.793 . . . . 0.0 109.755 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.886 HD11 ' CE2' ' A' ' 48' ' ' PHE . 56.4 mt -120.73 91.48 3.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 110.275 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.446 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 76.8 mt -131.71 108.65 14.37 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.381 -0.824 . . . . 0.0 110.111 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.82 85.24 0.97 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.64 1.337 . . . . 0.0 110.335 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 150.65 -39.87 0.83 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.0 -49.45 72.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.491 -1.006 . . . . 0.0 110.088 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 91' ' ' PHE . 1.3 m -115.75 156.06 26.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.421 -0.8 . . . . 0.0 110.09 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.2 mmt -70.56 126.25 29.1 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.325 -0.859 . . . . 0.0 110.325 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.474 ' C ' HG13 ' A' ' 76' ' ' VAL . 47.9 p90 -96.52 124.81 40.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.415 -0.803 . . . . 0.0 109.659 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.929 HG23 ' HB3' ' A' ' 88' ' ' ALA . 29.8 m -151.39 90.24 4.06 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.211 -0.93 . . . . 0.0 110.287 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.2 -31.5 11.81 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.646 1.34 . . . . 0.0 110.493 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.467 ' O ' HG22 ' A' ' 78' ' ' ILE . 50.6 mm -84.55 63.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.365 -0.834 . . . . 0.0 110.042 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -53.82 48.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.336 -0.852 . . . . 0.0 110.138 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 t -83.82 168.19 16.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.0 110.111 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.1 m -64.43 -52.06 60.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.396 -0.815 . . . . 0.0 110.21 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -109.47 157.43 18.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.0 m 52.13 91.48 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.457 -0.777 . . . . 0.0 110.443 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.43 ' HA3' HD13 ' A' ' 78' ' ' ILE . . . -119.61 94.49 0.57 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -117.23 -27.33 6.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.355 -1.085 . . . . 0.0 110.393 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 99' ' ' PHE . 67.6 mt -70.63 123.62 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.232 -0.918 . . . . 0.0 110.385 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.97 114.5 19.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.37 -0.831 . . . . 0.0 109.799 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.929 ' HB3' HG23 ' A' ' 76' ' ' VAL . . . -101.43 132.16 47.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.63 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -124.43 105.33 9.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.439 -0.788 . . . . 0.0 109.689 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.898 HG13 ' HG2' ' A' ' 96' ' ' ARG . 58.3 t -115.89 108.21 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.35 -0.844 . . . . 0.0 110.499 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.528 ' HB2' HG23 ' A' ' 73' ' ' THR . 23.9 t80 -73.13 -68.77 0.46 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 0.0 109.993 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.2 p -141.94 -68.93 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.95 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.5 p -170.58 45.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.47 -0.768 . . . . 0.0 109.981 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -161.96 -33.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.868 . . . . 0.0 110.894 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -119.94 49.87 1.35 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.193 -0.942 . . . . 0.0 110.967 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.898 ' HG2' HG13 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -94.43 111.47 23.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.151 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 47.3 m-85 -114.68 158.09 22.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.254 -0.904 . . . . 0.0 110.62 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.673 ' CE2' ' HB1' ' A' ' 88' ' ' ALA . 63.0 m-85 -133.76 146.56 50.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.519 -0.738 . . . . 0.0 109.721 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.841 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 48.8 m-85 -142.4 165.96 25.98 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.217 -0.927 . . . . 0.0 110.787 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.511 ' CD2' ' HB3' ' A' ' 26' ' ' PRO . 2.2 p-90 -159.44 146.84 17.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.46 -0.775 . . . . 0.0 109.99 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 101' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.295 -0.878 . . . . 0.0 110.254 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.188 0.518 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 61.6 t -95.41 84.16 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.31 -0.868 . . . . 0.0 110.373 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -84.42 163.12 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.395 -0.815 . . . . 0.0 109.516 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.406 ' HG3' ' CG ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -123.57 139.93 53.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.437 -0.79 . . . . 0.0 110.106 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.53 -174.98 3.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.294 -0.879 . . . . 0.0 110.079 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.98 134.88 54.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.293 -0.879 . . . . 0.0 110.781 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.083 ' HB3' HD11 ' A' ' 33' ' ' ILE . . . -163.93 -157.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.569 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -149.67 151.64 23.72 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.2 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.528 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.5 t -89.84 -136.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.609 -0.936 . . . . 0.0 109.32 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 0.9 OUTLIER -162.71 109.0 1.21 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.04 -1.038 . . . . 0.0 109.906 179.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.61 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -76.78 152.53 35.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.367 -0.833 . . . . 0.0 109.995 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -138.01 149.21 45.88 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.677 -0.639 . . . . 0.0 110.07 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -123.96 140.68 52.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.458 -0.776 . . . . 0.0 110.207 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' HG3' ' CE1' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -81.53 -26.35 35.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.405 -0.809 . . . . 0.0 110.212 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -58.45 -34.23 70.62 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.352 -0.843 . . . . 0.0 110.192 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -124.65 -2.07 7.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.423 -0.798 . . . . 0.0 110.413 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 52.42 58.98 4.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 0.0 110.219 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.88 160.14 28.11 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.438 -0.789 . . . . 0.0 110.542 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -119.25 72.49 0.9 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.393 -0.817 . . . . 0.0 110.133 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 p -80.07 156.38 74.43 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.281 -0.887 . . . . 0.0 110.306 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.483 ' HB2' ' CE2' ' A' ' 100' ' ' TRP . 44.8 Cg_endo -72.44 151.99 54.14 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.783 1.412 . . . . 0.0 110.256 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.61 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -84.23 137.66 39.7 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.873 . . . . 0.0 109.494 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.29 -11.28 31.09 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.716 1.377 . . . . 0.0 111.038 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.633 HG13 ' OE2' ' A' ' 54' ' ' GLU . 84.8 t -100.28 115.43 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 110.083 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.69 81.44 8.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.383 -0.823 . . . . 0.0 110.021 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.666 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.43 -161.4 0.1 OUTLIER Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.823 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 65.1 mt-10 -126.45 151.68 47.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -1.07 . . . . 0.0 112.299 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.083 HD11 ' HB3' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -101.86 169.0 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.033 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.557 ' HB2' ' CB ' ' A' ' 49' ' ' GLU . 15.0 mt-10 -144.21 112.83 6.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.431 -0.793 . . . . 0.0 109.752 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.544 ' CD1' ' CE1' ' A' ' 48' ' ' PHE . 32.4 mm -69.84 120.42 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.441 -0.787 . . . . 0.0 110.201 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 1.0 OUTLIER -126.11 114.08 23.97 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.211 -0.931 . . . . 0.0 109.916 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -85.59 52.34 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.802 1.422 . . . . 0.0 109.864 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.82 155.52 0.07 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.583 -0.698 . . . . 0.0 109.872 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -60.76 -42.52 97.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.638 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -131.12 30.44 4.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.392 -0.818 . . . . 0.0 110.411 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 51.23 54.82 10.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.289 -0.882 . . . . 0.0 110.338 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -99.36 -40.65 7.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 109.733 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.18 -6.88 19.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.486 -0.759 . . . . 0.0 110.186 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.12 27.53 70.66 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.468 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 5.1 m-30 -89.45 118.82 29.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -1.076 . . . . 0.0 109.953 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.638 ' O ' HD12 ' A' ' 68' ' ' LEU . 10.2 m0 -84.97 73.52 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.51 ' HB2' ' CG ' ' A' ' 36' ' ' LYS . 41.6 m-20 -55.34 139.86 41.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.357 -0.84 . . . . 0.0 110.327 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.77 ' CE2' HD11 ' A' ' 68' ' ' LEU . 10.0 m-30 -109.75 102.27 11.08 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.862 0.839 . . . . 0.0 109.289 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.557 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.7 mt-10 -82.4 130.59 35.14 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.805 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.944 ' CE3' HD12 ' A' ' 64' ' ' ILE 0.252 68.7 t90 -105.45 161.45 14.32 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.394 -0.816 . . . . 0.0 109.501 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.4 ptm85 -166.93 142.03 3.43 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 120.795 -1.191 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.502 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 48.2 Cg_endo -70.75 80.53 1.15 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.633 1.333 . . . . 0.0 110.102 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.475 HG23 ' CD ' ' A' ' 32' ' ' GLU . 6.3 t -127.06 9.64 6.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.266 -0.896 . . . . 0.0 109.93 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.633 ' OE2' HG13 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -100.15 -169.53 1.74 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.785 -0.572 . . . . 0.0 109.724 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt -89.1 110.44 38.22 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 54' ' ' GLU . 50.6 Cg_endo -84.22 171.61 10.07 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.538 1.283 . . . . 0.0 110.931 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 57' ' ' VAL . 13.2 p -129.25 28.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.482 -0.761 . . . . 0.0 110.047 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.19 17.2 6.33 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 18.2 mmt180 -129.49 102.46 6.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.244 -1.151 . . . . 0.0 110.201 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.66 109.61 14.22 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.405 -0.809 . . . . 0.0 110.318 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.439 HD11 ' HB ' ' A' ' 29' ' ' VAL . 39.9 mt -105.65 -166.95 1.26 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.289 -0.882 . . . . 0.0 110.34 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.519 ' HB2' ' HD2' ' A' ' 63' ' ' PRO . 3.7 p30 -148.94 165.86 16.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.769 . . . . 0.0 110.299 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.7 Cg_endo -61.82 145.5 97.1 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.646 1.34 . . . . 0.0 111.813 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.944 HD12 ' CE3' ' A' ' 50' ' ' TRP . 4.8 mt -136.73 113.4 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.9 m -70.56 115.52 9.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.122 -0.986 . . . . 0.0 109.736 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.792 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 42.8 mt -102.82 149.75 24.17 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.877 . . . . 0.0 110.012 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.7 mm -117.15 158.16 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.299 -0.876 . . . . 0.0 109.717 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.77 HD11 ' CE2' ' A' ' 48' ' ' PHE . 71.8 mt -129.52 94.33 3.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.468 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 68.0 mt -135.68 103.57 10.12 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.453 -0.779 . . . . 0.0 110.149 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.43 68.83 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.668 1.352 . . . . 0.0 110.394 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.04 -39.29 0.18 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.45 -74.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.357 -1.084 . . . . 0.0 110.15 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.764 HG22 ' C ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -75.19 -164.23 0.3 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.408 -0.808 . . . . 0.0 110.013 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.9 tpp -134.34 125.73 28.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.328 -0.858 . . . . 0.0 110.211 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -80.29 111.44 16.67 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.381 -0.824 . . . . 0.0 110.167 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.92 106.03 41.99 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 0.0 110.013 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.38 177.86 6.83 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.693 1.365 . . . . 0.0 110.46 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.1 mt -144.22 -56.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 110.164 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.3 mttt 52.14 45.15 28.88 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.413 -0.804 . . . . 0.0 110.46 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.5 p -78.76 -55.23 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 110.236 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.2 m -67.03 155.86 37.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.37 -0.831 . . . . 0.0 110.202 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -68.26 133.95 49.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.359 -0.838 . . . . 0.0 110.203 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.5 m 52.26 86.48 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.355 -0.841 . . . . 0.0 110.523 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -174.04 175.97 46.51 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -159.22 127.65 5.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.421 -1.046 . . . . 0.0 110.214 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 62.8 mt -133.7 105.78 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.342 -0.849 . . . . 0.0 110.301 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -86.16 108.57 18.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.781 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.594 ' HB2' ' CD2' ' A' ' 98' ' ' PHE . . . -98.74 151.0 21.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.39 -0.819 . . . . 0.0 110.626 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -121.86 119.54 31.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.492 -0.755 . . . . 0.0 109.839 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.8 HG13 ' CD ' ' A' ' 96' ' ' ARG . 79.3 t -115.11 132.4 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.9 . . . . 0.0 110.472 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.528 ' HB2' HG23 ' A' ' 73' ' ' THR . 46.5 t80 -101.7 -77.1 0.55 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.418 -0.801 . . . . 0.0 110.133 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.402 ' OG ' ' CD2' ' A' ' 91' ' ' PHE . 10.0 p -175.87 -59.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.269 -0.894 . . . . 0.0 110.301 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.6 t -60.88 -78.87 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.458 -0.776 . . . . 0.0 110.406 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -166.36 20.1 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.259 -0.901 . . . . 0.0 110.782 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' HG3' ' HB3' ' A' ' 91' ' ' PHE . 1.3 pt-20 -94.37 48.11 1.22 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.264 -0.897 . . . . 0.0 110.149 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.8 ' CD ' HG13 ' A' ' 90' ' ' VAL . 61.5 mtm180 -94.05 119.47 32.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.421 -0.799 . . . . 0.0 110.205 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 29.4 m-85 -114.6 162.03 17.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 0.0 110.546 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CD2' ' HB2' ' A' ' 88' ' ' ALA . 33.8 m-85 -129.81 141.25 50.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.837 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.792 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 23.2 m-85 -137.78 163.1 32.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.209 -0.932 . . . . 0.0 110.517 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.483 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 1.8 p-90 -158.5 165.97 33.29 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 110.1 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 110.148 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 60.6 m . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.218 0.532 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 82.4 t -110.45 85.32 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.413 -0.804 . . . . 0.0 110.069 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 35' ' ' ILE . 14.9 tt -105.61 177.62 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.365 -0.834 . . . . 0.0 108.956 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 2.7 ptmt -146.6 158.29 43.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.826 -1.171 . . . . 0.0 111.094 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -134.23 -174.76 3.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 109.925 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 8.5 mpt_? -110.23 139.76 45.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.424 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.56 -158.44 0.51 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.428 -0.795 . . . . 0.0 110.131 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.428 ' O ' ' CD2' ' A' ' 99' ' ' PHE . . . -151.12 157.01 26.97 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.866 HG13 ' CE1' ' A' ' 99' ' ' PHE . 0.9 OUTLIER -93.91 -140.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.494 -1.003 . . . . 0.0 110.047 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 98' ' ' PHE . 1.6 m -157.56 109.32 2.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 109.573 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' N ' HG12 ' A' ' 27' ' ' ILE . 5.4 pt-20 -79.59 150.5 31.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 110.082 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.456 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -133.22 148.19 52.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.612 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -115.61 133.38 56.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 0.0 110.291 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -79.03 -25.6 43.24 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.5 -0.75 . . . . 0.0 110.246 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -62.86 -33.84 76.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 0.0 110.017 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 m -122.8 -2.65 8.76 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.479 -0.763 . . . . 0.0 110.373 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.456 ' HA ' ' CE2' ' A' ' 17' ' ' TYR . 7.7 mtp180 52.23 57.46 6.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.154 -0.966 . . . . 0.0 110.226 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.23 162.34 20.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.336 -0.852 . . . . 0.0 110.356 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -120.59 95.36 4.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.432 -0.792 . . . . 0.0 110.296 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.5 p -106.69 157.92 34.0 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 110.122 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.513 ' HB2' ' CE2' ' A' ' 100' ' ' TRP . 44.0 Cg_endo -72.05 146.1 46.05 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.84 1.442 . . . . 0.0 110.267 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.618 HG21 HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -82.04 138.83 45.93 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.439 ' HD2' HG22 ' A' ' 27' ' ' ILE . 41.2 Cg_endo -67.02 -13.69 40.86 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.656 1.345 . . . . 0.0 110.496 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.722 HG21 ' O ' ' A' ' 59' ' ' ARG . 94.6 t -86.31 115.68 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 109.817 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -93.74 68.5 3.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.069 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -60.67 -150.91 0.01 OUTLIER Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.774 ' OE2' HG21 ' A' ' 53' ' ' THR . 2.6 pt-20 -145.1 155.53 43.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.053 -1.263 . . . . 0.0 110.496 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.539 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 96.3 mt -102.05 167.6 2.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.599 -0.688 . . . . 0.0 110.096 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 49' ' ' GLU . 8.0 mt-10 -131.29 109.33 10.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.648 -0.658 . . . . 0.0 109.58 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.551 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -68.6 123.52 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.472 -0.767 . . . . 0.0 109.291 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -126.99 137.89 31.54 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 110.31 -179.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 49.8 Cg_endo -90.8 57.25 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.38 1.387 . . . . 0.0 109.751 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.446 ' CG ' ' O ' ' A' ' 37' ' ' PRO . 11.9 p30 43.26 -153.23 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.902 -0.499 . . . . 0.0 110.79 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -75.75 -76.35 0.16 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.198 -0.939 . . . . 0.0 110.45 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -139.63 69.48 1.36 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.397 -0.815 . . . . 0.0 110.45 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 50.64 55.16 9.94 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.367 -0.833 . . . . 0.0 110.492 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -111.02 -40.36 4.51 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.37 -0.831 . . . . 0.0 109.739 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -117.76 -11.2 10.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.528 -0.732 . . . . 0.0 110.08 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.26 29.7 72.0 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.466 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 4.3 m-30 -91.78 119.64 31.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.508 -0.995 . . . . 0.0 110.09 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 93.9 m95 -79.71 77.19 6.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 110.189 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 1.9 t0 -54.09 130.02 36.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 0.0 109.961 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.828 ' CE2' HD11 ' A' ' 68' ' ' LEU . 3.8 m-30 -110.49 103.14 11.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.194 -0.941 . . . . 0.0 109.68 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 34' ' ' GLU . 31.6 tt0 -87.59 119.03 27.49 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.669 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.907 ' CE3' HD12 ' A' ' 64' ' ' ILE . 67.7 t90 -93.2 169.28 10.52 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.521 -0.737 . . . . 0.0 109.449 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.457 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 0.7 OUTLIER -176.57 145.99 0.71 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.215 -0.928 . . . . 0.0 110.801 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.553 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 50.0 Cg_endo -74.68 78.7 2.72 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.595 1.313 . . . . 0.0 109.675 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.774 HG21 ' OE2' ' A' ' 32' ' ' GLU . 8.1 t -115.37 2.35 13.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.146 -0.971 . . . . 0.0 109.762 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 30' ' ' GLN . 54.9 mm-40 -109.84 -168.76 1.36 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.57 113.22 43.11 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.186 -0.946 . . . . 0.0 110.273 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.537 ' O ' HG12 ' A' ' 57' ' ' VAL . 45.0 Cg_endo -76.55 -61.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.618 1.325 . . . . 0.0 110.547 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 56' ' ' PRO . 10.9 p 37.93 34.34 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-O 121.408 0.623 . . . . 0.0 111.109 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.403 ' HA3' ' HG2' ' A' ' 28' ' ' PRO . . . -153.43 -47.25 0.02 OUTLIER Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.722 ' O ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -172.59 133.73 0.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.168 -1.195 . . . . 0.0 109.899 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.412 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 20.4 mt-10 -53.94 124.53 15.71 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.275 -0.891 . . . . 0.0 110.529 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.623 HD22 ' HD2' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -113.89 -171.17 1.85 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.328 -0.858 . . . . 0.0 110.421 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.553 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 5.8 m-20 -160.82 168.43 11.75 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.462 -0.774 . . . . 0.0 110.003 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.8 Cg_endo -62.12 131.84 36.41 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.746 1.393 . . . . 0.0 111.646 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.907 HD12 ' CE3' ' A' ' 50' ' ' TRP . 4.9 mt -127.16 114.87 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.769 -0.582 . . . . 0.0 109.536 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 p -69.91 118.03 12.24 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.271 -0.893 . . . . 0.0 110.375 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.674 HD11 ' CZ ' ' A' ' 99' ' ' PHE . 17.5 mt -109.72 148.97 30.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.232 -0.917 . . . . 0.0 109.825 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.5 mt -122.33 147.23 26.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.391 -0.818 . . . . 0.0 109.855 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.828 HD11 ' CE2' ' A' ' 48' ' ' PHE . 53.2 mt -121.14 106.41 11.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.37 -0.831 . . . . 0.0 110.283 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.466 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 72.6 mt -135.56 118.85 12.71 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.349 -0.844 . . . . 0.0 109.987 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.11 77.18 2.44 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.574 1.302 . . . . 0.0 110.507 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.09 -56.43 0.41 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -60.85 -58.47 8.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.369 -1.077 . . . . 0.0 110.218 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.611 HG23 ' C ' ' A' ' 90' ' ' VAL . 1.7 m -99.0 145.1 27.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.842 . . . . 0.0 110.188 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.32 132.41 53.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -0.826 . . . . 0.0 110.29 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.41 ' CD1' ' O ' ' A' ' 75' ' ' TRP . 36.5 p90 -88.94 140.47 29.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.441 -0.787 . . . . 0.0 110.259 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.768 ' O ' HD12 ' A' ' 78' ' ' ILE . 61.9 t -141.02 100.39 6.47 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.288 -0.882 . . . . 0.0 110.137 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.81 -13.11 19.88 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.771 1.406 . . . . 0.0 110.813 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.768 HD12 ' O ' ' A' ' 76' ' ' VAL . 2.3 mp 52.38 91.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -96.96 117.03 30.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.863 . . . . 0.0 110.179 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 80.1 p -156.6 120.79 4.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.386 -0.821 . . . . 0.0 110.09 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.5 t 52.38 -155.44 0.18 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.441 -0.787 . . . . 0.0 110.383 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 69.38 0.56 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.345 -0.847 . . . . 0.0 110.25 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.73 173.01 9.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.302 -0.873 . . . . 0.0 110.229 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.23 53.71 0.05 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.14 2.76 5.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.31 -1.112 . . . . 0.0 110.729 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 86' ' ' ILE . 24.6 mm -88.69 85.14 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.167 -0.958 . . . . 0.0 110.21 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -75.35 95.54 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.864 . . . . 0.0 109.742 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . . . -85.11 120.85 27.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.819 . . . . 0.0 110.774 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mp -106.07 77.93 1.27 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.416 -0.803 . . . . 0.0 109.752 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.867 HG12 ' HB3' ' A' ' 96' ' ' ARG . 30.6 m -81.99 123.59 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.395 -0.816 . . . . 0.0 110.939 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.586 ' N ' HG23 ' A' ' 73' ' ' THR . 0.2 OUTLIER -72.14 -75.12 0.14 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.389 -0.819 . . . . 0.0 110.128 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.5 m -131.85 -67.27 0.68 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 110.145 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.06 43.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.347 -0.846 . . . . 0.0 110.435 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -167.92 -38.18 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.261 -0.899 . . . . 0.0 110.442 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -114.58 50.25 0.97 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 110.475 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.867 ' HB3' HG12 ' A' ' 90' ' ' VAL . 33.9 mtm180 -90.95 112.23 24.01 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.344 -0.847 . . . . 0.0 110.232 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -99.9 138.71 36.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.381 -0.825 . . . . 0.0 110.628 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.447 ' O ' ' HB2' ' A' ' 15' ' ' CYS . 4.7 m-85 -102.74 142.81 33.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.446 -0.784 . . . . 0.0 109.427 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.866 ' CE1' HG13 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -142.62 168.63 19.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.113 -0.992 . . . . 0.0 110.616 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.513 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 1.1 p-90 -159.65 153.81 23.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.491 -0.756 . . . . 0.0 110.003 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.35 -0.844 . . . . 0.0 110.368 -179.878 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.0 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.482 0.658 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 85.4 t -91.16 75.68 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.611 -0.681 . . . . 0.0 109.904 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -72.1 167.43 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.341 -0.849 . . . . 0.0 109.824 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -124.31 136.04 53.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.508 -0.745 . . . . 0.0 109.932 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.83 -177.45 3.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.919 . . . . 0.0 109.917 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.63 139.3 54.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 110.466 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.093 ' HB3' HD11 ' A' ' 33' ' ' ILE . . . -167.69 -155.53 0.18 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.45 -0.781 . . . . 0.0 109.888 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 100' ' ' TRP . . . -144.52 150.65 22.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.504 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.4 t -90.68 -139.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.481 -1.011 . . . . 0.0 109.735 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.4 ' CB ' ' HB2' ' A' ' 98' ' ' PHE . 1.2 m -159.05 107.69 1.87 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.081 -1.012 . . . . 0.0 109.66 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -79.37 147.58 32.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.469 -0.769 . . . . 0.0 109.842 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.442 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -123.25 148.69 45.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.887 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 22' ' ' ARG . 9.6 t30 -111.5 118.78 36.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.815 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -72.91 -25.32 61.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.784 . . . . 0.0 110.412 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.25 -32.96 74.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.773 . . . . 0.0 110.544 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.93 3.2 5.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.366 -0.834 . . . . 0.0 110.687 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 18' ' ' ASN . 4.3 mtp180 51.22 56.43 7.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.191 -0.943 . . . . 0.0 110.048 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.553 HD13 HG23 ' A' ' 25' ' ' THR . 3.4 pp -112.94 167.82 10.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.83 . . . . 0.0 110.739 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.6 p -126.59 111.28 14.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.488 -0.757 . . . . 0.0 110.074 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.553 HG23 HD13 ' A' ' 23' ' ' LEU . 8.4 p -127.9 159.77 64.77 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.187 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' CB ' ' CD2' ' A' ' 100' ' ' TRP . 44.4 Cg_endo -72.2 142.12 37.21 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.833 1.438 . . . . 0.0 110.138 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.521 HG22 HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -80.31 139.4 52.13 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 27' ' ' ILE . 40.1 Cg_endo -65.94 -27.81 50.52 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.581 1.306 . . . . 0.0 110.555 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.722 HG23 ' OE2' ' A' ' 54' ' ' GLU . 11.3 p -84.72 115.31 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.298 -0.877 . . . . 0.0 109.787 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -93.32 79.41 4.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.308 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' HA2' ' HG2' ' A' ' 54' ' ' GLU . . . -61.98 -154.2 0.05 OUTLIER Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.629 ' C ' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -137.97 160.57 38.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.115 -1.227 . . . . 0.0 110.434 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.093 HD11 ' HB3' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -103.12 176.88 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-O 121.409 0.623 . . . . 0.0 110.312 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 2.7 mt-10 -138.59 108.16 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.551 HG13 ' CE1' ' A' ' 48' ' ' PHE . 1.5 mp -68.51 126.1 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.203 -0.935 . . . . 0.0 108.935 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 28.1 mtpt -134.64 140.95 36.97 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.045 -1.034 . . . . 0.0 110.623 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 51.2 Cg_endo -88.06 53.63 2.27 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 O-C-N 123.739 1.389 . . . . 0.0 109.965 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 t30 66.22 -177.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.646 -0.659 . . . . 0.0 110.075 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 40' ' ' GLU . 8.4 pt-20 -77.27 -25.96 51.95 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.291 -0.881 . . . . 0.0 110.848 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.408 ' N ' ' HG3' ' A' ' 39' ' ' GLU . 39.3 mt-10 -148.23 28.5 0.9 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.235 -0.916 . . . . 0.0 110.471 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 50.57 49.38 20.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.393 -0.817 . . . . 0.0 110.576 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.612 ' OE1' HD21 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -116.46 -26.18 7.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.236 -0.915 . . . . 0.0 110.616 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.612 HD21 ' OE1' ' A' ' 42' ' ' GLU . 14.7 mt -106.3 -8.48 17.24 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.12 -0.988 . . . . 0.0 110.002 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.27 27.47 70.71 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 6.4 m-30 -90.2 119.8 30.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.456 -1.026 . . . . 0.0 109.926 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.566 ' HB2' HD12 ' A' ' 68' ' ' LEU . 4.4 m-90 -75.44 76.91 2.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.081 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -54.79 122.72 11.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.443 -0.786 . . . . 0.0 109.989 179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.903 ' CD2' HD11 ' A' ' 68' ' ' LEU . 4.7 m-30 -106.97 102.81 12.14 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.002 -1.061 . . . . 0.0 109.774 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.486 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 1.9 tp10 -87.71 126.68 35.12 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.778 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.903 ' CE3' HD12 ' A' ' 64' ' ' ILE . 75.6 t90 -99.18 172.42 7.38 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.459 -0.776 . . . . 0.0 109.817 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.463 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -179.79 145.29 0.41 Allowed Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.338 -0.851 . . . . 0.0 110.759 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 48.9 Cg_endo -71.88 80.98 1.43 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.808 1.425 . . . . 0.0 109.799 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.1 t -120.51 11.34 11.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 109.696 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.722 ' OE2' HG23 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -100.63 -169.65 1.74 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.988 -0.445 . . . . 0.0 109.837 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.27 109.5 50.09 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -78.79 145.82 20.43 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.398 1.209 . . . . 0.0 110.81 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.624 ' O ' HG12 ' A' ' 57' ' ' VAL . 55.3 t -142.32 29.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 109.632 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.29 -61.83 0.02 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -131.22 -157.59 0.83 Allowed 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.374 -1.074 . . . . 0.0 109.661 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.77 ' O ' HD22 ' A' ' 61' ' ' LEU . 11.1 pt-20 -150.96 146.09 26.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.6 -0.687 . . . . 0.0 110.339 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.77 HD22 ' O ' ' A' ' 60' ' ' GLU . 1.4 mm? -131.29 -161.13 1.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.301 -0.874 . . . . 0.0 110.513 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 1.7 m-20 -147.08 171.97 5.74 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.434 -0.791 . . . . 0.0 109.704 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 36.2 Cg_endo -58.43 135.87 70.61 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.528 1.278 . . . . 0.0 111.859 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.903 HD12 ' CE3' ' A' ' 50' ' ' TRP . 4.7 mt -128.94 116.74 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.58 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -69.76 118.87 13.16 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.215 -0.928 . . . . 0.0 110.059 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.812 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 15.8 mt -109.57 145.16 36.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.396 -0.815 . . . . 0.0 109.781 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.0 mt -119.94 148.02 23.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.33 -0.857 . . . . 0.0 110.066 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.903 HD11 ' CD2' ' A' ' 48' ' ' PHE . 62.9 mt -125.57 97.56 5.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.437 -0.789 . . . . 0.0 110.282 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.763 HG21 ' HG3' ' A' ' 72' ' ' GLU . 61.6 mt -131.29 108.93 14.94 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.256 -0.902 . . . . 0.0 110.23 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.3 80.84 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.603 1.317 . . . . 0.0 110.214 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 154.05 -30.11 0.73 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.763 ' HG3' HG21 ' A' ' 69' ' ' ILE . 4.1 mm-40 -89.87 -34.53 16.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.429 -1.042 . . . . 0.0 110.164 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.428 HG21 ' HB3' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -104.3 168.95 8.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.416 -0.802 . . . . 0.0 110.043 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 tpp -109.66 151.42 26.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.393 -0.817 . . . . 0.0 110.387 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -90.78 119.28 30.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 110.076 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.869 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 73.7 t -138.15 113.96 9.01 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.148 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -74.28 -79.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.497 1.262 . . . . 0.0 110.514 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 78' ' ' ILE . 2.7 pp -144.0 174.83 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.073 -1.017 . . . . 0.0 110.128 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -102.39 -65.41 0.99 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.21 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 t -133.22 99.16 4.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.402 -0.812 . . . . 0.0 110.269 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 28.9 t -166.09 168.01 15.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.858 . . . . 0.0 110.223 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.2 mttt -99.09 27.39 5.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.383 -0.823 . . . . 0.0 110.193 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.6 t -160.9 177.65 10.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.413 -0.805 . . . . 0.0 110.13 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.76 101.84 0.21 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -140.58 22.65 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.329 -1.101 . . . . 0.0 110.261 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.2 mt -122.67 108.32 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.387 -0.821 . . . . 0.0 110.1 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.69 79.9 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 0.0 109.994 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.869 ' HB3' ' O ' ' A' ' 76' ' ' VAL . . . -75.36 113.43 12.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.124 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.428 ' HB3' HG21 ' A' ' 73' ' ' THR . 6.2 mt -104.84 125.71 51.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.893 HG13 ' CD ' ' A' ' 96' ' ' ARG . 50.9 t -114.94 109.63 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 110.417 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.415 ' HB2' ' HG3' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -67.0 -78.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.333 -0.854 . . . . 0.0 110.236 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.2 t -176.44 -70.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.181 -0.949 . . . . 0.0 110.491 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.2 m -57.69 -83.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.319 -0.863 . . . . 0.0 110.446 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.35 15.64 0.39 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 110.72 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 91' ' ' PHE . 4.8 pt-20 -99.85 50.95 0.91 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 110.13 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.893 ' CD ' HG13 ' A' ' 90' ' ' VAL . 38.0 mtm105 -90.36 121.48 32.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.448 -0.782 . . . . 0.0 110.095 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 26.6 m-85 -106.44 162.63 13.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.313 -0.867 . . . . 0.0 110.506 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.414 ' O ' ' CD1' ' A' ' 99' ' ' PHE . 8.3 m-85 -137.6 141.51 41.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.498 -0.751 . . . . 0.0 109.536 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.812 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 19.8 m-85 -135.58 161.71 34.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 110.409 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.465 ' CD2' ' CB ' ' A' ' 26' ' ' PRO . 3.0 p-90 -143.77 162.76 35.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 0.0 109.73 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.365 -0.834 . . . . 0.0 110.242 -179.925 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.2 m . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.198 0.523 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.51 76.12 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.726 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -89.18 168.48 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.531 -0.73 . . . . 0.0 109.751 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.44 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 8.9 mttt -130.38 131.19 45.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -124.4 131.92 53.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.866 . . . . 0.0 110.127 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -79.45 121.88 25.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.344 -0.848 . . . . 0.0 110.48 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . . . -146.68 -154.83 0.57 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.436 -0.79 . . . . 0.0 110.039 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.92 159.04 26.9 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.487 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 1.3 t -95.52 -137.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.388 -1.066 . . . . 0.0 109.52 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.706 ' SG ' HD11 ' A' ' 86' ' ' ILE . 42.5 t -162.46 107.96 1.21 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.973 -1.08 . . . . 0.0 110.033 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.495 ' HG2' HD13 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -77.37 161.49 27.99 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.377 -0.827 . . . . 0.0 110.112 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' CE2' ' HA ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -145.63 141.72 28.41 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.892 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -107.75 135.33 49.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 110.135 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -79.54 -25.12 41.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.538 -0.726 . . . . 0.0 110.156 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.81 -39.28 91.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -115.73 -5.68 12.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 0.0 110.363 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HA ' ' CE2' ' A' ' 17' ' ' TYR . 0.2 OUTLIER 54.41 58.75 4.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.254 -0.904 . . . . 0.0 110.287 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.42 169.78 14.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.268 -0.895 . . . . 0.0 110.414 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.3 141.53 52.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.45 -0.781 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.83 163.71 25.96 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.829 . . . . 0.0 110.26 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.468 ' HB3' ' CD2' ' A' ' 100' ' ' TRP . 47.2 Cg_endo -72.53 135.38 24.07 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.75 1.395 . . . . 0.0 110.206 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.495 HD13 ' HG2' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -82.51 138.4 44.5 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.932 . . . . 0.0 109.786 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.491 ' C ' HG23 ' A' ' 29' ' ' VAL . 48.1 Cg_endo -74.77 51.86 2.81 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.75 1.395 . . . . 0.0 110.747 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.491 HG23 ' C ' ' A' ' 28' ' ' PRO . 83.4 t -152.19 116.12 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.176 -0.953 . . . . 0.0 109.815 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -80.89 70.14 7.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.321 -0.862 . . . . 0.0 110.212 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.636 ' HA3' ' CZ2' ' A' ' 50' ' ' TRP . . . -59.12 -167.48 0.19 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.79 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 26.4 mt-10 -129.7 138.72 51.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -1.151 . . . . 0.0 112.29 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.567 HG23 ' HB3' ' A' ' 48' ' ' PHE . 39.9 mt -101.79 167.63 2.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.487 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -136.75 113.81 10.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.335 -0.853 . . . . 0.0 109.425 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 1.2 mp -68.35 123.71 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.334 -0.854 . . . . 0.0 109.106 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -132.88 142.81 46.08 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.292 -0.88 . . . . 0.0 110.282 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 51.5 Cg_endo -88.1 52.76 2.13 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.656 1.345 . . . . 0.0 109.978 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 t30 64.83 161.54 0.12 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.532 -0.73 . . . . 0.0 109.991 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.36 -56.21 20.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.401 -0.812 . . . . 0.0 110.636 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -128.06 36.84 4.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.456 -0.777 . . . . 0.0 110.331 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 51.31 52.33 15.05 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.418 -0.801 . . . . 0.0 110.406 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -102.28 -38.67 7.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.432 -0.792 . . . . 0.0 109.781 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 11.8 mt -108.06 -8.79 15.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.574 -0.703 . . . . 0.0 110.262 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.23 27.36 71.43 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.467 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 12.6 m-30 -88.46 120.5 29.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.39 -1.065 . . . . 0.0 110.033 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.616 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 22.8 m-90 -68.06 75.66 0.22 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.844 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 6.3 t0 -52.31 129.84 29.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.355 -0.841 . . . . 0.0 110.283 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.818 ' CD2' HD11 ' A' ' 68' ' ' LEU . 6.8 m-30 -110.54 103.0 11.54 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.487 -0.758 . . . . 0.0 109.673 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -83.84 116.58 22.81 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.218 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.947 ' CE3' HD12 ' A' ' 64' ' ' ILE . 74.2 t90 -94.7 154.05 17.5 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.664 -0.648 . . . . 0.0 109.683 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -163.27 138.56 5.13 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.931 -1.106 . . . . 0.0 110.638 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HD3' ' C ' ' A' ' 62' ' ' ASP . 44.0 Cg_endo -68.6 81.1 0.58 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.55 1.289 . . . . 0.0 110.372 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.417 ' CG2' ' HB2' ' A' ' 32' ' ' GLU . 7.0 t -120.86 5.68 10.45 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.383 -0.823 . . . . 0.0 109.473 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.483 ' HG2' ' HA2' ' A' ' 31' ' ' GLY . 0.8 OUTLIER -100.34 -169.68 1.76 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 109.71 51.54 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.2 -0.937 . . . . 0.0 109.908 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -81.08 -179.22 4.9 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.464 1.244 . . . . 0.0 110.801 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 57' ' ' VAL . 13.1 p -131.18 29.38 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.794 . . . . 0.0 109.895 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.75 22.79 3.53 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -134.59 105.6 6.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -1.184 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -80.95 132.54 35.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 0.0 110.338 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 mt -129.82 -158.71 0.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 110.177 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.552 ' C ' ' HD3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -162.66 172.23 5.6 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.28 -0.888 . . . . 0.0 110.269 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.799 ' HA ' ' O ' ' A' ' 50' ' ' TRP . 37.2 Cg_endo -61.36 126.44 19.3 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.72 1.379 . . . . 0.0 111.308 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.947 HD12 ' CE3' ' A' ' 50' ' ' TRP . 9.9 mt -124.96 111.33 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.788 -0.57 . . . . 0.0 110.088 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.9 m -69.8 117.48 11.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.144 -0.973 . . . . 0.0 109.438 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.86 HD22 ' CZ ' ' A' ' 99' ' ' PHE . 26.7 mt -104.04 144.32 31.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.294 -0.879 . . . . 0.0 110.398 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.417 ' CG2' ' CD1' ' A' ' 69' ' ' ILE . 8.8 mm -113.04 148.39 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.421 -0.8 . . . . 0.0 109.585 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.818 HD11 ' CD2' ' A' ' 48' ' ' PHE . 77.7 mt -121.71 87.57 2.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 110.188 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.467 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 74.2 mt -127.71 108.48 20.58 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.447 -0.783 . . . . 0.0 110.019 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.39 64.01 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.58 1.305 . . . . 0.0 110.449 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 175.85 -37.32 0.1 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -71.48 -53.35 14.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.339 -1.095 . . . . 0.0 110.227 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.801 HG22 ' N ' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -101.25 148.24 25.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.416 -0.803 . . . . 0.0 110.2 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mmt -76.12 132.64 40.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.422 -0.799 . . . . 0.0 110.194 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.44 83.17 4.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.408 -0.807 . . . . 0.0 110.051 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.85 139.23 19.91 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.324 -0.86 . . . . 0.0 110.096 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -74.87 -78.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.7 1.369 . . . . 0.0 110.688 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.0 tt -166.48 160.77 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.172 -0.955 . . . . 0.0 110.167 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -58.75 164.93 2.51 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.289 -0.882 . . . . 0.0 110.265 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.9 t 53.07 -162.32 0.1 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.335 -0.853 . . . . 0.0 110.421 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 p -131.46 52.4 2.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.419 -0.801 . . . . 0.0 110.226 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.94 -49.65 7.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.363 -0.836 . . . . 0.0 110.157 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -155.84 -160.27 1.0 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.316 -0.865 . . . . 0.0 110.183 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.19 57.43 0.11 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.45 -39.14 8.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.326 -1.103 . . . . 0.0 110.114 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.706 HD11 ' SG ' ' A' ' 15' ' ' CYS . 2.1 tt -80.88 105.21 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.309 -0.87 . . . . 0.0 110.188 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -69.71 139.36 53.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.23 117.88 28.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.47 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 89' ' ' LEU . 6.7 mp -104.32 124.14 48.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.988 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.836 HG13 ' CD ' ' A' ' 96' ' ' ARG . 75.7 t -125.37 112.39 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.36 -0.837 . . . . 0.0 110.381 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.801 ' N ' HG22 ' A' ' 73' ' ' THR . 24.5 t80 -76.17 -76.38 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.331 -0.855 . . . . 0.0 110.004 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.8 m -129.85 -66.65 0.78 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.374 -0.829 . . . . 0.0 110.213 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.06 36.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.373 -0.829 . . . . 0.0 110.205 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -166.67 -39.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.397 -0.815 . . . . 0.0 110.415 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -97.51 43.14 1.07 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.447 -0.783 . . . . 0.0 110.144 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.836 ' CD ' HG13 ' A' ' 90' ' ' VAL . 42.3 mtm180 -98.83 111.21 23.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 0.0 110.261 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 41.7 m-85 -113.75 159.52 19.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.381 -0.825 . . . . 0.0 110.236 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.427 ' HB2' ' CB ' ' A' ' 15' ' ' CYS . 0.4 OUTLIER -141.55 141.46 33.53 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.258 -0.901 . . . . 0.0 109.827 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.86 ' CZ ' HD22 ' A' ' 66' ' ' LEU . 6.7 m-85 -137.66 169.51 17.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.149 -0.97 . . . . 0.0 110.328 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.468 ' CD2' ' HB3' ' A' ' 26' ' ' PRO . 3.2 p-90 -150.32 161.28 42.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.337 -0.852 . . . . 0.0 110.185 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 110.286 -179.883 . . . . . . . . 0 0 . 1 stop_ save_